{
  "runner_argument": {
    "topic": "AlphaFold 3",
    "retrieve_top_k": 10,
    "max_search_queries": 2,
    "total_conv_turn": 20,
    "max_search_thread": 5,
    "max_search_queries_per_turn": 3,
    "warmstart_max_num_experts": 3,
    "warmstart_max_turn_per_experts": 2,
    "warmstart_max_thread": 3,
    "max_thread_num": 10,
    "max_num_round_table_experts": 2,
    "moderator_override_N_consecutive_answering_turn": 3,
    "node_expansion_trigger_count": 10,
    "disable_moderator": false,
    "disable_multi_experts": false,
    "rag_only_baseline_mode": false
  },
  "lm_config": {
    "question_answering_lm": {
      "temperature": 1.0,
      "max_tokens": 1000,
      "top_p": 0.9,
      "frequency_penalty": 0,
      "presence_penalty": 0,
      "n": 1,
      "model": "gpt-3.5-turbo"
    },
    "discourse_manage_lm": {
      "temperature": 1.0,
      "max_tokens": 500,
      "top_p": 0.9,
      "frequency_penalty": 0,
      "presence_penalty": 0,
      "n": 1,
      "model": "gpt-3.5-turbo"
    },
    "utterance_polishing_lm": {
      "temperature": 1.0,
      "max_tokens": 2000,
      "top_p": 0.9,
      "frequency_penalty": 0,
      "presence_penalty": 0,
      "n": 1,
      "model": "gpt-3.5-turbo"
    },
    "warmstart_outline_gen_lm": {
      "temperature": 1.0,
      "max_tokens": 500,
      "top_p": 0.9,
      "frequency_penalty": 0,
      "presence_penalty": 0,
      "n": 1,
      "model": "gpt-3.5-turbo"
    },
    "question_asking_lm": {
      "temperature": 1.0,
      "max_tokens": 300,
      "top_p": 0.9,
      "frequency_penalty": 0,
      "presence_penalty": 0,
      "n": 1,
      "model": "gpt-3.5-turbo"
    },
    "knowledge_base_lm": {
      "temperature": 1.0,
      "max_tokens": 1000,
      "top_p": 0.9,
      "frequency_penalty": 0,
      "presence_penalty": 0,
      "n": 1,
      "model": "gpt-3.5-turbo"
    }
  },
  "conversation_history": [
    {
      "utterance": "How is AlphaFold 3 revolutionizing drug discovery in the pharmaceutical industry?",
      "raw_utterance": "How is AlphaFold 3 revolutionizing drug discovery in the pharmaceutical industry?",
      "role": "Background discussion moderator",
      "role_description": "",
      "queries": [],
      "utterance_type": "Original Question",
      "claim_to_make": "",
      "raw_retrieved_info": [],
      "cited_info": null
    },
    {
      "utterance": "AlphaFold 3 is revolutionizing drug discovery in the pharmaceutical industry by providing scientists with accessible predictive capabilities through the AlphaFold Server[22]. This collaboration with Isomorphic Labs aims to tackle real-world drug design challenges and develop new life-changing treatments for patients[22]. Despite current commercial restrictions, the open-source nature of AlphaFold 3 will undoubtedly advance academic research, offering insights into disease mechanisms and drug interactions[23]. While AI's potential in the pharmaceutical industry is widely recognized, challenges such as data integrity and interoperability persist, emphasizing the need for meticulous attention to detail when implementing advanced tools like AlphaFold[24]. The integration of AlphaFold 3 in the drug discovery process holds great promise for advancing research and developing innovative treatments[25].",
      "raw_utterance": "AlphaFold 3 is revolutionizing drug discovery in the pharmaceutical industry by providing scientists with accessible predictive capabilities through the AlphaFold Server[22]. This collaboration with Isomorphic Labs aims to tackle real-world drug design challenges and develop new life-changing treatments for patients[22]. Despite current commercial restrictions, the open-source nature of AlphaFold 3 will undoubtedly advance academic research, offering insights into disease mechanisms and drug interactions[23]. While AI's potential in the pharmaceutical industry is widely recognized, challenges such as data integrity and interoperability persist, emphasizing the need for meticulous attention to detail when implementing advanced tools like AlphaFold[24]. The integration of AlphaFold 3 in the drug discovery process holds great promise for advancing research and developing innovative treatments[25].",
      "role": "Background discussion expert",
      "role_description": "",
      "queries": [],
      "utterance_type": "Potential Answer",
      "claim_to_make": "",
      "raw_retrieved_info": [],
      "cited_info": null
    },
    {
      "utterance": "How can we ensure equitable access to cutting-edge technology like AlphaFold 3 while addressing ethical concerns surrounding its limited and proprietary nature?",
      "raw_utterance": "How can we ensure equitable access to cutting-edge technology like AlphaFold 3 while addressing ethical concerns surrounding its limited and proprietary nature?",
      "role": "Background discussion moderator",
      "role_description": "",
      "queries": [],
      "utterance_type": "Original Question",
      "claim_to_make": "",
      "raw_retrieved_info": [],
      "cited_info": null
    },
    {
      "utterance": "To ensure equitable access to cutting-edge technology like AlphaFold 3 and address ethical concerns surrounding its limited and proprietary nature, researchers and policymakers must collaborate to establish guidelines and regulations that mitigate risks associated with misuse (source: [27]). Implementing safeguards to prevent technology from falling into the wrong hands and promoting ethical research practices are essential steps in this process (source: [27]). Additionally, addressing potential biases in AI models and allowing for independent reproduction of AlphaFold 3 could further enhance its value and impact in medical science and research (source: [30]).",
      "raw_utterance": "To ensure equitable access to cutting-edge technology like AlphaFold 3 and address ethical concerns surrounding its limited and proprietary nature, researchers and policymakers must collaborate to establish guidelines and regulations that mitigate risks associated with misuse (source: [27]). Implementing safeguards to prevent technology from falling into the wrong hands and promoting ethical research practices are essential steps in this process (source: [27]). Additionally, addressing potential biases in AI models and allowing for independent reproduction of AlphaFold 3 could further enhance its value and impact in medical science and research (source: [30]).",
      "role": "Background discussion expert",
      "role_description": "",
      "queries": [],
      "utterance_type": "Potential Answer",
      "claim_to_make": "",
      "raw_retrieved_info": [],
      "cited_info": null
    },
    {
      "utterance": "How have advancements in data training methods for AlphaFold 3 contributed to enhancing its predictive accuracy and expanding its modelling abilities?",
      "raw_utterance": "How have advancements in data training methods for AlphaFold 3 contributed to enhancing its predictive accuracy and expanding its modelling abilities?",
      "role": "Background discussion moderator",
      "role_description": "",
      "queries": [],
      "utterance_type": "Original Question",
      "claim_to_make": "",
      "raw_retrieved_info": [],
      "cited_info": null
    },
    {
      "utterance": "Advancements in data training methods for AlphaFold 3 have played a crucial role in enhancing its predictive accuracy by filtering modified residues dataset focusing on challenging protein structures with low homology to the training set[16]. Additionally, AlphaFold 3 has expanded its modelling abilities to include covalent modifications like phosphorylation in predicted biomolecules, crucial for understanding functional implications of structural changes[16]. These advancements not only improve individual protein predictions but also enhance overall accuracy of protein complex predictions compared to previous versions like AlphaFold-Multimer (v.2.3)[16].",
      "raw_utterance": "Advancements in data training methods for AlphaFold 3 have played a crucial role in enhancing its predictive accuracy by filtering modified residues dataset focusing on challenging protein structures with low homology to the training set[16]. Additionally, AlphaFold 3 has expanded its modelling abilities to include covalent modifications like phosphorylation in predicted biomolecules, crucial for understanding functional implications of structural changes[16]. These advancements not only improve individual protein predictions but also enhance overall accuracy of protein complex predictions compared to previous versions like AlphaFold-Multimer (v.2.3)[16].",
      "role": "Background discussion expert",
      "role_description": "",
      "queries": [],
      "utterance_type": "Potential Answer",
      "claim_to_make": "",
      "raw_retrieved_info": [],
      "cited_info": null
    },
    {
      "utterance": "How can potential ethical concerns surrounding AlphaFold 3 in scientific research be effectively addressed to ensure equitable access and transparency?",
      "raw_utterance": "How can potential ethical concerns surrounding AlphaFold 3 in scientific research be effectively addressed to ensure equitable access and transparency?",
      "role": "Background discussion moderator",
      "role_description": "",
      "queries": [],
      "utterance_type": "Original Question",
      "claim_to_make": "",
      "raw_retrieved_info": [],
      "cited_info": null
    },
    {
      "utterance": "By establishing guidelines and regulations to mitigate risks associated with the limited accessibility of AlphaFold 3, researchers and policymakers can ensure equitable access and transparency in scientific research [26]. Additionally, addressing potential biases in AI models and data privacy issues related to the prediction of molecules can help promote ethical research practices and accelerate scientific discovery [28][29]. Open-sourcing the model and its data can further enhance transparency and democratization of scientific research, allowing for a broader spectrum of the scientific community to benefit from this revolutionary technology [27].",
      "raw_utterance": "By establishing guidelines and regulations to mitigate risks associated with the limited accessibility of AlphaFold 3, researchers and policymakers can ensure equitable access and transparency in scientific research [26]. Additionally, addressing potential biases in AI models and data privacy issues related to the prediction of molecules can help promote ethical research practices and accelerate scientific discovery [28][29]. Open-sourcing the model and its data can further enhance transparency and democratization of scientific research, allowing for a broader spectrum of the scientific community to benefit from this revolutionary technology [27].",
      "role": "Background discussion expert",
      "role_description": "",
      "queries": [],
      "utterance_type": "Potential Answer",
      "claim_to_make": "",
      "raw_retrieved_info": [],
      "cited_info": null
    },
    {
      "utterance": "How is AlphaFold 3 revolutionizing the drug discovery process and its impact on the timeline and cost of bringing new drugs to market?",
      "raw_utterance": "How is AlphaFold 3 revolutionizing the drug discovery process and its impact on the timeline and cost of bringing new drugs to market?",
      "role": "Background discussion moderator",
      "role_description": "",
      "queries": [],
      "utterance_type": "Original Question",
      "claim_to_make": "",
      "raw_retrieved_info": [],
      "cited_info": null
    },
    {
      "utterance": "AlphaFold 3 is revolutionizing the drug discovery process by significantly impacting the timeline and cost of bringing new drugs to market. The AI program, developed by Google DeepMind and Isomorphic Labs, is described as \"groundbreaking\" with transformative potential in drug discovery[53]. Building upon the predictive capabilities of AlphaFold 2, AlphaFold 3 now includes modeling protein interactions with other molecules, DNA, RNA, small molecule ligands, and structural impacts of post-translational modifications and ions on molecular systems[56]. This advanced model provides unprecedented breadth and accuracy in structure prediction, allowing for rational development of therapeutics against previously difficult targets. The technology's potential was recognized with the 2024 Nobel Prize in Chemistry awarded to its developers, highlighting AI's significant impact on molecular biology and drug development[55]. Additionally, AlphaFold 3 has the potential to revolutionize various fields, accelerate research, and raise ethical considerations beyond predicting molecule shapes[57]. The adoption of AlphaFold 3 is expected to make the drug discovery process more efficient and effective, potentially reducing the timeline and cost associated with bringing new drugs to market, ultimately leading to advancements in the pharmaceutical industry.",
      "raw_utterance": "AlphaFold 3 is revolutionizing the drug discovery process by significantly impacting the timeline and cost of bringing new drugs to market. The AI program, developed by Google DeepMind and Isomorphic Labs, is described as \"groundbreaking\" with transformative potential in drug discovery[53]. Building upon the predictive capabilities of AlphaFold 2, AlphaFold 3 now includes modeling protein interactions with other molecules, DNA, RNA, small molecule ligands, and structural impacts of post-translational modifications and ions on molecular systems[56]. This advanced model provides unprecedented breadth and accuracy in structure prediction, allowing for rational development of therapeutics against previously difficult targets. The technology's potential was recognized with the 2024 Nobel Prize in Chemistry awarded to its developers, highlighting AI's significant impact on molecular biology and drug development[55]. Additionally, AlphaFold 3 has the potential to revolutionize various fields, accelerate research, and raise ethical considerations beyond predicting molecule shapes[57]. The adoption of AlphaFold 3 is expected to make the drug discovery process more efficient and effective, potentially reducing the timeline and cost associated with bringing new drugs to market, ultimately leading to advancements in the pharmaceutical industry.",
      "role": "Background discussion expert",
      "role_description": "",
      "queries": [],
      "utterance_type": "Potential Answer",
      "claim_to_make": "",
      "raw_retrieved_info": [],
      "cited_info": null
    },
    {
      "utterance": "How has the evolution of data training methods in AlphaFold 3 impacted its predictive accuracy compared to previous versions?",
      "raw_utterance": "How has the evolution of data training methods in AlphaFold 3 impacted its predictive accuracy compared to previous versions?",
      "role": "Background discussion moderator",
      "role_description": "",
      "queries": [],
      "utterance_type": "Original Question",
      "claim_to_make": "",
      "raw_retrieved_info": [],
      "cited_info": null
    },
    {
      "utterance": "The evolution of data training methods in AlphaFold 3 has significantly impacted its predictive accuracy compared to previous versions. By vastly expanding the training data to include DNA, RNA, and small molecules, AlphaFold 3 was able to train on a wider range of biomolecules, ultimately enhancing its predictive accuracy[37]. Additionally, the release of OpenFold by researchers at Columbia University provided the scientific community with valuable insights into the training data and procedures used in AlphaFold 2, further contributing to the advancement of predictive accuracy in this latest version[38].",
      "raw_utterance": "The evolution of data training methods in AlphaFold 3 has significantly impacted its predictive accuracy compared to previous versions. By vastly expanding the training data to include DNA, RNA, and small molecules, AlphaFold 3 was able to train on a wider range of biomolecules, ultimately enhancing its predictive accuracy[37]. Additionally, the release of OpenFold by researchers at Columbia University provided the scientific community with valuable insights into the training data and procedures used in AlphaFold 2, further contributing to the advancement of predictive accuracy in this latest version[38].",
      "role": "Background discussion expert",
      "role_description": "",
      "queries": [],
      "utterance_type": "Potential Answer",
      "claim_to_make": "",
      "raw_retrieved_info": [],
      "cited_info": null
    },
    {
      "utterance": "How can AlphaFold 3 revolutionize drug discovery and transform the landscape of medical science for the scientific community?",
      "raw_utterance": "How can AlphaFold 3 revolutionize drug discovery and transform the landscape of medical science for the scientific community?",
      "role": "Background discussion moderator",
      "role_description": "",
      "queries": [],
      "utterance_type": "Original Question",
      "claim_to_make": "",
      "raw_retrieved_info": [],
      "cited_info": null
    },
    {
      "utterance": "By integrating AlphaFold 3 into drug discovery processes, this revolutionary technology has the potential to transform medical science and research, benefiting a broader spectrum of the scientific community[17]. AlphaFold 3's ability to predict interactions at the atomic level signifies a transformative shift in drug discovery, offering a more cost-effective alternative to traditional methods in medicinal chemistry[18]. This breakthrough technology allows for the rational development of therapeutics against previously difficult targets, drastically reducing drug discovery time and opening up exciting possibilities for treating currently untreatable diseases[19][20]. The integration of AlphaFold 3 holds transformative potential, making it a groundbreaking technology in the field of drug discovery[21].",
      "raw_utterance": "By integrating AlphaFold 3 into drug discovery processes, this revolutionary technology has the potential to transform medical science and research, benefiting a broader spectrum of the scientific community[17]. AlphaFold 3's ability to predict interactions at the atomic level signifies a transformative shift in drug discovery, offering a more cost-effective alternative to traditional methods in medicinal chemistry[18]. This breakthrough technology allows for the rational development of therapeutics against previously difficult targets, drastically reducing drug discovery time and opening up exciting possibilities for treating currently untreatable diseases[19][20]. The integration of AlphaFold 3 holds transformative potential, making it a groundbreaking technology in the field of drug discovery[21].",
      "role": "Background discussion expert",
      "role_description": "",
      "queries": [],
      "utterance_type": "Potential Answer",
      "claim_to_make": "",
      "raw_retrieved_info": [],
      "cited_info": null
    },
    {
      "utterance": "How is AlphaFold 3 revolutionizing research in the field of computational structural biology and its impact on drug discovery in the life sciences?",
      "raw_utterance": "How is AlphaFold 3 revolutionizing research in the field of computational structural biology and its impact on drug discovery in the life sciences?",
      "role": "Background discussion moderator",
      "role_description": "",
      "queries": [],
      "utterance_type": "Original Question",
      "claim_to_make": "",
      "raw_retrieved_info": [],
      "cited_info": null
    },
    {
      "utterance": "AlphaFold 3, developed by Google DeepMind and Isomorphic Labs, is pushing the boundaries of computational structural biology by predicting not just protein folding structures, but also interactions of various biomolecules like DNA and RNA[6]. This groundbreaking AI model can accurately predict complex structures containing diverse molecular types, offering a significant advancement in the field[1]. By releasing the model code and weights for academic use, AlphaFold 3 aims to accelerate research in structural biology, with transformative potential in drug discovery and precise 3D protein structure predictions[4][5].",
      "raw_utterance": "AlphaFold 3, developed by Google DeepMind and Isomorphic Labs, is pushing the boundaries of computational structural biology by predicting not just protein folding structures, but also interactions of various biomolecules like DNA and RNA[6]. This groundbreaking AI model can accurately predict complex structures containing diverse molecular types, offering a significant advancement in the field[1]. By releasing the model code and weights for academic use, AlphaFold 3 aims to accelerate research in structural biology, with transformative potential in drug discovery and precise 3D protein structure predictions[4][5].",
      "role": "Background discussion expert",
      "role_description": "",
      "queries": [],
      "utterance_type": "Potential Answer",
      "claim_to_make": "",
      "raw_retrieved_info": [],
      "cited_info": null
    },
    {
      "utterance": "How is the adoption of AlphaFold 3 in the drug discovery process expected to impact the timeline and cost of bringing new drugs to market?",
      "raw_utterance": "How is the adoption of AlphaFold 3 in the drug discovery process expected to impact the timeline and cost of bringing new drugs to market?",
      "role": "Background discussion moderator",
      "role_description": "",
      "queries": [],
      "utterance_type": "Original Question",
      "claim_to_make": "",
      "raw_retrieved_info": [],
      "cited_info": null
    },
    {
      "utterance": "The adoption of AlphaFold 3 in the drug discovery process is poised to revolutionize the timeline and cost of bringing new drugs to market. AlphaFold 3's capability to predict protein structures in seconds, compared to years for humans, can lead to quicker identification of promising compounds and potential drug candidates[48]. Additionally, by efficiently predicting how ligands bind to target proteins, AlphaFold 3 can guide researchers in designing drug candidate structures that offer improved efficacy and reduced side effects[50]. This accelerated process not only speeds up drug discovery but also has the potential to impact the overall cost of drug development. Moreover, AlphaFold 3's broader understanding of drug targets can lead to the development of more effective medications, as demonstrated in a study focusing on the immune checkpoint protein TIM-3[49]. While not a solution to all challenges in drug development, AlphaFold 3 provides a valuable piece of the puzzle that contributes to more efficient and effective drug discovery[52].",
      "raw_utterance": "The adoption of AlphaFold 3 in the drug discovery process is poised to revolutionize the timeline and cost of bringing new drugs to market. AlphaFold 3's capability to predict protein structures in seconds, compared to years for humans, can lead to quicker identification of promising compounds and potential drug candidates[48]. Additionally, by efficiently predicting how ligands bind to target proteins, AlphaFold 3 can guide researchers in designing drug candidate structures that offer improved efficacy and reduced side effects[50]. This accelerated process not only speeds up drug discovery but also has the potential to impact the overall cost of drug development. Moreover, AlphaFold 3's broader understanding of drug targets can lead to the development of more effective medications, as demonstrated in a study focusing on the immune checkpoint protein TIM-3[49]. While not a solution to all challenges in drug development, AlphaFold 3 provides a valuable piece of the puzzle that contributes to more efficient and effective drug discovery[52].",
      "role": "Background discussion expert",
      "role_description": "",
      "queries": [],
      "utterance_type": "Potential Answer",
      "claim_to_make": "",
      "raw_retrieved_info": [],
      "cited_info": null
    },
    {
      "utterance": "How has the latest version of AlphaFold, AlphaFold 3, revolutionized the field of biomolecular structure prediction?",
      "raw_utterance": "How has the latest version of AlphaFold, AlphaFold 3, revolutionized the field of biomolecular structure prediction?",
      "role": "Background discussion moderator",
      "role_description": "",
      "queries": [],
      "utterance_type": "Original Question",
      "claim_to_make": "",
      "raw_retrieved_info": [],
      "cited_info": null
    },
    {
      "utterance": "AlphaFold 3 has revolutionized the field of biomolecular structure prediction through significant improvements in accuracy and predictive power compared to its predecessors [31]. One key aspect that sets AlphaFold 3 apart is its enhanced data training methods, utilizing a neural network approach to predict the 3D coordinates of all non-hydrogen atoms for a given protein [32]. This updated version was trained on a larger dataset, including DNA, RNA, small molecules, to expand its capabilities [37]. In terms of predictive accuracy, AlphaFold 3 can now predict the structure of almost all biomolecules with higher accuracy compared to traditional docking programs [34]. It has demonstrated significant improvements in interactions of proteins with other molecule types, achieving at least a 50% improvement over existing prediction methods [35]. Additionally, AlphaFold 3 has achieved impressive results in terms of the placement of alpha-carbon atoms of the protein backbone chain [36]. These advancements position AlphaFold 3 as a cutting-edge tool in biomolecular structure prediction, with great promise for transforming our understanding of the biological world and enhancing drug discovery efforts [35].",
      "raw_utterance": "AlphaFold 3 has revolutionized the field of biomolecular structure prediction through significant improvements in accuracy and predictive power compared to its predecessors [31]. One key aspect that sets AlphaFold 3 apart is its enhanced data training methods, utilizing a neural network approach to predict the 3D coordinates of all non-hydrogen atoms for a given protein [32]. This updated version was trained on a larger dataset, including DNA, RNA, small molecules, to expand its capabilities [37]. In terms of predictive accuracy, AlphaFold 3 can now predict the structure of almost all biomolecules with higher accuracy compared to traditional docking programs [34]. It has demonstrated significant improvements in interactions of proteins with other molecule types, achieving at least a 50% improvement over existing prediction methods [35]. Additionally, AlphaFold 3 has achieved impressive results in terms of the placement of alpha-carbon atoms of the protein backbone chain [36]. These advancements position AlphaFold 3 as a cutting-edge tool in biomolecular structure prediction, with great promise for transforming our understanding of the biological world and enhancing drug discovery efforts [35].",
      "role": "Background discussion expert",
      "role_description": "",
      "queries": [],
      "utterance_type": "Potential Answer",
      "claim_to_make": "",
      "raw_retrieved_info": [],
      "cited_info": null
    },
    {
      "utterance": "The enhanced predictive accuracy and expanded capabilities of AlphaFold 3 can greatly impact the field of protein engineering and design by providing more accurate and reliable structural information for designing novel proteins with specific functions. With AlphaFold 3's ability to predict the 3D coordinates of non-hydrogen atoms for various biomolecules, including proteins, DNA, RNA, and small molecules, researchers can now have a better understanding of protein interactions and structural features [2]. This can lead to the design of proteins with improved stability, functionality, and specificity, which is crucial for developing new therapeutic agents, enzymes, and biomaterials. By leveraging AlphaFold 3's advancements in biomolecular structure prediction, protein engineers can accelerate the process of designing custom proteins tailored for specific applications in biotechnology, medicine, and other fields [1].",
      "raw_utterance": "How can the enhanced predictive accuracy and expanded capabilities of AlphaFold 3 impact the field of protein engineering and design? [1][2]",
      "role": "Moderator",
      "role_description": "",
      "queries": [],
      "utterance_type": "Original Question",
      "claim_to_make": "",
      "raw_retrieved_info": [],
      "cited_info": null
    },
    {
      "utterance": "Absolutely! AlphaFold 3's improved predictive accuracy and expanded capabilities are truly groundbreaking for protein engineering and design. By accurately predicting the 3D structures of biomolecules like proteins, DNA, and RNA, researchers can design novel proteins with enhanced stability and functionality [-1]. This can have a huge impact on drug discovery and the development of therapeutic agents by improving protein-ligand interactions and antibody-antigen complexes [-1]. The model's ability to predict structures of various biomolecular complexes broadens its applicability across different types of biomolecules, which is crucial for advancing research in biotechnology and medicine [-1]. Overall, AlphaFold 3's advancements have the potential to revolutionize our understanding of biological systems and accelerate the design of custom proteins for specific applications [-1][58].",
      "raw_utterance": "AlphaFold 3's enhanced predictive accuracy and expanded capabilities are poised to revolutionize the field of protein engineering and design. By accurately predicting the 3D structures of biomolecules such as proteins, DNA, RNA, and small molecules, researchers can gain a better understanding of protein interactions and design novel proteins with improved stability and functionality [-1][-1]. The model's improved accuracy in predicting protein-ligand interactions and antibody-antigen complexes can significantly impact drug discovery and the development of therapeutic agents [-1][-1]. AlphaFold 3's ability to predict the structures of complexes involving proteins, nucleic acids, small molecules, ions, and modified residues broadens its applicability across various biomolecular types [-1]. The model's success rate in generating near-native top-ranked predictions further highlights its reliability and potential for accelerating the design of custom proteins tailored for specific applications [-1]. Overall, AlphaFold 3's advancements hold immense promise for transforming our understanding of biological systems and advancing research in biotechnology and medicine [-1][58].",
      "role": "General Knowledge Provider",
      "role_description": " Focus on broadly covering the basic facts about the question.",
      "queries": [
        "AlphaFold 3 enhanced predictive accuracy",
        "AlphaFold 3 expanded capabilities"
      ],
      "utterance_type": "Potential Answer",
      "claim_to_make": "The enhanced predictive accuracy and expanded capabilities of AlphaFold 3 can greatly impact the field of protein engineering and design by providing more accurate and reliable structural information for designing novel proteins with specific functions. With AlphaFold 3's ability to predict the 3D coordinates of non-hydrogen atoms for various biomolecules, including proteins, DNA, RNA, and small molecules, researchers can now have a better understanding of protein interactions and structural features . This can lead to the design of proteins with improved stability, functionality, and specificity, which is crucial for developing new therapeutic agents, enzymes, and biomaterials. By leveraging AlphaFold 3's advancements in biomolecular structure prediction, protein engineers can accelerate the process of designing custom proteins tailored for specific applications in biotechnology, medicine, and other fields .",
      "raw_retrieved_info": [
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
          "description": "Leveraging advanced deep learning methodologies, AlphaFold 3 has achieved unprecedented accuracy in predicting the three-dimensional structures of proteins, a cornerstone in understanding biomolecular interactions and functions [2]. This capability not only enhances our grasp of biological ...",
          "snippets": [
            "Leveraging advanced deep learning methodologies, AlphaFold 3 has achieved unprecedented accuracy in predicting the three-dimensional structures of proteins, a cornerstone in understanding biomolecular interactions and functions . This capability not only enhances our grasp of biological machinery but also accelerates the pace at which we can address some of the most pressing challenges in medical biology, from antibiotic resistance to the development of malaria vaccines .",
            "AlphaFold 3 represents a significant evolution from its predecessor, AlphaFold 2, primarily through its advanced architectural framework . The core of this new model, the Evoformer module, has been significantly enhanced to improve performance across a broader spectrum of biomolecules, extending beyond proteins to include DNA, RNA, and ligands . This architectural refinement has enabled AlphaFold 3 to achieve unprecedented accuracy in predicting drug-like interactions, setting a new benchmark in the field .",
            "Additionally, the diffusion module, a new addition to AlphaFold 3, directly handles raw atom coordinates, streamlining the prediction process by eliminating the need for complex rotational adjustments . ... AlphaFold 3 utilizes a unique iterative refinement process, termed \"recycling\", which significantly contributes to its enhanced accuracy.",
            "AlphaFold 3's predictive prowess is rooted in its next-generation architecture, which includes an improved version of the Evoformer module . This deep learning architecture was instrumental in the success of its predecessor, AlphaFold 2, and has been further refined to enhance performance."
          ],
          "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
          "meta": {
            "query": "AlphaFold 3 enhanced predictive accuracy",
            "question": "The enhanced predictive accuracy and expanded capabilities of AlphaFold 3 can greatly impact the field of protein engineering and design by providing more accurate and reliable structural information for designing novel proteins with specific functions. With AlphaFold 3's ability to predict the 3D coordinates of non-hydrogen atoms for various biomolecules, including proteins, DNA, RNA, and small molecules, researchers can now have a better understanding of protein interactions and structural features . This can lead to the design of proteins with improved stability, functionality, and specificity, which is crucial for developing new therapeutic agents, enzymes, and biomaterials. By leveraging AlphaFold 3's advancements in biomolecular structure prediction, protein engineers can accelerate the process of designing custom proteins tailored for specific applications in biotechnology, medicine, and other fields ."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10751731/",
          "description": "On this subset of 100 cases, the ... from the AlphaFold pipeline resulted in 18% success in generating near\u2010native (medium or high accuracy) top\u2010ranked predictions (Figure 5a), which is similar to the performance on the full benchmark (Figure 1a). ... Improved subunit modeling enhances antibody\u2013antigen ...",
          "snippets": [
            "On this subset of 100 cases, the use of default templates identified from the AlphaFold pipeline resulted in 18% success in generating near\u2010native (medium or high accuracy) top\u2010ranked predictions (Figure 5a), which is similar to the performance on the full benchmark (Figure 1a). ... Improved subunit modeling enhances antibody\u2013antigen complex modeling success.",
            "Previous work showed that AlphaFold prediction of protein\u2013protein complexes can be augmented with improved MSA cross\u2010chain pairing (Bryant et al., 2022), while others have developed alternative MSA methods such as DeepMSA2 (Zheng et al., 2021), which was part of a successful pipeline in a recent CASP/CAPRI complex structure prediction round (Lensink, Brysbaert, Raouraoua, et al., 2023). Recent work leveraging protein language models shows promise in constructing diversified and informative MSAs for enhancing accuracy in AlphaFold protein complex prediction (Bo et al., 2009), while it may be possible to replace or augment the MSA in AlphaFold with language model representations, potentially building on recent language models developed for antibodies (Olsen et al., 2022; Ruffolo et al., 2021) or proteins in general (Hie et al., 2023).",
            "The L\u2010RMSDs of the predictions across recycling iterations 0, 1, 2, 3 were 49.95 \u00c5, 24.68 \u00c5, 5.42 \u00c5, 4.25 \u00c5, respectively. Antibody and antigen chains of the predictions and x\u2010ray structure are colored as indicated. Predictions were generated with ColabFold due to its faster model generation speed compared to AlphaFold. Next, we analyzed specific changes in antibody\u2013antigen model across recycling iterations, identifying notably enhanced features and those that are unchanged.",
            "This model has high CAPRI accuracy (I\u2010RMSD = 0.68 \u00c5) and has the highest model confidence of all 25 predictions of this complex (model confidence = 0.88). (c) An example of an acceptable accuracy complex model from AlphaFold, in comparison with the experimentally determined structure (PDB: 6j15; antibody/PD\u20101 complex). This model has acceptable CAPRI accuracy (I\u2010RMSD = 3.35 \u00c5), and has the highest model confidence of all 25 predictions of this complex (model confidence = 0.75)."
          ],
          "title": "Evaluation of AlphaFold antibody\u2013antigen modeling with implications ...",
          "meta": {
            "query": "AlphaFold 3 enhanced predictive accuracy",
            "question": "The enhanced predictive accuracy and expanded capabilities of AlphaFold 3 can greatly impact the field of protein engineering and design by providing more accurate and reliable structural information for designing novel proteins with specific functions. With AlphaFold 3's ability to predict the 3D coordinates of non-hydrogen atoms for various biomolecules, including proteins, DNA, RNA, and small molecules, researchers can now have a better understanding of protein interactions and structural features . This can lead to the design of proteins with improved stability, functionality, and specificity, which is crucial for developing new therapeutic agents, enzymes, and biomaterials. By leveraging AlphaFold 3's advancements in biomolecular structure prediction, protein engineers can accelerate the process of designing custom proteins tailored for specific applications in biotechnology, medicine, and other fields ."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.nature.com/articles/s41586-021-03819-2",
          "description": "This creates a strong bias for ... 1.9.3 and Supplementary Fig. 9). The AlphaFold architecture is able to train to high accuracy using only supervised learning on PDB data, but we are able to enhance accuracy (Fig. 4a) using an approach similar to noisy student self-distillation35. In this procedure, we use a trained network to predict the structure ...",
          "snippets": [
            "This creates a strong bias for atoms to be correct relative to the local frame of each residue and hence correct with respect to its side-chain interactions, as well as providing the main source of chirality for AlphaFold (Supplementary Methods 1.9.3 and Supplementary Fig. 9). The AlphaFold architecture is able to train to high accuracy using only supervised learning on PDB data, but we are able to enhance accuracy (Fig. 4a) using an approach similar to noisy student self-distillation35. In this procedure, we use a trained network to predict the structure of around 350,000 diverse sequences from Uniclust3036 and make a new dataset of predicted structures filtered to a high-confidence subset.",
            "We validated an entirely redesigned version of our neural network-based model, AlphaFold, in the challenging 14th Critical Assessment of protein Structure Prediction (CASP14)15, demonstrating accuracy competitive with experimental structures in a majority of cases and greatly outperforming other methods. Underpinning the latest version of AlphaFold is a novel machine learning approach that incorporates physical and biological knowledge about protein structure, leveraging multi-sequence alignments, into the design of the deep learning algorithm. ... The development of computational methods to predict three-dimensional (3D) protein structures from the protein sequence has proceeded along two complementary paths that focus on either the physical interactions or the evolutionary history.",
            "In particular, we demonstrate a new architecture to jointly embed multiple sequence alignments (MSAs) and pairwise features, a new output representation and associated loss that enable accurate end-to-end structure prediction, a new equivariant attention architecture, use of intermediate losses to achieve iterative refinement of predictions, masked MSA loss to jointly train with the structure, learning from unlabelled protein sequences using self-distillation and self-estimates of accuracy. The AlphaFold network directly predicts the 3D coordinates of all heavy atoms for a given protein using the primary amino acid sequence and aligned sequences of homologues as inputs (Fig.",
            "A few recent studies have been developed to predict the 3D coordinates directly47,48,49,50, but the accuracy of these approaches does not match traditional, hand-crafted structure prediction pipelines51. In parallel, the success of attention-based networks for language processing52 and, more recently, computer vision31,53 has inspired the exploration of attention-based methods for interpreting protein sequences54,55,56. The methodology that we have taken in designing AlphaFold is a combination of the bioinformatics and physical approaches: we use a physical and geometric inductive bias to build components that learn from PDB data with minimal imposition of handcrafted features (for example, AlphaFold builds hydrogen bonds effectively without a hydrogen bond score function)."
          ],
          "title": "Highly accurate protein structure prediction with AlphaFold | Nature",
          "meta": {
            "query": "AlphaFold 3 enhanced predictive accuracy",
            "question": "The enhanced predictive accuracy and expanded capabilities of AlphaFold 3 can greatly impact the field of protein engineering and design by providing more accurate and reliable structural information for designing novel proteins with specific functions. With AlphaFold 3's ability to predict the 3D coordinates of non-hydrogen atoms for various biomolecules, including proteins, DNA, RNA, and small molecules, researchers can now have a better understanding of protein interactions and structural features . This can lead to the design of proteins with improved stability, functionality, and specificity, which is crucial for developing new therapeutic agents, enzymes, and biomaterials. By leveraging AlphaFold 3's advancements in biomolecular structure prediction, protein engineers can accelerate the process of designing custom proteins tailored for specific applications in biotechnology, medicine, and other fields ."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://blog.google/technology/ai/google-deepmind-isomorphic-alphafold-3-ai-model/",
          "description": "Our new AI model AlphaFold 3 can predict the structure and interactions of all life\u2019s molecules with unprecedented accuracy.",
          "snippets": [
            "For the interactions of proteins with other molecule types we see at least a 50% improvement compared with existing prediction methods, and for some important categories of interaction we have doubled prediction accuracy. We hope AlphaFold 3 will help transform our understanding of the biological world and drug discovery.",
            "AlphaFold 3 creates capabilities for drug design with predictions for molecules commonly used in drugs, such as ligands and antibodies, that bind to proteins to change how they interact in human health and disease. AlphaFold 3 achieves unprecedented accuracy in predicting drug-like interactions, including the binding of proteins with ligands and antibodies with their target proteins.",
            "In a paper published in Nature, we introduce AlphaFold 3, a revolutionary model that can predict the structure and interactions of all life\u2019s molecules with unprecedented accuracy.",
            "AlphaFold 3\u2019s predictions of molecular interactions surpass the accuracy of all existing systems."
          ],
          "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
          "meta": {
            "query": "AlphaFold 3 enhanced predictive accuracy",
            "question": "The enhanced predictive accuracy and expanded capabilities of AlphaFold 3 can greatly impact the field of protein engineering and design by providing more accurate and reliable structural information for designing novel proteins with specific functions. With AlphaFold 3's ability to predict the 3D coordinates of non-hydrogen atoms for various biomolecules, including proteins, DNA, RNA, and small molecules, researchers can now have a better understanding of protein interactions and structural features . This can lead to the design of proteins with improved stability, functionality, and specificity, which is crucial for developing new therapeutic agents, enzymes, and biomaterials. By leveraging AlphaFold 3's advancements in biomolecular structure prediction, protein engineers can accelerate the process of designing custom proteins tailored for specific applications in biotechnology, medicine, and other fields ."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.nature.com/articles/s41586-024-07487-w",
          "description": "AlphaFold 3 has a substantially updated architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and modified residues with greatly improved accuracy over many previous specialized tools.",
          "snippets": [
            "The introduction of AlphaFold 21 has spurred a revolution in modelling the structure of proteins and their interactions, enabling a huge range of applications in protein modelling and design2,3,4,5,6. Here we describe our AlphaFold 3 model with a substantially updated diffusion-based architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and modified residues. The new AlphaFold model demonstrates substantially improved accuracy over many previous specialized tools: far greater accuracy for protein\u2013ligand interactions compared with state-of-the-art docking tools, much higher accuracy for protein\u2013nucleic acid interactions compared with nucleic-acid-specific predictors and substantially higher antibody\u2013antigen prediction accuracy compared with AlphaFold-Multimer v.2.37,8.",
            "Together, these results show that high-accuracy modelling across biomolecular space is possible within a single unified deep-learning framework. ... Accurate models of biological complexes are critical to our understanding of cellular functions and for the rational design of therapeutics2,3,4,9. Enormous progress has been achieved in protein structure prediction with the development of AlphaFold1, and the field has grown tremendously with a number of later methods that build on the ideas and techniques of AlphaFold 2 (AF2)10,11,12.",
            "A wide range of predictors for various specific interaction types has been developed16,17,18,19,20,21,22,23,24,25,26,27,28, as well as one generalist method developed concurrently with the present work29, but the accuracy of such deep-learning attempts has been mixed and often below that of physics-inspired methods30,31. Almost all of these methods are also highly specialized to particular interaction types and cannot predict the structure of general biomolecular complexes containing many types of entities. Here we present AlphaFold 3 (AF3)\u2014a model that is capable of high-accuracy prediction of complexes containing nearly all molecular types present in the Protein Data Bank32 (PDB) (Fig.",
            "Protein monomer LDDT improvement is also significant (paired Wilcoxon signed-rank test, P = 1.7 \u00d7 10\u221234). AF3 has a very similar dependence on MSA depth to AlphaFold-Multimer v.2.3; proteins with shallow MSAs are predicted with lower accuracy (a comparison of the dependence of single-chain LDDT on MSA depth is shown in Extended Data Fig."
          ],
          "title": "Accurate structure prediction of biomolecular interactions with ...",
          "meta": {
            "query": "AlphaFold 3 enhanced predictive accuracy",
            "question": "The enhanced predictive accuracy and expanded capabilities of AlphaFold 3 can greatly impact the field of protein engineering and design by providing more accurate and reliable structural information for designing novel proteins with specific functions. With AlphaFold 3's ability to predict the 3D coordinates of non-hydrogen atoms for various biomolecules, including proteins, DNA, RNA, and small molecules, researchers can now have a better understanding of protein interactions and structural features . This can lead to the design of proteins with improved stability, functionality, and specificity, which is crucial for developing new therapeutic agents, enzymes, and biomaterials. By leveraging AlphaFold 3's advancements in biomolecular structure prediction, protein engineers can accelerate the process of designing custom proteins tailored for specific applications in biotechnology, medicine, and other fields ."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.drugdiscoverytrends.com/meet-alphafold-3-which-can-accurately-model-more-than-99-of-molecular-types-in-the-protein-data-bank/",
          "description": "By incorporating these training enhancements, AlphaFold 3 takes a significant step forward in generating reliable and biologically meaningful structure predictions. AlphaFold 3\u2019s remarkable ability to predict the interactions between proteins and small molecules holds immense promise for revolutionizing drug discovery. The paper highlights that \u201cAF3 shows far greater accuracy ...",
          "snippets": [
            "By incorporating these training enhancements, AlphaFold 3 takes a significant step forward in generating reliable and biologically meaningful structure predictions. AlphaFold 3\u2019s remarkable ability to predict the interactions between proteins and small molecules holds immense promise for revolutionizing drug discovery. The paper highlights that \u201cAF3 shows far greater accuracy on protein-ligand interactions than state-of-the-art docking tools,\u201d suggesting that the model can reliably predict the binding sites and optimal shapes for potential drug molecules.",
            "AlphaFold 3 by DeepMind accurately predicts protein structures and interactions, transforming drug discovery and structural biology.",
            "Unlike its predecessor, AlphaFold 2, which relied on an architecture optimized for predicting the structure of individual proteins, AlphaFold 3 (AF3) uses a diffusion model that predicts raw atom coordinates. This shift towards a diffusion-based architecture allows AF3 to model an array of biomolecular interactions, including proteins, nucleic acids, small molecules, ions and modified residues with high accuracy.",
            "The adoption of a diffusion-based approach allows AlphaFold 3 to generate accurate 3D models of biomolecular complexes by predicting the raw coordinates of individual atoms, a significant departure from its predecessor\u2019s protein-centric architecture."
          ],
          "title": "AlphaFold 3 offers even more accurate protein structure prediction",
          "meta": {
            "query": "AlphaFold 3 enhanced predictive accuracy",
            "question": "The enhanced predictive accuracy and expanded capabilities of AlphaFold 3 can greatly impact the field of protein engineering and design by providing more accurate and reliable structural information for designing novel proteins with specific functions. With AlphaFold 3's ability to predict the 3D coordinates of non-hydrogen atoms for various biomolecules, including proteins, DNA, RNA, and small molecules, researchers can now have a better understanding of protein interactions and structural features . This can lead to the design of proteins with improved stability, functionality, and specificity, which is crucial for developing new therapeutic agents, enzymes, and biomaterials. By leveraging AlphaFold 3's advancements in biomolecular structure prediction, protein engineers can accelerate the process of designing custom proteins tailored for specific applications in biotechnology, medicine, and other fields ."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://medium.com/meta-multiomics/alphafold-3-a-leap-forward-in-biomolecular-structure-prediction-opportunities-and-limitations-924350af1181",
          "description": "Generalizability Across Biomolecular ... can now predict structures of complexes involving not just proteins but also nucleic acids, small molecules, ions, and modified residues. This broadens its applicability to almost all molecular types found in the Protein Data Bank. Accuracy and Performance: AlphaFold 3 exhibits enhanced accuracy in ...",
          "snippets": [
            "Generalizability Across Biomolecular Complexes: The system can now predict structures of complexes involving not just proteins but also nucleic acids, small molecules, ions, and modified residues. This broadens its applicability to almost all molecular types found in the Protein Data Bank. Accuracy and Performance: AlphaFold 3 exhibits enhanced accuracy in predicting protein-ligand interactions, protein-nucleic acid interactions, and antibody-antigen interactions.",
            "AlphaFold 3 (AF3) represents a monumental stride in the domain of protein structure prediction, establishing new paradigms in accuracy and\u2026",
            "The latest release of DeepMind\u2019s AlphaFold 3 (AF3) represents a monumental stride in the domain of protein structure prediction, establishing new paradigms in accuracy and applicability that far\u2026",
            "The latest release of DeepMind\u2019s AlphaFold 3 (AF3) represents a monumental stride in the domain of protein structure prediction, establishing new paradigms in accuracy and applicability that far surpass its predecessor, AlphaFold 2 (AF2)."
          ],
          "title": "AlphaFold 3: A Leap Forward in Biomolecular Structure Prediction ...",
          "meta": {
            "query": "AlphaFold 3 enhanced predictive accuracy",
            "question": "The enhanced predictive accuracy and expanded capabilities of AlphaFold 3 can greatly impact the field of protein engineering and design by providing more accurate and reliable structural information for designing novel proteins with specific functions. With AlphaFold 3's ability to predict the 3D coordinates of non-hydrogen atoms for various biomolecules, including proteins, DNA, RNA, and small molecules, researchers can now have a better understanding of protein interactions and structural features . This can lead to the design of proteins with improved stability, functionality, and specificity, which is crucial for developing new therapeutic agents, enzymes, and biomaterials. By leveraging AlphaFold 3's advancements in biomolecular structure prediction, protein engineers can accelerate the process of designing custom proteins tailored for specific applications in biotechnology, medicine, and other fields ."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11292590/",
          "description": "Leveraging advanced deep learning methodologies, AlphaFold 3 has achieved unprecedented accuracy in predicting the three-dimensional structures of proteins, a cornerstone in understanding biomolecular interactions and functions [2]. This capability not only enhances our grasp of biological ...",
          "snippets": [
            "Leveraging advanced deep learning methodologies, AlphaFold 3 has achieved unprecedented accuracy in predicting the three-dimensional structures of proteins, a cornerstone in understanding biomolecular interactions and functions . This capability not only enhances our grasp of biological machinery but also accelerates the pace at which we can address some of the most pressing challenges in medical biology, from antibiotic resistance to the development of malaria vaccines .",
            "AlphaFold 3 represents a significant evolution from its predecessor, AlphaFold 2, primarily through its advanced architectural framework . The core of this new model, the Evoformer module, has been significantly enhanced to improve performance across a broader spectrum of biomolecules, extending beyond proteins to include DNA, RNA, and ligands . This architectural refinement has enabled AlphaFold 3 to achieve unprecedented accuracy in predicting drug-like interactions, setting a new benchmark in the field .",
            "Additionally, the diffusion module, a new addition to AlphaFold 3, directly handles raw atom coordinates, streamlining the prediction process by eliminating the need for complex rotational adjustments . ... AlphaFold 3 utilizes a unique iterative refinement process, termed \"recycling\", which significantly contributes to its enhanced accuracy.",
            "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor AlphaFold ..."
          ],
          "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
          "meta": {
            "query": "AlphaFold 3 enhanced predictive accuracy",
            "question": "The enhanced predictive accuracy and expanded capabilities of AlphaFold 3 can greatly impact the field of protein engineering and design by providing more accurate and reliable structural information for designing novel proteins with specific functions. With AlphaFold 3's ability to predict the 3D coordinates of non-hydrogen atoms for various biomolecules, including proteins, DNA, RNA, and small molecules, researchers can now have a better understanding of protein interactions and structural features . This can lead to the design of proteins with improved stability, functionality, and specificity, which is crucial for developing new therapeutic agents, enzymes, and biomaterials. By leveraging AlphaFold 3's advancements in biomolecular structure prediction, protein engineers can accelerate the process of designing custom proteins tailored for specific applications in biotechnology, medicine, and other fields ."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://en.wikipedia.org/wiki/AlphaFold",
          "description": "AlphaFold 3 was announced on 8 May 2024. It can predict the structure of complexes created by proteins with DNA, RNA, various ligands, and ions. The new prediction method shows a minimum 50% improvement in accuracy for protein interactions with other molecules compared to existing methods.",
          "snippets": [
            "Measured by the root-mean-square deviation (RMS-D) of the placement of the alpha-carbon atoms of the protein backbone chain, which tends to be dominated by the performance of the worst-fitted outliers, 88% of AlphaFold 2's predictions had an RMS deviation of less than 4 \u00c5 for the set of overlapped C-alpha atoms. 76% of predictions achieved better than 3 \u00c5, and 46% had a C-alpha atom RMS accuracy better than 2 \u00c5, with a median RMS deviation in its predictions of 2.1 \u00c5 for a set of overlapped CA atoms.",
            "It was particularly successful at predicting the most accurate structures for targets rated as most difficult by the competition organizers, where no existing template structures were available from proteins with partially similar sequences. AlphaFold 2 (2020) repeated this placement in the CASP14 competition in November 2020. It achieved a level of accuracy much higher than any other entry.",
            "The inclusion of metagenomic data has improved the quality of the prediction of MSAs. One of the biggest sources of the training data was the custom-built Big Fantastic Database (BFD) of 65,983,866 protein families, represented as MSAs and hidden Markov models (HMMs), covering 2,204,359,010 protein sequences from reference databases, metagenomes, and metatranscriptomes. AlphaFold 2's results at CASP14 were described as \"astounding\" and \"transformational\". However, some researchers noted that the accuracy was insufficient for a third of its predictions, and that it did not reveal the underlying mechanism or rules of protein folding for the protein folding problem remains unsolved.",
            "Moreover, for certain key categories of interactions, the prediction accuracy has effectively doubled. Demis Hassabis and John Jumper of Google DeepMind shared one half of the 2024 Nobel Prize in Chemistry, awarded \"for protein structure prediction,\" while the other half went to David Baker \"for computational protein design.\" Hassabis and Jumper had previously won the Breakthrough Prize in Life Sciences and the Albert Lasker Award for Basic Medical Research in 2023 for their leadership of the AlphaFold project.",
            "AlphaFold is an artificial intelligence (AI) program developed by DeepMind, a subsidiary of Alphabet, which performs predictions of protein structure. It is designed using deep learning techniques. AlphaFold 1 (2018) placed first in the overall rankings of the 13th Critical Assessment of Structure ..."
          ],
          "title": "AlphaFold - Wikipedia",
          "meta": {
            "query": "AlphaFold 3 enhanced predictive accuracy",
            "question": "The enhanced predictive accuracy and expanded capabilities of AlphaFold 3 can greatly impact the field of protein engineering and design by providing more accurate and reliable structural information for designing novel proteins with specific functions. With AlphaFold 3's ability to predict the 3D coordinates of non-hydrogen atoms for various biomolecules, including proteins, DNA, RNA, and small molecules, researchers can now have a better understanding of protein interactions and structural features . This can lead to the design of proteins with improved stability, functionality, and specificity, which is crucial for developing new therapeutic agents, enzymes, and biomaterials. By leveraging AlphaFold 3's advancements in biomolecular structure prediction, protein engineers can accelerate the process of designing custom proteins tailored for specific applications in biotechnology, medicine, and other fields ."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.prescouter.com/2024/05/google-deepmind-alphafold-3/",
          "description": "AlphaFold 3 has significantly enhanced prediction accuracy for antibody-antigen interactions. Learning about these interactions is essential for applications in immunology and therapeutic antibody development.",
          "snippets": [
            "Google DeepMind's AlphaFold 3 improves drug discovery by predicting complex protein interactions and structures with high accuracy.",
            "AlphaFold\u2019s structural prediction for a spike protein of a common cold virus accurately depicted how the virus protein interacts with antibodies and simple sugars. This provided a more precise match to the true virus protein structure. The discovery improved the understanding of the interactions between the immune system and the behavior of coronaviruses. The AlphaFold AI model could greatly impact the pharmaceutical landscape by aiding drug discovery. It enhances drug development processes and leads to potential new treatments for various diseases.",
            "These are examples of how the AlphaFold AI predictive model could impact the pharmaceutical landscape by improving collaborative drug discovery. It enhances drug development processes and leads to potential new treatments for various diseases.",
            "AlphaFold 3 uses precise protein structure predictions to expedite the identification of new drug targets and enhance the design of more effective therapeutics."
          ],
          "title": "AlphaFold 3: Google DeepMind\u2019s latest AI tech in drug discovery",
          "meta": {
            "query": "AlphaFold 3 enhanced predictive accuracy",
            "question": "The enhanced predictive accuracy and expanded capabilities of AlphaFold 3 can greatly impact the field of protein engineering and design by providing more accurate and reliable structural information for designing novel proteins with specific functions. With AlphaFold 3's ability to predict the 3D coordinates of non-hydrogen atoms for various biomolecules, including proteins, DNA, RNA, and small molecules, researchers can now have a better understanding of protein interactions and structural features . This can lead to the design of proteins with improved stability, functionality, and specificity, which is crucial for developing new therapeutic agents, enzymes, and biomaterials. By leveraging AlphaFold 3's advancements in biomolecular structure prediction, protein engineers can accelerate the process of designing custom proteins tailored for specific applications in biotechnology, medicine, and other fields ."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
          "description": "One of the most notable advancements of AlphaFold 3 is its expanded capabilities to model large biomolecules such as proteins, DNA, and RNA, as well as small molecules known as ligands. This expansion is crucial for drug discovery as it includes many drugs under the ligand category.",
          "snippets": [
            "One of the most notable advancements in AlphaFold 3 is its expanded predictive abilities. The model now accurately predicts protein-molecule complexes that include a variety of biomolecules such as DNA and RNA. This expansion is crucial for applications in genomics research and drug discovery, providing researchers with a powerful tool for faster and more accurate predictions.",
            "AlphaFold 3's expanded predictive abilities include interactions with DNA, RNA, and small molecules, crucial for understanding most disease mechanisms . This broadened scope allows for the identification of new drug targets and the optimization of lead compounds, further enhancing the efficiency and scope of drug discovery efforts.",
            "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor AlphaFold 2, this innovation has astonished the world with its capacity and speed.",
            "It takes humans years to determine the structure of various proteins and how the shape works with the receptors but AlphaFold 3 predicts the same structure in seconds. The version's utility is unimaginable in the field of drug discoveries, vaccines, enzymatic processes, and determining the rate and effect of different biological processes."
          ],
          "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
          "meta": {
            "query": "AlphaFold 3 expanded capabilities",
            "question": "The enhanced predictive accuracy and expanded capabilities of AlphaFold 3 can greatly impact the field of protein engineering and design by providing more accurate and reliable structural information for designing novel proteins with specific functions. With AlphaFold 3's ability to predict the 3D coordinates of non-hydrogen atoms for various biomolecules, including proteins, DNA, RNA, and small molecules, researchers can now have a better understanding of protein interactions and structural features . This can lead to the design of proteins with improved stability, functionality, and specificity, which is crucial for developing new therapeutic agents, enzymes, and biomaterials. By leveraging AlphaFold 3's advancements in biomolecular structure prediction, protein engineers can accelerate the process of designing custom proteins tailored for specific applications in biotechnology, medicine, and other fields ."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11292590/",
          "description": "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor AlphaFold ...",
          "snippets": [
            "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor AlphaFold 2, this innovation has astonished the world with its capacity and speed.",
            "One of the most notable advancements of AlphaFold 3 is its expanded capabilities to model large biomolecules such as proteins, DNA, and RNA, as well as small molecules known as ligands. This expansion is crucial for drug discovery as it includes many drugs under the ligand category.",
            "One of the most notable advancements in AlphaFold 3 is its expanded predictive abilities. The model now accurately predicts protein-molecule complexes that include a variety of biomolecules such as DNA and RNA. This expansion is crucial for applications in genomics research and drug discovery, providing researchers with a powerful tool for faster and more accurate predictions.",
            "AlphaFold 3's expanded predictive abilities include interactions with DNA, RNA, and small molecules, crucial for understanding most disease mechanisms . This broadened scope allows for the identification of new drug targets and the optimization of lead compounds, further enhancing the efficiency and scope of drug discovery efforts."
          ],
          "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
          "meta": {
            "query": "AlphaFold 3 expanded capabilities",
            "question": "The enhanced predictive accuracy and expanded capabilities of AlphaFold 3 can greatly impact the field of protein engineering and design by providing more accurate and reliable structural information for designing novel proteins with specific functions. With AlphaFold 3's ability to predict the 3D coordinates of non-hydrogen atoms for various biomolecules, including proteins, DNA, RNA, and small molecules, researchers can now have a better understanding of protein interactions and structural features . This can lead to the design of proteins with improved stability, functionality, and specificity, which is crucial for developing new therapeutic agents, enzymes, and biomaterials. By leveraging AlphaFold 3's advancements in biomolecular structure prediction, protein engineers can accelerate the process of designing custom proteins tailored for specific applications in biotechnology, medicine, and other fields .",
            "placement": "root -> Impact -> Scientific community -> Benefits of AlphaFold 3 in drug discovery -> Impact on protein engineering and design"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://blog.google/technology/ai/google-deepmind-isomorphic-alphafold-3-ai-model/",
          "description": "We also participated in community-wide forums and discussions ahead of AlphaFold 3\u2019s launch. AlphaFold Server reflects our ongoing commitment to share the benefits of AlphaFold, including our free database of 200 million protein structures. We\u2019ll also be expanding our free AlphaFold education ...",
          "snippets": [
            "We also participated in community-wide forums and discussions ahead of AlphaFold 3\u2019s launch. AlphaFold Server reflects our ongoing commitment to share the benefits of AlphaFold, including our free database of 200 million protein structures. We\u2019ll also be expanding our free AlphaFold education online course with EMBL-EBI and partnerships with organizations in the Global South to equip scientists with the tools they need to accelerate adoption and research, including on underfunded areas such as neglected diseases and food security.",
            "Our new AI model AlphaFold 3 can predict the structure and interactions of all life\u2019s molecules with unprecedented accuracy.",
            "We hope AlphaFold 3 will help transform our understanding of the biological world and drug discovery. Scientists can access the majority of its capabilities, for free, through our newly launched AlphaFold Server, an easy-to-use research tool.",
            "To build on AlphaFold 3\u2019s potential for drug design, Isomorphic Labs is already collaborating with pharmaceutical companies to apply it to real-world drug design challenges and, ultimately, develop new life-changing treatments for patients."
          ],
          "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
          "meta": {
            "query": "AlphaFold 3 expanded capabilities",
            "question": "The enhanced predictive accuracy and expanded capabilities of AlphaFold 3 can greatly impact the field of protein engineering and design by providing more accurate and reliable structural information for designing novel proteins with specific functions. With AlphaFold 3's ability to predict the 3D coordinates of non-hydrogen atoms for various biomolecules, including proteins, DNA, RNA, and small molecules, researchers can now have a better understanding of protein interactions and structural features . This can lead to the design of proteins with improved stability, functionality, and specificity, which is crucial for developing new therapeutic agents, enzymes, and biomaterials. By leveraging AlphaFold 3's advancements in biomolecular structure prediction, protein engineers can accelerate the process of designing custom proteins tailored for specific applications in biotechnology, medicine, and other fields ."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://blog.google/technology/ai/how-we-built-alphafold-3/",
          "description": "In order to get AlphaFold 3 to work with this much wider range of biomolecules, the team vastly expanded the data that the newer model was trained on to include DNA, RNA, small molecules and more. \u201cWe were able to say, \u2018Let's just train on everything that exists in this dataset that helped ...",
          "snippets": [
            "In order to get AlphaFold 3 to work with this much wider range of biomolecules, the team vastly expanded the data that the newer model was trained on to include DNA, RNA, small molecules and more. \u201cWe were able to say, \u2018Let's just train on everything that exists in this dataset that helped us so much with proteins and let\u2019s see how far we can get,\u2019\u201d Lindsay says.",
            "Another major change in AlphaFold 3 is a shift in architecture for the final part of the model that generates the structure. Where AlphaFold 2 used a complex custom geometry-based module, AlphaFold 3 uses a generative model that\u2019s based on diffusion \u2014 similar to our other cutting-edge image generation models, like Imagen \u2014 which greatly simplified how the model handles all the new molecule types.",
            "So the team turned to AlphaFold 2, which is already extremely good at predicting which interactions would be disordered \u2014 which look like a pile of chaotic spaghetti \u2014 and which ones were not. \u201cWe were able to use those predicted structures from AlphaFold 2 as distillation training for AlphaFold 3, so that AlphaFold 3 could learn to predict disorder,\u201d Lindsay says.",
            "Instead, they got started on AlphaFold 3."
          ],
          "title": "How we built AlphaFold 3 to predict the structure and interaction ...",
          "meta": {
            "query": "AlphaFold 3 expanded capabilities",
            "question": "The enhanced predictive accuracy and expanded capabilities of AlphaFold 3 can greatly impact the field of protein engineering and design by providing more accurate and reliable structural information for designing novel proteins with specific functions. With AlphaFold 3's ability to predict the 3D coordinates of non-hydrogen atoms for various biomolecules, including proteins, DNA, RNA, and small molecules, researchers can now have a better understanding of protein interactions and structural features . This can lead to the design of proteins with improved stability, functionality, and specificity, which is crucial for developing new therapeutic agents, enzymes, and biomaterials. By leveraging AlphaFold 3's advancements in biomolecular structure prediction, protein engineers can accelerate the process of designing custom proteins tailored for specific applications in biotechnology, medicine, and other fields ."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.genengnews.com/topics/artificial-intelligence/alphafold-3-angst-limited-accessibility-stirs-outcry-from-researchers/",
          "description": "Google DeepMind\u2019s renowned protein ... its sequence, has received a major update. In a report published in Nature on May 8, researchers unveiled AlphaFold 3\u2019s expanded predictive capabilities from proteins to a broad spectrum of biomolecular interactions, including DNA, RNA, ...",
          "snippets": [
            "Google DeepMind\u2019s renowned protein structure prediction algorithm, AlphaFold, which made a grand leap in solving one of biology\u2019s biggest problems, determining a protein\u2019s 3D structure from its sequence, has received a major update. In a report published in Nature on May 8, researchers unveiled AlphaFold 3\u2019s expanded predictive capabilities from proteins to a broad spectrum of biomolecular interactions, including DNA, RNA, ligands, and more.",
            "Researchers are angered by the latest update to Google DeepMind\u2019s renowned protein structure prediction algorithm, which published in Nature without the open access code",
            "The publication, which is a collaboration between DeepMind and Isomorphic Labs, a London-based company launched in 2021 to build upon DeepMind\u2019s AI research to tackle biological problems, emphasizes AlphaFold 3\u2019s potential to advance therapeutic applications, including drug discovery. Sir Demis Hassabis, PhD, co-founder and CEO of DeepMind and Isomorphic Labs, declared he was \u201cthrilled to announce AlphaFold 3, which can predict the structures and interactions of nearly all of life\u2019s molecules with state-of-the-art accuracy\u2026",
            "Scientists took to social media to complain how ligand inputs to the web server were limited to a finite list of biological molecules and did not allow custom inputs, such as small molecule drugs. In that vein, while Isomorphic Labs has reported applying AlphaFold 3 to drug design for internal projects as well as with pharmaceutical partners, the public web server is under a license that is limited to non-commercial use."
          ],
          "title": "AlphaFold 3 Angst: Limited Accessibility Stirs Outcry from Researchers",
          "meta": {
            "query": "AlphaFold 3 expanded capabilities",
            "question": "The enhanced predictive accuracy and expanded capabilities of AlphaFold 3 can greatly impact the field of protein engineering and design by providing more accurate and reliable structural information for designing novel proteins with specific functions. With AlphaFold 3's ability to predict the 3D coordinates of non-hydrogen atoms for various biomolecules, including proteins, DNA, RNA, and small molecules, researchers can now have a better understanding of protein interactions and structural features . This can lead to the design of proteins with improved stability, functionality, and specificity, which is crucial for developing new therapeutic agents, enzymes, and biomaterials. By leveraging AlphaFold 3's advancements in biomolecular structure prediction, protein engineers can accelerate the process of designing custom proteins tailored for specific applications in biotechnology, medicine, and other fields ."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.isomorphiclabs.com/articles/alphafold-3-predicts-the-structure-and-interactions-of-all-of-lifes-molecules",
          "description": "We are reimagining the entire drug discovery process from first principles with an AI-first approach.",
          "snippets": [
            "AlphaFold 3 predicts the structure and interactions of all of life\u2019s molecules",
            "We hope AlphaFold 3 will help transform our understanding of the biological world and drug discovery. Scientists can access the majority of its capabilities, for free, through the newly launched AlphaFold Server, an easy-to-use research tool.",
            "To build on AlphaFold 3\u2019s potential for drug design, we at Isomorphic Labs are already collaborating with pharmaceutical companies to apply it to real-world drug design challenges and, ultimately, develop new life-changing treatments for patients.",
            "So far, millions of researchers globally have used AlphaFold 2 to make discoveries in areas including malaria vaccines, cancer treatments, and enzyme design. AlphaFold has been cited more than 20,000 times and its scientific impact recognized through many prizes, most recently the Breakthrough Prize in Life Sciences. AlphaFold 3 takes us beyond proteins to a broad spectrum of biomolecules."
          ],
          "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
          "meta": {
            "query": "AlphaFold 3 expanded capabilities",
            "question": "The enhanced predictive accuracy and expanded capabilities of AlphaFold 3 can greatly impact the field of protein engineering and design by providing more accurate and reliable structural information for designing novel proteins with specific functions. With AlphaFold 3's ability to predict the 3D coordinates of non-hydrogen atoms for various biomolecules, including proteins, DNA, RNA, and small molecules, researchers can now have a better understanding of protein interactions and structural features . This can lead to the design of proteins with improved stability, functionality, and specificity, which is crucial for developing new therapeutic agents, enzymes, and biomaterials. By leveraging AlphaFold 3's advancements in biomolecular structure prediction, protein engineers can accelerate the process of designing custom proteins tailored for specific applications in biotechnology, medicine, and other fields ."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://en.wikipedia.org/wiki/AlphaFold",
          "description": "The database does not include proteins with fewer than 16 or more than 2700 amino acid residues, but for humans they are available in the whole batch file. AlphaFold's initial goal (as of early 2022) was to expand the database to cover most of the UniRef90 set, which contains over 100 million ...",
          "snippets": [
            "The database does not include proteins with fewer than 16 or more than 2700 amino acid residues, but for humans they are available in the whole batch file. AlphaFold's initial goal (as of early 2022) was to expand the database to cover most of the UniRef90 set, which contains over 100 million proteins.",
            "AlphaFold 3 was announced on 8 May 2024. It can predict the structure of complexes created by proteins with DNA, RNA, various ligands, and ions. The new prediction method shows a minimum 50% improvement in accuracy for protein interactions with other molecules compared to existing methods.",
            "Hassabis and Jumper had previously won the Breakthrough Prize in Life Sciences and the Albert Lasker Award for Basic Medical Research in 2023 for their leadership of the AlphaFold project. Proteins consist of chains of amino acids which spontaneously fold to form the three dimensional (3-D) structures of the proteins.",
            "AlphaFold 1 (2018) was built on work developed by various teams in the 2010s, work that looked at the large databanks of related DNA sequences now available from many different organisms (most without known 3D structures), to try to find changes at different residues (peptides) that appeared to be correlated, even though the residues were not consecutive in the main chain.",
            "AlphaFold 3 introduces the \"Pairformer,\" a deep learning architecture inspired by the transformer, which is considered similar to, but simpler than, the Evoformer used in AlphaFold 2. The Pairformer module's initial predictions are refined by a diffusion model."
          ],
          "title": "AlphaFold - Wikipedia",
          "meta": {
            "query": "AlphaFold 3 expanded capabilities",
            "question": "The enhanced predictive accuracy and expanded capabilities of AlphaFold 3 can greatly impact the field of protein engineering and design by providing more accurate and reliable structural information for designing novel proteins with specific functions. With AlphaFold 3's ability to predict the 3D coordinates of non-hydrogen atoms for various biomolecules, including proteins, DNA, RNA, and small molecules, researchers can now have a better understanding of protein interactions and structural features . This can lead to the design of proteins with improved stability, functionality, and specificity, which is crucial for developing new therapeutic agents, enzymes, and biomaterials. By leveraging AlphaFold 3's advancements in biomolecular structure prediction, protein engineers can accelerate the process of designing custom proteins tailored for specific applications in biotechnology, medicine, and other fields ."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.nature.com/articles/s41586-024-07487-w",
          "description": "AlphaFold 3 has a substantially updated architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and modified residues with greatly improved accuracy over many previous specialized tools.",
          "snippets": [
            "Nature - AlphaFold 3 has a substantially updated architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and...",
            "While expanding in modelling abilities, AF3 has also improved in protein complex accuracy relative to AlphaFold-Multimer (v.2.3)7,8.",
            "The introduction of AlphaFold 21 has spurred a revolution in modelling the structure of proteins and their interactions, enabling a huge range of applications in protein modelling and design2,3,4,5,6. Here we describe our AlphaFold 3 model with a substantially updated diffusion-based architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and modified residues.",
            "Here we present AlphaFold 3 (AF3)\u2014a model that is capable of high-accuracy prediction of complexes containing nearly all molecular types present in the Protein Data Bank32 (PDB) (Fig. 1a,b). In all but one category, it achieves a substantially higher performance than strong methods that specialize in just the given task (Fig."
          ],
          "title": "Accurate structure prediction of biomolecular interactions with ...",
          "meta": {
            "query": "AlphaFold 3 expanded capabilities",
            "question": "The enhanced predictive accuracy and expanded capabilities of AlphaFold 3 can greatly impact the field of protein engineering and design by providing more accurate and reliable structural information for designing novel proteins with specific functions. With AlphaFold 3's ability to predict the 3D coordinates of non-hydrogen atoms for various biomolecules, including proteins, DNA, RNA, and small molecules, researchers can now have a better understanding of protein interactions and structural features . This can lead to the design of proteins with improved stability, functionality, and specificity, which is crucial for developing new therapeutic agents, enzymes, and biomaterials. By leveraging AlphaFold 3's advancements in biomolecular structure prediction, protein engineers can accelerate the process of designing custom proteins tailored for specific applications in biotechnology, medicine, and other fields ."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://deepmind.google/technologies/alphafold/",
          "description": "Access the AlphaFold 3 model code and weights for academic use. ... Inside every cell of your body, billions of tiny machines \u2013 proteins \u2013 are hard at work. ... Jump back to 2020, when AlphaFold solved one of the biggest scientific challenges in over 50 years. ... Introducing a new AI model developed by Google DeepMind and Isomorphic Labs. ... Progress update: Our latest AlphaFold model shows significantly improved accuracy and expands ...",
          "snippets": [
            "Access the AlphaFold 3 model code and weights for academic use. ... Inside every cell of your body, billions of tiny machines \u2013 proteins \u2013 are hard at work. ... Jump back to 2020, when AlphaFold solved one of the biggest scientific challenges in over 50 years. ... Introducing a new AI model developed by Google DeepMind and Isomorphic Labs. ... Progress update: Our latest AlphaFold model shows significantly improved accuracy and expands coverage beyond proteins to other biological molecules, including ligands.",
            "AlphaFold has revealed millions of intricate 3D protein structures, and is helping scientists understand how all of life\u2019s molecules interact.",
            "Made from long chains of amino acids, each has a unique complex 3D structure. But figuring out just one of these can take several years, and hundreds of thousands of dollars. In 2020, AlphaFold solved this problem, with the ability to predict protein structures in minutes, to a remarkable degree of accuracy.",
            "AlphaFold has revealed millions of intricate 3D protein structures, and is helping scientists understand how life\u2019s molecules interact."
          ],
          "title": "AlphaFold - Google DeepMind",
          "meta": {
            "query": "AlphaFold 3 expanded capabilities",
            "question": "The enhanced predictive accuracy and expanded capabilities of AlphaFold 3 can greatly impact the field of protein engineering and design by providing more accurate and reliable structural information for designing novel proteins with specific functions. With AlphaFold 3's ability to predict the 3D coordinates of non-hydrogen atoms for various biomolecules, including proteins, DNA, RNA, and small molecules, researchers can now have a better understanding of protein interactions and structural features . This can lead to the design of proteins with improved stability, functionality, and specificity, which is crucial for developing new therapeutic agents, enzymes, and biomaterials. By leveraging AlphaFold 3's advancements in biomolecular structure prediction, protein engineers can accelerate the process of designing custom proteins tailored for specific applications in biotechnology, medicine, and other fields ."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://310.ai/blog/alphafold2-alphafold-multimer-alphafold3",
          "description": "AlphaFold3 extends its predecessors\u2019 capabilities by predicting structures not only for proteins but also for DNA, RNA, and their interactions. It marks a breakthrough in biomolecular modeling but still struggles with dynamic proteins and complex environments.",
          "snippets": [
            "AlphaFold2 became a breakthrough in computational protein structure prediction, advancing a solution to a 50-year-old life science grand challenge. AlphaFold-Multimer expanded the capabilities of AlphaFold2 on protein-protein complexes, boosting even more the field of computational biology.",
            "Here we cover practical considerations for people with a biological background: strong and weak sides of all AlphaFold models, types of structures AlphaFold3 fails to predict, things to be cautious about, and why we still need experimental structures even with all AlphaFold models. Structure prediction is often used in the context of protein structure prediction in particular (even though you can also predict structure of RNA or DNA or small molecules). It\u2019s a computational method used to determine the 3D structure of a protein based on its amino acid sequence.",
            "It mainly relies on multiple sequence alignments (MSAs), pairwise features, specific output representation and associated loss, and transformer-based equivariant attention architecture. AlphaFold was designed to predict the 3D coordinates of amino acid residues in a protein monomer, providing accurate and reliable structural models.",
            "To read the initial announcement from the source, look at blog posts from Google DeepMind and Isomorphic Labs \u2013 \u201cAlphaFold 3 predicts the structure and interactions of all of life\u2019s molecules\u201d and \u201cRational drug design with AlphaFold3\u201d."
          ],
          "title": "AlphaFold2, AlphaFold-Multimer, AlphaFold3",
          "meta": {
            "query": "AlphaFold 3 expanded capabilities",
            "question": "The enhanced predictive accuracy and expanded capabilities of AlphaFold 3 can greatly impact the field of protein engineering and design by providing more accurate and reliable structural information for designing novel proteins with specific functions. With AlphaFold 3's ability to predict the 3D coordinates of non-hydrogen atoms for various biomolecules, including proteins, DNA, RNA, and small molecules, researchers can now have a better understanding of protein interactions and structural features . This can lead to the design of proteins with improved stability, functionality, and specificity, which is crucial for developing new therapeutic agents, enzymes, and biomaterials. By leveraging AlphaFold 3's advancements in biomolecular structure prediction, protein engineers can accelerate the process of designing custom proteins tailored for specific applications in biotechnology, medicine, and other fields ."
          },
          "citation_uuid": -1
        }
      ],
      "cited_info": null
    },
    {
      "utterance": "Absolutely, the enhanced predictive accuracy of AlphaFold 3 has significant implications for designing novel proteins with improved stability and functionality. The updated diffusion-based architecture and Evoformer module allow for accurate predictions of a wide range of biomolecules, including proteins, nucleic acids, and small molecules [59][60][61]. This not only offers insights into how mutations impact protein structure but also aids in understanding genetic diseases [60]. Additionally, the integration of metagenomic data enhances the model's accuracy and has potential implications for advancements in medical science and research, particularly in understanding immune-system processes related to viruses like COVID-19 [62][63]. Isomorphic Labs is already utilizing AlphaFold 3 to accelerate drug design and identify new disease targets [64]. Overall, AlphaFold 3's advancements have the potential to revolutionize protein structural biology and impact fields from medical science to drug design [59][64].",
      "raw_utterance": "AlphaFold 3 represents a significant advancement in protein structure prediction, surpassing its predecessor, AlphaFold 2, in accuracy and versatility. The updated diffusion-based architecture of AlphaFold 3 can predict the joint structures of various biomolecules, including proteins, nucleic acids, small molecules, ions, and modified residues[59]. This enhanced predictive accuracy opens up new possibilities in designing novel proteins with improved stability and functionality, offering insights into how mutations impact protein structure and aiding in understanding human genetic diseases[60].\n\nThe Evoformer module at the core of AlphaFold 3 has been greatly improved to extend its predictive capabilities to a wider range of biomolecules, including DNA, RNA, and ligands. This architectural refinement has enabled AlphaFold 3 to achieve unparalleled accuracy in predicting drug-like interactions, setting a new standard in the field of protein structure prediction[61]. Furthermore, AlphaFold 3 can model large biomolecules like proteins, DNA, and RNA, as well as small molecules or ligands, shedding light on how these molecules interact and influence biological functions[62].\n\nThe integration of metagenomic data has enhanced the accuracy of AlphaFold 3's predictions, and its ability to model the joint 3D structures of molecules has broad implications, including potential advancements in medical science and research, particularly in understanding immune-system processes related to coronaviruses like COVID-19[62][63]. Isomorphic Labs is utilizing AlphaFold 3 to accelerate drug design, providing insights into new disease targets and novel approaches to previously unreachable targets[64].\n\nIn summary, AlphaFold 3's enhanced predictive accuracy and expanded capabilities are poised to revolutionize protein structural biology, offering groundbreaking insights into designing novel proteins with enhanced stability and functionality, impacting various fields from medical science to drug design.",
      "role": "Protein Engineer",
      "role_description": " A seasoned expert in the field of protein engineering and design, this speaker will focus on the practical implications of AlphaFold 3's enhanced predictive accuracy in revolutionizing the process of designing novel proteins with improved stability and functionality.",
      "queries": [
        "AlphaFold 3 enhanced predictive accuracy implications on designing novel proteins",
        "How does AlphaFold 3 improved stability and functionality of proteins"
      ],
      "utterance_type": "Potential Answer",
      "claim_to_make": "Highlight the specific implications of AlphaFold 3's enhanced predictive accuracy on designing novel proteins with improved stability and functionality.",
      "raw_retrieved_info": [
        {
          "url": "https://www.nature.com/articles/s41586-024-07487-w",
          "description": "AlphaFold 3 has a substantially updated architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and modified residues with greatly improved accuracy over many previous specialized tools.",
          "snippets": [
            "The introduction of AlphaFold 21 has spurred a revolution in modelling the structure of proteins and their interactions, enabling a huge range of applications in protein modelling and design2\u20136. Here we describe our AlphaFold 3 model with a substantially updated diffusion-based architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and modified residues.",
            "Nature - AlphaFold 3 has a substantially updated architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and...",
            "The introduction of AlphaFold 21 has spurred a revolution in modelling the structure of proteins and their interactions, enabling a huge range of applications in protein modelling and design2,3,4,5,6. Here we describe our AlphaFold 3 model with a substantially updated diffusion-based architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and modified residues. The new AlphaFold model demonstrates substantially improved accuracy over many previous specialized tools: far greater accuracy for protein\u2013ligand interactions compared with state-of-the-art docking tools, much higher accuracy for protein\u2013nucleic acid interactions compared with nucleic-acid-specific predictors and substantially higher antibody\u2013antigen prediction accuracy compared with AlphaFold-Multimer v.2.37,8.",
            "Protein monomer LDDT improvement is also significant (paired Wilcoxon signed-rank test, P = 1.7 \u00d7 10\u221234). AF3 has a very similar dependence on MSA depth to AlphaFold-Multimer v.2.3; proteins with shallow MSAs are predicted with lower accuracy (a comparison of the dependence of single-chain LDDT on MSA depth is shown in Extended Data Fig."
          ],
          "title": "Accurate structure prediction of biomolecular interactions with ...",
          "meta": {
            "query": "How does AlphaFold 3 improved stability and functionality of proteins",
            "question": "Highlight the specific implications of AlphaFold 3's enhanced predictive accuracy on designing novel proteins with improved stability and functionality.",
            "placement": "root -> Impact -> Scientific community -> How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry? -> Implications of AlphaFold 3 on Protein Design"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.nature.com/articles/s41586-021-03819-2",
          "description": "Proteins are essential to life, and understanding their structure can facilitate a mechanistic understanding of their function. Through an enormous experimental effort1\u20134, the structures of around 100,000 unique proteins have been determined5, but this represents a small fraction of the billions ...",
          "snippets": [
            "Proteins are essential to life, and understanding their structure can facilitate a mechanistic understanding of their function. Through an enormous experimental effort1\u20134, the structures of around 100,000 unique proteins have been determined5, but this represents a small fraction of the billions of known protein sequences6,7. Structural coverage is bottlenecked by the months to years of painstaking effort required to determine a single protein structure.",
            "Nature - AlphaFold predicts protein structures with an accuracy competitive with experimental structures in the majority of cases using a novel deep learning architecture.",
            "Least-squares linear fit TM-score = 0.98 \u00d7 pTM + 0.07 (Pearson\u2019s r = 0.85). n = 10,795 protein chains. The shaded region of the linear fit represents a 95% confidence interval estimated from 10,000 bootstrap samples. ... AlphaFold greatly improves the accuracy of structure prediction by incorporating novel neural network architectures and training procedures based on the evolutionary, physical and geometric constraints of protein structures.",
            "The resulting trajectories are surprisingly smooth after the first few blocks, showing that AlphaFold makes constant incremental improvements to the structure until it can no longer improve (see Fig. 4b for a trajectory of accuracy). These trajectories also illustrate the role of network depth. For very challenging proteins such as ORF8 of SARS-CoV-2 (T1064), the network searches and rearranges secondary structure elements for many layers before settling on a good structure."
          ],
          "title": "Highly accurate protein structure prediction with AlphaFold | Nature",
          "meta": {
            "query": "How does AlphaFold 3 improved stability and functionality of proteins",
            "question": "Highlight the specific implications of AlphaFold 3's enhanced predictive accuracy on designing novel proteins with improved stability and functionality."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.isomorphiclabs.com/articles/alphafold-3-predicts-the-structure-and-interactions-of-all-of-lifes-molecules",
          "description": "We are reimagining the entire drug discovery process from first principles with an AI-first approach.",
          "snippets": [
            "AlphaFold 3 predicts the structure and interactions of all of life\u2019s molecules",
            "Advancing our knowledge of such immune-system processes helps better understand coronaviruses, including COVID-19, raising possibilities for improved treatments. ... Given an input list of molecules, AlphaFold 3 generates their joint 3D structure, revealing how they all fit together. It models large biomolecules such as proteins, DNA, and RNA, as well as small molecules, also known as ligands - a category encompassing many drugs. Furthermore, AlphaFold 3 can model chemical modifications to these molecules which control the healthy functioning of cells, that when disrupted can lead to disease.",
            "In a paper published in Nature, we introduce AlphaFold 3, a revolutionary model that can predict the structure and interactions of all life\u2019s molecules with unprecedented accuracy. For the interactions of proteins with other molecule types we see at least a 50% improvement compared with existing prediction methods, and for some important categories of interaction we have doubled prediction accuracy.",
            "The ability to predict antibody-protein binding is critical to understanding aspects of the human immune response and the design of new antibodies - a growing class of therapeutics. ... Using AlphaFold 3 in combination with a complementary suite of in-house AI models, we are working on drug design for internal projects as well as with pharmaceutical partners. We are using AlphaFold 3 to accelerate and improve the success of drug design - by helping understand how to approach new disease targets, and developing novel ways to pursue existing ones that were previously out of reach."
          ],
          "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
          "meta": {
            "query": "How does AlphaFold 3 improved stability and functionality of proteins",
            "question": "Highlight the specific implications of AlphaFold 3's enhanced predictive accuracy on designing novel proteins with improved stability and functionality."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011655/",
          "description": "Three-dimensional protein structure is directly correlated with its function and its determination is critical to understanding biological processes and addressing human health and life science problems in general. Although new protein structures are ...",
          "snippets": [
            "For this, ESM Metagenomic Atlas is an important 3D protein structures resource to be deeply investigated by the scientific community (Lin et al., 2022). Finally, the efforts to better predict how mutations affect protein structure using these new approaches are essential to gain insights in human genetic disease and further improve disease management and prediction. Today, these methods do not outperform AlphaFold2, but with the improvement of deep language models and the enrichment of these models with biological information through multi-task learning, they promise to revolutionize the protein structural biology.",
            "As demonstrated by Buel and Walters (2022), the differences between mutated and wild-type models predicted by AlphaFold are very small, represented by backbones RMSD lower than 1\u212b. Moreover, Pak et al. (2021) also demonstrated that there is no correlation between AlphaFold accuracy metrics (pLDDT) and the impact of mutations on protein stability change (\u0394\u0394G), neither with the side chain size change.",
            "Pak M., Markhieva K., Novikova M., Petrov D., Vorobyev I., Maksimova E., et al. (2021). Using AlphaFold to predict the impact of single mutations on protein stability and function.",
            "Moreover, it presented an accuracy comparable to AlphaFold2 for structures predicted with high confidence, demonstrating a median all-atom RMSD of 1.91\u212b and a backbone RMSD of 1.33\u212b, reaching similar experimental-level accuracy. Finally, this approach also demonstrated a significant improvement in prediction speed, since it does not require the construction of MSA."
          ],
          "title": "Before and after AlphaFold2: An overview of protein structure ...",
          "meta": {
            "query": "How does AlphaFold 3 improved stability and functionality of proteins",
            "question": "Highlight the specific implications of AlphaFold 3's enhanced predictive accuracy on designing novel proteins with improved stability and functionality.",
            "placement": "root -> Impact -> Scientific community -> How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry? -> Implications of AlphaFold 3 on Protein Design"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://alphafold.ebi.ac.uk/",
          "description": "AlphaFold Protein Structure Database",
          "snippets": [],
          "title": "AlphaFold Protein Structure Database",
          "meta": {
            "query": "How does AlphaFold 3 improved stability and functionality of proteins",
            "question": "Highlight the specific implications of AlphaFold 3's enhanced predictive accuracy on designing novel proteins with improved stability and functionality."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
          "description": "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor ...",
          "snippets": [
            "By providing detailed insights into how molecules interact and influence biological functions, it paves the way for groundbreaking advancements in medical science and research . ... AlphaFold 3 represents a significant evolution from its predecessor, AlphaFold 2, primarily through its advanced architectural framework . The core of this new model, the Evoformer module, has been significantly enhanced to improve performance across a broader spectrum of biomolecules, extending beyond proteins to include DNA, RNA, and ligands . This architectural refinement has enabled AlphaFold 3 to achieve unprecedented accuracy in predicting drug-like interactions, setting a new benchmark in the field .",
            "AlphaFold 3, developed by Isomorphic Labs Limited (London, United Kingdom) and Google DeepMind, represents a significant leap forward in the field of molecular biology through its ability to predict the structure and interactions of biomolecules with unparalleled accuracy . This revolutionary model extends its predictive capabilities beyond proteins to encompass a broad spectrum of biomolecules, including proteins, DNA, RNA, and ligands, thereby offering a comprehensive understanding of the biological world. ... AlphaFold 3's predictive prowess is rooted in its next-generation architecture, which includes an improved version of the Evoformer module . This deep learning architecture was instrumental in the success of its predecessor, AlphaFold 2, and has been further refined to enhance performance.",
            "The introduction of AlphaFold 3 has the potential to transform drug discovery by providing a more rapid and accurate tool for examining fundamental biology . Its ability to predict the structure of protein-molecule complexes, including those containing DNA and RNA, marks a significant improvement over existing prediction methods.",
            "AlphaFold 3 extends its utility to predicting ADME properties, which are crucial for understanding a drug's performance within the body. This capability supports the optimization of clinical trial designs by predicting how drugs behave in different biological systems, thereby improving the safety and efficacy of therapeutic candidates . ... By enabling the rapid design and customization of drugs based on individual protein structures, AlphaFold 3 opens doors to personalized medicine."
          ],
          "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
          "meta": {
            "query": "How does AlphaFold 3 improved stability and functionality of proteins",
            "question": "Highlight the specific implications of AlphaFold 3's enhanced predictive accuracy on designing novel proteins with improved stability and functionality.",
            "placement": "root -> Impact -> Scientific community -> How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry? -> Implications of AlphaFold 3 on Protein Design"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://blog.google/technology/ai/google-deepmind-isomorphic-alphafold-3-ai-model/",
          "description": "Our new AI model AlphaFold 3 can predict the structure and interactions of all life\u2019s molecules with unprecedented accuracy.",
          "snippets": [
            "Advancing our knowledge of such immune-system processes helps better understand coronaviruses, including COVID-19, raising possibilities for improved treatments. Given an input list of molecules, AlphaFold 3 generates their joint 3D structure, revealing how they all fit together. It models large biomolecules such as proteins, DNA and RNA, as well as small molecules, also known as ligands \u2014 a category encompassing many drugs. Furthermore, AlphaFold 3 can model chemical modifications to these molecules which control the healthy functioning of cells, that when disrupted can lead to disease.",
            "In a paper published in Nature, we introduce AlphaFold 3, a revolutionary model that can predict the structure and interactions of all life\u2019s molecules with unprecedented accuracy. For the interactions of proteins with other molecule types we see at least a 50% improvement compared with existing prediction methods, and for some important categories of interaction we have doubled prediction accuracy.",
            "The ability to predict antibody-protein binding is critical to understanding aspects of the human immune response and the design of new antibodies \u2014 a growing class of therapeutics. Using AlphaFold 3 in combination with a complementary suite of in-house AI models, Isomorphic Labs is working on drug design for internal projects as well as with pharmaceutical partners. Isomorphic Labs is using AlphaFold 3 to accelerate and improve the success of drug design \u2014 by helping understand how to approach new disease targets, and developing novel ways to pursue existing ones that were previously out of reach.",
            "Introducing AlphaFold 3, a new AI model developed by Google DeepMind and Isomorphic Labs. By accurately predicting the structure of proteins, DNA, RNA, ligands and more, and how they interact, we hope it will transform our understanding of the biological world and drug discovery."
          ],
          "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
          "meta": {
            "query": "How does AlphaFold 3 improved stability and functionality of proteins",
            "question": "Highlight the specific implications of AlphaFold 3's enhanced predictive accuracy on designing novel proteins with improved stability and functionality.",
            "placement": "root -> Impact -> Scientific community -> How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry? -> Implications of AlphaFold 3 on Protein Design"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.frontiersin.org/journals/bioinformatics/articles/10.3389/fbinf.2023.1120370/full",
          "description": "Three-dimensional protein structure is directly correlated with its function and its determination is critical to understanding biological processes and addr...",
          "snippets": [
            "For this, ESM Metagenomic Atlas is an important 3D protein structures resource to be deeply investigated by the scientific community (Lin et al., 2022). Finally, the efforts to better predict how mutations affect protein structure using these new approaches are essential to gain insights in human genetic disease and further improve disease management and prediction. Today, these methods do not outperform AlphaFold2, but with the improvement of deep language models and the enrichment of these models with biological information through multi-task learning, they promise to revolutionize the protein structural biology.",
            "As demonstrated by Buel and Walters (2022), the differences between mutated and wild-type models predicted by AlphaFold are very small, represented by backbones RMSD lower than 1\u212b. Moreover, Pak et al. (2021) also demonstrated that there is no correlation between AlphaFold accuracy metrics (pLDDT) and the impact of mutations on protein stability change (\u0394\u0394G), neither with the side chain size change.",
            "Pak, M., Markhieva, K., Novikova, M., Petrov, D., Vorobyev, I., Maksimova, E., et al. (2021). Using AlphaFold to predict the impact of single mutations on protein stability and function.",
            "Moreover, it presented an accuracy comparable to AlphaFold2 for structures predicted with high confidence, demonstrating a median all-atom RMSD of 1.91\u212b and a backbone RMSD of 1.33\u212b, reaching similar experimental-level accuracy. Finally, this approach also demonstrated a significant improvement in prediction speed, since it does not require the construction of MSA."
          ],
          "title": "Frontiers | Before and after AlphaFold2: An overview of protein ...",
          "meta": {
            "query": "How does AlphaFold 3 improved stability and functionality of proteins",
            "question": "Highlight the specific implications of AlphaFold 3's enhanced predictive accuracy on designing novel proteins with improved stability and functionality."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://en.wikipedia.org/wiki/AlphaFold",
          "description": "AlphaFold 3 was announced on 8 May 2024. It can predict the structure of complexes created by proteins with DNA, RNA, various ligands, and ions. The new prediction method shows a minimum 50% improvement in accuracy for protein interactions with other molecules compared to existing methods.",
          "snippets": [
            "The inclusion of metagenomic data has improved the quality of the prediction of MSAs. One of the biggest sources of the training data was the custom-built Big Fantastic Database (BFD) of 65,983,866 protein families, represented as MSAs and hidden Markov models (HMMs), covering 2,204,359,010 protein sequences from reference databases, metagenomes, and metatranscriptomes. AlphaFold 2's results at CASP14 were described as \"astounding\" and \"transformational\".",
            "Hassabis and Jumper had previously won the Breakthrough Prize in Life Sciences and the Albert Lasker Award for Basic Medical Research in 2023 for their leadership of the AlphaFold project. Proteins consist of chains of amino acids which spontaneously fold to form the three dimensional (3-D) structures of the proteins.",
            "However, the October 2021 update, named AlphaFold-Multimer, included protein complexes in its training data. DeepMind stated this update succeeded about 70% of the time at accurately predicting protein-protein interactions. Announced on 8 May 2024, AlphaFold 3 was co-developed by Google DeepMind and Isomorphic Labs, both subsidiaries of Alphabet.",
            "The AlphaFold server was created to provide free access to AlphaFold 3 for non-commercial research. In December 2018, DeepMind's AlphaFold placed first in the overall rankings of the 13th Critical Assessment of Techniques for Protein Structure Prediction (CASP).",
            "AlphaFold is an artificial intelligence (AI) program developed by DeepMind, a subsidiary of Alphabet, which performs predictions of protein structure. It is designed using deep learning techniques. AlphaFold 1 (2018) placed first in the overall rankings of the 13th Critical Assessment of Structure ..."
          ],
          "title": "AlphaFold - Wikipedia",
          "meta": {
            "query": "How does AlphaFold 3 improved stability and functionality of proteins",
            "question": "Highlight the specific implications of AlphaFold 3's enhanced predictive accuracy on designing novel proteins with improved stability and functionality.",
            "placement": "root -> Impact -> Scientific community -> How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry? -> Implications of AlphaFold 3 on Protein Design"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://blog.google/technology/ai/how-we-built-alphafold-3/",
          "description": "Since its launch in 2020, more than 2 million researchers have used Google DeepMind\u2019s AlphaFold 2 model for protein predictions in their work on vaccine development, cancer treatments and more \u2014 helping solve a problem that researchers had been working on for over 50 years.",
          "snippets": [
            "Instead, they got started on AlphaFold 3. This newer model, which the teams at Google DeepMind and Isomorphic Labs launched in May, builds on our previous models by predicting not just protein folding structures, but predicting the structure and interactions of all of life's molecules, including DNA, RNA and ligands (small molecules that bind to proteins).",
            "Where AlphaFold 2 used a complex custom geometry-based module, AlphaFold 3 uses a generative model that\u2019s based on diffusion \u2014 similar to our other cutting-edge image generation models, like Imagen \u2014 which greatly simplified how the model handles all the new molecule types. That shift led to a new issue, though: Since so-called \u201cdisordered regions\u201d of proteins weren\u2019t included in the training data, the diffusion model would try to create an inaccurate \u201cordered\u201d structure with a defined spiral shape, instead of predicting disordered regions.",
            "\u201cWith AlphaFold 2, we made enormous progress on this decades-old open problem of protein folding, but if you look at recent high-impact research, researchers are moving beyond that,\u201d says Jonas Adler, research scientist at Google DeepMind. \u201cTheir conclusions were often about something more detailed, like binding of small molecules, or RNA, which AlphaFold 2 couldn\u2019t do.",
            "\u201cAt Isomorphic Labs, we see the tremendous potential of AlphaFold 3 for rational drug design, and we\u2019re already using it in our day-to-day work,\u201d says Adrian Stecula, research leader at Isomorphic Labs. \u201cInvestigating the binding of novel small molecules to novel drug targets, answering questions like, \u2018How do proteins engage with DNA and RNA?,\u2019 looking into the effects of chemical modifications on protein structure \u2014 the new model unlocks all of those capabilities.\u201d"
          ],
          "title": "How we built AlphaFold 3 to predict the structure and interaction ...",
          "meta": {
            "query": "How does AlphaFold 3 improved stability and functionality of proteins",
            "question": "Highlight the specific implications of AlphaFold 3's enhanced predictive accuracy on designing novel proteins with improved stability and functionality."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.nature.com/articles/s41586-024-07487-w",
          "description": "AlphaFold 3 has a substantially updated architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and modified residues with greatly improved accuracy over many previous specialized tools.",
          "snippets": [
            "The introduction of AlphaFold 21 has spurred a revolution in modelling the structure of proteins and their interactions, enabling a huge range of applications in protein modelling and design2\u20136. Here we describe our AlphaFold 3 model with a substantially updated diffusion-based architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and modified residues.",
            "Nature - AlphaFold 3 has a substantially updated architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and...",
            "The new AlphaFold model demonstrates substantially improved accuracy over many previous specialized tools: far greater accuracy for protein\u2013ligand interactions compared with state-of-the-art docking tools, much higher accuracy for protein\u2013nucleic acid interactions compared with nucleic-acid-specific predictors and substantially higher antibody\u2013antigen prediction accuracy compared with AlphaFold-Multimer v.2.37,8.",
            "Accurate models of biological complexes are critical to our understanding of cellular functions and for the rational design of therapeutics2,3,4,9. Enormous progress has been achieved in protein structure prediction with the development of AlphaFold1, and the field has grown tremendously with a number of later methods that build on the ideas and techniques of AlphaFold 2 (AF2)10,11,12."
          ],
          "title": "Accurate structure prediction of biomolecular interactions with ...",
          "meta": {
            "query": "AlphaFold 3 enhanced predictive accuracy implications on designing novel proteins",
            "question": "Highlight the specific implications of AlphaFold 3's enhanced predictive accuracy on designing novel proteins with improved stability and functionality."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.nature.com/articles/s41586-021-03819-2",
          "description": "Proteins are essential to life, and understanding their structure can facilitate a mechanistic understanding of their function. Through an enormous experimental effort1\u20134, the structures of around 100,000 unique proteins have been determined5, but this represents a small fraction of the billions ...",
          "snippets": [
            "Proteins are essential to life, and understanding their structure can facilitate a mechanistic understanding of their function. Through an enormous experimental effort1\u20134, the structures of around 100,000 unique proteins have been determined5, but this represents a small fraction of the billions of known protein sequences6,7. Structural coverage is bottlenecked by the months to years of painstaking effort required to determine a single protein structure.",
            "Nature - AlphaFold predicts protein structures with an accuracy competitive with experimental structures in the majority of cases using a novel deep learning architecture.",
            "We validated an entirely redesigned version of our neural network-based model, AlphaFold, in the challenging 14th Critical Assessment of protein Structure Prediction (CASP14)15, demonstrating accuracy competitive with experimental structures in a majority of cases and greatly outperforming other methods. Underpinning the latest version of AlphaFold is a novel machine learning approach that incorporates physical and biological knowledge about protein structure, leveraging multi-sequence alignments, into the design of the deep learning algorithm.",
            "AlphaFold greatly improves the accuracy of structure prediction by incorporating novel neural network architectures and training procedures based on the evolutionary, physical and geometric constraints of protein structures."
          ],
          "title": "Highly accurate protein structure prediction with AlphaFold | Nature",
          "meta": {
            "query": "AlphaFold 3 enhanced predictive accuracy implications on designing novel proteins",
            "question": "Highlight the specific implications of AlphaFold 3's enhanced predictive accuracy on designing novel proteins with improved stability and functionality."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://bjbas.springeropen.com/articles/10.1186/s43088-024-00503-y",
          "description": "Breakthrough achievements in protein structure prediction have occurred recently, mostly due to the advent of sophisticated machine learning methods and significant advancements in algorithmic approaches. The most recent version of the AlphaFold model, known as \u201cAlphaFold-latest,\u201d which ...",
          "snippets": [
            "Breakthrough achievements in protein structure prediction have occurred recently, mostly due to the advent of sophisticated machine learning methods and significant advancements in algorithmic approaches. The most recent version of the AlphaFold model, known as \u201cAlphaFold-latest,\u201d which expands the functionalities of the groundbreaking AlphaFold2, is the subject of this article.",
            "The model's current capabilities, especially in predicting diverse biomolecular interactions, open avenues for advancing research in understanding biological processes and designing novel therapeutics . Future research could focus on refining the model further and extending its applications. Continuous refinement of AlphaFold-latest could involve addressing specific challenges, such as improving accuracy in large complexes or enhancing predictions for specific classes of biomolecules.",
            "Facilitating drug discovery The ability to accurately predict protein structures has profound implications for drug discovery and development. With AlphaFold-latest, researchers can now elucidate the three-dimensional architectures of key drug targets with unprecedented precision. This enables rational drug design, wherein therapeutics can be tailored to interact more effectively with their target proteins, thereby enhancing efficacy and minimizing off-target effects.",
            "Integrating experimental data into the model training process could also enhance accuracy and reliability. Combining computational predictions with experimental results may provide a more comprehensive understanding of biomolecular structures and interactions (Fig. 1). ... Chat illustrating potential functionalities of AlphaFold-latest which represents a watershed moment in the field of protein structure prediction, catalyzing a paradigm shift that holds profound implications for comprehensive biomolecular insights and therapeutic advancements"
          ],
          "title": "AlphaFold-latest: revolutionizing protein structure prediction ...",
          "meta": {
            "query": "AlphaFold 3 enhanced predictive accuracy implications on designing novel proteins",
            "question": "Highlight the specific implications of AlphaFold 3's enhanced predictive accuracy on designing novel proteins with improved stability and functionality."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://blog.google/technology/ai/google-deepmind-isomorphic-alphafold-3-ai-model/",
          "description": "Our new AI model AlphaFold 3 can predict the structure and interactions of all life\u2019s molecules with unprecedented accuracy.",
          "snippets": [
            "Isomorphic Labs is using AlphaFold 3 to accelerate and improve the success of drug design \u2014 by helping understand how to approach new disease targets, and developing novel ways to pursue existing ones that were previously out of reach. 8AW3 - RNA modifying protein: AlphaFold 3\u2019s prediction for a molecular complex featuring a protein (blue), a strand of RNA (purple), and two ions (yellow) closely matches the true structure (gray).",
            "With just a few clicks, biologists can harness the power of AlphaFold 3 to model structures composed of proteins, DNA, RNA and a selection of ligands, ions and chemical modifications. AlphaFold Server helps scientists make novel hypotheses to test in the lab, speeding up workflows and enabling further innovation.",
            "They\u2019re made up of proteins, DNA and other molecules, but no single piece works on its own. Only by seeing how they interact together, across millions of types of combinations, can we start to truly understand life\u2019s processes. In a paper published in Nature, we introduce AlphaFold 3, a revolutionary model that can predict the structure and interactions of all life\u2019s molecules with unprecedented accuracy.",
            "For the interactions of proteins with other molecule types we see at least a 50% improvement compared with existing prediction methods, and for some important categories of interaction we have doubled prediction accuracy. We hope AlphaFold 3 will help transform our understanding of the biological world and drug discovery."
          ],
          "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
          "meta": {
            "query": "AlphaFold 3 enhanced predictive accuracy implications on designing novel proteins",
            "question": "Highlight the specific implications of AlphaFold 3's enhanced predictive accuracy on designing novel proteins with improved stability and functionality.",
            "placement": "root -> Comparisons -> AlphaFold 3 vs previous versions predictive accuracy comparison"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.frontiersin.org/journals/bioinformatics/articles/10.3389/fbinf.2023.1120370/full",
          "description": "Three-dimensional protein structure is directly correlated with its function and its determination is critical to understanding biological processes and addr...",
          "snippets": [
            "In this context, studies have emerged to predict protein structures by methods based on a template or free modeling. In the last years, different methods have been combined to overcome their individual limitations, until the emergence of AlphaFold2, which demonstrated that predicting protein structure with high accuracy at unprecedented scale is possible.",
            "Recently, new methods based on protein language models have promised to revolutionize the protein structural biology allowing the discovery of protein structure and function only from evolutionary patterns present on protein sequence. Even though these methods do not reach AlphaFold2 accuracy, they already covered some of its limitations, being able to predict with high accuracy more than 200 million proteins from metagenomic databases.",
            "Here, we provide an overview of the methods developed to perform protein structure prediction to compare with AlphaFold2, which combines neural networks and homology modeling to generate models that may have experimental accuracy in a growing number of examples.",
            "This was possible in part due to the development and improvement of computer processing. One of the breakthrough methods that not only combines methodology but also uses artificial intelligence is AlphaFold, an algorithm that beats the other tools in CASP13 and currently represents the state of art in protein structure prediction."
          ],
          "title": "Frontiers | Before and after AlphaFold2: An overview of protein ...",
          "meta": {
            "query": "AlphaFold 3 enhanced predictive accuracy implications on designing novel proteins",
            "question": "Highlight the specific implications of AlphaFold 3's enhanced predictive accuracy on designing novel proteins with improved stability and functionality."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
          "description": "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor ...",
          "snippets": [
            "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor AlphaFold 2, this innovation has astonished the world with its capacity and speed. It takes humans years to determine the structure of various proteins and how the shape works with the receptors but AlphaFold 3 predicts the same structure in seconds.",
            "AlphaFold 3 represents a significant evolution from its predecessor, AlphaFold 2, primarily through its advanced architectural framework . The core of this new model, the Evoformer module, has been significantly enhanced to improve performance across a broader spectrum of biomolecules, extending beyond proteins to include DNA, RNA, and ligands . This architectural refinement has enabled AlphaFold 3 to achieve unprecedented accuracy in predicting drug-like interactions, setting a new benchmark in the field . ... The introduction of novel neural network architectures in AlphaFold 3 has been pivotal in enhancing its predictive capabilities . These innovations include a scaled-down MSA processing unit and the new \"Pairformer,\" which focuses solely on pair and single representations, eliminating the need for MSA representation.",
            "Insights gained from these studies could lead to breakthroughs in various fields, including the development of more resilient crops and novel therapeutic proteins and antibodies [22-24]. ... By integrating AlphaFold 3 with other AI models and tools, Isomorphic Labs is pioneering new treatments and approaches to drug design. This collaborative effort leverages the enhanced predictive abilities of AlphaFold 3 to tackle disease targets that were previously challenging to address, paving the way for the development of innovative treatments.",
            "AlphaFold 3's capability to predict the structure of small molecules paves the way for creating novel biomaterials. These materials could be specifically designed for biocompatibility and functionality, ranging from medical implants to bioengineered enzymes, which could revolutionize multiple industries. ... The tool enhances fundamental biological research by providing a deeper understanding of protein folding, cellular signaling, and gene regulation."
          ],
          "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
          "meta": {
            "query": "AlphaFold 3 enhanced predictive accuracy implications on designing novel proteins",
            "question": "Highlight the specific implications of AlphaFold 3's enhanced predictive accuracy on designing novel proteins with improved stability and functionality."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.sciencedirect.com/science/article/pii/S0022283621004411",
          "description": "Accurate predictions of the three-dimensional structures of proteins from their amino acid sequences have come of age. AlphaFold, a deep learning-base\u2026",
          "snippets": [
            "Accurate predictions of the three-dimensional structures of proteins from their amino acid sequences have come of age. AlphaFold, a deep learning-based approach to protein structure prediction, shows remarkable success in independent assessments of prediction accuracy.",
            "Predicted structures generated by AlphaFold, highlight the importance of IDRs.",
            "That over 30% of regions within the proteome are disordered is congruent with estimates that have been made over the past two decades, as intense efforts have been undertaken to generalize the structure\u2013function paradigm to include the importance of conformational heterogeneity and dynamics. With structural annotations from AlphaFold in hand, there is the temptation to draw inferences regarding the \u201cstructures\u201d of IDRs and their interactomes."
          ],
          "title": "AlphaFold and Implications for Intrinsically Disordered Proteins ...",
          "meta": {
            "query": "AlphaFold 3 enhanced predictive accuracy implications on designing novel proteins",
            "question": "Highlight the specific implications of AlphaFold 3's enhanced predictive accuracy on designing novel proteins with improved stability and functionality."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://laskerfoundation.org/winners/alphafold-a-technology-for-predicting-protein-structures/",
          "description": "Explore All 2023 Winners & Awards > Demis Hassabis Google DeepMind John Jumper Google DeepMind For the invention of AlphaFold, a revolutionary technology for predicting the three-dimensional structure of proteins The 2023 Albert Lasker Basic Medical",
          "snippets": [
            "AlphaFold2 also computed how much to trust its predictions, and these confidence ratings allowed the researchers to squeeze more information from the available data and thus, to enhance its performance. After they fed it the roughly 140,000 PDB sequences, they ran another set whose structures had not been solved.",
            "The 2023 Albert Lasker Basic Medical Research Award honors two scientists for the invention of AlphaFold, the artificial intelligence (AI) system that solved the long-standing challenge of predicting the three-dimensional structure of proteins from the one-dimensional sequence of their amino acids.",
            "With brilliant ideas, intensive efforts, and supreme engineering, Demis Hassabis and John Jumper (both of Google DeepMind, London) led the AlphaFold team and propelled structure prediction to an unprecedented level of accuracy and speed.",
            "Hassabis, Jumper, and the AlphaFold team started over and brainstormed intensively. They added geometric and genetic concepts, and they integrated established wisdom about proteins. Atoms have characteristic radii, for instance, and bonds have characteristic angles."
          ],
          "title": "AlphaFold\u2014for predicting protein structures - Lasker Foundation",
          "meta": {
            "query": "AlphaFold 3 enhanced predictive accuracy implications on designing novel proteins",
            "question": "Highlight the specific implications of AlphaFold 3's enhanced predictive accuracy on designing novel proteins with improved stability and functionality."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://deepmind.google/technologies/alphafold/",
          "description": "AlphaFold has revealed millions of intricate 3D protein structures, and is helping scientists understand how all of life\u2019s molecules interact.",
          "snippets": [
            "Proteins underpin every biological process, in every living thing. Made from long chains of amino acids, each has a unique complex 3D structure. But figuring out just one of these can take several years, and hundreds of thousands of dollars. In 2020, AlphaFold solved this problem, with the ability to predict protein structures in minutes, to a remarkable degree of accuracy.",
            "So far, AlphaFold has predicted over 200 million protein structures \u2013 nearly all catalogued proteins known to science. The AlphaFold Protein Structure Database makes this data freely available. So far, it has over two million users in 190 countries.",
            "Researchers are using AlphaFold in nearly every field of biology. Explore some of their stories. ... A powerful suite of tools, helping the scientific community advance research. ... View over 200 million protein structure predictions to support your research.",
            "Predict the structure and interactions of all life\u2019s molecules with unprecedented accuracy. ... Access the AlphaFold 3 model code and weights for academic use. ... Inside every cell of your body, billions of tiny machines \u2013 proteins \u2013 are hard at work."
          ],
          "title": "AlphaFold - Google DeepMind",
          "meta": {
            "query": "AlphaFold 3 enhanced predictive accuracy implications on designing novel proteins",
            "question": "Highlight the specific implications of AlphaFold 3's enhanced predictive accuracy on designing novel proteins with improved stability and functionality."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.isomorphiclabs.com/articles/alphafold-3-predicts-the-structure-and-interactions-of-all-of-lifes-molecules",
          "description": "We are reimagining the entire drug discovery process from first principles with an AI-first approach.",
          "snippets": [
            "AlphaFold 3 predicts the structure and interactions of all of life\u2019s molecules",
            "We are using AlphaFold 3 to accelerate and improve the success of drug design - by helping understand how to approach new disease targets, and developing novel ways to pursue existing ones that were previously out of reach. \u200d \u00b7 Read more about how we are using AlphaFold 3 for drug design. ... 8AW3 - RNA modifying protein: AlphaFold 3\u2019s prediction for a molecular complex featuring a protein (blue), a strand of RNA (purple), and two ions (yellow) closely matches the true structure (gray).",
            "With just a few clicks, biologists can harness the power of AlphaFold 3 to model structures composed of proteins, DNA, RNA, and a selection of ligands, ions, and chemical modifications. ... AlphaFold Server helps scientists make novel hypotheses to test in the lab, speeding up workflows and enabling further innovation.",
            "They\u2019re made up of proteins, DNA, and other molecules, but no single piece works on its own. Only by seeing how they interact together, across millions of types of combinations, can we start to truly understand life\u2019s processes. ... In a paper published in Nature, we introduce AlphaFold 3, a revolutionary model that can predict the structure and interactions of all life\u2019s molecules with unprecedented accuracy."
          ],
          "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
          "meta": {
            "query": "AlphaFold 3 enhanced predictive accuracy implications on designing novel proteins",
            "question": "Highlight the specific implications of AlphaFold 3's enhanced predictive accuracy on designing novel proteins with improved stability and functionality."
          },
          "citation_uuid": -1
        }
      ],
      "cited_info": null
    },
    {
      "utterance": "I completely agree with the exciting potential of AlphaFold 3 in revolutionizing drug discovery processes and identifying new disease targets in the pharmaceutical industry. The accurate prediction of 3-D protein structures by AlphaFold 3 could significantly shorten the time to market for new drugs [65]. Isomorphic Labs, a leading player in the field, is already leveraging AlphaFold 3 alongside other AI models to speed up drug design for both internal projects and collaborations with industry partners [66]. This cutting-edge technology offers a more cost-effective approach compared to traditional methods, making it a game-changer in drug discovery [71]. The ability of AlphaFold 3 to predict the structures of various biomolecules and model chemical modifications provides a powerful framework for understanding and addressing medical conditions [67][69]. Moreover, the exclusive access to AlphaFold 3 for commercial use by researchers at Isomorphic Labs underscores the significant impact of this AI breakthrough in the pharmaceutical industry [70]. Overall, AlphaFold 3 has the potential to accelerate drug discovery processes, identify new disease targets, and drive innovation in pharmaceutical development [68].",
      "raw_utterance": "AlphaFold 3, the latest iteration of Google DeepMind's AI model, has revolutionized drug discovery by accurately predicting 3-D protein structures, potentially cutting years off the time to market [65]. This advancement has sparked interest in its impact on identifying new disease targets in the pharmaceutical industry. Isomorphic Labs, utilizing AlphaFold 3 alongside other AI models, aims to accelerate drug design for both internal projects and collaborations with pharmaceutical partners [66]. This cutting-edge technology is a game-changer in drug discovery, offering a more cost-effective approach compared to traditional methods [71]. The potential for AlphaFold 3 to predict the structures of proteins, DNA, RNA, and small molecule ligands, and its ability to model chemical modifications, makes it a powerful tool in understanding and addressing medical conditions [67][69]. Its impact on drug discovery and biological understanding is vast, providing scientists with a powerful framework for exploring new research avenues [68]. The exclusive access to AlphaFold 3 for commercial use by researchers at Isomorphic Labs highlights the significance of this AI breakthrough in the pharmaceutical industry [70]. In essence, AlphaFold 3 holds tremendous potential to accelerate drug discovery processes, identify new disease targets, and revolutionize the field of pharmaceutical development.",
      "role": "Pharmaceutical Industry Representative",
      "role_description": " Representing the pharmaceutical industry, this speaker will shed light on how AlphaFold 3's improved accuracy in predicting protein-ligand interactions and antibody-antigen complexes can significantly impact drug discovery and the development of therapeutic agents.",
      "queries": [
        "AlphaFold 3 impact on drug discovery",
        "AlphaFold 3 disease targets pharmaceutical industry"
      ],
      "utterance_type": "Further Details",
      "claim_to_make": "Request additional information on the potential impact of AlphaFold 3 on accelerating drug discovery processes and identifying new disease targets in the pharmaceutical industry.",
      "raw_retrieved_info": [
        {
          "url": "https://www.pharmavoice.com/news/google-alphafold-3-drug-discovery-pharma-buzz/716496/",
          "description": "The \u201cNobel Prize-worthy invention\u201d could be worth hundreds of billions commercially \u2014 and have a deep impact on drug R&D.",
          "snippets": [
            "AlphaFold 3\u2019s capabilities, outlined in the journal Nature, build on two of its earlier AI models, enabling drug developers to quickly identify promising targets, potentially slashing the time to market by years. Earlier versions of AlphaFold spurred a leap forward in drug development by rapidly and accurately predicting 3-D protein structures, a decades-long problem that had vexed computational biologists seeking to understand how shape affects protein function as a disease indicator.",
            "That\u2019s not to say companies using AlphaFold in drug development won\u2019t face challenges. \u201cYou have to have funding to be able to do this. And the second thing you need is data,\u201d he said. \u201cIt's a protein fitting problem. You have the disease protein, and then you have the candidate protein and you're trying to fit them, which means that you have to have enough data of the disease protein available to you to be able to do that.\u201d",
            "Trendline Inside the growing treatment market for rare diseases Supported by The MRN ... Inizio accelerates growth with a trio of strategic leadership appointments From Inizio View all | Post a press release ... Conference European Medical Device & Diagnostic Regulatory Affairs Conference Brussels, Belgium Presented by TT Lifesciences ... Big Pharma CEOs are hedging all bets by supporting both sides of the aisle in the 2024 election. By Amy Baxter \u2022 Oct. 28, 2024 ... Industry Dive is an Informa TechTarget business.",
            "The artificial intelligence program AlphaFold 3, rolled out by Google DeepMind and Isomorphic Labs earlier this month, has been called \u201cgroundbreaking,\u201d holding transformative potential in drug discovery."
          ],
          "title": "Why AlphaFold 3 is stirring up so much buzz in pharma | PharmaVoice",
          "meta": {
            "query": "AlphaFold 3 disease targets pharmaceutical industry",
            "question": "Request additional information on the potential impact of AlphaFold 3 on accelerating drug discovery processes and identifying new disease targets in the pharmaceutical industry.",
            "placement": "root -> Impact -> Drug discovery"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
          "description": "Isomorphic Labs leverages AlphaFold 3 in collaboration with pharmaceutical partners to enhance drug design processes [6]. This partnership approach not only accelerates drug development cycles but also ensures that new treatments are both innovative and effective, addressing previously intractable disease targets...",
          "snippets": [
            "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor ...",
            "Moreover, AlphaFold 3's ability to model chemical modifications to these molecules provides insights into cellular processes essential for health, the disruption of which can lead to disease. ... The model's predictive accuracy in modeling molecular interactions, including the binding of proteins with ligands and antibodies with their target proteins, sets a new standard.",
            "While AlphaFold 3 brings unparalleled precision to protein structure prediction, its utility in drug discovery is complemented by tools like Cognit (Cognit AI, San Francisco, California, United States), which focus on the genomic and transcriptomic foundations of health and disease. The integration of Cognit's upstream genomic and transcriptomic insights with AlphaFold 3's structural predictions creates a powerful synergy in drug discovery . This holistic approach covers the entire spectrum of drug development, from early-stage target discovery and validation to the optimization of therapeutic interactions at the molecular level.",
            "AlphaFold 3 can predict complex molecular structures in a fraction of the time, dramatically reducing both the time and financial costs associated with drug development . This efficiency allows researchers to focus on the most promising drug targets and biological questions without the burden of lengthy and expensive traditional methods . ... AlphaFold 3's ability to predict interactions between the spike protein of common viruses and antibodies provides critical insights into immune response mechanisms. This capability is instrumental in advancing our understanding of how diseases l"
          ],
          "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
          "meta": {
            "query": "AlphaFold 3 disease targets pharmaceutical industry",
            "question": "Request additional information on the potential impact of AlphaFold 3 on accelerating drug discovery processes and identifying new disease targets in the pharmaceutical industry."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://news.mit.edu/2022/alphafold-potential-protein-drug-0906",
          "description": "Using protein structures generated by the AI software AlphaFold, MIT researchers investigated whether existing computational models could identify the mechanisms of action of antibacterial compounds.",
          "snippets": [
            "Caption: Using protein structures generated by the AI software AlphaFold, MIT researchers investigated whether existing computational models could identify the mechanisms of action of antibacterial compounds.",
            "Using protein structures generated by an artificial intelligence program called AlphaFold, the researchers explored whether existing models could accurately predict the interactions between bacterial proteins and antibacterial compounds. If so, then researchers could begin to use this type of modeling to do large-scale screens for new compounds that target previously untargeted proteins.",
            "In their new study, the researchers were able to improve the performance of these types of models, known as molecular docking simulations, by applying machine-learning techniques to refine the results. However, more improvement will be necessary to fully take advantage of the protein structures provided by AlphaFold, the researchers say.",
            "AlphaFold, an AI software developed by DeepMind and Google, has accurately predicted protein structures from their amino acid sequences."
          ],
          "title": "Analyzing the potential of AlphaFold in drug discovery | MIT News ...",
          "meta": {
            "query": "AlphaFold 3 disease targets pharmaceutical industry",
            "question": "Request additional information on the potential impact of AlphaFold 3 on accelerating drug discovery processes and identifying new disease targets in the pharmaceutical industry."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.drugdiscoverytrends.com/laying-groundwork-alphafold-3-drug-discovery/",
          "description": "With the right approach, AlphaFold 3 promises to streamline drug discovery with advanced biomolecular predictions.",
          "snippets": [
            "The industry\u2019s reliance on a small fraction of drugs to subsidize the rest underscores the high-stakes nature of pharmaceutical development. \u201cIt is basically playing roulette, right? You just have to play roulette enough many times before you hit the jackpot,\u201d Bangert said. AlphaFold\u2019s computational approach offers significant advantages over traditional medicinal chemistry methods.",
            "Some 70% acknowledged AI\u2019s potential in the industry but noted struggles with data integrity and interoperability. The survey found that 63% of respondents were concerned about poor data quality. Given these data challenges, implementing advanced tools like AlphaFold requires meticulous attention to detail and a significant capital outlay. \u201cThe pipeline of tools that you require both before and after AlphaFold to make this into a commercial proposition for a pharmaceutical company or a healthcare company is fairly serious,\u201d Bangert stressed.",
            "Filed Under: Data science, Drug Discovery, machine learning and AI Tagged With: AI in Pharma, AI tools, AlphaFold 3, biopharma innovation, drug discovery, pharmaceutical R&D, protein structure prediction",
            "Last week, Google DeepMind launched AlphaFold 3, a significant update to its predecessor, AlphaFold 2. The latter has profoundly influenced structural biology and biomedicine in recent years while also attracting some skepticism. While AlphaFold 2 could accurately predict the structures of vast swathes of proteins, AlphaFold 3 ups the ante."
          ],
          "title": "Laying the groundwork to tap AlphaFold 3's potential in drug ...",
          "meta": {
            "query": "AlphaFold 3 disease targets pharmaceutical industry",
            "question": "Request additional information on the potential impact of AlphaFold 3 on accelerating drug discovery processes and identifying new disease targets in the pharmaceutical industry."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.nature.com/articles/d41586-023-02984-w",
          "description": "Nature - Questions remain about whether the AI tool for predicting protein structures can really shake up the pharmaceutical industry.",
          "snippets": [
            "Questions remain about whether the AI tool for predicting protein structures can really shake up the pharmaceutical industry. Questions remain about whether the AI tool for predicting protein structures can really shake up the pharmaceutical industry.",
            "Questions remain about whether the AI tool for predicting protein structures can really shake up the pharmaceutical industry. ... After Google Deepmind\u2019s AlphaFold proved that it could predict the 3D shapes of proteins with high accuracy in 2020, chemists became excited about the promise of using the open-source artificial-intelligence (AI) programme to discover drugs more quickly and cheaply."
          ],
          "title": "AlphaFold touted as next big thing for drug discovery \u2014 but is it?",
          "meta": {
            "query": "AlphaFold 3 disease targets pharmaceutical industry",
            "question": "Request additional information on the potential impact of AlphaFold 3 on accelerating drug discovery processes and identifying new disease targets in the pharmaceutical industry."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.nature.com/articles/d41586-024-01383-z",
          "description": "Latest version of the AI models how proteins interact with other molecules \u2014 but DeepMind restricts access to the tool.",
          "snippets": [
            "Latest version of the AI models how proteins interact with other molecules \u2014 but DeepMind restricts access to the tool. Latest version of the AI models how proteins interact with other molecules \u2014 but DeepMind restricts access to the tool.",
            "Nature - Latest version of the AI models how proteins interact with other molecules \u2014 but DeepMind restricts access to the tool.",
            "Since the powerhouse artificial intelligence (AI) tool AlphaFold2 was released in 2021, scientists have used the protein-structure-prediction model to map one of our cells\u2019 biggest machines, discover drugs and chart the universe of every known protein."
          ],
          "title": "Major AlphaFold upgrade offers boost for drug discovery",
          "meta": {
            "query": "AlphaFold 3 disease targets pharmaceutical industry",
            "question": "Request additional information on the potential impact of AlphaFold 3 on accelerating drug discovery processes and identifying new disease targets in the pharmaceutical industry."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4983123",
          "description": "We argue that AlphaFold 3 should support broad patent claims for the developers of therapeutic monoclonal antibodies to novel targets and revolutionize the half-trillion-dollar therapeutic antibodies market. We conclude with a brief discussion of the role of patents and the pharmaceutical industry ...",
          "snippets": [
            "We argue that AlphaFold 3 should support broad patent claims for the developers of therapeutic monoclonal antibodies to novel targets and revolutionize the half-trillion-dollar therapeutic antibodies market. We conclude with a brief discussion of the role of patents and the pharmaceutical industry in a future where much of drug development will be done in silico, many of the types of inventions that are patentable today will become obvious, and the risk of drug development will be far lower than it is today.",
            "AlphaFold 3, the most recent version of Google's DeepMind artificial intelligence engine (AI) used to predict protein structures, is a breakthrough AI with majo"
          ],
          "title": "AlphaFold 3, AI, Antibody Patents, the Future of Broad Pharmaceutical ...",
          "meta": {
            "query": "AlphaFold 3 disease targets pharmaceutical industry",
            "question": "Request additional information on the potential impact of AlphaFold 3 on accelerating drug discovery processes and identifying new disease targets in the pharmaceutical industry."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11292590/",
          "description": "Isomorphic Labs leverages AlphaFold 3 in collaboration with pharmaceutical partners to enhance drug design processes [6]. This partnership approach not only accelerates drug development cycles but also ensures that new treatments are both innovative and effective, addressing previously intractable disease targets...",
          "snippets": [
            "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor AlphaFold ...",
            "Moreover, AlphaFold 3's ability to model chemical modifications to these molecules provides insights into cellular processes essential for health, the disruption of which can lead to disease. ... The model's predictive accuracy in modeling molecular interactions, including the binding of proteins with ligands and antibodies with their target proteins, sets a new standard.",
            "While AlphaFold 3 brings unparalleled precision to protein structure prediction, its utility in drug discovery is complemented by tools like Cognit (Cognit AI, San Francisco, California, United States), which focus on the genomic and transcriptomic foundations of health and disease. The integration of Cognit's upstream genomic and transcriptomic insights with AlphaFold 3's structural predictions creates a powerful synergy in drug discovery . This holistic approach covers the entire spectrum of drug development, from early-stage target discovery and validation to the optimization of therapeutic interactions at the molecular level.",
            "AlphaFold 3 can predict complex molecular structures in a fraction of the time, dramatically reducing both the time and financial costs associated with drug development . This efficiency allows researchers to focus on the most promising drug targets and biological questions without the burden of lengthy and expensive traditional methods . ... AlphaFold 3's ability to predict interactions between the spike protein of common viruses and antibodies provides critical insights into immune response mechanisms. This capability is instrumental in advancing our understanding of how diseases l"
          ],
          "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
          "meta": {
            "query": "AlphaFold 3 disease targets pharmaceutical industry",
            "question": "Request additional information on the potential impact of AlphaFold 3 on accelerating drug discovery processes and identifying new disease targets in the pharmaceutical industry."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://blog.google/technology/ai/google-deepmind-isomorphic-alphafold-3-ai-model/",
          "description": "Using AlphaFold 3 in combination ... projects as well as with pharmaceutical partners. Isomorphic Labs is using AlphaFold 3 to accelerate and improve the success of drug design \u2014 by helping understand how to approach new disease targets, and developing novel ways to pursue ...",
          "snippets": [
            "Using AlphaFold 3 in combination with a complementary suite of in-house AI models, Isomorphic Labs is working on drug design for internal projects as well as with pharmaceutical partners. Isomorphic Labs is using AlphaFold 3 to accelerate and improve the success of drug design \u2014 by helping understand how to approach new disease targets, and developing novel ways to pursue existing ones that were previously out of reach.",
            "Our new AI model AlphaFold 3 can predict the structure and interactions of all life\u2019s molecules with unprecedented accuracy.",
            "AlphaFold 3 creates capabilities for drug design with predictions for molecules commonly used in drugs, such as ligands and antibodies, that bind to proteins to change how they interact in human health and disease. AlphaFold 3 achieves unprecedented accuracy in predicting drug-like interactions, including the binding of proteins with ligands and antibodies with their target proteins.",
            "Scientists can access the majority of its capabilities, for free, through our newly launched AlphaFold Server, an easy-to-use research tool. To build on AlphaFold 3\u2019s potential for drug design, Isomorphic Labs is already collaborating with pharmaceutical companies to apply it to real-world drug design challenges and, ultimately, develop new life-changing treatments for patients."
          ],
          "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
          "meta": {
            "query": "AlphaFold 3 disease targets pharmaceutical industry",
            "question": "Request additional information on the potential impact of AlphaFold 3 on accelerating drug discovery processes and identifying new disease targets in the pharmaceutical industry.",
            "placement": "root -> Impact -> Drug discovery"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.isomorphiclabs.com/articles/rational-drug-design-with-alphafold-3",
          "description": "We are reimagining the entire drug discovery process from first principles with an AI-first approach.",
          "snippets": [
            "We\u2019ve already deployed our frontier version of AlphaFold 3 in our own internal pipeline of projects, and in our partnerships with pharmaceutical companies.",
            "Understanding the biomolecular world within us, and how complex networks of molecules interact within our cells, is a crucial starting point for understanding and treating disease with rational drug design. ... To move this understanding forwards, together with Google DeepMind we have developed AlphaFold 3, our breakthrough artificial intelligence (AI) model that provides an accurate atomic-level view of the structure of biomolecular systems.",
            "This breakthrough opens up exciting possibilities for drug discovery, allowing us to rationally develop therapeutics against targets that were previously difficult or deemed intractable to modulate. ... AlphaFold 3 is an AI model that allows a scientist to input a description of a biomolecular complex that they are interested in, and predicts the 3D structure of that biomolecular complex.",
            "We believe that this broader understanding of the context within which drug targets operate will translate into more effective drugs in the clinic. ... To demonstrate the potential for rational structure-based drug design with AlphaFold 3, we examined TIM-3, an immune checkpoint protein identified as a potential target for cancer immunotherapy following a 2021 publication."
          ],
          "title": "Rational drug design with AlphaFold 3 - Isomorphic Labs",
          "meta": {
            "query": "AlphaFold 3 disease targets pharmaceutical industry",
            "question": "Request additional information on the potential impact of AlphaFold 3 on accelerating drug discovery processes and identifying new disease targets in the pharmaceutical industry."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.isomorphiclabs.com/articles/rational-drug-design-with-alphafold-3",
          "description": "This builds upon Google DeepMind\u2019s ... with AlphaFold 2, to now include how multiple proteins, DNA, RNA, and small molecule ligands come together and interact, as well as predicting the structural impact of post-translational modifications and ions on these molecular systems. This model is a powerful unified framework for structure prediction, encompassing unprecedented breadth and accuracy. ... This breakthrough opens up exciting possibilities for drug discovery, allowing ...",
          "snippets": [
            "This builds upon Google DeepMind\u2019s foundational work of predicting the structure of proteins with AlphaFold 2, to now include how multiple proteins, DNA, RNA, and small molecule ligands come together and interact, as well as predicting the structural impact of post-translational modifications and ions on these molecular systems. This model is a powerful unified framework for structure prediction, encompassing unprecedented breadth and accuracy. ... This breakthrough opens up exciting possibilities for drug discovery, allowing us to rationally develop therapeutics against targets that were previously difficult or deemed intractable to modulate.",
            "We are reimagining the entire drug discovery process from first principles with an AI-first approach.",
            "To demonstrate the potential for rational structure-based drug design with AlphaFold 3, we examined TIM-3, an immune checkpoint protein identified as a potential target for cancer immunotherapy following a 2021 publication. ... The study focused on the discovery and design of small molecules capable of binding TIM-3 with high affinity.",
            "But AlphaFold 3 is one of the many AI-powered breakthroughs we\u2019re working on which are needed to transform drug discovery - structural understanding is just a part of the picture. We\u2019re combining AlphaFold 3 with our other proprietary AI models in our platform that help us understand more about the properties, function, and dynamics of molecular systems."
          ],
          "title": "Rational drug design with AlphaFold 3 - Isomorphic Labs",
          "meta": {
            "query": "AlphaFold 3 impact on drug discovery",
            "question": "Request additional information on the potential impact of AlphaFold 3 on accelerating drug discovery processes and identifying new disease targets in the pharmaceutical industry.",
            "placement": "root -> Impact -> Scientific community -> Benefits of AlphaFold 3 in drug discovery -> Accelerating drug discovery processes"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://blog.google/technology/ai/google-deepmind-isomorphic-alphafold-3-ai-model/",
          "description": "This new window on the molecules ... actions of drugs, the production of hormones and the health-preserving process of DNA repair. The impacts of AlphaFold 3 and our free AlphaFold Server will be realized through how they empower scientists to accelerate discovery across open ...",
          "snippets": [
            "This new window on the molecules of life reveals how they\u2019re all connected and helps understand how those connections affect biological functions \u2014 such as the actions of drugs, the production of hormones and the health-preserving process of DNA repair. The impacts of AlphaFold 3 and our free AlphaFold Server will be realized through how they empower scientists to accelerate discovery across open questions in biology and new lines of research.",
            "Our new AI model AlphaFold 3 can predict the structure and interactions of all life\u2019s molecules with unprecedented accuracy.",
            "Introducing AlphaFold 3, a new AI model developed by Google DeepMind and Isomorphic Labs. By accurately predicting the structure of proteins, DNA, RNA, ligands and more, and how they interact, we hope it will transform our understanding of the biological world and drug discovery.",
            "We hope AlphaFold 3 will help transform our understanding of the biological world and drug discovery. Scientists can access the majority of its capabilities, for free, through our newly launched AlphaFold Server, an easy-to-use research tool."
          ],
          "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
          "meta": {
            "query": "AlphaFold 3 impact on drug discovery",
            "question": "Request additional information on the potential impact of AlphaFold 3 on accelerating drug discovery processes and identifying new disease targets in the pharmaceutical industry.",
            "placement": "root -> Impact -> Scientific community -> Benefits of AlphaFold 3 in drug discovery -> Accelerating drug discovery processes"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.nature.com/articles/d41586-024-01383-z",
          "description": "Latest version of the AI models how proteins interact with other molecules \u2014 but DeepMind restricts access to the tool.",
          "snippets": [
            "Latest version of the AI models how proteins interact with other molecules \u2014 but DeepMind restricts access to the tool. Latest version of the AI models how proteins interact with other molecules \u2014 but DeepMind restricts access to the tool.",
            "Nature - Latest version of the AI models how proteins interact with other molecules \u2014 but DeepMind restricts access to the tool.",
            "Since the powerhouse artificial intelligence (AI) tool AlphaFold2 was released in 2021, scientists have used the protein-structure-prediction model to map one of our cells\u2019 biggest machines, discover drugs and chart the universe of every known protein."
          ],
          "title": "Major AlphaFold upgrade offers boost for drug discovery",
          "meta": {
            "query": "AlphaFold 3 impact on drug discovery",
            "question": "Request additional information on the potential impact of AlphaFold 3 on accelerating drug discovery processes and identifying new disease targets in the pharmaceutical industry."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11292590/",
          "description": "This expansion is crucial for drug discovery as it includes many drugs under the ligand category. Additionally, AlphaFold 3 can model chemical modifications to these molecules, which play a significant role in the healthy functioning of cells. Disruptions in these processes can lead to disease, thus highlighting the model's potential in understanding and addressing medical conditions [9-11]. Impact ...",
          "snippets": [
            "This expansion is crucial for drug discovery as it includes many drugs under the ligand category. Additionally, AlphaFold 3 can model chemical modifications to these molecules, which play a significant role in the healthy functioning of cells. Disruptions in these processes can lead to disease, thus highlighting the model's potential in understanding and addressing medical conditions [9-11]. Impact on Drug Discovery and Biological Understanding",
            "Researchers are excited about the prospect of speedier drug discovery, facilitated by the greater range of predictive abilities offered by AlphaFold 3 . ... To maximize the impact of AlphaFold 3 on scientific research and drug discovery, its capabilities are made accessible to scientists through the AlphaFold Server.",
            "This section delves into the core of AlphaFold 3's capabilities, shedding light on its profound impact on our understanding of biomolecular interactions . ... AlphaFold 3's methodology allows for the generation of joint 3D structures of molecules, facilitating a comprehensive view of how various biomolecules, including proteins, DNA, RNA, and ligands, interact within a cellular context. This capability is crucial for drug discovery, as many drugs fall under the ligand category.",
            "By integrating these advanced predictive tools, AlphaFold 3 not only streamlines the drug discovery process but also opens up new possibilities for innovative therapeutic approaches, ultimately aiming to improve patient outcomes and advance the field of medical science. ... AlphaFold's capabilities extend into the realm of viral research, significantly impacting the development of therapies."
          ],
          "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
          "meta": {
            "query": "AlphaFold 3 impact on drug discovery",
            "question": "Request additional information on the potential impact of AlphaFold 3 on accelerating drug discovery processes and identifying new disease targets in the pharmaceutical industry.",
            "placement": "root -> Impact -> Scientific community -> Benefits of AlphaFold 3 in drug discovery -> Accelerating drug discovery processes"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.pharmavoice.com/news/google-alphafold-3-drug-discovery-pharma-buzz/716496/",
          "description": "The \u201cNobel Prize-worthy invention\u201d ... a deep impact on drug R&D. ... This audio is auto-generated. Please let us know if you have feedback. The artificial intelligence program AlphaFold 3, rolled out by Google DeepMind and Isomorphic Labs earlier this month, has been called \u201cgroundbreaking,\u201d holding transformative potential in drug discovery...",
          "snippets": [
            "The \u201cNobel Prize-worthy invention\u201d could be worth hundreds of billions commercially \u2014 and have a deep impact on drug R&D. ... This audio is auto-generated. Please let us know if you have feedback. The artificial intelligence program AlphaFold 3, rolled out by Google DeepMind and Isomorphic Labs earlier this month, has been called \u201cgroundbreaking,\u201d holding transformative potential in drug discovery.",
            "And while AlphaFold 3 could identify promising compounds faster, the usual hurdles to market will remain. \u201cThis isn't necessarily a Holy Grail to instantly make the drug development process more successful,\u201d Bangert said. \u201cYou're still going to have the traditional challenges, but this is a piece of that puzzle that's fitting better now.\u201d \u00b7 AI has secured a footing in drug discovery.",
            "It\u2019s hard to find the downside of AlphaFold 3, Bangert said. \u201cThis is actually one of those rare examples where I genuinely can't think of a drawback, mainly because this protein folding problem is so early in the process of drug development,\u201d he said. \u201cThis is prior to doing any chemical experimentation, certainly prior to any kind of clinical trials, that even if you did make a mistake, it wouldn't matter because you wouldn't be impacting anything.",
            "\u201cSo far, millions of researchers globally have used AlphaFold 2 to make discoveries in areas including malaria vaccines, cancer treatments, and enzyme design,\u201d according to the Google AlphaFold 3 announcement. \u201cAlphaFold has been cited more than 20,000 times and its scientific impact recognized through many prizes, most recently the Breakthrough Prize in Life Sciences.\u201d"
          ],
          "title": "Why AlphaFold 3 is stirring up so much buzz in pharma | PharmaVoice",
          "meta": {
            "query": "AlphaFold 3 impact on drug discovery",
            "question": "Request additional information on the potential impact of AlphaFold 3 on accelerating drug discovery processes and identifying new disease targets in the pharmaceutical industry."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://time.com/6975934/google-deepmind-alphafold-3-ai/",
          "description": "The innovative AI model, announced on May 8, is likely to dramatically accelerate biological research.",
          "snippets": [
            "In 2021, Google parent company Alphabet announced the creation of Isomorphic Labs, which aims to take an AI-first approach to drug discovery. Researchers from Isomorphic Labs contributed to the development of AlphaFold 3 and, while AlphaFold Server can be used by anyone from non-commercial research, researchers at Isomorphic Labs will have exclusive access to AlphaFold 3 for commercial use.",
            "\u201cWe've been using AlphaFold 3\u2019s capabilities day-to-day in our drug design programmes,\u201d said Max Jaderberg, chief AI officer at Isomorphic labs, at the announcement briefing. \u201cWe're already seeing that potential to accelerate, improve, and ultimately transform the way that we do drug discovery, and it's really because of the new level of accuracy of this model, and the increased breadth of biomolecules that this model is able to predict, that really enables that for us.\u201d",
            "In addition to the AlphaFold family of AI systems, Google DeepMind has made several breakthroughs that use AI to further science and technology. In 2022 the company released an AI system that can discover novel algorithms, and in 2023 it released an AI model that could forecast the weather with unprecedented accuracy.",
            "Researchers at Google DeepMind have developed AlphaFold 3, an AI model that can predict the structure of and interactions between biological molecules including proteins, DNA and RNA, and small molecules that could function as drugs. Google DeepMind will make the model available for non-commercial use through AlphaFold server."
          ],
          "title": "Google DeepMind\u2019s AlphaFold 3 Could Transform Drug Discovery",
          "meta": {
            "query": "AlphaFold 3 impact on drug discovery",
            "question": "Request additional information on the potential impact of AlphaFold 3 on accelerating drug discovery processes and identifying new disease targets in the pharmaceutical industry.",
            "placement": "root -> Impact -> Scientific community -> Benefits of AlphaFold 3 in drug discovery -> Accelerating drug discovery processes"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.drugdiscoverytrends.com/laying-groundwork-alphafold-3-drug-discovery/",
          "description": "With the right approach, AlphaFold 3 promises to streamline drug discovery with advanced biomolecular predictions.",
          "snippets": [
            "Despite this challenge and the significant costs of building the necessary foundation, AlphaFold is an order of magnitude \u2014 or two \u2014 less expensive than traditional methods in medicinal chemistry. \u201cWe\u2019re talking about a completely game-changing technology as far as drug discovery is concerned,\u201d Bangert said.",
            "\u201cAlphaFold itself is like the heart but you need the lungs and the liver and the kidneys and blood vessels and all that as well,\u201d Bangert said. Deploying AlphaFold 3 at a production scale to accelerate drug discovery involves assembling an ecosystem of IT infrastructure, data pipelines and domain expertise.",
            "Filed Under: Data science, Drug Discovery, machine learning and AI Tagged With: AI in Pharma, AI tools, AlphaFold 3, biopharma innovation, drug discovery, pharmaceutical R&D, protein structure prediction",
            "All the users of AlphaFold don\u2019t really care about speed, performance, latency, or any of those usual IT topics,\u201d Bangert said. \u201cWhat they really care about is accuracy. And that\u2019s why this move beyond essentially just a language model into molecular dynamics is really a good one.\u201d \u00b7 While R&D productivity rates in biopharma have declined in recent decades, blockbuster drugs still deliver substantial returns."
          ],
          "title": "Laying the groundwork to tap AlphaFold 3's potential in drug ...",
          "meta": {
            "query": "AlphaFold 3 impact on drug discovery",
            "question": "Request additional information on the potential impact of AlphaFold 3 on accelerating drug discovery processes and identifying new disease targets in the pharmaceutical industry.",
            "placement": "root -> Impact -> Scientific community -> Benefits of AlphaFold 3 in drug discovery -> Accelerating drug discovery processes"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://pubs.rsc.org/en/content/articlelanding/2023/sc/d2sc05709c",
          "description": "The application of artificial intelligence (AI) has been considered a revolutionary change in drug discovery and development. In 2020, the AlphaFold computer program predicted protein structures for the whole human genome, which has been considered a remarkable breakthrough in both AI applications ...",
          "snippets": [
            "The application of artificial intelligence (AI) has been considered a revolutionary change in drug discovery and development. In 2020, the AlphaFold computer program predicted protein structures for the whole human genome, which has been considered a remarkable breakthrough in both AI applications and struct Computational protein design and structure prediction: Celebrating the 2024 Nobel Prize in Chemistry Most popular 2023 physical and theoretical chemistry articles",
            "Based on the available data, a second round of AI-powered compound generation was conducted and through this, a more potent hit molecule, ISM042-2-048, was discovered with an average Kd value of 566.7 \u00b1 256.2 nM (n = 3). Compound ISM042-2-048 also showed good CDK20 inhibitory activity with an IC50 value of 33.4 \u00b1 22.6 nM (n = 3). In addition, ISM042-2-048 demonstrated selective anti-proliferation activity in an HCC cell line with CDK20 overexpression, Huh7, with an IC50 of 208.7 \u00b1 3.3 nM, compared to a counter screen cell line HEK293 (IC50 = 1706.7 \u00b1 670.0 nM). This work is the first demonstration of applying AlphaFold to the hit identification process in drug discovery.",
            "This article is licensed under a Creative Commons Attribution 3.0 Unported Licence.",
            "b Insilico Medicine Kong Kong Ltd, Unit 310, 3/F, Building 8W, Phase 2, Hong Kong Science Park, Pak Shek Kok, Hong Kong, China"
          ],
          "title": "AlphaFold accelerates artificial intelligence powered drug discovery: ...",
          "meta": {
            "query": "AlphaFold 3 impact on drug discovery",
            "question": "Request additional information on the potential impact of AlphaFold 3 on accelerating drug discovery processes and identifying new disease targets in the pharmaceutical industry.",
            "placement": "root -> Impact -> Scientific community -> Benefits of AlphaFold 3 in drug discovery -> Accelerating drug discovery processes"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://news.mit.edu/2022/alphafold-potential-protein-drug-0906",
          "description": "Using protein structures generated by the AI software AlphaFold, MIT researchers investigated whether existing computational models could identify the mechanisms of action of antibacterial compounds.",
          "snippets": [
            "Study finds computer models that predict molecular interactions need improvement before they can help identify drug mechanisms of action. ... Caption: Using protein structures generated by the AI software AlphaFold, MIT researchers investigated whether existing computational models could identify the mechanisms of action of antibacterial compounds.",
            "The new study is part of an effort recently launched by Collins\u2019 lab called the Antibiotics-AI Project, which has the goal of using artificial intelligence to discover and design new antibiotics. AlphaFold, an AI software developed by DeepMind and Google, has accurately predicted protein structures from their amino acid sequences. This technology has generated excitement among researchers looking for new antibiotics, who hope that they could use the AlphaFold structures to find drugs that bind to specific bacterial proteins.",
            "\u201cBreakthroughs such as AlphaFold are expanding the possibilities for in silico drug discovery efforts, but these developments need to be coupled with additional advances in other aspects of modeling that are part of drug discovery efforts,\u201d Collins says.",
            "\u201cOur study speaks to both the current abilities and the current limitations of computational platforms for drug discovery.\u201d \u00b7 In their new study, the researchers were able to improve the performance of these types of models, known as molecular docking simulations, by applying machine-learning techniques to refine the results. However, more improvement will be necessary to fully take advantage of the protein structures provided by AlphaFold, the researchers say."
          ],
          "title": "Analyzing the potential of AlphaFold in drug discovery | MIT News ...",
          "meta": {
            "query": "AlphaFold 3 impact on drug discovery",
            "question": "Request additional information on the potential impact of AlphaFold 3 on accelerating drug discovery processes and identifying new disease targets in the pharmaceutical industry."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.sify.com/ai-analytics/alphafold-3-by-deepmind-the-future-of-protein-folding-and-drug-discovery/",
          "description": "Tiny Tech, Big Impact: Edge AI and TinyML are revolutionising data processing \u00b7 Tech in the Shadows: The Rise of Ambient Computing and Seamless Integration \u00b7 GPT-2 Chatbot Mystery: Outperforming GPT-4 or Next-Gen AI? ... AI AlphaFold 3 Artificial Intelligence DeepMind DNA drug discovery Gautham ...",
          "snippets": [
            "Tiny Tech, Big Impact: Edge AI and TinyML are revolutionising data processing \u00b7 Tech in the Shadows: The Rise of Ambient Computing and Seamless Integration \u00b7 GPT-2 Chatbot Mystery: Outperforming GPT-4 or Next-Gen AI? ... AI AlphaFold 3 Artificial Intelligence DeepMind DNA drug discovery Gautham T medicine protein folding RNA",
            "A super artificial intelligence that is as smart as an architect and may predict the molecular configuration of proteins to a great extent.",
            "Medicine: AlphaFold 3 facilitates faster drug discovery since it effectively captures protein folds. It recently supported a study of a protein that is important for a malaria vaccine. In the past, the images were not clear enough and thus it was challenging to identify the most effective target.",
            "But how do these single but indisputably essential proteins design their unique form as if they are made by special origami skills? This over time has become a \u2018science fiction conjecture\u2019 that has immensely hit the area of disease diagnosis and drug development. Now, there\u2019s a game-changer: AlphaFold 3."
          ],
          "title": "AlphaFold 3 by DeepMind: The Future of Protein Folding and Drug ...",
          "meta": {
            "query": "AlphaFold 3 impact on drug discovery",
            "question": "Request additional information on the potential impact of AlphaFold 3 on accelerating drug discovery processes and identifying new disease targets in the pharmaceutical industry."
          },
          "citation_uuid": -1
        }
      ],
      "cited_info": null
    },
    {
      "utterance": "What strategies or partnerships do you think could help maximize the impact of AlphaFold 3 in uncovering new disease targets and driving innovation in the pharmaceutical industry? [72]",
      "raw_utterance": "How can the integration of AlphaFold 3 technology in drug discovery processes be further optimized to enhance the identification of new disease targets and accelerate pharmaceutical innovation?",
      "role": "Moderator",
      "role_description": "",
      "queries": [],
      "utterance_type": "Original Question",
      "claim_to_make": "",
      "raw_retrieved_info": [],
      "cited_info": null
    },
    {
      "utterance": "please provider some strategies or partnerships",
      "raw_utterance": "please provider some strategies or partnerships",
      "role": "Guest",
      "role_description": "",
      "queries": [],
      "utterance_type": "Original Question",
      "claim_to_make": "",
      "raw_retrieved_info": [],
      "cited_info": null
    },
    {
      "utterance": "One exciting way to leverage AlphaFold 3 is by forming strategic partnerships with pharmaceutical companies like Eli Lilly and Novartis, as demonstrated by Isomorphic Labs[73][76]. These collaborations not only speed up drug design processes but also drive the development of cutting-edge treatments[73]. AlphaFold 3's ability to accurately predict protein structures in minutes has truly transformed the field of drug discovery[78][79].\n\nFurthermore, AlphaFold 3's updated model has been trained on a diverse range of biomolecules, including DNA, RNA, and small molecules, allowing for the prediction of a wide variety of biomolecular structures[80]. This includes the ability to predict the structures of complex molecular interactions involving proteins, nucleic acids, small molecules, ions, and more, providing a comprehensive understanding of how these molecules interact[81]. This revolutionary AI-first approach to drug discovery with AlphaFold 3 presents a promising opportunity for startups with venture capital funding to develop new drugs[74].\n\nBy accurately modeling biomolecular interactions, AlphaFold 3 is advancing the development of tailored therapeutic strategies, particularly in understanding the complexities of the immune system for more effective treatments and vaccines[77]. This groundbreaking technology has the potential to significantly impact the understanding and treatment of diseases like COVID-19, pushing forward drug development efforts[77]. Through initiatives like the AlphaFold Server and partnerships with organizations worldwide, AlphaFold 3 is working towards democratizing access to its capabilities and accelerating research in critical areas such as neglected diseases and food security[75][78].",
      "raw_utterance": "One effective strategy for leveraging AlphaFold 3 is through partnerships with pharmaceutical companies like Eli Lilly and Novartis, as seen with Isomorphic Labs[73][76]. These collaborations not only accelerate drug design processes but also enhance the development of innovative and effective treatments[73]. AlphaFold 3's ability to predict protein structures with high accuracy in minutes has revolutionized the understanding of biological processes and drug discovery[78][79].\n\nAdditionally, the expanded training data of AlphaFold 3 includes DNA, RNA, small molecules, and more, enabling the prediction of a wide range of biomolecular structures[80]. This updated model can predict the joint structure of complexes involving proteins, nucleic acids, small molecules, ions, and modified residues, providing a comprehensive view of molecular interactions[81]. Furthermore, the AI-first approach of reimagining the drug discovery process with AlphaFold 3 offers startups with VC funding a realistic chance at developing new drugs[74].\n\nBy modeling biomolecular interactions accurately, AlphaFold 3 contributes to the development of therapeutic strategies tailored to the nuances of the immune system, potentially leading to more effective treatments and vaccines[77]. This transformative technology opens new possibilities in understanding diseases like COVID-19 and advancing drug development efforts[77]. Through initiatives like the AlphaFold Server and partnerships with organizations worldwide, AlphaFold 3 aims to democratize access to its capabilities and accelerate research in underfunded areas such as neglected diseases and food security[75][78].",
      "role": "General Knowledge Provider",
      "role_description": " Focus on broadly covering the basic facts about the question.",
      "queries": [
        "AlphaFold 3 strategies",
        "AlphaFold 3 partnerships"
      ],
      "utterance_type": "Potential Answer",
      "claim_to_make": "please provider some strategies or partnerships",
      "raw_retrieved_info": [
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
          "description": "Isomorphic Labs leverages AlphaFold 3 in collaboration with pharmaceutical partners to enhance drug design processes [6]. This partnership approach not only accelerates drug development cycles but also ensures that new treatments are both innovative and effective, addressing previously intractable ...",
          "snippets": [
            "Isomorphic Labs leverages AlphaFold 3 in collaboration with pharmaceutical partners to enhance drug design processes . This partnership approach not only accelerates drug development cycles but also ensures that new treatments are both innovative and effective, addressing previously intractable disease targets.",
            "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor AlphaFold 2, this innovation has astonished the world with its capacity and speed.",
            "It takes humans years to determine the structure of various proteins and how the shape works with the receptors but AlphaFold 3 predicts the same structure in seconds. The version's utility is unimaginable in the field of drug discoveries, vaccines, enzymatic processes, and determining the rate and effect of different biological processes.",
            "AlphaFold 3 uses similar machine learning and deep learning models such as Gemini (Google DeepMind Technologies Limited). AlphaFold 3 has already established itself as a turning point in the field of computational biochemistry and drug development along with receptor modulation and biomolecular development."
          ],
          "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
          "meta": {
            "query": "AlphaFold 3 partnerships",
            "question": "please provider some strategies or partnerships",
            "placement": "root -> Impact -> Scientific community -> How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry? -> Partnerships for AlphaFold 3 Integration"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://en.wikipedia.org/wiki/AlphaFold",
          "description": "AlphaFold 3 was announced on 8 May 2024. It can predict the structure of complexes created by proteins with DNA, RNA, various ligands, and ions. The new prediction method shows a minimum 50% improvement in accuracy for protein interactions with other molecules compared to existing methods.",
          "snippets": [
            "Hassabis and Jumper had previously won the Breakthrough Prize in Life Sciences and the Albert Lasker Award for Basic Medical Research in 2023 for their leadership of the AlphaFold project. Proteins consist of chains of amino acids which spontaneously fold to form the three dimensional (3-D) structures of the proteins.",
            "AlphaFold 1 (2018) was built on work developed by various teams in the 2010s, work that looked at the large databanks of related DNA sequences now available from many different organisms (most without known 3D structures), to try to find changes at different residues (peptides) that appeared to be correlated, even though the residues were not consecutive in the main chain.",
            "AlphaFold 3 introduces the \"Pairformer,\" a deep learning architecture inspired by the transformer, which is considered similar to, but simpler than, the Evoformer used in AlphaFold 2. The Pairformer module's initial predictions are refined by a diffusion model.",
            "This model begins with a cloud of atoms and iteratively refines their positions, guided by the Pairformer's output, to generate a 3D representation of the molecular structure. The AlphaFold server was created to provide free access to AlphaFold 3 for non-commercial research.",
            "AlphaFold is an artificial intelligence (AI) program developed by DeepMind, a subsidiary of Alphabet, which performs predictions of protein structure. It is designed using deep learning techniques. AlphaFold 1 (2018) placed first in the overall rankings of the 13th Critical Assessment of Structure ..."
          ],
          "title": "AlphaFold - Wikipedia",
          "meta": {
            "query": "AlphaFold 3 partnerships",
            "question": "please provider some strategies or partnerships"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://alphafold.ebi.ac.uk/",
          "description": "AlphaFold Protein Structure Database",
          "snippets": [],
          "title": "AlphaFold Protein Structure Database",
          "meta": {
            "query": "AlphaFold 3 partnerships",
            "question": "please provider some strategies or partnerships"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.drugdiscoverytrends.com/laying-groundwork-alphafold-3-drug-discovery/",
          "description": "Thanks to AlphaFold, startups with roughly $5\u201310 million in VC funding have \u201ca realistic chance at developing a new drug,\u201d which can be sufficient to cover the costs of infrastructure, talent acquisition and initial research. But Big Pharma companies tend to accumulate vast datasets over the years while forging partnerships ...",
          "snippets": [
            "Thanks to AlphaFold, startups with roughly $5\u201310 million in VC funding have \u201ca realistic chance at developing a new drug,\u201d which can be sufficient to cover the costs of infrastructure, talent acquisition and initial research. But Big Pharma companies tend to accumulate vast datasets over the years while forging partnerships with organizations.",
            "With the right approach, AlphaFold 3 promises to streamline drug discovery with advanced biomolecular predictions.",
            "Last week, Google DeepMind launched AlphaFold 3, a significant update to its predecessor, AlphaFold 2. The latter has profoundly influenced structural biology and biomedicine in recent years while also attracting some skepticism. While AlphaFold 2 could accurately predict the structures of vast swathes of proteins, AlphaFold 3 ups the ante.",
            "A Nature paper, published early as it undergoes further editing, explains that AlphaFold 3 boasts a 58% success rate on ligand binding prediction, compared to 24% for AutoDock Vina, an open-source molecular docking program. AlphaFold also outperformed RoseTTAFold2NA, a machine learning-based tool for predicting 3D structures of protein-RNA and protein-DNA complexes."
          ],
          "title": "Laying the groundwork to tap AlphaFold 3's potential in drug ...",
          "meta": {
            "query": "AlphaFold 3 partnerships",
            "question": "please provider some strategies or partnerships",
            "placement": "root -> Impact -> Scientific community -> How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry? -> Partnerships for AlphaFold 3 Integration"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://blog.google/technology/ai/google-deepmind-isomorphic-alphafold-3-ai-model/",
          "description": "We also participated in community-wide ... 3\u2019s launch. AlphaFold Server reflects our ongoing commitment to share the benefits of AlphaFold, including our free database of 200 million protein structures. We\u2019ll also be expanding our free AlphaFold education online course with EMBL-EBI and partnerships with organizations ...",
          "snippets": [
            "We also participated in community-wide forums and discussions ahead of AlphaFold 3\u2019s launch. AlphaFold Server reflects our ongoing commitment to share the benefits of AlphaFold, including our free database of 200 million protein structures. We\u2019ll also be expanding our free AlphaFold education online course with EMBL-EBI and partnerships with organizations in the Global South to equip scientists with the tools they need to accelerate adoption and research, including on underfunded areas such as neglected diseases and food security.",
            "Our new AI model AlphaFold 3 can predict the structure and interactions of all life\u2019s molecules with unprecedented accuracy.",
            "We hope AlphaFold 3 will help transform our understanding of the biological world and drug discovery. Scientists can access the majority of its capabilities, for free, through our newly launched AlphaFold Server, an easy-to-use research tool.",
            "To build on AlphaFold 3\u2019s potential for drug design, Isomorphic Labs is already collaborating with pharmaceutical companies to apply it to real-world drug design challenges and, ultimately, develop new life-changing treatments for patients."
          ],
          "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
          "meta": {
            "query": "AlphaFold 3 partnerships",
            "question": "please provider some strategies or partnerships",
            "placement": "root -> Impact -> Scientific community -> How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry? -> Partnerships for AlphaFold 3 Integration"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.isomorphiclabs.com/articles/rational-drug-design-with-alphafold-3",
          "description": "We\u2019ve already deployed our frontier version of AlphaFold 3 in our own internal pipeline of projects, and in our partnerships with pharmaceutical companies.",
          "snippets": [
            "We are reimagining the entire drug discovery process from first principles with an AI-first approach.",
            "To move this understanding forwards, together with Google DeepMind we have developed AlphaFold 3, our breakthrough artificial intelligence (AI) model that provides an accurate atomic-level view of the structure of biomolecular systems.",
            "These inputs are processed by AlphaFold 3, which is a generative model composed of a neural network architecture that builds upon a custom Transformer with triangular attention, and uses a diffusion process to generate individual 3D coordinates of every atom in the input-specified system.",
            "For Isomorphic Labs, AlphaFold 3 equips our drug designers with the ability to quickly and accurately predict the structure of complexes that have never been characterised before, giving us a fundamental tool that allows us to take novel approaches to drug design."
          ],
          "title": "Rational drug design with AlphaFold 3 - Isomorphic Labs",
          "meta": {
            "query": "AlphaFold 3 partnerships",
            "question": "please provider some strategies or partnerships"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://github.com/kyegomez/AlphaFold3",
          "description": "Implementation of Alpha Fold 3 from the paper: \"Accurate structure prediction of biomolecular interactions with AlphaFold3\" in PyTorch - kyegomez/AlphaFold3",
          "snippets": [
            "@article{Abramson2024-fj, title = \"Accurate structure prediction of biomolecular interactions with {AlphaFold} 3\", author = \"Abramson, Josh and Adler, Jonas and Dunger, Jack and Evans, Richard and Green, Tim and Pritzel, Alexander and Ronneberger, Olaf and Willmore, Lindsay and Ballard, Andrew J and Bambrick, Joshua and Bodenstein, Sebastian W and Evans, David A and Hung, Chia-Chun and O'Neill, Michael and Reiman, David and Tunyasuvunakool, Kathryn and Wu, Zachary and {\\v Z}emgulyt{\\.e}, Akvil{\\.e} and Arvaniti, Eirini and Beattie, Charles and Bertolli, Ottavia and Bridgland, Alex and Cherepan",
            "-> to counteract hallucination, they use a novel cross distillation method where they enrich the training data with alphafold multimer v2.3 predicted strutctures.",
            "-> confidence head uses the pairwise representation to predict the lddt (pddt) and a predicted aligned error matrix as used in alphafold 2 as well as distance error matrix which is the error in the distance matrix of the predicted structure as compared to the true structure",
            "Implement input Embedder from Alphafold2 openfold implementation LINK"
          ],
          "title": "GitHub - kyegomez/AlphaFold3: Implementation of Alpha Fold 3 from ...",
          "meta": {
            "query": "AlphaFold 3 partnerships",
            "question": "please provider some strategies or partnerships"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11292590/",
          "description": "Isomorphic Labs leverages AlphaFold 3 in collaboration with pharmaceutical partners to enhance drug design processes [6]. This partnership approach not only accelerates drug development cycles but also ensures that new treatments are both innovative and effective, addressing previously intractable ...",
          "snippets": [
            "Isomorphic Labs leverages AlphaFold 3 in collaboration with pharmaceutical partners to enhance drug design processes . This partnership approach not only accelerates drug development cycles but also ensures that new treatments are both innovative and effective, addressing previously intractable disease targets.",
            "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor AlphaFold 2, this innovation has astonished the world with its capacity and speed.",
            "It takes humans years to determine the structure of various proteins and how the shape works with the receptors but AlphaFold 3 predicts the same structure in seconds. The version's utility is unimaginable in the field of drug discoveries, vaccines, enzymatic processes, and determining the rate and effect of different biological processes.",
            "AlphaFold 3 uses similar machine learning and deep learning models such as Gemini (Google DeepMind Technologies Limited). AlphaFold 3 has already established itself as a turning point in the field of computational biochemistry and drug development along with receptor modulation and biomolecular development."
          ],
          "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
          "meta": {
            "query": "AlphaFold 3 partnerships",
            "question": "please provider some strategies or partnerships"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://github.com/google-deepmind/alphafold3",
          "description": "AlphaFold 3 inference pipeline. Contribute to google-deepmind/alphafold3 development by creating an account on GitHub.",
          "snippets": [
            "This package provides an implementation of the inference pipeline of AlphaFold 3. See below for how to access the model parameters. You may only use AlphaFold 3 model parameters if received directly from Google.",
            "Any publication that discloses findings arising from using this source code, the model parameters or outputs produced by those should cite the Accurate structure prediction of biomolecular interactions with AlphaFold 3 paper.",
            "This repository contains all necessary code for AlphaFold 3 inference. To request access to the AlphaFold 3 model parameters, please complete this form. Access will be granted at Google DeepMind\u2019s sole discretion. We will aim to respond to requests within 2\u20133 business days.",
            "The AlphaFold 3 source code is licensed under the Creative Commons Attribution-Non-Commercial ShareAlike International License, Version 4.0 (CC-BY-NC-SA 4.0) (the \"License\"); you may not use this file except in compliance with the License."
          ],
          "title": "GitHub - google-deepmind/alphafold3: AlphaFold 3 inference pipeline.",
          "meta": {
            "query": "AlphaFold 3 partnerships",
            "question": "please provider some strategies or partnerships"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.labiotech.eu/in-depth/alpha-fold-3-drug-discovery/",
          "description": "The withholding of the code was largely down to commercial reasons, as co-developer Isomorphic Labs, a DeepMind spinoff company, is using AlphaFold3 internally to speed up its drug discovery efforts. The company currently has partnerships potentially worth $3 billion with Eli Lilly and Novartis ...",
          "snippets": [
            "The withholding of the code was largely down to commercial reasons, as co-developer Isomorphic Labs, a DeepMind spinoff company, is using AlphaFold3 internally to speed up its drug discovery efforts. The company currently has partnerships potentially worth $3 billion with Eli Lilly and Novartis aimed at developing multiple drugs.",
            "Find out how Google DeepMind's AlphaFold3 platform could help scientists revolutionize the field of drug discovery.",
            "To learn how to puzzle out the precise atomic structures of molecules, AlphaFold3 uses a diffusion model, similar to ones used for popular text-to-image generation models such as OpenAI\u2019s DALL-E 3.",
            "Building on the foundations of its hugely successful AlphaFold2, which made a fundamental breakthrough in protein structure prediction in 2020, Google DeepMind and its sister company Isomorphic Labs launched AlphaFold3 in May."
          ],
          "title": "Can AlphaFold3's open-source platform revolutionize the way we ...",
          "meta": {
            "query": "AlphaFold 3 partnerships",
            "question": "please provider some strategies or partnerships",
            "placement": "root -> Impact -> Scientific community -> How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry? -> Partnerships for AlphaFold 3 Integration"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
          "description": "This capability is instrumental ... treatments and vaccines [23,24]. By modeling these interactions with high accuracy, AlphaFold 3 aids in the development of therapeutic strategies that are finely tuned to the nuances of immune system behavior [8]....",
          "snippets": [
            "This capability is instrumental in advancing our understanding of how diseases like COVID-19 can be combated through the immune system, potentially leading to more effective treatments and vaccines . By modeling these interactions with high accuracy, AlphaFold 3 aids in the development of therapeutic strategies that are finely tuned to the nuances of immune system behavior .",
            "The detailed structural insights provided by AlphaFold 3 into DNA and RNA open new avenues in genomics, significantly impacting personalized medicine. By understanding how genetic variations affect protein functions, tailored therapeutic strategies can be developed for individuals based on their unique genetic profiles .",
            "These predictions facilitate the discovery of enzymes originating from bacteriophages that can degrade bacterial pathogens' cell walls, offering new avenues in antibacterial treatment strategies . ... In the fight against viruses like SARS-CoV-2, AlphaFold has been instrumental.",
            "AlphaFold has also made significant contributions outside of human medicine, such as in agriculture. By predicting the structure of enzymes from soil-borne fungi that affect plant health, researchers can develop strategies to enhance crop resilience and health."
          ],
          "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
          "meta": {
            "query": "AlphaFold 3 strategies",
            "question": "please provider some strategies or partnerships",
            "placement": "root -> Impact -> Scientific community -> How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry? -> Strategies for AlphaFold 3 Integration"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://en.wikipedia.org/wiki/AlphaFold",
          "description": "AlphaFold 3 was announced on 8 May 2024. It can predict the structure of complexes created by proteins with DNA, RNA, various ligands, and ions. The new prediction method shows a minimum 50% improvement in accuracy for protein interactions with other molecules compared to existing methods.",
          "snippets": [
            "Hassabis and Jumper had previously won the Breakthrough Prize in Life Sciences and the Albert Lasker Award for Basic Medical Research in 2023 for their leadership of the AlphaFold project. Proteins consist of chains of amino acids which spontaneously fold to form the three dimensional (3-D) structures of the proteins.",
            "AlphaFold 1 (2018) was built on work developed by various teams in the 2010s, work that looked at the large databanks of related DNA sequences now available from many different organisms (most without known 3D structures), to try to find changes at different residues (peptides) that appeared to be correlated, even though the residues were not consecutive in the main chain.",
            "AlphaFold 3 introduces the \"Pairformer,\" a deep learning architecture inspired by the transformer, which is considered similar to, but simpler than, the Evoformer used in AlphaFold 2. The Pairformer module's initial predictions are refined by a diffusion model.",
            "This model begins with a cloud of atoms and iteratively refines their positions, guided by the Pairformer's output, to generate a 3D representation of the molecular structure. The AlphaFold server was created to provide free access to AlphaFold 3 for non-commercial research.",
            "AlphaFold is an artificial intelligence (AI) program developed by DeepMind, a subsidiary of Alphabet, which performs predictions of protein structure. It is designed using deep learning techniques. AlphaFold 1 (2018) placed first in the overall rankings of the 13th Critical Assessment of Structure ..."
          ],
          "title": "AlphaFold - Wikipedia",
          "meta": {
            "query": "AlphaFold 3 strategies",
            "question": "please provider some strategies or partnerships"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://blog.google/technology/ai/google-deepmind-isomorphic-alphafold-3-ai-model/",
          "description": "Our new AI model AlphaFold 3 can predict the structure and interactions of all life\u2019s molecules with unprecedented accuracy.",
          "snippets": [
            "We hope AlphaFold 3 will help transform our understanding of the biological world and drug discovery. Scientists can access the majority of its capabilities, for free, through our newly launched AlphaFold Server, an easy-to-use research tool.",
            "To build on AlphaFold 3\u2019s potential for drug design, Isomorphic Labs is already collaborating with pharmaceutical companies to apply it to real-world drug design challenges and, ultimately, develop new life-changing treatments for patients.",
            "So far, millions of researchers globally have used AlphaFold 2 to make discoveries in areas including malaria vaccines, cancer treatments and enzyme design. AlphaFold has been cited more than 20,000 times and its scientific impact recognized through many prizes, most recently the Breakthrough Prize in Life Sciences. AlphaFold 3 takes us beyond proteins to a broad spectrum of biomolecules.",
            "Given an input list of molecules, AlphaFold 3 generates their joint 3D structure, revealing how they all fit together. It models large biomolecules such as proteins, DNA and RNA, as well as small molecules, also known as ligands \u2014 a category encompassing many drugs."
          ],
          "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
          "meta": {
            "query": "AlphaFold 3 strategies",
            "question": "please provider some strategies or partnerships",
            "placement": "root -> Impact -> Scientific community -> How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry? -> Strategies for AlphaFold 3 Integration"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11292590/",
          "description": "This capability is instrumental ... treatments and vaccines [23,24]. By modeling these interactions with high accuracy, AlphaFold 3 aids in the development of therapeutic strategies that are finely tuned to the nuances of immune system behavior [8]....",
          "snippets": [
            "This capability is instrumental in advancing our understanding of how diseases like COVID-19 can be combated through the immune system, potentially leading to more effective treatments and vaccines . By modeling these interactions with high accuracy, AlphaFold 3 aids in the development of therapeutic strategies that are finely tuned to the nuances of immune system behavior .",
            "The detailed structural insights provided by AlphaFold 3 into DNA and RNA open new avenues in genomics, significantly impacting personalized medicine. By understanding how genetic variations affect protein functions, tailored therapeutic strategies can be developed for individuals based on their unique genetic profiles .",
            "These predictions facilitate the discovery of enzymes originating from bacteriophages that can degrade bacterial pathogens' cell walls, offering new avenues in antibacterial treatment strategies . ... In the fight against viruses like SARS-CoV-2, AlphaFold has been instrumental.",
            "AlphaFold has also made significant contributions outside of human medicine, such as in agriculture. By predicting the structure of enzymes from soil-borne fungi that affect plant health, researchers can develop strategies to enhance crop resilience and health."
          ],
          "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
          "meta": {
            "query": "AlphaFold 3 strategies",
            "question": "please provider some strategies or partnerships"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://deepmind.google/technologies/alphafold/",
          "description": "AlphaFold has revealed millions of intricate 3D protein structures, and is helping scientists understand how all of life\u2019s molecules interact.",
          "snippets": [
            "Made from long chains of amino acids, each has a unique complex 3D structure. But figuring out just one of these can take several years, and hundreds of thousands of dollars. In 2020, AlphaFold solved this problem, with the ability to predict protein structures in minutes, to a remarkable degree of accuracy.",
            "AlphaFold has revealed millions of intricate 3D protein structures, and is helping scientists understand how life\u2019s molecules interact.",
            "Access the AlphaFold 3 model code and weights for academic use.",
            "So far, AlphaFold has predicted over 200 million protein structures \u2013 nearly all catalogued proteins known to science. The AlphaFold Protein Structure Database makes this data freely available. So far, it has over two million users in 190 countries."
          ],
          "title": "AlphaFold - Google DeepMind",
          "meta": {
            "query": "AlphaFold 3 strategies",
            "question": "please provider some strategies or partnerships",
            "placement": "root -> Impact -> Scientific community -> How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry? -> Strategies for AlphaFold 3 Integration"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://blog.google/technology/ai/how-we-built-alphafold-3/",
          "description": "In order to get AlphaFold 3 to work with this much wider range of biomolecules, the team vastly expanded the data that the newer model was trained on to include DNA, RNA, small molecules and more. \u201cWe were able to say, \u2018Let's just train on everything that exists in this dataset that helped ...",
          "snippets": [
            "In order to get AlphaFold 3 to work with this much wider range of biomolecules, the team vastly expanded the data that the newer model was trained on to include DNA, RNA, small molecules and more. \u201cWe were able to say, \u2018Let's just train on everything that exists in this dataset that helped us so much with proteins and let\u2019s see how far we can get,\u2019\u201d Lindsay says.",
            "Where AlphaFold 2 used a complex custom geometry-based module, AlphaFold 3 uses a generative model that\u2019s based on diffusion \u2014 similar to our other cutting-edge image generation models, like Imagen \u2014 which greatly simplified how the model handles all the new molecule types.",
            "So the team turned to AlphaFold 2, which is already extremely good at predicting which interactions would be disordered \u2014 which look like a pile of chaotic spaghetti \u2014 and which ones were not. \u201cWe were able to use those predicted structures from AlphaFold 2 as distillation training for AlphaFold 3, so that AlphaFold 3 could learn to predict disorder,\u201d Lindsay says.",
            "Instead, they got started on AlphaFold 3."
          ],
          "title": "How we built AlphaFold 3 to predict the structure and interaction ...",
          "meta": {
            "query": "AlphaFold 3 strategies",
            "question": "please provider some strategies or partnerships",
            "placement": "root -> Impact -> Scientific community -> How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry? -> Strategies for AlphaFold 3 Integration"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://github.com/kyegomez/AlphaFold3",
          "description": "Implementation of Alpha Fold 3 from the paper: \"Accurate structure prediction of biomolecular interactions with AlphaFold3\" in PyTorch - kyegomez/AlphaFold3",
          "snippets": [
            "@article{Abramson2024-fj, title = \"Accurate structure prediction of biomolecular interactions with {AlphaFold} 3\", author = \"Abramson, Josh and Adler, Jonas and Dunger, Jack and Evans, Richard and Green, Tim and Pritzel, Alexander and Ronneberger, Olaf and Willmore, Lindsay and Ballard, Andrew J and Bambrick, Joshua and Bodenstein, Sebastian W and Evans, David A and Hung, Chia-Chun and O'Neill, Michael and Reiman, David and Tunyasuvunakool, Kathryn and Wu, Zachary and {\\v Z}emgulyt{\\.e}, Akvil{\\.e} and Arvaniti, Eirini and Beattie, Charles and Bertolli, Ottavia and Bridgland, Alex and Cherepan",
            "-> to counteract hallucination, they use a novel cross distillation method where they enrich the training data with alphafold multimer v2.3 predicted strutctures.",
            "-> confidence head uses the pairwise representation to predict the lddt (pddt) and a predicted aligned error matrix as used in alphafold 2 as well as distance error matrix which is the error in the distance matrix of the predicted structure as compared to the true structure",
            "Implement input Embedder from Alphafold2 openfold implementation LINK"
          ],
          "title": "GitHub - kyegomez/AlphaFold3: Implementation of Alpha Fold 3 from ...",
          "meta": {
            "query": "AlphaFold 3 strategies",
            "question": "please provider some strategies or partnerships"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.nature.com/articles/s41586-024-07487-w",
          "description": "AlphaFold 3 has a substantially updated architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and modified residues with greatly improved accuracy over many previous specialized tools.",
          "snippets": [
            "The introduction of AlphaFold 21 has spurred a revolution in modelling the structure of proteins and their interactions, enabling a huge range of applications in protein modelling and design2\u20136. Here we describe our AlphaFold 3 model with a substantially updated diffusion-based architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and modified residues.",
            "Nature - AlphaFold 3 has a substantially updated architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and...",
            "The new AlphaFold model demonstrates substantially improved accuracy over many previous specialized tools: far greater accuracy for protein\u2013ligand interactions compared with state-of-the-art docking tools, much higher accuracy for protein\u2013nucleic acid interactions compared with nucleic-acid-specific predictors and substantially higher antibody\u2013antigen prediction accuracy compared with AlphaFold-Multimer v.2.37,8. Together, these results show that high-accuracy modelling across biomolecular space is possible within a single unified deep-learning framework. ... Accurate models of biological complexes are critical to our understanding of cellular functions and for the rational design of therapeutics2,3,4,9.",
            "Here we present AlphaFold 3 (AF3)\u2014a model that is capable of high-accuracy prediction of complexes containing nearly all molecular types present in the Protein Data Bank32 (PDB) (Fig. 1a,b). In all but one category, it achieves a substantially higher performance than strong methods that specialize in just the given task (Fig."
          ],
          "title": "Accurate structure prediction of biomolecular interactions with ...",
          "meta": {
            "query": "AlphaFold 3 strategies",
            "question": "please provider some strategies or partnerships",
            "placement": "root -> Impact -> Scientific community -> How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry? -> Strategies for AlphaFold 3 Integration"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.isomorphiclabs.com/articles/alphafold-3-predicts-the-structure-and-interactions-of-all-of-lifes-molecules",
          "description": "We are reimagining the entire drug discovery process from first principles with an AI-first approach.",
          "snippets": [
            "AlphaFold 3 predicts the structure and interactions of all of life\u2019s molecules",
            "We hope AlphaFold 3 will help transform our understanding of the biological world and drug discovery. Scientists can access the majority of its capabilities, for free, through the newly launched AlphaFold Server, an easy-to-use research tool.",
            "To build on AlphaFold 3\u2019s potential for drug design, we at Isomorphic Labs are already collaborating with pharmaceutical companies to apply it to real-world drug design challenges and, ultimately, develop new life-changing treatments for patients.",
            "So far, millions of researchers globally have used AlphaFold 2 to make discoveries in areas including malaria vaccines, cancer treatments, and enzyme design. AlphaFold has been cited more than 20,000 times and its scientific impact recognized through many prizes, most recently the Breakthrough Prize in Life Sciences. AlphaFold 3 takes us beyond proteins to a broad spectrum of biomolecules."
          ],
          "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
          "meta": {
            "query": "AlphaFold 3 strategies",
            "question": "please provider some strategies or partnerships"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://cen.acs.org/analytical-chemistry/structural-biology/AlphaFold-3-offer-structure-prediction/102/i15",
          "description": "Tool can predict structures of proteins and nucleic acids bound to ions, ligands, and one another",
          "snippets": [
            "Could you just tell me how it binds the DNA?\u201d John Jumper, a director at Google DeepMind, said during a press conference. Unlike past versions, AlphaFold 3, which was codeveloped with drug company Isomorphic Labs and first announced in October, can tackle such interactions.",
            "AlphaFold 3 shares many capabilities with the recently published RoseTTAFold All-Atom model. Though it lacks RoseTTAFold\u2019s ability to design new proteins, AlphaFold 3 has one big advantage: a new web server with a simple interface that requires no coding by the user.",
            "Casual users beware: AlphaFold 3 will predict the most likely structure of any combination of input molecules, whether or not they genuinely interact. According to Jaderberg, the model assigns low confidence scores to complexes that are not thought to occur in the real world.",
            "This article was updated on May 16, 2024, to add information about a letter to Nature by structural and computational biologists as well as a paper on an open-source program called OpenFold. The update also added a space to correct the name of AlphaFold 3."
          ],
          "title": "AlphaFold 3 to offer structure prediction via web browser",
          "meta": {
            "query": "AlphaFold 3 strategies",
            "question": "please provider some strategies or partnerships"
          },
          "citation_uuid": -1
        }
      ],
      "cited_info": null
    }
  ],
  "warmstart_conv_archive": [
    {
      "utterance": "AlphaFold 3, the latest iteration of the groundbreaking AI program developed by Google DeepMind and Isomorphic Labs, represents a significant advancement in predicting the structures and interactions of biomolecules[6][7]. This new model, released in May, goes beyond just protein folding structures to accurately predict protein-molecule complexes containing DNA, RNA, and more[7]. By vastly expanding the data it was trained on to include a wider range of biomolecules, AlphaFold 3 is able to provide high-accuracy predictions for nearly all molecular types present in the Protein Data Bank[1][3].\n\nThe potential of AlphaFold 3 in revolutionizing research and drug discovery has been widely acknowledged, with experts recognizing its transformative impact in understanding how all of life's molecules interact[2][8]. The technology's ability to predict intricate 3D protein structures has already provided valuable insights for scientists and researchers, paving the way for new discoveries and advancements in the field[2].\n\nDespite the initial controversy surrounding the limited access to the code of AlphaFold 3, its release for academic use in November 2024 is a significant step towards advancing research in computational structural biology[4][9]. With its promise of greater predictive abilities and the ability to identify promising compounds faster, AlphaFold 3 has the potential to become a valuable tool in life science research, potentially evolving into a multi-hundred billion dollar business[5][8].\n\nOverall, AlphaFold 3 represents a major leap forward in the field of computational structural biology, offering researchers a powerful tool to predict biomolecular complexes with high accuracy and efficiency[10]. The continuous development and refinement of this technology highlight its importance in shaping the future of scientific research and drug discovery.",
      "raw_utterance": "AlphaFold 3, the latest iteration of the groundbreaking AI program developed by Google DeepMind and Isomorphic Labs, represents a significant advancement in predicting the structures and interactions of biomolecules[6][7]. This new model, released in May, goes beyond just protein folding structures to accurately predict protein-molecule complexes containing DNA, RNA, and more[7]. By vastly expanding the data it was trained on to include a wider range of biomolecules, AlphaFold 3 is able to provide high-accuracy predictions for nearly all molecular types present in the Protein Data Bank[1][3].\n\nThe potential of AlphaFold 3 in revolutionizing research and drug discovery has been widely acknowledged, with experts recognizing its transformative impact in understanding how all of life's molecules interact[2][8]. The technology's ability to predict intricate 3D protein structures has already provided valuable insights for scientists and researchers, paving the way for new discoveries and advancements in the field[2].\n\nDespite the initial controversy surrounding the limited access to the code of AlphaFold 3, its release for academic use in November 2024 is a significant step towards advancing research in computational structural biology[4][9]. With its promise of greater predictive abilities and the ability to identify promising compounds faster, AlphaFold 3 has the potential to become a valuable tool in life science research, potentially evolving into a multi-hundred billion dollar business[5][8].\n\nOverall, AlphaFold 3 represents a major leap forward in the field of computational structural biology, offering researchers a powerful tool to predict biomolecular complexes with high accuracy and efficiency[10]. The continuous development and refinement of this technology highlight its importance in shaping the future of scientific research and drug discovery.",
      "role": "Default Background Researcher",
      "role_description": "",
      "queries": [
        "What is AlphaFold 3?",
        "How does AlphaFold 3 work?"
      ],
      "utterance_type": "Questioning",
      "claim_to_make": "Background information about AlphaFold 3",
      "raw_retrieved_info": [
        {
          "url": "https://www.nature.com/articles/s41586-024-07487-w",
          "description": "A wide range of predictors for ... present work29, but the accuracy of such deep-learning attempts has been mixed and often below that of physics-inspired methods30,31. Almost all of these methods are also highly specialized to particular interaction types and cannot predict the structure of general biomolecular complexes containing many types of entities. Here we present AlphaFold 3 (AF3)\u2014a ...",
          "snippets": [
            "A wide range of predictors for various specific interaction types has been developed16,17,18,19,20,21,22,23,24,25,26,27,28, as well as one generalist method developed concurrently with the present work29, but the accuracy of such deep-learning attempts has been mixed and often below that of physics-inspired methods30,31. Almost all of these methods are also highly specialized to particular interaction types and cannot predict the structure of general biomolecular complexes containing many types of entities. Here we present AlphaFold 3 (AF3)\u2014a model that is capable of high-accuracy prediction of complexes containing nearly all molecular types present in the Protein Data Bank32 (PDB) (Fig.",
            "Nature thanks Justas Dapkunas, Roland Dunbrack and Hashim Al-Hashimi for their contribution to the peer review of this work. Publisher\u2019s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. a, Example prediction for a disordered protein from AlphaFoldMultimer v2.3, AlphaFold 3, and AlphaFold 3 trained without the disordered protein PDB cross distillation set.",
            "AlphaFold 3 has a substantially updated architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and modified residues with greatly improved accuracy over many previous specialized tools.",
            "The introduction of AlphaFold 21 has spurred a revolution in modelling the structure of proteins and their interactions, enabling a huge range of applications in protein modelling and design2\u20136. Here we describe our AlphaFold 3 model with a substantially updated diffusion-based architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and modified residues."
          ],
          "title": "Accurate structure prediction of biomolecular interactions with ...",
          "meta": {
            "query": "How does AlphaFold 3 work?",
            "question": "Background information about AlphaFold 3",
            "placement": "root -> History -> Development"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://blog.google/technology/ai/google-deepmind-isomorphic-alphafold-3-ai-model/",
          "description": "Update November 11, 2024: As of ... 3 model code and weights for academic use to help advance research. Learn more about AlphaFold tools. Original post: Inside every plant, animal and human cell are billions of molecular machines. They\u2019re made up of proteins, DNA and other molecules, but no single piece works on its ...",
          "snippets": [
            "Update November 11, 2024: As of November 2024, we have released AlphaFold 3 model code and weights for academic use to help advance research. Learn more about AlphaFold tools. Original post: Inside every plant, animal and human cell are billions of molecular machines. They\u2019re made up of proteins, DNA and other molecules, but no single piece works on its own.",
            "With just a few clicks, biologists can harness the power of AlphaFold 3 to model structures composed of proteins, DNA, RNA and a selection of ligands, ions and chemical modifications. AlphaFold Server helps scientists make novel hypotheses to test in the lab, speeding up workflows and enabling further innovation.",
            "We\u2019ll continue to work with the scientific community and policy makers to develop and deploy AI technologies responsibly. 7BBV - Enzyme: AlphaFold 3\u2019s prediction for a molecular complex featuring an enzyme protein (blue), an ion (yellow sphere) and simple sugars (yellow), along with the true structure (gray).",
            "Using AlphaFold 3 in combination with a complementary suite of in-house AI models, Isomorphic Labs is working on drug design for internal projects as well as with pharmaceutical partners."
          ],
          "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
          "meta": {
            "query": "How does AlphaFold 3 work?",
            "question": "Background information about AlphaFold 3"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://deepmind.google/technologies/alphafold/",
          "description": "Access the AlphaFold 3 model code and weights for academic use. ... Inside every cell of your body, billions of tiny machines \u2013 proteins \u2013 are hard at work.",
          "snippets": [
            "AlphaFold has revealed millions of intricate 3D protein structures, and is helping scientists understand how all of life\u2019s molecules interact.",
            "Made from long chains of amino acids, each has a unique complex 3D structure. But figuring out just one of these can take several years, and hundreds of thousands of dollars. In 2020, AlphaFold solved this problem, with the ability to predict protein structures in minutes, to a remarkable degree of accuracy.",
            "AlphaFold has revealed millions of intricate 3D protein structures, and is helping scientists understand how life\u2019s molecules interact.",
            "So far, AlphaFold has predicted over 200 million protein structures \u2013 nearly all catalogued proteins known to science. The AlphaFold Protein Structure Database makes this data freely available. So far, it has over two million users in 190 countries."
          ],
          "title": "AlphaFold - Google DeepMind",
          "meta": {
            "query": "How does AlphaFold 3 work?",
            "question": "Background information about AlphaFold 3",
            "placement": "root -> History -> Development"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.nature.com/articles/d41586-024-01385-x",
          "description": "And now there's a new version, AlphaFold 3, which promises even greater predictive abilities. To dive into the details of this upgrade, I'm joined by Ewen Callaway who has been writing about AlphaFold, well, basically since the beginning \u2014 for years now \u2014 and has been working on a new story ...",
          "snippets": [
            "And now there's a new version, AlphaFold 3, which promises even greater predictive abilities. To dive into the details of this upgrade, I'm joined by Ewen Callaway who has been writing about AlphaFold, well, basically since the beginning \u2014 for years now \u2014 and has been working on a new story about the latest iteration AlphaFold3.",
            "And so with the predictions that he got from AlphaFold 3 his lab started making mutations to their protein to try and alter, you know, how it bound DNA and found that some of these really panned out that the predictions were kind of on the spot. So it gives him some insight into how this protein he's interested in does its job.",
            "Deepmind\u2019s protein-structure predictor adds other molecules to the mix, and a big step towards a \u2018nuclear clock\u2019. Hear the biggest stories from the world of science | 8 May 2024",
            "Nature - Hear the biggest stories from the world of science | 8 May 2024"
          ],
          "title": "Alphafold 3.0: the AI protein predictor gets an upgrade",
          "meta": {
            "query": "How does AlphaFold 3 work?",
            "question": "Background information about AlphaFold 3"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.reddit.com/r/singularity/comments/1cn6tfk/announcing_alphafold_3_our_stateoftheart_ai_model/",
          "description": "You still have to figure out which drugs will work, and then do clinical trials. In addition, CRISP did not have access to anything like the AI in 2009 that it does now. AlphaFold 3 has significantly reduced the bottleneck by being able to much better predict which drugs will actually work.",
          "snippets": [
            "And how does it relate to AlphaFold? Because I would make an educated guess that sickle cell anemia therapy is a much older thing. ... It is slow, that's true. A lot of it is the glacial regulatory approval processes, e.g. without COVID we likely wouldn't have mRNA-based vaccines yet. But it's also that technology like gene editing is useless if you can't work out what edits to make.",
            "There has been over 21k research papers based on work with alphafold since it's first release. Alphafold 3 will put that into hyper drive.",
            "Seems fine to me, big pharma doesn't need subsidies. And they open sourced the previous two models. ... That is an bit odd comparison tbh. One is a wildly applicable deep learning architecture and the other one is a specialized trained model which probably cost hundreds of millions of dollars to develop with the models that came beforehand included. ... The code for AlphaFold 3 will be available online in about six months anyway, according to a source I can't recall now.",
            "1.2K votes, 236 comments. 3.6M subscribers in the singularity community. Everything pertaining to the technological singularity and related topics\u2026"
          ],
          "title": "r/singularity on Reddit: Announcing AlphaFold 3: our state-of-the-art ...",
          "meta": {
            "query": "How does AlphaFold 3 work?",
            "question": "Background information about AlphaFold 3"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://frontlinegenomics.com/alphafold-3-stepping-into-the-future-of-structure-prediction/",
          "description": "We love the excitement & results from the community on AlphaFold 3 and are doubling the AF Server daily job limit to 20. Happy to also share that we're working on releasing the AF3 model (incl weights) for academic use, which doesn\u2019t depend on our research infra, within 6 months.\u2014 Pushmeet ...",
          "snippets": [
            "We love the excitement & results from the community on AlphaFold 3 and are doubling the AF Server daily job limit to 20. Happy to also share that we're working on releasing the AF3 model (incl weights) for academic use, which doesn\u2019t depend on our research infra, within 6 months.\u2014 Pushmeet Kohli (@pushmeet) May 13, 2024",
            "Although the release of AlphaFold 3 may feel like a huge jump from where we were just a few short years ago, it\u2019s likely that we\u2019ll continue to see improvements to this technology in the not-too-distant future. Even with AI tools like AlphaFold, the latter stages of the drug discovery journey, in particular, still take a significant length of time. Whilst the emergence of new AI models will cut the time and cost required to an extent, there is a still a huge amount of work to be done before we truly see a transformation of the journey from bench to clinic.",
            "The first version of the technology was released in 2018, but it was 2020\u2019s AlphaFold 2 that made headlines \u2013 winning the prestigious Critical Assessment of Structure Prediction (CASP) 14 competition. Having gone through multiple major iterations, the most recent release, AlphaFold 3, is set to further transform the protein space. But what does it do, and how may it outperform its predecessor?",
            "In this news highlight, we explore AlphaFold3, compare it to its predecessor and take a look to the future."
          ],
          "title": "AlphaFold 3: Stepping into the future of structure prediction - ...",
          "meta": {
            "query": "How does AlphaFold 3 work?",
            "question": "Background information about AlphaFold 3"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://blog.google/technology/ai/how-we-built-alphafold-3/",
          "description": "\u201cAny user who doesn't know how to code at all can just copy and paste the sequences of their proteins, DNA, RNA or the name of their small molecule, press a button and wait a few minutes. Their structure and the confidence metrics will come out so that they're able to look at and evaluate their prediction.\u201d \u00b7 In order to get AlphaFold 3 to work ...",
          "snippets": [
            "\u201cAny user who doesn't know how to code at all can just copy and paste the sequences of their proteins, DNA, RNA or the name of their small molecule, press a button and wait a few minutes. Their structure and the confidence metrics will come out so that they're able to look at and evaluate their prediction.\u201d \u00b7 In order to get AlphaFold 3 to work with this much wider range of biomolecules, the team vastly expanded the data that the newer model was trained on to include DNA, RNA, small molecules and more.",
            "\u201cEverything\u201d includes ligands, which make up about half of all drugs. \u201cAt Isomorphic Labs, we see the tremendous potential of AlphaFold 3 for rational drug design, and we\u2019re already using it in our day-to-day work,\u201d says Adrian Stecula, research leader at Isomorphic Labs.",
            "Instead, they got started on AlphaFold 3. This newer model, which the teams at Google DeepMind and Isomorphic Labs launched in May, builds on our previous models by predicting not just protein folding structures, but predicting the structure and interactions of all of life's molecules, including DNA, RNA and ligands (small molecules that bind to proteins). \u201cWith AlphaFold 2, we made enormous progress on this decades-old open problem of protein folding, but if you look at recent high-impact research, researchers are moving beyond that,\u201d says Jonas Adler, research scientist at Google DeepMind.",
            "Another major change in AlphaFold 3 is a shift in architecture for the final part of the model that generates the structure. Where AlphaFold 2 used a complex custom geometry-based module, AlphaFold 3 uses a generative model that\u2019s based on diffusion \u2014 similar to our other cutting-edge image generation models, like Imagen \u2014 which greatly simplified how the model handles all the new molecule types."
          ],
          "title": "How we built AlphaFold 3 to predict the structure and interaction ...",
          "meta": {
            "query": "How does AlphaFold 3 work?",
            "question": "Background information about AlphaFold 3",
            "placement": "root -> History -> Development"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.isomorphiclabs.com/articles/alphafold-3-predicts-the-structure-and-interactions-of-all-of-lifes-molecules",
          "description": "Update November 11, 2024: As of ... 3 model code and weights for academic use to help advance research. Learn more about AlphaFold tools. ... Inside every plant, animal, and human cell are billions of molecular machines. They\u2019re made up of proteins, DNA, and other molecules, but no single piece works on its ...",
          "snippets": [
            "Update November 11, 2024: As of November 2024, we have released AlphaFold 3 model code and weights for academic use to help advance research. Learn more about AlphaFold tools. ... Inside every plant, animal, and human cell are billions of molecular machines. They\u2019re made up of proteins, DNA, and other molecules, but no single piece works on its own.",
            "With just a few clicks, biologists can harness the power of AlphaFold 3 to model structures composed of proteins, DNA, RNA, and a selection of ligands, ions, and chemical modifications. ... AlphaFold Server helps scientists make novel hypotheses to test in the lab, speeding up workflows and enabling further innovation.",
            "We also participated in community-wide forums and discussions ahead of AlphaFold 3\u2019s launch. AlphaFold Server reflects the ongoing commitment to share the benefits of AlphaFold, including the free database of 200 million protein structures. We\u2019ll continue to work with the scientific community and policy makers to develop and deploy AI technologies responsibly.",
            "Using AlphaFold 3 in combination with a complementary suite of in-house AI models, we are working on drug design for internal projects as well as with pharmaceutical partners."
          ],
          "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
          "meta": {
            "query": "How does AlphaFold 3 work?",
            "question": "Background information about AlphaFold 3",
            "placement": "root -> History -> Development"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.pharmavoice.com/news/google-alphafold-3-drug-discovery-pharma-buzz/716496/",
          "description": "But while researchers have had ... workers to carry out earlier-stage research, the technology may reduce that need. Rather than posing a threat to existing jobs, the AI program could become a pressure release valve for an area often stretched too thin, Bangert said. Given its potential in life science research, DeepMind and Isomorphic\u2019s CEO said this month the platform could eventually be a \u201cmulti-hundred billion\u201d dollar business. And while AlphaFold 3 could identify ...",
          "snippets": [
            "But while researchers have had difficulties finding qualified workers to carry out earlier-stage research, the technology may reduce that need. Rather than posing a threat to existing jobs, the AI program could become a pressure release valve for an area often stretched too thin, Bangert said. Given its potential in life science research, DeepMind and Isomorphic\u2019s CEO said this month the platform could eventually be a \u201cmulti-hundred billion\u201d dollar business. And while AlphaFold 3 could identify promising compounds faster, the usual hurdles to market will remain.",
            "The \u201cNobel Prize-worthy invention\u201d could be worth hundreds of billions commercially \u2014 and have a deep impact on drug R&D.",
            "The artificial intelligence program AlphaFold 3, rolled out by Google DeepMind and Isomorphic Labs earlier this month, has been called \u201cgroundbreaking,\u201d holding transformative potential in drug discovery.",
            "AlphaFold 3\u2019s capabilities, outlined in the journal Nature, build on two of its earlier AI models, enabling drug developers to quickly identify promising targets, potentially slashing the time to market by years."
          ],
          "title": "Why AlphaFold 3 is stirring up so much buzz in pharma | PharmaVoice",
          "meta": {
            "query": "How does AlphaFold 3 work?",
            "question": "Background information about AlphaFold 3",
            "placement": "root -> History -> Development"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.reddit.com/r/singularity/comments/1cnp5u7/alphafold_3_is_a_fantastic_breakthrough_and/",
          "description": "AlphaFold 3 can make things that were already possible MUCH MUCH faster. So even though the bad actors could develop new deadly viruses, I dont want to give them tools to accelerate their work.",
          "snippets": [
            "336 votes, 140 comments. The model itself is closed source and heavily restricted. Yes, the dataset of all known proteins is available, but Deepmind\u2026",
            "Posted by u/AlterandPhil - 336 votes and 140 comments",
            "F@H also open sources all its results and was probably used to train AlphaFold. ... The @home stuff was a cool time on the internet. Felt like everyone was working for a greater good.",
            "The US gov (or any gov) having that capability is bad, but spreading it openly doesn't solve anything, and just increases the risk that some very bad organization gets a hold of it. ... Sergey Ovchinnikov, an evolutionary biologist at the Massachusetts Institute of Technology in Cambridge, had hoped to develop a web version of AlphaFold3, as he and his colleagues have done for AlphaFold2 shortly after its code was released."
          ],
          "title": "r/singularity on Reddit: AlphaFold 3 is a Fantastic Breakthrough ...",
          "meta": {
            "query": "How does AlphaFold 3 work?",
            "question": "Background information about AlphaFold 3"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://blog.google/technology/ai/how-we-built-alphafold-3/",
          "description": "Instead, they got started on AlphaFold 3. This newer model, which the teams at Google DeepMind and Isomorphic Labs launched in May, builds on our previous models by predicting not just protein folding structures, but predicting the structure and interactions of all of life's molecules, including ...",
          "snippets": [
            "Instead, they got started on AlphaFold 3. This newer model, which the teams at Google DeepMind and Isomorphic Labs launched in May, builds on our previous models by predicting not just protein folding structures, but predicting the structure and interactions of all of life's molecules, including DNA, RNA and ligands (small molecules that bind to proteins).",
            "Where AlphaFold 2 used a complex custom geometry-based module, AlphaFold 3 uses a generative model that\u2019s based on diffusion \u2014 similar to our other cutting-edge image generation models, like Imagen \u2014 which greatly simplified how the model handles all the new molecule types. That shift led to a new issue, though: Since so-called \u201cdisordered regions\u201d of proteins weren\u2019t included in the training data, the diffusion model would try to create an inaccurate \u201cordered\u201d structure with a defined spiral shape, instead of predicting disordered regions.",
            "So the team turned to AlphaFold 2, which is already extremely good at predicting which interactions would be disordered \u2014 which look like a pile of chaotic spaghetti \u2014 and which ones were not. \u201cWe were able to use those predicted structures from AlphaFold 2 as distillation training for AlphaFold 3, so that AlphaFold 3 could learn to predict disorder,\u201d Lindsay says.",
            "An example of a prediction from AlphaFold 3 with ordered \u201cfusilli\u201d regions in blue and disordered \u201cspaghetti\u201d regions in orange. The colors represent the model\u2019s confidence of predicted accuracy. The team is looking forward to seeing how researchers will use AlphaFold 3 to advance fields like genomics research, drug design and more."
          ],
          "title": "How we built AlphaFold 3 to predict the structure and interaction ...",
          "meta": {
            "query": "What is AlphaFold 3?",
            "question": "Background information about AlphaFold 3",
            "placement": "root -> History -> Development"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.nature.com/articles/d41586-024-01385-x",
          "description": "Deepmind\u2019s AlphaFold has revolutionized research by making it simple to predict the 3D structures of proteins, but it has lacked the ability to predict situations where a protein is bound to another molecule. Now, the AI has been upgraded to AlphaFold 3 and can accurately predict protein-molecule ...",
          "snippets": [
            "Deepmind\u2019s AlphaFold has revolutionized research by making it simple to predict the 3D structures of proteins, but it has lacked the ability to predict situations where a protein is bound to another molecule. Now, the AI has been upgraded to AlphaFold 3 and can accurately predict protein-molecule complexes containing DNA, RNA and more.",
            "When exposed to an external magnetic field these particles self-assemble into an intricate 3D network that remains intact even after the field is removed. The team used their substance to make liquid bioelectronics that could be injected into the body and convert biomechanical motion into detectable electrical signals. These kinds of devices could be used for self-powered and wireless monitoring of the cardiovascular system. If you are magnetically attracted to that research, you can read it in Nature Materials. ... AlphaFold and its successor AlphaFold 2 have been game changers in biology, as the AIs have made it easier than ever to predict the structures of proteins \u2013 the molecules that make up so much of life.",
            "Yeah, I like to see AlphaFold 3 as \u201cThe Return of the Jedi\u201d of AlphaFold kind of completing the trilogy. Or \u201cThe Godfather III\u201d. I don\u2019t know which was deemed better. ... Hopefully it's not Godfather III because that one was not the best one in my opinion. But let's start off by talking about what this version can do. So, what is it that AlphaFold 3 promises that maybe the other versions lacked?",
            "The only problem \u2014 I wouldn't say a problem \u2014 was that it just predicted protein structures, it didn't predict proteins alongside all the other, you know, players of the cellular ecosystem. That was just not part of AlphaFold 2\u2019s language, part of its abilities. And so AlphaFold 3, this latest update, is exactly that it brings in the rest of the ecosystem, all these other players and you know, predicts proteins alongside of them."
          ],
          "title": "Alphafold 3.0: the AI protein predictor gets an upgrade",
          "meta": {
            "query": "What is AlphaFold 3?",
            "question": "Background information about AlphaFold 3",
            "placement": "root -> History -> Development"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.pharmavoice.com/news/google-alphafold-3-drug-discovery-pharma-buzz/716496/",
          "description": "The \u201cNobel Prize-worthy invention\u201d could be worth hundreds of billions commercially \u2014 and have a deep impact on drug R&D.",
          "snippets": [
            "This audio is auto-generated. Please let us know if you have feedback. The artificial intelligence program AlphaFold 3, rolled out by Google DeepMind and Isomorphic Labs earlier this month, has been called \u201cgroundbreaking,\u201d holding transformative potential in drug discovery.",
            "The hype is warranted, said Patrick Bangert, senior vice president of data, analytics, and AI at Searce, a cloud services company. \u201cIt's a Nobel Prize-worthy invention,\u201d he said. AlphaFold 3\u2019s capabilities, outlined in the journal Nature, build on two of its earlier AI models, enabling drug developers to quickly identify promising targets, potentially slashing the time to market by years.",
            "It\u2019s hard to find the downside of AlphaFold 3, Bangert said. \u201cThis is actually one of those rare examples where I genuinely can't think of a drawback, mainly because this protein folding problem is so early in the process of drug development,\u201d he said.",
            "Given its potential in life science research, DeepMind and Isomorphic\u2019s CEO said this month the platform could eventually be a \u201cmulti-hundred billion\u201d dollar business. And while AlphaFold 3 could identify promising compounds faster, the usual hurdles to market will remain."
          ],
          "title": "Why AlphaFold 3 is stirring up so much buzz in pharma | PharmaVoice",
          "meta": {
            "query": "What is AlphaFold 3?",
            "question": "Background information about AlphaFold 3",
            "placement": "root -> History -> Development"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://en.wikipedia.org/wiki/AlphaFold",
          "description": "Hassabis and Jumper had previously ... 2023 for their leadership of the AlphaFold project. Proteins consist of chains of amino acids which spontaneously fold to form the three dimensional (3-D) structures of the proteins. The 3-D structure is crucial to understanding the biological ...",
          "snippets": [
            "Hassabis and Jumper had previously won the Breakthrough Prize in Life Sciences and the Albert Lasker Award for Basic Medical Research in 2023 for their leadership of the AlphaFold project. Proteins consist of chains of amino acids which spontaneously fold to form the three dimensional (3-D) structures of the proteins. The 3-D structure is crucial to understanding the biological function of the protein.",
            "AlphaFold 3 introduces the \"Pairformer,\" a deep learning architecture inspired by the transformer, which is considered similar to, but simpler than, the Evoformer used in AlphaFold 2. The Pairformer module's initial predictions are refined by a diffusion model.",
            "The model's ability to predict multiple native conformations of proteins is limited. AlphaFold 3 version can predict structures of protein complexes with a very limited set of selected cofactors and co- and post-translational modifications. Between 50% and 70% of the structures of the human proteome are incomplete without covalently-attached glycans.",
            "Announced on 8 May 2024, AlphaFold 3 was co-developed by Google DeepMind and Isomorphic Labs, both subsidiaries of Alphabet.",
            "AlphaFold 3 is not limited to single-chain proteins, as it can also predict the structures of protein complexes with DNA, RNA, post-translational modifications and selected ligands and ions."
          ],
          "title": "AlphaFold - Wikipedia",
          "meta": {
            "query": "What is AlphaFold 3?",
            "question": "Background information about AlphaFold 3"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://frontlinegenomics.com/alphafold-3-stepping-into-the-future-of-structure-prediction/",
          "description": "We\u2019ve all heard about the potential of artificial intelligence in the life sciences field. In 2020, the launch of AlphaFold 2, pioneered by Google DeepMind, took the world by storm and marked a new age in protein structure prediction. But now, AlphaFold 3 is transforming the landscape again.",
          "snippets": [
            "The first version of the technology was released in 2018, but it was 2020\u2019s AlphaFold 2 that made headlines \u2013 winning the prestigious Critical Assessment of Structure Prediction (CASP) 14 competition. Having gone through multiple major iterations, the most recent release, AlphaFold 3, is set to further transform the protein space.",
            "But what about AlphaFold 3? DeepMind state that the Evoformer model has been updated in this iteration of the technology. The model is now \u2018simpler\u2019, and focuses more on the pair representation. In addition, after processing inputs, AlphaFold 3 uses a \u2018diffusion network\u2019, described by DeepMind as being similar to the tools used in AI image generation.",
            "Perhaps the most exciting comparison that can be drawn between AlphaFold 2 and 3 is the latter\u2019s ability to make predictions not just about protein structure, but about interactions between proteins and biological molecules such as DNA, RNA and ligands \u2013 an acknowledgment that no molecules operate on their own.",
            "These interactions are crucial in understanding the underpinnings of life, and in identifying potential drug candidates. This is reflected in AlphaFold 3\u2019s large training set, which includes a wider range of molecules."
          ],
          "title": "AlphaFold 3: Stepping into the future of structure prediction - ...",
          "meta": {
            "query": "What is AlphaFold 3?",
            "question": "Background information about AlphaFold 3"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://venturebeat.com/ai/google-deepmind-open-sources-alphafold-3-ushering-in-a-new-era-for-drug-discovery-and-molecular-biology/",
          "description": "When AlphaFold 3 debuted in May, DeepMind\u2019s decision to withhold the code while offering limited access through a web interface drew criticism from researchers. The controversy exposed a key challenge in AI research: how to balance open science with commercial interests, particularly as companies like DeepMind\u2019s sister organization Isomorphic ...",
          "snippets": [
            "When AlphaFold 3 debuted in May, DeepMind\u2019s decision to withhold the code while offering limited access through a web interface drew criticism from researchers. The controversy exposed a key challenge in AI research: how to balance open science with commercial interests, particularly as companies like DeepMind\u2019s sister organization Isomorphic Labs work to develop new drugs using these advances.",
            "While the code is freely available under a Creative Commons license, access to the crucial model weights requires Google\u2019s explicit permission for academic use. This approach attempts to satisfy both scientific and commercial needs \u2014 though some researchers argue it should go further. The technical advances in AlphaFold 3 set it apart.",
            "Google DeepMind releases AlphaFold 3's source code to academics, marking a significant advance in AI-powered molecular biology and drug discovery, while balancing open science with commercial interests in the wake of its creators' Nobel Prize win.",
            "AlphaFold 3 represents a quantum leap beyond its predecessors. While AlphaFold 2 could predict protein structures, version 3 can model the complex interactions between proteins, DNA, RNA, and small molecules \u2014 the fundamental processes of life. This matters because understanding these molecular interactions drives modern drug discovery and disease treatment."
          ],
          "title": "Google DeepMind open-sources AlphaFold 3, ushering in a new era ...",
          "meta": {
            "query": "What is AlphaFold 3?",
            "question": "Background information about AlphaFold 3",
            "placement": "root -> History -> Development"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.sciencedirect.com/science/article/pii/S0969212624003356",
          "description": "Computational structural biology aims to accurately predict biomolecular complexes with AlphaFold 3 spearheading the field. However, challenges loom f\u2026",
          "snippets": [
            "Author links open overlay panelToni K. Tr\u00e4ger 1 2, Christian T\u00fcting 1 2, Panagiotis L. Kastritis 1 2 3 4Show more ... Computational structural biology aims to accurately predict biomolecular complexes with AlphaFold 3 spearheading the field.",
            "Supervised modeling, i.e., integrative structural biology, will continue to play a role in fine-tuning this type of prediction (e.g., removing clashes, rebuilding loops/disordered regions, and redocking interfaces). 3D analysis of endogenous metabolic complexes continues to require, in addition to AI, precise and multi-faceted interrogation methods."
          ],
          "title": "The human touch: Utilizing AlphaFold 3 to analyze structures of ...",
          "meta": {
            "query": "What is AlphaFold 3?",
            "question": "Background information about AlphaFold 3",
            "placement": "root -> History -> Development"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://deeperinsights.com/ai-blog/alphafold-3-the-key-to-understanding-lifes-building-blocks",
          "description": "AlphaFold 3 is a monumental leap that is revolutionising our understanding of life's most fundamental structures [source]. Building on the astounding successes of AlphaFold 2, which already set a new benchmark by predicting protein structures with near-experimental accuracy, AlphaFold 3 takes ...",
          "snippets": [
            "AlphaFold 3 is a monumental leap that is revolutionising our understanding of life's most fundamental structures [source]. Building on the astounding successes of AlphaFold 2, which already set a new benchmark by predicting protein structures with near-experimental accuracy, AlphaFold 3 takes innovation to an entirely new level.",
            "AlphaFold 2 succeeded through innovative techniques, using neural networks and deep learning. It trained on a vast database of known protein structures, predicting how a protein\u2019s amino acid sequence would fold into its 3D structure. This approach dramatically outperformed previous methods, achieving near-experimental accuracy. [source] In 2024, DeepMind, in collaboration with Isomorphic Labs, introduced AlphaFold 3.",
            "The primary input to AlphaFold 3 is the amino acid sequence of the protein. Proteins are made up of chains of amino acids, and the specific order of these amino acids (the sequence) determines how the protein will fold into its three-dimensional shape.",
            "The output of the diffusion network is a highly accurate 3D structure of the protein. This structure includes detailed atomic positions, which are essential for understanding the protein's function and interactions. Accurate 3D structures are critical for numerous applications in biology and medicine, including drug design, understanding disease mechanisms, and exploring protein functions. After generating the initial 3D structure, AlphaFold 3 applies post-processing techniques such as energy minimization and conformational validation."
          ],
          "title": "AlphaFold 3: The Key to Understanding Life's Building Blocks - ...",
          "meta": {
            "query": "What is AlphaFold 3?",
            "question": "Background information about AlphaFold 3"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.genengnews.com/topics/artificial-intelligence/alphafold-3-angst-limited-accessibility-stirs-outcry-from-researchers/",
          "description": "In a report published in Nature on May 8, researchers unveiled AlphaFold 3\u2019s expanded predictive capabilities from proteins to a broad spectrum of biomolecular interactions, including DNA, RNA, ligands, and more. The publication, which is a collaboration between DeepMind and Isomorphic Labs, ...",
          "snippets": [
            "In a report published in Nature on May 8, researchers unveiled AlphaFold 3\u2019s expanded predictive capabilities from proteins to a broad spectrum of biomolecular interactions, including DNA, RNA, ligands, and more. The publication, which is a collaboration between DeepMind and Isomorphic Labs, a London-based company launched in 2021 to build upon DeepMind\u2019s AI research to tackle biological problems, emphasizes AlphaFold 3\u2019s potential to advance therapeutic applications, including drug discovery.",
            "Biology is a complex dynamical system so modeling interactions is crucial.\u201d \u00b7 But his enthusiasm was not universally shared. In contrast to the launch of AlphaFold 2 in 2021, Nature\u2019s publication of AlphaFold 3 lacked the open source code.",
            "In lieu of code, AlphaFold 3 was released to the community as a web server, accessible to individuals without a computational background. While a recent blog post from DeepMind and Isomorphic Labs described the new AlphaFold Server as a facilitator of \u201cnovel hypotheses to test in the lab, speeding up workflows and enabling further innovation,\u201d researchers were quick to note the web server\u2019s limitations.",
            "Scientists took to social media to complain how ligand inputs to the web server were limited to a finite list of biological molecules and did not allow custom inputs, such as small molecule drugs. In that vein, while Isomorphic Labs has reported applying AlphaFold 3 to drug design for internal projects as well as with pharmaceutical partners, the public web server is under a license that is limited to non-commercial use."
          ],
          "title": "AlphaFold 3 Angst: Limited Accessibility Stirs Outcry from Researchers",
          "meta": {
            "query": "What is AlphaFold 3?",
            "question": "Background information about AlphaFold 3"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://medium.com/@CompXBio/alphafold-3-a-real-game-changer-ef0add53f364",
          "description": "Building on the successes of AlphaFold ... 3, on May 8, 2024. Demonstrating the prediction of protein-DNA complex. Source: AlphaFold \u00b7 Proteins, the fundamental building blocks of all living organisms, are key to understanding the complex mechanisms that govern life. Elucidating protein structures is crucial for ...",
          "snippets": [
            "Building on the successes of AlphaFold 2 and AlphaFold-Multimer, Google DeepMind released its state-of-the-art protein structure and interaction predictor, AlphaFold 3, on May 8, 2024. Demonstrating the prediction of protein-DNA complex. Source: AlphaFold \u00b7 Proteins, the fundamental building blocks of all living organisms, are key to understanding the complex mechanisms that govern life. Elucidating protein structures is crucial for comprehending biological processes.",
            "While 200,000 structures may sound substantial, it is a mere drop in the ocean compared to the total number of proteins in humans and other organisms. ... This context underscores the significance of AlphaFold\u2019s debut, leveraging decades of data from one of the most informative datasets in life sciences. AlphaFold 3 (AF3) goes beyond previous versions by focusing on protein-ligand binding, antibody-antigen binding, protein-nucleic acid interactions, ion binding, and post-translational modifications (PTMs).",
            "AF3 can handle multiple protein sequences with PTMs and small molecules in the Simplified Molecular Input Line Entry System (SMILES) format, predicting structures with the atoms' 3D coordinates. Unlike the relationship between AlphaFold 2 (AF2) and AlphaFold-Multimer (AFM), AF3 fundamentally differs from AF2. AF3 introduces several significant changes/issues:",
            "Building on the successes of AlphaFold 2 and AlphaFold-Multimer, Google DeepMind released its state-of-the-art protein structure and interaction predictor, AlphaFold 3, on May 8, 2024. Proteins, the\u2026"
          ],
          "title": "AlphaFold 3: A Real Game Changer? | by Ian Lee | Medium",
          "meta": {
            "query": "What is AlphaFold 3?",
            "question": "Background information about AlphaFold 3"
          },
          "citation_uuid": -1
        }
      ],
      "cited_info": null
    },
    {
      "utterance": "The increased predictive accuracy of AlphaFold 3 can be attributed to several advancements in data training methods. One significant factor is the vast expansion of the data used to train the model, including DNA, RNA, small molecules, and more[11]. This broader training dataset allows AlphaFold 3 to predict the structure of complexes created by proteins with various molecules with a minimum 50% improvement in accuracy compared to existing methods[12].\n\nMoreover, the introduction of a substantially updated diffusion-based architecture in AlphaFold 3 enables the prediction of the joint structure of complexes involving proteins, nucleic acids, small molecules, ions, and modified residues[13]. This enhanced architecture plays a crucial role in improving the accuracy of protein complex predictions relative to previous versions of AlphaFold[16].\n\nAnother key advancement that contributes to the increased accuracy of AlphaFold 3 is the utilization of cross-distillation methods to augment the training data with predicted structures, thus overcoming issues such as hallucination in unstructured regions[14]. This approach helps refine the model and enhance its predictive capabilities.\n\nFurthermore, recent breakthrough achievements in protein structure prediction, driven by sophisticated machine learning methods and algorithmic approaches, have paved the way for models like AlphaFold 3 to push the boundaries of predictive accuracy and applicability[15]. The continuous development and refinement of these machine learning techniques play a vital role in the evolution of protein structure prediction models like AlphaFold 3.\n\nIn conclusion, the advancements in data training methods, such as expanded training datasets, updated architecture, cross-distillation methods, and breakthroughs in machine learning techniques, have collectively contributed to the increased predictive accuracy of AlphaFold 3. These developments mark a significant leap forward in the field of protein structure prediction and have the potential to revolutionize our understanding of biomolecular interactions and functions.",
      "raw_utterance": "The increased predictive accuracy of AlphaFold 3 can be attributed to several advancements in data training methods. One significant factor is the vast expansion of the data used to train the model, including DNA, RNA, small molecules, and more[11]. This broader training dataset allows AlphaFold 3 to predict the structure of complexes created by proteins with various molecules with a minimum 50% improvement in accuracy compared to existing methods[12].\n\nMoreover, the introduction of a substantially updated diffusion-based architecture in AlphaFold 3 enables the prediction of the joint structure of complexes involving proteins, nucleic acids, small molecules, ions, and modified residues[13]. This enhanced architecture plays a crucial role in improving the accuracy of protein complex predictions relative to previous versions of AlphaFold[16].\n\nAnother key advancement that contributes to the increased accuracy of AlphaFold 3 is the utilization of cross-distillation methods to augment the training data with predicted structures, thus overcoming issues such as hallucination in unstructured regions[14]. This approach helps refine the model and enhance its predictive capabilities.\n\nFurthermore, recent breakthrough achievements in protein structure prediction, driven by sophisticated machine learning methods and algorithmic approaches, have paved the way for models like AlphaFold 3 to push the boundaries of predictive accuracy and applicability[15]. The continuous development and refinement of these machine learning techniques play a vital role in the evolution of protein structure prediction models like AlphaFold 3.\n\nIn conclusion, the advancements in data training methods, such as expanded training datasets, updated architecture, cross-distillation methods, and breakthroughs in machine learning techniques, have collectively contributed to the increased predictive accuracy of AlphaFold 3. These developments mark a significant leap forward in the field of protein structure prediction and have the potential to revolutionize our understanding of biomolecular interactions and functions.",
      "role": "Computational biologist",
      "role_description": " This expert specializes in using computational methods to study biological systems. They will focus on the technical aspects of AlphaFold 3, its data training, and the implications of its predictive accuracy on understanding biomolecular interactions.",
      "queries": [
        "Advancements in data training methods for AlphaFold 3",
        "How has data training improved AlphaFold 3 predictive accuracy?"
      ],
      "utterance_type": "Support",
      "claim_to_make": "What advancements in data training methods have contributed to the increased predictive accuracy of AlphaFold 3?",
      "raw_retrieved_info": [
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
          "description": "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor ...",
          "snippets": [
            "At the forefront of this revolution is AlphaFold 3, the latest iteration of Google DeepMind's groundbreaking protein folding AI. Leveraging advanced deep learning methodologies, AlphaFold 3 has achieved unprecedented accuracy in predicting the three-dimensional structures of proteins, a cornerstone in understanding biomolecular interactions and functions . This capability not only enhances our grasp of biological machinery but also accelerates the pace at which we can address some of the most pressing challenges in medical biology, from antibiotic resistance to the development of malaria vaccines .",
            "This methodology allows AlphaFold 3 to generate joint three-dimensional (3D) structures of input molecules, revealing how they fit together holistically . ... One of the most notable advancements of AlphaFold 3 is its expanded capabilities to model large biomolecules such as proteins, DNA, and RNA, as well as small molecules known as ligands.",
            "AlphaFold 3 stands as a monumental advancement in the realm of computational biology, offering unprecedented insights into the intricate dance of biomolecules that underpin life itself. This section delves into the core of AlphaFold 3's capabilities, shedding light on its profound impact on our understanding of biomolecular interactions . ... AlphaFold 3's methodology allows for the generation of joint 3D structures of molecules, facilitating a comprehensive view of how various biomolecules, including proteins, DNA, RNA, and ligands, interact within a cellular context.",
            "This process involves the repeated application of the final loss to outputs, which are then recursively fed back into the network . This method allows for continuous refinement and development of highly accurate protein structures with precise atomic details. The structure module has also been redesigned to include an explicit 3D structure for each residue, rapidly developing and refining a highly accurate protein structure . ... One of the most notable advancements in AlphaFold 3 is its expanded predictive abilities."
          ],
          "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
          "meta": {
            "query": "Advancements in data training methods for AlphaFold 3",
            "question": "What advancements in data training methods have contributed to the increased predictive accuracy of AlphaFold 3?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://blog.google/technology/ai/how-we-built-alphafold-3/",
          "description": "In order to get AlphaFold 3 to work with this much wider range of biomolecules, the team vastly expanded the data that the newer model was trained on to include DNA, RNA, small molecules and more. \u201cWe were able to say, \u2018Let's just train on everything that exists in this dataset that helped ...",
          "snippets": [
            "In order to get AlphaFold 3 to work with this much wider range of biomolecules, the team vastly expanded the data that the newer model was trained on to include DNA, RNA, small molecules and more. \u201cWe were able to say, \u2018Let's just train on everything that exists in this dataset that helped us so much with proteins and let\u2019s see how far we can get,\u2019\u201d Lindsay says.",
            "Where AlphaFold 2 used a complex custom geometry-based module, AlphaFold 3 uses a generative model that\u2019s based on diffusion \u2014 similar to our other cutting-edge image generation models, like Imagen \u2014 which greatly simplified how the model handles all the new molecule types. That shift led to a new issue, though: Since so-called \u201cdisordered regions\u201d of proteins weren\u2019t included in the training data, the diffusion model would try to create an inaccurate \u201cordered\u201d structure with a defined spiral shape, instead of predicting disordered regions.",
            "The team is looking forward to seeing how researchers will use AlphaFold 3 to advance fields like genomics research, drug design and more.",
            "So the team turned to AlphaFold 2, which is already extremely good at predicting which interactions would be disordered \u2014 which look like a pile of chaotic spaghetti \u2014 and which ones were not. \u201cWe were able to use those predicted structures from AlphaFold 2 as distillation training for AlphaFold 3, so that AlphaFold 3 could learn to predict disorder,\u201d Lindsay says."
          ],
          "title": "How we built AlphaFold 3 to predict the structure and interaction ...",
          "meta": {
            "query": "Advancements in data training methods for AlphaFold 3",
            "question": "What advancements in data training methods have contributed to the increased predictive accuracy of AlphaFold 3?",
            "placement": "root -> Advancements in data training methods"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://en.wikipedia.org/wiki/AlphaFold",
          "description": "On 15 July 2021, the AlphaFold ... as an advance access publication alongside open source software and a searchable database of species proteomes. As of February 2025, the paper had been cited nearly 32,000 times. AlphaFold 3 was announced on 8 May 2024. It can predict the structure of complexes created by proteins with DNA, RNA, various ligands, and ions. The new prediction method shows a minimum ...",
          "snippets": [
            "On 15 July 2021, the AlphaFold 2 paper was published in Nature as an advance access publication alongside open source software and a searchable database of species proteomes. As of February 2025, the paper had been cited nearly 32,000 times. AlphaFold 3 was announced on 8 May 2024. It can predict the structure of complexes created by proteins with DNA, RNA, various ligands, and ions. The new prediction method shows a minimum 50% improvement in accuracy for protein interactions with other molecules compared to existing methods.",
            "It also used more advanced learning methods than previously to develop the inference. The 2020 version of the program (AlphaFold 2, 2020) is significantly different from the original version that won CASP 13 in 2018, according to the team at DeepMind. AlphaFold 1 used a number of separately trained modules to produce a guide potential, which was then combined with a physics-based energy potential.",
            "The overall training was conducted on processing power between 100 and 200 GPUs. AlphaFold 1 (2018) was built on work developed by various teams in the 2010s, work that looked at the large databanks of related DNA sequences now available from many different organisms (most without known 3D structures), to try to find changes at different residues (peptides) that appeared to be correlated, even though the residues were not consecutive in the main chain.",
            "However, the October 2021 update, named AlphaFold-Multimer, included protein complexes in its training data. DeepMind stated this update succeeded about 70% of the time at accurately predicting protein-protein interactions. Announced on 8 May 2024, AlphaFold 3 was co-developed by Google DeepMind and Isomorphic Labs, both subsidiaries of Alphabet.",
            "Therefore, it may not perform as well on synthetic proteins or proteins with very low homology to those in the training database. The model's ability to predict multiple native conformations of proteins is limited. AlphaFold 3 version can predict structures of protein complexes with a very limited set of selected cofactors and co- and post-translational modifications."
          ],
          "title": "AlphaFold - Wikipedia",
          "meta": {
            "query": "Advancements in data training methods for AlphaFold 3",
            "question": "What advancements in data training methods have contributed to the increased predictive accuracy of AlphaFold 3?",
            "placement": "root -> Advancements in data training methods"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://frontlinegenomics.com/alphafold-3-stepping-into-the-future-of-structure-prediction/",
          "description": "In this news highlight, we explore AlphaFold3, compare it to its predecessor and take a look to the future.",
          "snippets": [
            "It gained notoriety for its performance in the CASP 14 competition, where it significantly outperformed other methods, demonstrating the potential of powerful AI in solving a decades-long challenge. AlphaFold 2 utilised a deep learning architecture called Evoformer. This model has been instrumental in advancing research into protein structures and folding mechanisms, leading to breakthroughs in subsequent areas such as drug discovery and vaccine development.",
            "Perhaps the most exciting comparison that can be drawn between AlphaFold 2 and 3 is the latter\u2019s ability to make predictions not just about protein structure, but about interactions between proteins and biological molecules such as DNA, RNA and ligands \u2013 an acknowledgment that no molecules operate on their own. These interactions are crucial in understanding the underpinnings of life, and in identifying potential drug candidates. This is reflected in AlphaFold 3\u2019s large training set, which includes a wider range of molecules.",
            "But now, AlphaFold 3 is transforming the landscape again. In this news highlight, we explore the new tech, compare it to its predecessor and take a look to the future. Before the AI revolution, protein structure prediction heavily relied on experimental methods, such as X-ray crystallography, NMR spectroscopy and, later, some complex computational methods like homology modelling.",
            "These methods were time consuming and costly, and were a major limiting step in drug discovery and development processes in particular. For years, scientists have been attempting to integrate the latest and greatest AI models into the field, in order to speed up the process and improve accuracy. Enter AlphaFold, an artificial intelligence tool developed by Google\u2019s DeepMind."
          ],
          "title": "AlphaFold 3: Stepping into the future of structure prediction - ...",
          "meta": {
            "query": "Advancements in data training methods for AlphaFold 3",
            "question": "What advancements in data training methods have contributed to the increased predictive accuracy of AlphaFold 3?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.nature.com/articles/s41586-021-03819-2",
          "description": "Proteins are essential to life, and understanding their structure can facilitate a mechanistic understanding of their function. Through an enormous experimental effort1\u20134, the structures of around 100,000 unique proteins have been determined5, but this represents a small fraction of the billions ...",
          "snippets": [
            "Proteins are essential to life, and understanding their structure can facilitate a mechanistic understanding of their function. Through an enormous experimental effort1\u20134, the structures of around 100,000 unique proteins have been determined5, but this represents a small fraction of the billions of known protein sequences6,7. Structural coverage is bottlenecked by the months to years of painstaking effort required to determine a single protein structure.",
            "Nature - AlphaFold predicts protein structures with an accuracy competitive with experimental structures in the majority of cases using a novel deep learning architecture.",
            "In particular, we demonstrate a new architecture to jointly embed multiple sequence alignments (MSAs) and pairwise features, a new output representation and associated loss that enable accurate end-to-end structure prediction, a new equivariant attention architecture, use of intermediate losses to achieve iterative refinement of predictions, masked MSA loss to jointly train with the structure, learning from unlabelled protein sequences using self-distillation and self-estimates of accuracy. The AlphaFold network directly predicts the 3D coordinates of all heavy atoms for a given protein using the primary amino acid sequence and aligned sequences of homologues as inputs (Fig. 1e; see Methods for details of inputs including databases, MSA construction and use of templates).",
            "This creates a strong bias for atoms to be correct relative to the local frame of each residue and hence correct with respect to its side-chain interactions, as well as providing the main source of chirality for AlphaFold (Supplementary Methods 1.9.3 and Supplementary Fig. 9). The AlphaFold architecture is able to train to high accuracy using only supervised learning on PDB data, but we are able to enhance accuracy (Fig."
          ],
          "title": "Highly accurate protein structure prediction with AlphaFold | Nature",
          "meta": {
            "query": "Advancements in data training methods for AlphaFold 3",
            "question": "What advancements in data training methods have contributed to the increased predictive accuracy of AlphaFold 3?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11292590/",
          "description": "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor AlphaFold ...",
          "snippets": [
            "At the forefront of this revolution is AlphaFold 3, the latest iteration of Google DeepMind's groundbreaking protein folding AI. Leveraging advanced deep learning methodologies, AlphaFold 3 has achieved unprecedented accuracy in predicting the three-dimensional structures of proteins, a cornerstone in understanding biomolecular interactions and functions . This capability not only enhances our grasp of biological machinery but also accelerates the pace at which we can address some of the most pressing challenges in medical biology, from antibiotic resistance to the development of malaria vaccines .",
            "This methodology allows AlphaFold 3 to generate joint three-dimensional (3D) structures of input molecules, revealing how they fit together holistically . ... One of the most notable advancements of AlphaFold 3 is its expanded capabilities to model large biomolecules such as proteins, DNA, and RNA, as well as small molecules known as ligands.",
            "AlphaFold 3 stands as a monumental advancement in the realm of computational biology, offering unprecedented insights into the intricate dance of biomolecules that underpin life itself. This section delves into the core of AlphaFold 3's capabilities, shedding light on its profound impact on our understanding of biomolecular interactions . ... AlphaFold 3's methodology allows for the generation of joint 3D structures of molecules, facilitating a comprehensive view of how various biomolecules, including proteins, DNA, RNA, and ligands, interact within a cellular context.",
            "This process involves the repeated application of the final loss to outputs, which are then recursively fed back into the network . This method allows for continuous refinement and development of highly accurate protein structures with precise atomic details. The structure module has also been redesigned to include an explicit 3D structure for each residue, rapidly developing and refining a highly accurate protein structure . ... One of the most notable advancements in AlphaFold 3 is its expanded predictive abilities."
          ],
          "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
          "meta": {
            "query": "Advancements in data training methods for AlphaFold 3",
            "question": "What advancements in data training methods have contributed to the increased predictive accuracy of AlphaFold 3?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://deeperinsights.com/ai-blog/alphafold-3-the-key-to-understanding-lifes-building-blocks",
          "description": "AlphaFold 3 revolutionises biology by predicting molecular interactions with unprecedented accuracy, accelerating breakthroughs in drug discovery and synthetic biology.",
          "snippets": [
            "This could lead to a more equitable distribution of healthcare advancements, improving quality of life worldwide. ... There is still so much we don't know about our world and how life works but AlphaFold 3 represents a significant step towards achieving that understanding. In the future, scientists can look into expanding protein databases, integrating computational and experimental methods, and improving prediction accuracy.",
            "AlphaFold 2 succeeded through innovative techniques, using neural networks and deep learning. It trained on a vast database of known protein structures, predicting how a protein\u2019s amino acid sequence would fold into its 3D structure. This approach dramatically outperformed previous methods, achieving near-experimental accuracy.",
            "For decades, scientists sought a reliable computational method to predict protein structures. A successful solution would accelerate research, leading to rapid advancements in medicine and biotechnology. However, early computational models struggled with accurately predicting the complex 3D structures. ... The journey began in 2016 with inspiration from AlphaGo\u2019s success. DeepMind aimed to solve the protein-folding problem, and by 2020, AlphaFold 2 achieved remarkable accuracy in predicting protein structures.",
            "With a user-friendly interface, it allows scientists to submit amino acid sequences and receive detailed 3D structure predictions without needing advanced computational resources. One of the significant advantages of using the AlphaFold Server is the immense time savings compared to traditional methods."
          ],
          "title": "AlphaFold 3: The Key to Understanding Life's Building Blocks - ...",
          "meta": {
            "query": "Advancements in data training methods for AlphaFold 3",
            "question": "What advancements in data training methods have contributed to the increased predictive accuracy of AlphaFold 3?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.nature.com/articles/s41586-024-07487-w",
          "description": "AlphaFold 3 has a substantially updated architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and modified residues with greatly improved accuracy over many previous specialized tools.",
          "snippets": [
            "The introduction of AlphaFold 21 has spurred a revolution in modelling the structure of proteins and their interactions, enabling a huge range of applications in protein modelling and design2\u20136. Here we describe our AlphaFold 3 model with a substantially updated diffusion-based architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and modified residues.",
            "Nature - AlphaFold 3 has a substantially updated architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and...",
            "Accurate models of biological complexes are critical to our understanding of cellular functions and for the rational design of therapeutics2,3,4,9. Enormous progress has been achieved in protein structure prediction with the development of AlphaFold1, and the field has grown tremendously with a number of later methods that build on the ideas and techniques of AlphaFold 2 (AF2)10,11,12. Almost immediately after AlphaFold became available, it was shown that simple input modifications would enable surprisingly accurate protein interaction predictions13,14,15 and that training AF2 specifically for protein interaction prediction yielded a highly accurate system7.",
            "The biggest issue is that generative models are prone to hallucination35, whereby the model may invent plausible-looking structure even in unstructured regions. To counteract this effect, we use a cross-distillation method in which we enrich the training data with structures predicted by AlphaFold-Multimer (v.2.3)7,8."
          ],
          "title": "Accurate structure prediction of biomolecular interactions with ...",
          "meta": {
            "query": "Advancements in data training methods for AlphaFold 3",
            "question": "What advancements in data training methods have contributed to the increased predictive accuracy of AlphaFold 3?",
            "placement": "root -> Advancements in data training methods"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://towardsdatascience.com/how-alphafold-3-is-like-dalle-2-and-other-learnings-1f809010afc7/",
          "description": "Understanding AI applications in bio for machine learning engineers",
          "snippets": [
            "Generative models are very exciting but they come with the baggage of hallucination. Researchers found the model would invent plausible-looking structures in unstructured regions. To overcome this, a cross-distillation method was used to augment the training data with predicted structures AlphaFold-Multimer (v.2.3).",
            "The noise schedule is an important knob when training diffusion models. Turning it up or down affects the model\u2019s ability to learn both coarse and fine details. Doing so allowed for a significant simplification of AlphaFold because it eliminated the need to make intermediate predictions about side-chain torsion angles etc. Thank you again for reading, and stay tuned for the next installment. Until then, keep learning and keep exploring. ... A novel method in privacy-preserving speech processing which anonymizes the speaker attributes using space-filling vector\u2026",
            "In our last article, we explored how AlphaFold 2 and BERT were connected through transformer architecture. In this piece, we\u2019ll learn how the most recent update, AlphaFold 3 (hereafter Alphafold) is more similar to DALLE 2 (hereafter DALLE) and then dive into other changes to its architecture and training.",
            "AF3 architecture for inference showing where the diffusion module residues. From Accurate structure prediction of biomolecular interactions with AlphaFold 3 \u00b7 The impetus behind removing these intermediate steps was that the scope of training data for this iteration of the model grew substantially."
          ],
          "title": "How AlphaFold 3 Is Like DALLE 2 and Other Learnings | Towards Data ...",
          "meta": {
            "query": "Advancements in data training methods for AlphaFold 3",
            "question": "What advancements in data training methods have contributed to the increased predictive accuracy of AlphaFold 3?",
            "placement": "root -> Advancements in data training methods"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://bjbas.springeropen.com/articles/10.1186/s43088-024-00503-y",
          "description": "Breakthrough achievements in protein structure prediction have occurred recently, mostly due to the advent of sophisticated machine learning methods and significant advancements in algorithmic approaches. The most recent version of the AlphaFold model, known as \u201cAlphaFold-latest,\u201d which ...",
          "snippets": [
            "Breakthrough achievements in protein structure prediction have occurred recently, mostly due to the advent of sophisticated machine learning methods and significant advancements in algorithmic approaches. The most recent version of the AlphaFold model, known as \u201cAlphaFold-latest,\u201d which expands the functionalities of the groundbreaking AlphaFold2, is the subject of this article.",
            "Recent advances in protein structure prediction have witnessed groundbreaking developments, largely propelled by the emergence of advanced machine learning techniques and substantial improvements in algorithmic approaches . Key highlights in this dynamic field include the release of AlphaFold2 by DeepMind which marked a watershed moment in protein structure prediction . Leveraging deep learning methodologies, AlphaFold demonstrated remarkable accuracy, often rivaling experimental techniques such as X-ray crystallography and cryo-electron microscopy . This success has paved the way",
            "Fueled by advancements in machine learning techniques and algorithmic approaches, the field is witnessing unprecedented progress, propelled by seminal innovations such as DeepMind's AlphaFold2 . The release of AlphaFold2 marked a monumental milestone in protein structure prediction, revolutionizing the field with its remarkable accuracy. By harnessing the power of deep learning methodologies, AlphaFold2 overcame previous limitations, rivaling experimental techniques such as X-ray crystallography and cryo-electron microscopy in predictive precision . This breakthrough laid the foundation for subsequent iterations, including the highly anticipated AlphaFold-latest, which promises expanded capabilities across a broader spectrum of biomolecular interactions .",
            "They showcase improved generalization capabilities, allowing accurate predictions even for proteins with low homology to training data. This addresses a longstanding challenge in the field, making structural predictions applicable to a more extensive range of biological entities . Language model has become a household phrase. Yet, what many may not realize is the profound impact language models have had within the realm of protein research . Among these advancements stand the illustrious AlphaFold2, renowned for its uncanny ability to accurately predict protein structures solely from amino acid sequences, employing an attention-based transformer architecture . This transformative architecture, pioneered by Google in 2017, marked a paradigm shift in natural language processing, enabling machines to understand and process language with unprecedented nuance and context."
          ],
          "title": "AlphaFold-latest: revolutionizing protein structure prediction ...",
          "meta": {
            "query": "Advancements in data training methods for AlphaFold 3",
            "question": "What advancements in data training methods have contributed to the increased predictive accuracy of AlphaFold 3?",
            "placement": "root -> Advancements in data training methods"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.nature.com/articles/s41586-024-07487-w",
          "description": "The modified residues dataset is ... to the training set (Methods). See Extended Data Table 1 for detailed results, and Extended Data Fig. 6 for examples of predicted protein, DNA and RNA structures with covalent modifications, including analysis of the impact of phosphorylation on predictions. While expanding in modelling abilities, AF3 has also improved in protein complex accuracy relative to AlphaFold-Multimer (v.2.3)7...",
          "snippets": [
            "The modified residues dataset is filtered similarly to our other polymer test sets: it contains only modified residues in polymer chains with low homology to the training set (Methods). See Extended Data Table 1 for detailed results, and Extended Data Fig. 6 for examples of predicted protein, DNA and RNA structures with covalent modifications, including analysis of the impact of phosphorylation on predictions. While expanding in modelling abilities, AF3 has also improved in protein complex accuracy relative to AlphaFold-Multimer (v.2.3)7,8.",
            "AlphaFold 3 has a substantially updated architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and modified residues with greatly improved accuracy over many previous specialized tools.",
            "The introduction of AlphaFold 21 has spurred a revolution in modelling the structure of proteins and their interactions, enabling a huge range of applications in protein modelling and design2\u20136. Here we describe our AlphaFold 3 model with a substantially updated diffusion-based architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and modified residues.",
            "Nature - AlphaFold 3 has a substantially updated architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and..."
          ],
          "title": "Accurate structure prediction of biomolecular interactions with ...",
          "meta": {
            "query": "How has data training improved AlphaFold 3 predictive accuracy?",
            "question": "What advancements in data training methods have contributed to the increased predictive accuracy of AlphaFold 3?",
            "placement": "root -> History -> Milestones"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
          "description": "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor ...",
          "snippets": [
            "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor AlphaFold 2, this innovation has astonished the world with its capacity and speed.",
            "AlphaFold 3, developed by Isomorphic Labs Limited (London, United Kingdom) and Google DeepMind, represents a significant leap forward in the field of molecular biology through its ability to predict the structure and interactions of biomolecules with unparalleled accuracy . This revolutionary model extends its predictive capabilities beyond proteins to encompass a broad spectrum of biomolecules, including proteins, DNA, RNA, and ligands, thereby offering a comprehensive understanding of the biological world. ... AlphaFold 3's predictive prowess is rooted in its next-generation architecture, which includes an improved version of the Evoformer module . This deep learning architecture was instrumental in the success of its predecessor, AlphaFold 2, and has been further refined to enhance performance.",
            "AlphaFold 3 represents a significant evolution from its predecessor, AlphaFold 2, primarily through its advanced architectural framework . The core of this new model, the Evoformer module, has been significantly enhanced to improve performance across a broader spectrum of biomolecules, extending beyond proteins to include DNA, RNA, and ligands . This architectural refinement has enabled AlphaFold 3 to achieve unprecedented accuracy in predicting drug-like interactions, setting a new benchmark in the field .",
            "The introduction of AlphaFold 3 has the potential to transform drug discovery by providing a more rapid and accurate tool for examining fundamental biology . Its ability to predict the structure of protein-molecule complexes, including those containing DNA and RNA, marks a significant improvement over existing prediction methods."
          ],
          "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
          "meta": {
            "query": "How has data training improved AlphaFold 3 predictive accuracy?",
            "question": "What advancements in data training methods have contributed to the increased predictive accuracy of AlphaFold 3?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://medium.com/meta-multiomics/alphafold-3-a-leap-forward-in-biomolecular-structure-prediction-opportunities-and-limitations-924350af1181",
          "description": "AlphaFold 3 (AF3) represents a monumental stride in the domain of protein structure prediction, establishing new paradigms in accuracy and\u2026",
          "snippets": [
            "The latest release of DeepMind\u2019s AlphaFold 3 (AF3) represents a monumental stride in the domain of protein structure prediction, establishing new paradigms in accuracy and applicability that far\u2026",
            "Predictive Accuracy: There\u2019s a significant leap in the accuracy of predicting complex biomolecular structures. AlphaFold 3 provides high fidelity in structure prediction across different types of molecules, which is crucial for applications in drug discovery and understanding biological mechanisms. Cross-Molecular Predictive Ability: The ability to accurately model interactions not just between proteins, but also including RNA, DNA, and other molecules, marks a substantial improvement over the specialized models of AlphaFold 2.",
            "It outperforms not only specialized tools but also previous iterations like AlphaFold-Multimer v2. Generative Training Procedure: The diffusion model is a new addition that trains the system to de-noise \u201cnoised\u201d atomic coordinates, learning protein structures at various scales. This generative aspect allows for a more dynamic exploration of protein structures, improving the prediction of local and global molecular structures.",
            "Improved Data Efficiency: The modifications in the model architecture and training have made AlphaFold 3 more data-efficient, allowing it to make more accurate predictions with less data compared to AlphaFold 2."
          ],
          "title": "AlphaFold 3: A Leap Forward in Biomolecular Structure Prediction ...",
          "meta": {
            "query": "How has data training improved AlphaFold 3 predictive accuracy?",
            "question": "What advancements in data training methods have contributed to the increased predictive accuracy of AlphaFold 3?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10751731/",
          "description": "Additionally, we observed that ... 2.3. It is possible that additional sampling, or pooling with different sets of models and parameters, could improve this success further. Another potential avenue for elevating the accuracy of AlphaFold predictions is demonstrated by the recent development of fully trainable AlphaFold ...",
          "snippets": [
            "Additionally, we observed that a recently described AlphaFold\u2010based massive sampling approach, named AFsample (Wallner, 2023a), achieved even higher success than standard AlphaFold 2.3. It is possible that additional sampling, or pooling with different sets of models and parameters, could improve this success further. Another potential avenue for elevating the accuracy of AlphaFold predictions is demonstrated by the recent development of fully trainable AlphaFold implementations (Gustaf et al., 2020; Motmaen et al., 2023; Ziyao et al., 2008), which enable researchers to adapt and refine the model to specific datasets or domains of interest, opening up new possibilities for customization and optimization of the AlphaFold network.",
            "High resolution antibody\u2013antigen structures provide critical insights into immune recognition and can inform therapeutic design. The challenges of experimental structural determination and the diversity of the immune repertoire underscore the ...",
            "Upon examining the subset of cases with medium or higher accuracy at recycle 3, we observed that the antibody\u2013antigen binding conformation score L\u2010RMSD exhibited a pronounced and significant improvement (Figure 4b, right panel), while the improvement in CDRH3 loop RMSD was significant but not as pronounced (Figure 4c, right panel), indicating that for models to attain high accuracy at the end of the recycling iteration, it is helpful for AlphaFold to accurately predict the CDRH3 loop relatively accurately before recycling iterations begin.",
            "The capability of AlphaFold to perform rigid\u2010body protein movements over recycling iterations, is shown in Figure 4d (nanobody/Ricin complex). This prediction was of incorrect accuracy before recycling iterations and was improved to a medium accuracy prediction at Recycle 3."
          ],
          "title": "Evaluation of AlphaFold antibody\u2013antigen modeling with implications ...",
          "meta": {
            "query": "How has data training improved AlphaFold 3 predictive accuracy?",
            "question": "What advancements in data training methods have contributed to the increased predictive accuracy of AlphaFold 3?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://en.wikipedia.org/wiki/AlphaFold",
          "description": "AlphaFold 3 was announced on 8 May 2024. It can predict the structure of complexes created by proteins with DNA, RNA, various ligands, and ions. The new prediction method shows a minimum 50% improvement in accuracy for protein interactions with other molecules compared to existing methods.",
          "snippets": [
            "The inclusion of metagenomic data has improved the quality of the prediction of MSAs. One of the biggest sources of the training data was the custom-built Big Fantastic Database (BFD) of 65,983,866 protein families, represented as MSAs and hidden Markov models (HMMs), covering 2,204,359,010 protein sequences from reference databases, metagenomes, and metatranscriptomes. AlphaFold 2's results at CASP14 were described as \"astounding\" and \"transformational\".",
            "Measured by the root-mean-square deviation (RMS-D) of the placement of the alpha-carbon atoms of the protein backbone chain, which tends to be dominated by the performance of the worst-fitted outliers, 88% of AlphaFold 2's predictions had an RMS deviation of less than 4 \u00c5 for the set of overlapped C-alpha atoms. 76% of predictions achieved better than 3 \u00c5, and 46% had a C-alpha atom RMS accuracy better than 2 \u00c5, with a median RMS deviation in its predictions of 2.1 \u00c5 for a set of overlapped CA atoms.",
            "However, the October 2021 update, named AlphaFold-Multimer, included protein complexes in its training data. DeepMind stated this update succeeded about 70% of the time at accurately predicting protein-protein interactions. Announced on 8 May 2024, AlphaFold 3 was co-developed by Google DeepMind and Isomorphic Labs, both subsidiaries of Alphabet.",
            "Therefore, it may not perform as well on synthetic proteins or proteins with very low homology to those in the training database. The model's ability to predict multiple native conformations of proteins is limited. AlphaFold 3 version can predict structures of protein complexes with a very limited set of selected cofactors and co- and post-translational modifications.",
            "AlphaFold is an artificial intelligence (AI) program developed by DeepMind, a subsidiary of Alphabet, which performs predictions of protein structure. It is designed using deep learning techniques. AlphaFold 1 (2018) placed first in the overall rankings of the 13th Critical Assessment of Structure ..."
          ],
          "title": "AlphaFold - Wikipedia",
          "meta": {
            "query": "How has data training improved AlphaFold 3 predictive accuracy?",
            "question": "What advancements in data training methods have contributed to the increased predictive accuracy of AlphaFold 3?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://blog.google/technology/ai/google-deepmind-isomorphic-alphafold-3-ai-model/",
          "description": "Our new AI model AlphaFold 3 can predict the structure and interactions of all life\u2019s molecules with unprecedented accuracy.",
          "snippets": [
            "In a paper published in Nature, we introduce AlphaFold 3, a revolutionary model that can predict the structure and interactions of all life\u2019s molecules with unprecedented accuracy. For the interactions of proteins with other molecule types we see at least a 50% improvement compared with existing prediction methods, and for some important categories of interaction we have doubled prediction accuracy.",
            "AlphaFold 3\u2019s capabilities come from its next-generation architecture and training that now covers all of life\u2019s molecules. At the core of the model is an improved version of our Evoformer module \u2014 a deep learning architecture that underpinned AlphaFold 2\u2019s incredible performance. After processing the inputs, AlphaFold 3 assembles its predictions using a diffusion network, akin to those found in AI image generators.",
            "The ability to predict antibody-protein binding is critical to understanding aspects of the human immune response and the design of new antibodies \u2014 a growing class of therapeutics. Using AlphaFold 3 in combination with a complementary suite of in-house AI models, Isomorphic Labs is working on drug design for internal projects as well as with pharmaceutical partners. Isomorphic Labs is using AlphaFold 3 to accelerate and improve the success of drug design \u2014 by helping understand how to approach new disease targets, and developing novel ways to pursue existing ones that were previously out of reach.",
            "AlphaFold 3 creates capabilities for drug design with predictions for molecules commonly used in drugs, such as ligands and antibodies, that bind to proteins to change how they interact in human health and disease. AlphaFold 3 achieves unprecedented accuracy in predicting drug-like interactions, including the binding of proteins with ligands and antibodies with their target proteins."
          ],
          "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
          "meta": {
            "query": "How has data training improved AlphaFold 3 predictive accuracy?",
            "question": "What advancements in data training methods have contributed to the increased predictive accuracy of AlphaFold 3?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.isomorphiclabs.com/articles/alphafold-3-predicts-the-structure-and-interactions-of-all-of-lifes-molecules",
          "description": "We are reimagining the entire drug discovery process from first principles with an AI-first approach.",
          "snippets": [
            "AlphaFold 3 predicts the structure and interactions of all of life\u2019s molecules",
            "In a paper published in Nature, we introduce AlphaFold 3, a revolutionary model that can predict the structure and interactions of all life\u2019s molecules with unprecedented accuracy. For the interactions of proteins with other molecule types we see at least a 50% improvement compared with existing prediction methods, and for some important categories of interaction we have doubled prediction accuracy.",
            "AlphaFold 3\u2019s capabilities come from its next-generation architecture and training that now covers all of life\u2019s molecules. At the core of the model is an improved version of our Evoformer module \u2013 a deep learning architecture that underpinned AlphaFold 2\u2019s incredible performance. After processing the inputs, AlphaFold 3 assembles its predictions using a diffusion network, akin to those found in AI image generators.",
            "The ability to predict antibody-protein binding is critical to understanding aspects of the human immune response and the design of new antibodies - a growing class of therapeutics. ... Using AlphaFold 3 in combination with a complementary suite of in-house AI models, we are working on drug design for internal projects as well as with pharmaceutical partners. We are using AlphaFold 3 to accelerate and improve the success of drug design - by helping understand how to approach new disease targets, and developing novel ways to pursue existing ones that were previously out of reach."
          ],
          "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
          "meta": {
            "query": "How has data training improved AlphaFold 3 predictive accuracy?",
            "question": "What advancements in data training methods have contributed to the increased predictive accuracy of AlphaFold 3?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.drugdiscoverytrends.com/meet-alphafold-3-which-can-accurately-model-more-than-99-of-molecular-types-in-the-protein-data-bank/",
          "description": "AlphaFold 3 by DeepMind accurately predicts protein structures and interactions, transforming drug discovery and structural biology.",
          "snippets": [
            "This shift towards a diffusion-based architecture allows AF3 to model an array of biomolecular interactions, including proteins, nucleic acids, small molecules, ions and modified residues with high accuracy. A paper introducing the model, titled \u201cAccurate structure prediction of biomolecular 2 interactions with AlphaFold 3,\u201d notes that it can accurately predict \u201ccomplexes containing nearly all molecular types present in the Protein Data Bank,\u201d a widely used repository of 3D structural data for large biological molecules. The PDB was also a core resource for training and evaluating AlphaFold 3 and its predecessors.",
            "By incorporating these training enhancements, AlphaFold 3 takes a significant step forward in generating reliable and biologically meaningful structure predictions. AlphaFold 3\u2019s remarkable ability to predict the interactions between proteins and small molecules holds immense promise for revolutionizing drug discovery. The paper highlights that \u201cAF3 shows far greater accuracy on protein-ligand interactions than state-of-the-art docking tools,\u201d suggesting that the model can reliably predict the binding sites and optimal shapes for potential drug molecules.",
            "The adoption of a diffusion-based approach allows AlphaFold 3 to generate accurate 3D models of biomolecular complexes by predicting the raw coordinates of individual atoms, a significant departure from its predecessor\u2019s protein-centric architecture.",
            "In a press briefing, Demis Hassabis, CEO of DeepMind Technologies, explained the evolution of AlphaFold over the years and the significance of AlphaFold 3: \u201cWith AlphaFold 2, the big milestone moment in structural biology was in essence you can think of it as our solution to the static picture of proteins, going from predicting the amino acid sequence to the 3D structure of the protein,\u201d he said."
          ],
          "title": "AlphaFold 3 offers even more accurate protein structure prediction",
          "meta": {
            "query": "How has data training improved AlphaFold 3 predictive accuracy?",
            "question": "What advancements in data training methods have contributed to the increased predictive accuracy of AlphaFold 3?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://frontlinegenomics.com/alphafold-3-stepping-into-the-future-of-structure-prediction/",
          "description": "In this news highlight, we explore AlphaFold3, compare it to its predecessor and take a look to the future.",
          "snippets": [
            "For years, scientists have been attempting to integrate the latest and greatest AI models into the field, in order to speed up the process and improve accuracy. Enter AlphaFold, an artificial intelligence tool developed by Google\u2019s DeepMind. The first version of the technology was released in 2018, but it was 2020\u2019s AlphaFold 2 that made headlines \u2013 winning the prestigious Critical Assessment of Structure Prediction (CASP) 14 competition.",
            "These improvements to the model have led the company to claim that AlphaFold 3 has the highest accuracy yet. Perhaps the most exciting comparison that can be drawn between AlphaFold 2 and 3 is the latter\u2019s ability to make predictions not just about protein structure, but about interactions between proteins and biological molecules such as DNA, RNA and ligands \u2013 an acknowledgment that no molecules operate on their own.",
            "This is reflected in AlphaFold 3\u2019s large training set, which includes a wider range of molecules. How will this technology be used? Through a collaboration with Isomorphic Labs, the tool is now finding its way into the commercial sphere, due to its improved ability to upscale the drug development process. Plus, DeepMind have also released the AlphaFold server, which they describe as \u2018the most accurate tool in the world for predicting how proteins interact with other molecules throughout the cell.\u2019 The server is free to use for non-commercial purposes, providing researchers with a fast-paced, accurate tool.",
            "Although the release of AlphaFold 3 may feel like a huge jump from where we were just a few short years ago, it\u2019s likely that we\u2019ll continue to see improvements to this technology in the not-too-distant future. Even with AI tools like AlphaFold, the latter stages of the drug discovery journey, in particular, still take a significant length of time."
          ],
          "title": "AlphaFold 3: Stepping into the future of structure prediction - ...",
          "meta": {
            "query": "How has data training improved AlphaFold 3 predictive accuracy?",
            "question": "What advancements in data training methods have contributed to the increased predictive accuracy of AlphaFold 3?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://blog.google/technology/ai/how-we-built-alphafold-3/",
          "description": "\u201cWe were able to use those predicted ... training for AlphaFold 3, so that AlphaFold 3 could learn to predict disorder,\u201d Lindsay says. \u201cWe have a saying: \u2018Trust the fusilli, reject the spaghetti,\u2019\u201d adds Jonas. An example of a prediction from AlphaFold 3 with ordered \u201cfusilli\u201d regions in blue and disordered \u201cspaghetti\u201d regions in orange. The colors represent the model\u2019s confidence of predicted accuracy...",
          "snippets": [
            "\u201cWe were able to use those predicted structures from AlphaFold 2 as distillation training for AlphaFold 3, so that AlphaFold 3 could learn to predict disorder,\u201d Lindsay says. \u201cWe have a saying: \u2018Trust the fusilli, reject the spaghetti,\u2019\u201d adds Jonas. An example of a prediction from AlphaFold 3 with ordered \u201cfusilli\u201d regions in blue and disordered \u201cspaghetti\u201d regions in orange. The colors represent the model\u2019s confidence of predicted accuracy.",
            "Their structure and the confidence metrics will come out so that they're able to look at and evaluate their prediction.\u201d \u00b7 In order to get AlphaFold 3 to work with this much wider range of biomolecules, the team vastly expanded the data that the newer model was trained on to include DNA, RNA, small molecules and more.",
            "That shift led to a new issue, though: Since so-called \u201cdisordered regions\u201d of proteins weren\u2019t included in the training data, the diffusion model would try to create an inaccurate \u201cordered\u201d structure with a defined spiral shape, instead of predicting disordered regions. So the team turned to AlphaFold 2, which is already extremely good at predicting which interactions would be disordered \u2014 which look like a pile of chaotic spaghetti \u2014 and which ones were not.",
            "Since its launch in 2020, more than 2 million researchers have used Google DeepMind\u2019s AlphaFold 2 model for protein predictions in their work on vaccine development, cancer treatments and more \u2014 helping solve a problem that researchers had been working on for over 50 years."
          ],
          "title": "How we built AlphaFold 3 to predict the structure and interaction ...",
          "meta": {
            "query": "How has data training improved AlphaFold 3 predictive accuracy?",
            "question": "What advancements in data training methods have contributed to the increased predictive accuracy of AlphaFold 3?"
          },
          "citation_uuid": -1
        }
      ],
      "cited_info": null
    },
    {
      "utterance": "The integration of AlphaFold 3 technology in the drug discovery process within the pharmaceutical industry holds immense promise and potential. AlphaFold 3's ability to predict interactions at the atomic level signifies a transformative shift in drug discovery processes[17]. This groundbreaking technology, developed by Google DeepMind and Isomorphic Labs, has been described as \"groundbreaking\" and has the potential to revolutionize the field of medicinal chemistry[21].\n\nOne of the key advantages of AlphaFold 3 is its cost-effectiveness compared to traditional methods in medicinal chemistry. It is reported to be an order of magnitude less expensive, making it a game-changing technology in drug discovery[18]. This cost-effectiveness, coupled with its predictive capabilities, can significantly reduce drug discovery time by simulating and predicting the action of substances on proteins, potentially leading to the development of drugs for currently untreatable diseases[20].\n\nFurthermore, AlphaFold 3's ability to predict the structure and interactions of all life's molecules, including proteins, DNA, RNA, and small molecule ligands, opens up exciting possibilities for drug discovery. This unified framework for structure prediction encompasses unprecedented breadth and accuracy, allowing for the rational development of therapeutics against targets that were previously difficult to modulate[19].\n\nTo maximize the impact of AlphaFold 3 on scientific research and drug discovery, its capabilities are made accessible to scientists through the AlphaFold Server. This research tool allows the scientific community to leverage the model's predictive abilities for free, enabling collaborations with pharmaceutical companies to tackle real-world drug design challenges and develop new treatments[22][25]. \n\nWhile there are concerns about data integrity and interoperability in the pharmaceutical industry, the potential of AI tools like AlphaFold 3 is acknowledged by a majority of industry professionals. Implementing advanced tools like AlphaFold requires meticulous attention to detail and a significant capital outlay, but the transformative potential it holds in drug discovery cannot be understated[24].\n\nIn conclusion, the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry has the potential to revolutionize how new drugs are developed and could lead to groundbreaking treatments for various diseases. This cutting-edge technology represents a significant step forward in the field of medicinal chemistry and holds promise for the future of drug discovery and development[23].",
      "raw_utterance": "The integration of AlphaFold 3 technology in the drug discovery process within the pharmaceutical industry holds immense promise and potential. AlphaFold 3's ability to predict interactions at the atomic level signifies a transformative shift in drug discovery processes[17]. This groundbreaking technology, developed by Google DeepMind and Isomorphic Labs, has been described as \"groundbreaking\" and has the potential to revolutionize the field of medicinal chemistry[21].\n\nOne of the key advantages of AlphaFold 3 is its cost-effectiveness compared to traditional methods in medicinal chemistry. It is reported to be an order of magnitude less expensive, making it a game-changing technology in drug discovery[18]. This cost-effectiveness, coupled with its predictive capabilities, can significantly reduce drug discovery time by simulating and predicting the action of substances on proteins, potentially leading to the development of drugs for currently untreatable diseases[20].\n\nFurthermore, AlphaFold 3's ability to predict the structure and interactions of all life's molecules, including proteins, DNA, RNA, and small molecule ligands, opens up exciting possibilities for drug discovery. This unified framework for structure prediction encompasses unprecedented breadth and accuracy, allowing for the rational development of therapeutics against targets that were previously difficult to modulate[19].\n\nTo maximize the impact of AlphaFold 3 on scientific research and drug discovery, its capabilities are made accessible to scientists through the AlphaFold Server. This research tool allows the scientific community to leverage the model's predictive abilities for free, enabling collaborations with pharmaceutical companies to tackle real-world drug design challenges and develop new treatments[22][25]. \n\nWhile there are concerns about data integrity and interoperability in the pharmaceutical industry, the potential of AI tools like AlphaFold 3 is acknowledged by a majority of industry professionals. Implementing advanced tools like AlphaFold requires meticulous attention to detail and a significant capital outlay, but the transformative potential it holds in drug discovery cannot be understated[24].\n\nIn conclusion, the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry has the potential to revolutionize how new drugs are developed and could lead to groundbreaking treatments for various diseases. This cutting-edge technology represents a significant step forward in the field of medicinal chemistry and holds promise for the future of drug discovery and development[23].",
      "role": "Pharmaceutical industry representative",
      "role_description": " This expert works in the pharmaceutical industry and has experience in drug discovery. They will discuss how AlphaFold 3 can impact the process of identifying and designing new drugs, potentially speeding up the development of novel therapeutics.",
      "queries": [
        "AlphaFold 3 integration in drug discovery process pharmaceutical industry",
        "Benefits of AlphaFold 3 in drug discovery"
      ],
      "utterance_type": "Support",
      "claim_to_make": "How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry?",
      "raw_retrieved_info": [
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
          "description": "By addressing these challenges ... more fully realized, ensuring that this revolutionary technology benefits a broader spectrum of the scientific community. ... AlphaFold 3's integration into drug discovery processes signifies a transformative shift, particularly with its ability ...",
          "snippets": [
            "By addressing these challenges and limitations, the potential of AlphaFold 3 in transforming medical science and research can be more fully realized, ensuring that this revolutionary technology benefits a broader spectrum of the scientific community. ... AlphaFold 3's integration into drug discovery processes signifies a transformative shift, particularly with its ability to predict interactions at the atomic level.",
            "Despite current restrictions on access to AlphaFold 3, there is potential for the development of open-source versions by the end of the year . Such efforts would democratize access to this advanced technology, allowing a broader scientific community to contribute to and benefit from its capabilities. AlphaFold 3 stands at the forefront of a scientific revolution, with its impact extending beyond immediate applications in drug discovery and genomics to potentially reshape our approach to biological research and material science.",
            "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor ...",
            "It takes humans years to determine the structure of various proteins and how the shape works with the receptors but AlphaFold 3 predicts the same structure in seconds. The version's utility is unimaginable in the field of drug discoveries, vaccines, enzymatic processes, and determining the rate and effect of different biological processes."
          ],
          "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
          "meta": {
            "query": "Benefits of AlphaFold 3 in drug discovery",
            "question": "How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry?",
            "placement": "root -> Impact -> Scientific community -> Benefits of AlphaFold 3 in drug discovery -> Integration in drug discovery process"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://news.mit.edu/2022/alphafold-potential-protein-drug-0906",
          "description": "Using protein structures generated by the AI software AlphaFold, MIT researchers investigated whether existing computational models could identify the mechanisms of action of antibacterial compounds.",
          "snippets": [
            "Study finds computer models that predict molecular interactions need improvement before they can help identify drug mechanisms of action. ... Caption: Using protein structures generated by the AI software AlphaFold, MIT researchers investigated whether existing computational models could identify the mechanisms of action of antibacterial compounds.",
            "The new study is part of an effort recently launched by Collins\u2019 lab called the Antibiotics-AI Project, which has the goal of using artificial intelligence to discover and design new antibiotics. AlphaFold, an AI software developed by DeepMind and Google, has accurately predicted protein structures from their amino acid sequences. This technology has generated excitement among researchers looking for new antibiotics, who hope that they could use the AlphaFold structures to find drugs that bind to specific bacterial proteins.",
            "\u201cBreakthroughs such as AlphaFold are expanding the possibilities for in silico drug discovery efforts, but these developments need to be coupled with additional advances in other aspects of modeling that are part of drug discovery efforts,\u201d Collins says.",
            "\u201cOur study speaks to both the current abilities and the current limitations of computational platforms for drug discovery.\u201d \u00b7 In their new study, the researchers were able to improve the performance of these types of models, known as molecular docking simulations, by applying machine-learning techniques to refine the results. However, more improvement will be necessary to fully take advantage of the protein structures provided by AlphaFold, the researchers say."
          ],
          "title": "Analyzing the potential of AlphaFold in drug discovery | MIT News ...",
          "meta": {
            "query": "Benefits of AlphaFold 3 in drug discovery",
            "question": "How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.drugdiscoverytrends.com/laying-groundwork-alphafold-3-drug-discovery/",
          "description": "With the right approach, AlphaFold 3 promises to streamline drug discovery with advanced biomolecular predictions.",
          "snippets": [
            "Despite this challenge and the significant costs of building the necessary foundation, AlphaFold is an order of magnitude \u2014 or two \u2014 less expensive than traditional methods in medicinal chemistry. \u201cWe\u2019re talking about a completely game-changing technology as far as drug discovery is concerned,\u201d Bangert said.",
            "\u201cAlphaFold itself is like the heart but you need the lungs and the liver and the kidneys and blood vessels and all that as well,\u201d Bangert said. Deploying AlphaFold 3 at a production scale to accelerate drug discovery involves assembling an ecosystem of IT infrastructure, data pipelines and domain expertise.",
            "Filed Under: Data science, Drug Discovery, machine learning and AI Tagged With: AI in Pharma, AI tools, AlphaFold 3, biopharma innovation, drug discovery, pharmaceutical R&D, protein structure prediction",
            "\u201cAnd you tried that out in the lab physically and you had to go through a few thousand physical tests with each new attempt.\u201d Drug developers can now conduct these experiments computationally at a fraction of the cost using AlphaFold, compared to the time-consuming and resource-intensive process of traditional methods. The benefits of AlphaFold have not gone unnoticed by the scientific community."
          ],
          "title": "Laying the groundwork to tap AlphaFold 3's potential in drug ...",
          "meta": {
            "query": "Benefits of AlphaFold 3 in drug discovery",
            "question": "How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry?",
            "placement": "root -> Impact -> Scientific community -> Benefits of AlphaFold 3 in drug discovery -> Integration in drug discovery process"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11292590/",
          "description": "By addressing these challenges ... more fully realized, ensuring that this revolutionary technology benefits a broader spectrum of the scientific community. ... AlphaFold 3's integration into drug discovery processes signifies a transformative shift, particularly with its ability ...",
          "snippets": [
            "By addressing these challenges and limitations, the potential of AlphaFold 3 in transforming medical science and research can be more fully realized, ensuring that this revolutionary technology benefits a broader spectrum of the scientific community. ... AlphaFold 3's integration into drug discovery processes signifies a transformative shift, particularly with its ability to predict interactions at the atomic level.",
            "Despite current restrictions on access to AlphaFold 3, there is potential for the development of open-source versions by the end of the year . Such efforts would democratize access to this advanced technology, allowing a broader scientific community to contribute to and benefit from its capabilities. AlphaFold 3 stands at the forefront of a scientific revolution, with its impact extending beyond immediate applications in drug discovery and genomics to potentially reshape our approach to biological research and material science.",
            "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor AlphaFold ...",
            "It takes humans years to determine the structure of various proteins and how the shape works with the receptors but AlphaFold 3 predicts the same structure in seconds. The version's utility is unimaginable in the field of drug discoveries, vaccines, enzymatic processes, and determining the rate and effect of different biological processes."
          ],
          "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
          "meta": {
            "query": "Benefits of AlphaFold 3 in drug discovery",
            "question": "How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.nature.com/articles/d41586-023-02984-w",
          "description": "Nature - Questions remain about whether the AI tool for predicting protein structures can really shake up the pharmaceutical industry.",
          "snippets": [
            "Questions remain about whether the AI tool for predicting protein structures can really shake up the pharmaceutical industry. Questions remain about whether the AI tool for predicting protein structures can really shake up the pharmaceutical industry.",
            "After Google Deepmind\u2019s AlphaFold proved that it could predict the 3D shapes of proteins with high accuracy in 2020, chemists became excited about the promise of using the open-source artificial-intelligence (AI) programme to discover drugs more quickly and cheaply."
          ],
          "title": "AlphaFold touted as next big thing for drug discovery \u2014 but is it?",
          "meta": {
            "query": "Benefits of AlphaFold 3 in drug discovery",
            "question": "How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.isomorphiclabs.com/articles/alphafold-3-predicts-the-structure-and-interactions-of-all-of-lifes-molecules",
          "description": "We are reimagining the entire drug discovery process from first principles with an AI-first approach.",
          "snippets": [
            "AlphaFold 3 predicts the structure and interactions of all of life\u2019s molecules",
            "We hope AlphaFold 3 will help transform our understanding of the biological world and drug discovery. Scientists can access the majority of its capabilities, for free, through the newly launched AlphaFold Server, an easy-to-use research tool.",
            "To build on AlphaFold 3\u2019s potential for drug design, we at Isomorphic Labs are already collaborating with pharmaceutical companies to apply it to real-world drug design challenges and, ultimately, develop new life-changing treatments for patients. ... Our new model builds on the foundations of AlphaFold 2, which in 2020 made a fundamental breakthrough in protein structure prediction. So far, millions of researchers globally have used AlphaFold 2 to make discoveries in areas including malaria vaccines, cancer treatments, and enzyme design.",
            "7R6R - DNA binding protein: AlphaFold 3\u2019s prediction for a molecular complex featuring a protein (blue) bound to a double helix of DNA (pink) is a near-perfect match to the true molecular structure discovered through painstaking experiments (gray). ... AlphaFold 3 brings the biological world into high definition. It allows scientists to see cellular systems in all their complexity, across structures, interactions, and modifications. This new window on the molecules of life reveals how they\u2019re all connected and helps understand how those connections affect biological functions \u2013 such as the actions of drugs, the production of hormones, and the health-preserving process of DNA repair."
          ],
          "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
          "meta": {
            "query": "Benefits of AlphaFold 3 in drug discovery",
            "question": "How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.isomorphiclabs.com/articles/rational-drug-design-with-alphafold-3",
          "description": "We are reimagining the entire drug discovery process from first principles with an AI-first approach.",
          "snippets": [
            "This builds upon Google DeepMind\u2019s foundational work of predicting the structure of proteins with AlphaFold 2, to now include how multiple proteins, DNA, RNA, and small molecule ligands come together and interact, as well as predicting the structural impact of post-translational modifications and ions on these molecular systems. This model is a powerful unified framework for structure prediction, encompassing unprecedented breadth and accuracy. ... This breakthrough opens up exciting possibilities for drug discovery, allowing us to rationally develop therapeutics against targets that were previously difficult or deemed intractable to modulate.",
            "To demonstrate the potential for rational structure-based drug design with AlphaFold 3, we examined TIM-3, an immune checkpoint protein identified as a potential target for cancer immunotherapy following a 2021 publication. ... The study focused on the discovery and design of small molecules capable of binding TIM-3 with high affinity.",
            "But AlphaFold 3 is one of the many AI-powered breakthroughs we\u2019re working on which are needed to transform drug discovery - structural understanding is just a part of the picture. We\u2019re combining AlphaFold 3 with our other proprietary AI models in our platform that help us understand more about the properties, function, and dynamics of molecular systems.",
            "We used the raw sequence of the protein, and the SMILES representation of each ligand, without giving AlphaFold 3 any additional information about the pose, structure, or pocket. Excitingly, the predicted structures were in agreement with the published experimental structures. The pocket discovered by the study was also found by AlphaFold 3."
          ],
          "title": "Rational drug design with AlphaFold 3 - Isomorphic Labs",
          "meta": {
            "query": "Benefits of AlphaFold 3 in drug discovery",
            "question": "How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry?",
            "placement": "root -> Impact -> Scientific community -> Benefits of AlphaFold 3 in drug discovery -> Integration in drug discovery process"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.nature.com/articles/d41586-024-01383-z",
          "description": "Latest version of the AI models how proteins interact with other molecules \u2014 but DeepMind restricts access to the tool.",
          "snippets": [
            "Latest version of the AI models how proteins interact with other molecules \u2014 but DeepMind restricts access to the tool. Latest version of the AI models how proteins interact with other molecules \u2014 but DeepMind restricts access to the tool.",
            "Nature - Latest version of the AI models how proteins interact with other molecules \u2014 but DeepMind restricts access to the tool.",
            "Since the powerhouse artificial intelligence (AI) tool AlphaFold2 was released in 2021, scientists have used the protein-structure-prediction model to map one of our cells\u2019 biggest machines, discover drugs and chart the universe of every known protein."
          ],
          "title": "Major AlphaFold upgrade offers boost for drug discovery",
          "meta": {
            "query": "Benefits of AlphaFold 3 in drug discovery",
            "question": "How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.analyticsvidhya.com/blog/2024/05/deepmind-ai-alphafold/",
          "description": "Drug Discovery: First, as demonstrated above, AlphaFold 3 can drastically reduce drug discovery time by simulating and predicting the action of substances on proteins. This can result in the development of drugs for currently untreatable diseases, potentially curing them. Materials Science: Materials science, in turn, can similarly benefit ...",
          "snippets": [
            "Drug Discovery: First, as demonstrated above, AlphaFold 3 can drastically reduce drug discovery time by simulating and predicting the action of substances on proteins. This can result in the development of drugs for currently untreatable diseases, potentially curing them. Materials Science: Materials science, in turn, can similarly benefit from predictions about the action of molecules by designing new materials based on predicted properties.",
            "AlphaFold 3, the AI revolutionizing molecular understanding beyond proteins. Explore its power to predict DNA, RNA, and drug structures!",
            "The fast prediction time allows scientists to explore a larger set of potential drugs or materials and more molecules can be tested, which allows better chances that more of the best candidates will be tested. Focus on more complex problems: Protein structure prediction is reduced to zero. Without the bottleneck of protein structure prediction, researchers can focus on more difficult biological questions, resulting in quicker development of new science. While AlphaFold 3 offers immense benefits, its power requires careful consideration of some ethical issues:",
            "By predicting these interactions, AlphaFold 3 can: Reveal how proteins bind to DNA: This helps us understand how genes are turned on and off, crucial for regulating cellular activity. Predict how drugs interact with proteins: This is a game-changer in drug discovery."
          ],
          "title": "AlphaFold 3 Will Change the Biological World and Drug Discovery",
          "meta": {
            "query": "Benefits of AlphaFold 3 in drug discovery",
            "question": "How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry?",
            "placement": "root -> Impact -> Scientific community -> Benefits of AlphaFold 3 in drug discovery -> Integration in drug discovery process"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.pharmavoice.com/news/google-alphafold-3-drug-discovery-pharma-buzz/716496/",
          "description": "The \u201cNobel Prize-worthy invention\u201d could be worth hundreds of billions commercially \u2014 and have a deep impact on drug R&D.",
          "snippets": [
            "The artificial intelligence program AlphaFold 3, rolled out by Google DeepMind and Isomorphic Labs earlier this month, has been called \u201cgroundbreaking,\u201d holding transformative potential in drug discovery.",
            "And while AlphaFold 3 could identify promising compounds faster, the usual hurdles to market will remain. \u201cThis isn't necessarily a Holy Grail to instantly make the drug development process more successful,\u201d Bangert said. \u201cYou're still going to have the traditional challenges, but this is a piece of that puzzle that's fitting better now.\u201d \u00b7 AI has secured a footing in drug discovery.",
            "AlphaFold 3\u2019s capabilities, outlined in the journal Nature, build on two of its earlier AI models, enabling drug developers to quickly identify promising targets, potentially slashing the time to market by years. Earlier versions of AlphaFold spurred a leap forward in drug development by rapidly and accurately predicting 3-D protein structures, a decades-long problem that had vexed computational biologists seeking to understand how shape affects protein function as a disease indicator.",
            "However, AlphaFold and competing programs, such as RoseTTaFold, now make the process quicker and easier. \u201cInstead of trialing a hundred options in the lab, physically, I can trial tens of thousands of options in silico,\u201d he said. \u201cWhile it still costs money, it's a small fraction and, of course, it's almost instantaneous.\u201d \u00b7 If a company typically takes ten years to get a drug across the finish line, this technology will allow them to do it in seven, he said."
          ],
          "title": "Why AlphaFold 3 is stirring up so much buzz in pharma | PharmaVoice",
          "meta": {
            "query": "Benefits of AlphaFold 3 in drug discovery",
            "question": "How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry?",
            "placement": "root -> Impact -> Scientific community -> Benefits of AlphaFold 3 in drug discovery -> Integration in drug discovery process"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
          "description": "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor ...",
          "snippets": [
            "To maximize the impact of AlphaFold 3 on scientific research and drug discovery, its capabilities are made accessible to scientists through the AlphaFold Server. This easy-to-use research tool allows the scientific community to leverage the model's predictive abilities free. Furthermore, Isomorphic Labs is collaborating with pharmaceutical companies to apply AlphaFold 3 to real-world drug design challenges, aiming to develop new treatments that could change patients' lives.",
            "These materials could be specifically designed for biocompatibility and functionality, ranging from medical implants to bioengineered enzymes, which could revolutionize multiple industries. ... The tool enhances fundamental biological research by providing a deeper understanding of protein folding, cellular signaling, and gene regulation. Such insights lay the groundwork for pioneering discoveries across various biological fields, potentially leading to breakthroughs in understanding complex life processes . ... Continued advancements in AI, as seen with the introduction of AlphaFold 3, promise further enhancements in biomolecular modeling.",
            "AlphaFold 3's nuanced understanding of protein-ligand interactions holds immense potential for revolutionizing drug discovery . By accurately predicting the binding sites and optimal shapes for potential drug molecules, AlphaFold 3 significantly streamlines the drug design process. This efficiency could drastically reduce the time and cost associated with experimental methods, allowing researchers to focus on the most promising drug candidates. Integrating Structural Predictions with Genomic Insights",
            "While AlphaFold 3 brings unparalleled precision to protein structure prediction, its utility in drug discovery is complemented by tools like Cognit (Cognit AI, San Francisco, California, United States), which focus on the genomic and transcriptomic foundations of health and disease. The integration of Cognit's upstream genomic and transcriptomic insights with AlphaFold 3's structural predictions creates a powerful synergy in drug discovery . This holistic approach covers the entire spectrum of drug development, from early-stage target discovery and validation to the optimization of therapeutic interactions at the molecular level."
          ],
          "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
          "meta": {
            "query": "AlphaFold 3 integration in drug discovery process pharmaceutical industry",
            "question": "How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry?",
            "placement": "root -> Impact -> Drug discovery"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.labiotech.eu/in-depth/alpha-fold-3-drug-discovery/",
          "description": "Find out how Google DeepMind's AlphaFold3 platform could help scientists revolutionize the field of drug discovery.",
          "snippets": [
            "Ultimately, AlphaFold3\u2019s impact on drug discovery and development is expected to be substantial. And, while commercial restrictions currently limit pharmaceutical applications, DeepMind\u2019s decision to make the platform open-source means that academic research will inevitably be able to advance scientists\u2019 understanding of disease mechanisms and drug interactions.",
            "As scientists use AlphaFold3 to better understand protein structures and interactions, they can also create better targets for medications, better understand side effects, and delve into new areas of protein-drug interactions that may not have previously been fathomable. \u201cThe drug discovery industry is constantly evolving to explore innovative approaches that go beyond the traditional \u2018one drug per target\u2019 model,\u201d said Tan.",
            "The withholding of the code was largely down to commercial reasons, as co-developer Isomorphic Labs, a DeepMind spinoff company, is using AlphaFold3 internally to speed up its drug discovery efforts. The company currently has partnerships potentially worth $3 billion with Eli Lilly and Novartis aimed at developing multiple drugs.",
            "To learn how to puzzle out the precise atomic structures of molecules, AlphaFold3 uses a diffusion model, similar to ones used for popular text-to-image generation models such as OpenAI\u2019s DALL-E 3."
          ],
          "title": "AlphaFold3: Revolutionizing drug discovery and development",
          "meta": {
            "query": "AlphaFold 3 integration in drug discovery process pharmaceutical industry",
            "question": "How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry?",
            "placement": "root -> Impact -> Drug discovery"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.isomorphiclabs.com/articles/rational-drug-design-with-alphafold-3",
          "description": "We are reimagining the entire drug discovery process from first principles with an AI-first approach.",
          "snippets": [
            "We\u2019ve already deployed our frontier version of AlphaFold 3 in our own internal pipeline of projects, and in our partnerships with pharmaceutical companies. ... But AlphaFold 3 is one of the many AI-powered breakthroughs we\u2019re working on which are needed to transform drug discovery - structural understanding is just a part of the picture.",
            "This builds upon Google DeepMind\u2019s foundational work of predicting the structure of proteins with AlphaFold 2, to now include how multiple proteins, DNA, RNA, and small molecule ligands come together and interact, as well as predicting the structural impact of post-translational modifications and ions on these molecular systems. This model is a powerful unified framework for structure prediction, encompassing unprecedented breadth and accuracy. ... This breakthrough opens up exciting possibilities for drug discovery, allowing us to rationally develop therapeutics against targets that were previously difficult or deemed intractable to modulate.",
            "To demonstrate the potential for rational structure-based drug design with AlphaFold 3, we examined TIM-3, an immune checkpoint protein identified as a potential target for cancer immunotherapy following a 2021 publication. ... The study focused on the discovery and design of small molecules capable of binding TIM-3 with high affinity.",
            "We used the raw sequence of the protein, and the SMILES representation of each ligand, without giving AlphaFold 3 any additional information about the pose, structure, or pocket. Excitingly, the predicted structures were in agreement with the published experimental structures. The pocket discovered by the study was also found by AlphaFold 3."
          ],
          "title": "Rational drug design with AlphaFold 3 - Isomorphic Labs",
          "meta": {
            "query": "AlphaFold 3 integration in drug discovery process pharmaceutical industry",
            "question": "How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11292590/",
          "description": "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor AlphaFold ...",
          "snippets": [
            "To maximize the impact of AlphaFold 3 on scientific research and drug discovery, its capabilities are made accessible to scientists through the AlphaFold Server. This easy-to-use research tool allows the scientific community to leverage the model's predictive abilities free. Furthermore, Isomorphic Labs is collaborating with pharmaceutical companies to apply AlphaFold 3 to real-world drug design challenges, aiming to develop new treatments that could change patients' lives.",
            "Computer-aided drug design and drug discovery: a prospective analysis. Niazi SK, Mariam Z. Pharmaceuticals (Basel) 2023;17:22. [PMC free article] [PubMed] [Google Scholar] 15. AlphaFold M. Drug Discovery and Development: Alphafold M 3 which can accurately model more than 99% of molecular types in the protein data bank.",
            "These materials could be specifically designed for biocompatibility and functionality, ranging from medical implants to bioengineered enzymes, which could revolutionize multiple industries. ... The tool enhances fundamental biological research by providing a deeper understanding of protein folding, cellular signaling, and gene regulation. Such insights lay the groundwork for pioneering discoveries across various biological fields, potentially leading to breakthroughs in understanding complex life processes . ... Continued advancements in AI, as seen with the introduction of AlphaFold 3, promise further enhancements in biomolecular modeling.",
            "AlphaFold 3's nuanced understanding of protein-ligand interactions holds immense potential for revolutionizing drug discovery . By accurately predicting the binding sites and optimal shapes for potential drug molecules, AlphaFold 3 significantly streamlines the drug design process. This efficiency could drastically reduce the time and cost associated with experimental methods, allowing researchers to focus on the most promising drug candidates. Integrating Structural Predictions with Genomic Insights"
          ],
          "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
          "meta": {
            "query": "AlphaFold 3 integration in drug discovery process pharmaceutical industry",
            "question": "How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.pharmavoice.com/news/google-alphafold-3-drug-discovery-pharma-buzz/716496/",
          "description": "The \u201cNobel Prize-worthy invention\u201d could be worth hundreds of billions commercially \u2014 and have a deep impact on drug R&D.",
          "snippets": [
            "The artificial intelligence program AlphaFold 3, rolled out by Google DeepMind and Isomorphic Labs earlier this month, has been called \u201cgroundbreaking,\u201d holding transformative potential in drug discovery.",
            "And while AlphaFold 3 could identify promising compounds faster, the usual hurdles to market will remain. \u201cThis isn't necessarily a Holy Grail to instantly make the drug development process more successful,\u201d Bangert said. \u201cYou're still going to have the traditional challenges, but this is a piece of that puzzle that's fitting better now.\u201d \u00b7 AI has secured a footing in drug discovery.",
            "AlphaFold 3\u2019s capabilities, outlined in the journal Nature, build on two of its earlier AI models, enabling drug developers to quickly identify promising targets, potentially slashing the time to market by years. Earlier versions of AlphaFold spurred a leap forward in drug development by rapidly and accurately predicting 3-D protein structures, a decades-long problem that had vexed computational biologists seeking to understand how shape affects protein function as a disease indicator.",
            "However, AlphaFold and competing programs, such as RoseTTaFold, now make the process quicker and easier. \u201cInstead of trialing a hundred options in the lab, physically, I can trial tens of thousands of options in silico,\u201d he said. \u201cWhile it still costs money, it's a small fraction and, of course, it's almost instantaneous.\u201d \u00b7 If a company typically takes ten years to get a drug across the finish line, this technology will allow them to do it in seven, he said."
          ],
          "title": "Why AlphaFold 3 is stirring up so much buzz in pharma | PharmaVoice",
          "meta": {
            "query": "AlphaFold 3 integration in drug discovery process pharmaceutical industry",
            "question": "How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.nature.com/articles/d41586-023-02984-w",
          "description": "Nature - Questions remain about whether the AI tool for predicting protein structures can really shake up the pharmaceutical industry.",
          "snippets": [
            "Questions remain about whether the AI tool for predicting protein structures can really shake up the pharmaceutical industry. Questions remain about whether the AI tool for predicting protein structures can really shake up the pharmaceutical industry.",
            "Questions remain about whether the AI tool for predicting protein structures can really shake up the pharmaceutical industry. ... After Google Deepmind\u2019s AlphaFold proved that it could predict the 3D shapes of proteins with high accuracy in 2020, chemists became excited about the promise of using the open-source artificial-intelligence (AI) programme to discover drugs more quickly and cheaply."
          ],
          "title": "AlphaFold touted as next big thing for drug discovery \u2014 but is it?",
          "meta": {
            "query": "AlphaFold 3 integration in drug discovery process pharmaceutical industry",
            "question": "How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.drugdiscoverytrends.com/laying-groundwork-alphafold-3-drug-discovery/",
          "description": "With the right approach, AlphaFold 3 promises to streamline drug discovery with advanced biomolecular predictions.",
          "snippets": [
            "Some 70% acknowledged AI\u2019s potential in the industry but noted struggles with data integrity and interoperability. The survey found that 63% of respondents were concerned about poor data quality. Given these data challenges, implementing advanced tools like AlphaFold requires meticulous attention to detail and a significant capital outlay. \u201cThe pipeline of tools that you require both before and after AlphaFold to make this into a commercial proposition for a pharmaceutical company or a healthcare company is fairly serious,\u201d Bangert stressed.",
            "The industry\u2019s reliance on a small fraction of drugs to subsidize the rest underscores the high-stakes nature of pharmaceutical development. \u201cIt is basically playing roulette, right? You just have to play roulette enough many times before you hit the jackpot,\u201d Bangert said. AlphaFold\u2019s computational approach offers significant advantages over traditional medicinal chemistry methods.",
            "Filed Under: Data science, Drug Discovery, machine learning and AI Tagged With: AI in Pharma, AI tools, AlphaFold 3, biopharma innovation, drug discovery, pharmaceutical R&D, protein structure prediction",
            "Despite this challenge and the significant costs of building the necessary foundation, AlphaFold is an order of magnitude \u2014 or two \u2014 less expensive than traditional methods in medicinal chemistry. \u201cWe\u2019re talking about a completely game-changing technology as far as drug discovery is concerned,\u201d Bangert said."
          ],
          "title": "Laying the groundwork to tap AlphaFold 3's potential in drug ...",
          "meta": {
            "query": "AlphaFold 3 integration in drug discovery process pharmaceutical industry",
            "question": "How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry?",
            "placement": "root -> Impact -> Drug discovery"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://news.mit.edu/2022/alphafold-potential-protein-drug-0906",
          "description": "Using protein structures generated by the AI software AlphaFold, MIT researchers investigated whether existing computational models could identify the mechanisms of action of antibacterial compounds.",
          "snippets": [
            "Caption: Using protein structures generated by the AI software AlphaFold, MIT researchers investigated whether existing computational models could identify the mechanisms of action of antibacterial compounds.",
            "A new study from MIT reveals the potential and limitations of one such computational approach. Using protein structures generated by an artificial intelligence program called AlphaFold, the researchers explored whether existing models could accurately predict the interactions between bacterial proteins and antibacterial compounds.",
            "In their new study, the researchers were able to improve the performance of these types of models, known as molecular docking simulations, by applying machine-learning techniques to refine the results. However, more improvement will be necessary to fully take advantage of the protein structures provided by AlphaFold, the researchers say.",
            "AlphaFold, an AI software developed by DeepMind and Google, has accurately predicted protein structures from their amino acid sequences."
          ],
          "title": "Analyzing the potential of AlphaFold in drug discovery | MIT News ...",
          "meta": {
            "query": "AlphaFold 3 integration in drug discovery process pharmaceutical industry",
            "question": "How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.analyticsvidhya.com/blog/2024/05/deepmind-ai-alphafold/",
          "description": "AlphaFold 3, the AI revolutionizing molecular understanding beyond proteins. Explore its power to predict DNA, RNA, and drug structures!",
          "snippets": [
            "Scientists can access most of its capabilities for free through the newly launched AlphaFold Server, an easy-to-use research tool. To build on AlphaFold 3\u2019s potential for drug design, Isomorphic Labs is already collaborating with pharmaceutical companies to apply it to real-world drug design challenges and, ultimately, develop new life-changing treatments for patients.",
            "DNA: The blueprint of life, holding the genetic code within its double helix structure. AlphaFold 3 can predict this complex shape, providing insights into how DNA interacts with proteins and regulates cellular processes.",
            "Simulating Molecule Dynamics: AlphaFold 3 might not just predict static shapes but also simulate the movement and interactions of molecules over time. This could provide even deeper insights into cellular processes. Currently, AlphaFold 3 focuses on biomolecules.",
            "Predicting Material Properties: By understanding how non-biological molecules fold and interact, AlphaFold could be used to design new materials with specific properties, like stronger and lighter composites. Unraveling Complex Systems: It could help model complex systems like protein assemblies or even entire cells, providing a more holistic view of biological processes."
          ],
          "title": "AlphaFold 3 Will Change the Biological World and Drug Discovery",
          "meta": {
            "query": "AlphaFold 3 integration in drug discovery process pharmaceutical industry",
            "question": "How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry?",
            "placement": "root -> Impact -> Drug discovery"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.sciencedirect.com/science/article/pii/S2666675824001231",
          "description": "Cookies are used by this site. Cookie Settings \u00b7 All content on this site: Copyright \u00a9 2025 Elsevier B.V., its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the Creative Commons ...",
          "snippets": [],
          "title": "Drug development in the AI era: AlphaFold 3 is coming! - ScienceDirect",
          "meta": {
            "query": "AlphaFold 3 integration in drug discovery process pharmaceutical industry",
            "question": "How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry?"
          },
          "citation_uuid": -1
        }
      ],
      "cited_info": null
    },
    {
      "utterance": "The advent of AlphaFold 3 has brought about a significant advancement in the field of scientific research, particularly in predicting the structure and interactions of various molecules[29]. While the potential benefits of this technology are immense, there are also ethical concerns that need to be addressed, especially in terms of data privacy and biases in predictions[28].\n\nOne of the primary ethical concerns surrounding AlphaFold 3 is the limited and proprietary nature of its accessibility[26]. This raises questions about equitable access to cutting-edge technology and the impact on scientific transparency and public accountability. While the software is accessible through the AlphaFold Server for global non-commercial research, it is not open-sourced like its predecessors[28]. This restricted access could potentially hinder the democratization of scientific research and limit the benefits of this revolutionary technology to a broader spectrum of the scientific community.\n\nMoreover, the potential for biases in AI models, including AlphaFold 3, poses another ethical challenge[28]. As with any AI technology, there is a risk of introducing biases into predictions, which could have far-reaching implications in scientific research and decision-making processes. Addressing these biases and ensuring the accuracy and fairness of predictions generated by AlphaFold 3 are crucial steps in maximizing its potential benefits while minimizing potential harms.\n\nIn addition, the issue of data privacy comes to the forefront when considering the use of AlphaFold 3 in scientific research[30]. Independently reproducing the model could be valuable for training new variants, potentially on private data repositories[30]. This raises concerns about the privacy and security of sensitive data used in training and validating AI models like AlphaFold 3. Establishing clear guidelines and regulations to safeguard data privacy and prevent misuse of the technology is essential in harnessing its full potential for scientific advancement.\n\nOverall, while AlphaFold 3 holds great promise in transforming medical science and research, it is imperative to address the ethical concerns surrounding its use, particularly in terms of data privacy and biases in predictions. By promoting ethical research practices, ensuring equitable access to the technology, and mitigating potential risks, researchers and policymakers can harness the full potential of AlphaFold 3 while upholding ethical standards in scientific research[27].",
      "raw_utterance": "The advent of AlphaFold 3 has brought about a significant advancement in the field of scientific research, particularly in predicting the structure and interactions of various molecules[29]. While the potential benefits of this technology are immense, there are also ethical concerns that need to be addressed, especially in terms of data privacy and biases in predictions[28].\n\nOne of the primary ethical concerns surrounding AlphaFold 3 is the limited and proprietary nature of its accessibility[26]. This raises questions about equitable access to cutting-edge technology and the impact on scientific transparency and public accountability. While the software is accessible through the AlphaFold Server for global non-commercial research, it is not open-sourced like its predecessors[28]. This restricted access could potentially hinder the democratization of scientific research and limit the benefits of this revolutionary technology to a broader spectrum of the scientific community.\n\nMoreover, the potential for biases in AI models, including AlphaFold 3, poses another ethical challenge[28]. As with any AI technology, there is a risk of introducing biases into predictions, which could have far-reaching implications in scientific research and decision-making processes. Addressing these biases and ensuring the accuracy and fairness of predictions generated by AlphaFold 3 are crucial steps in maximizing its potential benefits while minimizing potential harms.\n\nIn addition, the issue of data privacy comes to the forefront when considering the use of AlphaFold 3 in scientific research[30]. Independently reproducing the model could be valuable for training new variants, potentially on private data repositories[30]. This raises concerns about the privacy and security of sensitive data used in training and validating AI models like AlphaFold 3. Establishing clear guidelines and regulations to safeguard data privacy and prevent misuse of the technology is essential in harnessing its full potential for scientific advancement.\n\nOverall, while AlphaFold 3 holds great promise in transforming medical science and research, it is imperative to address the ethical concerns surrounding its use, particularly in terms of data privacy and biases in predictions. By promoting ethical research practices, ensuring equitable access to the technology, and mitigating potential risks, researchers and policymakers can harness the full potential of AlphaFold 3 while upholding ethical standards in scientific research[27].",
      "role": "Ethicist",
      "role_description": " This expert focuses on the ethical implications of technology in research and development. They will explore the ethical considerations surrounding the use of AI like AlphaFold 3 in scientific research, including issues of data privacy, accessibility, and potential biases in the predictions generated.",
      "queries": [
        "Potential ethical concerns of AlphaFold 3 in scientific research",
        "Data privacy issues with AlphaFold 3"
      ],
      "utterance_type": "Support",
      "claim_to_make": "What are some potential ethical concerns that arise from the use of AlphaFold 3 in scientific research, particularly in terms of data privacy and biases in predictions?",
      "raw_retrieved_info": [
        {
          "url": "https://www.analyticsvidhya.com/blog/2024/05/deepmind-ai-alphafold/",
          "description": "AlphaFold 3, the AI revolutionizing molecular understanding beyond proteins. Explore its power to predict DNA, RNA, and drug structures!",
          "snippets": [
            "AlphaFold 3\u2019s impact goes far beyond predicting molecule shapes. It can potentially revolutionize various fields, accelerate research, and raise ethical considerations.",
            "While AlphaFold 3 offers immense benefits, its power requires careful consideration of some ethical issues: Bias in AI Models: AI models like AlphaFold 3 are trained on data sets. If these data sets are biased, the predictions can be skewed. Ensuring fairness and inclusivity in the data used to train AlphaFold 3 is crucial. Accessibility and Equity: Widespread access to AlphaFold 3 should avoid widening the gap between developed and developing nations regarding scientific progress and healthcare.",
            "Scientists can design more effective and targeted therapies by understanding how a potential drug binds to a specific protein. One of the most exciting applications of AlphaFold 3 lies in drug discovery. Traditionally, this process can be slow and expensive. AlphaFold 3 can significantly accelerate it by: Predicting drug interactions with disease-causing proteins: This allows researchers to prioritize promising drug candidates and eliminate those unlikely to be effective.",
            "Imagine a scenario where researchers can quickly identify potential drugs that perfectly fit the target protein, like a key fitting a lock. This paves the way for faster development of life-saving medications and personalized treatments. Scientists can access most of its capabilities for free through the newly launched AlphaFold Server, an easy-to-use research tool."
          ],
          "title": "AlphaFold 3: The Next Generation in Molecular Prediction",
          "meta": {
            "query": "Potential ethical concerns of AlphaFold 3 in scientific research",
            "question": "What are some potential ethical concerns that arise from the use of AlphaFold 3 in scientific research, particularly in terms of data privacy and biases in predictions?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
          "description": "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor ...",
          "snippets": [
            "The limited and proprietary nature of AlphaFold's accessibility raises concerns regarding equitable access to cutting-edge technology. Such restrictions can impact scientific transparency and public accountability, which are crucial for the advancement and democratization of scientific research . By addressing these challenges and limitations, the potential of AlphaFold 3 in transforming medical science and research can be more fully realized, ensuring that this revolutionary technology benefits a broader spectrum of the scientific community.",
            "This easy-to-use research tool allows the scientific community to leverage the model's predictive abilities free. Furthermore, Isomorphic Labs is collaborating with pharmaceutical companies to apply AlphaFold 3 to real-world drug design challenges, aiming to develop new treatments that could change patients' lives. This collaborative approach underscores the commitment to harnessing the potential of AlphaFold 3 for advancing medical science and research.",
            "This capability is instrumental in advancing our understanding of how diseases like COVID-19 can be combated through the immune system, potentially leading to more effective treatments and vaccines . By modeling these interactions with high accuracy, AlphaFold 3 aids in the development of therapeutic strategies that are finely tuned to the nuances of immune system behavior . ... With its comprehensive approach to modeling life\u2019s molecules, AlphaFold 3 broadens the scope of scientific inquiry, enabling researchers to explore a wider range of biological molecules and their interactions . This expansion of capabilities accelerates the discovery process and opens new avenues for research that were previously limited by technological constraints.",
            "By predicting the structure of enzymes from soil-borne fungi that affect plant health, researchers can develop strategies to enhance crop resilience and health. This application demonstrates the versatility of AlphaFold in contributing to various scientific fields beyond human health . These real-life examples underscore the transformative potential of AlphaFold in advancing our understanding of complex biological interactions and accelerating the pace of medical and scientific discovery."
          ],
          "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
          "meta": {
            "query": "Potential ethical concerns of AlphaFold 3 in scientific research",
            "question": "What are some potential ethical concerns that arise from the use of AlphaFold 3 in scientific research, particularly in terms of data privacy and biases in predictions?",
            "placement": "root -> Ethical Concerns"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.genengnews.com/topics/artificial-intelligence/alphafold-3-angst-limited-accessibility-stirs-outcry-from-researchers/",
          "description": "Researchers are angered by the latest update to Google DeepMind\u2019s renowned protein structure prediction algorithm, which published in Nature without the open access code",
          "snippets": [
            "Nature\u2019s editor-in-chief, Magdalena Skipper, PhD stated that when making a decision on data and code availability, the journal reflects on several factors including \u201cthe potential implications for biosecurity and the ethical challenges this presents.\u201d In such cases, the journal works with authors to provide alternatives that will support reproducibility, such as pseudocode. However, John Jumper, PhD, one of the senior authors of the AlphaFold 3 article and lead author on AlphaFold 2, reportedly told the press that DeepMind and Isomorphic Labs had consulted more than 50 experts in biosecurity, bioethics, and AI safety and concluded that AlphaFold 3\u2019s marginal biosecurity risks were far outweighed by the system\u2019s potential benefits to science.",
            "Dunbrack emphasizes that these access restrictions prevent the scientific community from applying AlphaFold 3 to its full potential.",
            "The publication, which is a collaboration between DeepMind and Isomorphic Labs, a London-based company launched in 2021 to build upon DeepMind\u2019s AI research to tackle biological problems, emphasizes AlphaFold 3\u2019s potential to advance therapeutic applications, including drug discovery.",
            "AlQuraishi added that independently reproducing AlphaFold 3 would be highly valuable to permit training new variants of the system, including potentially training on private data repositories."
          ],
          "title": "AlphaFold 3 Angst: Limited Accessibility Stirs Outcry from Researchers",
          "meta": {
            "query": "Potential ethical concerns of AlphaFold 3 in scientific research",
            "question": "What are some potential ethical concerns that arise from the use of AlphaFold 3 in scientific research, particularly in terms of data privacy and biases in predictions?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://sidecarglobal.com/blog/the-breakthrough-of-alphafold-3-revolutionizing-biological-research",
          "description": "Discover the groundbreaking capabilities of AlphaFold 3 in biological research. Learn how this advanced AI model revolutionizes drug discovery, personalized medicine, and fundamental research by accurately predicting the structure and interactions of biological molecules.",
          "snippets": [
            "Researchers and policymakers must work together to establish guidelines and regulations that mitigate the risks associated with the misuse of AlphaFold 3. This includes implementing safeguards to prevent the technology from falling into the wrong hands and promoting ethical research practices. One of the significant advantages of AlphaFold 3 is the potential for collaborative research. By open-sourcing the model and its data, researchers worldwide can access and build upon its capabilities. This collaborative approach can accelerate scientific discovery and innovation, leading to more rapid advancements in various fields.",
            "With its advanced features and practical applications, the model has the potential to transform drug discovery, personalized medicine, and fundamental biological research. While challenges and ethical considerations remain, the benefits of AlphaFold 3 far outweigh the risks. By leveraging this groundbreaking technology, the scientific community can drive innovation and discovery, leading to more effective treatments and a deeper understanding of complex biological systems.",
            "Another potential benefit of AlphaFold 3 is the possibility of bypassing animal testing in some cases. By providing accurate predictions of how drugs interact with their targets, the model can help researchers assess the safety and efficacy of drug candidates without the need for extensive animal studies. This capability not only reduces the ethical concerns associated with animal testing but also accelerates the drug development process.",
            "The release of AlphaFold 3 represents a major breakthrough in this domain, offering unprecedented capabilities in predicting the structure and interactions of biological molecules. Today, we\u2019ll explore the key features, practical applications, broader implications, and potential concerns surrounding AlphaFold 3, highlighting its transformative potential."
          ],
          "title": "The Breakthrough of AlphaFold 3: Revolutionizing Biological Research",
          "meta": {
            "query": "Potential ethical concerns of AlphaFold 3 in scientific research",
            "question": "What are some potential ethical concerns that arise from the use of AlphaFold 3 in scientific research, particularly in terms of data privacy and biases in predictions?",
            "placement": "root -> Ethical Concerns"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://mexicobusiness.news/health/news/google-deepmind-tackles-drug-discovery-alphafold-3",
          "description": "AlphaFold 3 aims to transform drug discovery with advanced biomolecular structure prediction technology, but ethical concerns persist.",
          "snippets": [
            "Developed with Isomorphic Labs, a sister company of Alphabet, the software is accessible through the AlphaFold Server for global non-commercial research. However, AlphaFold 3 will not be open-sourced like its predecessors. This approach allows AlphaFold 3 to create plausible protein structures by learning patterns from verified data, similar to how image generators produce realistic visuals, states Wired. While powerful, AlphaFold 3 raises significant ethical concerns that must be addressed. One major issue is the potential for bias in AI models.",
            "Google DeepMind, in collaboration with Isomorphic Labs, has launched AlphaFold 3, an advanced AI model that predicts the structures of critical biomolecules such as proteins and DNA. This breakthrough technology is set to significantly impact drug discovery, research, biotechnology, and disease understanding. Nonetheless, ethical considerations around bias in AI models raise concerns, according to Analytics Vidhya.",
            "Accessibility is another critical concern. The tool\u2019s capabilities could exacerbate the gap between developed and developing nations in scientific research and healthcare.",
            "AlphaFold 3 represents a significant upgrade in accurately modeling the shapes of proteins and DNA. It integrates diffusion modeling\u2014an algorithm used in AI image generators like Dall-E and Midjourney\u2014to refine its molecular structures."
          ],
          "title": "Google DeepMind Tackles Drug Discovery With AlphaFold 3",
          "meta": {
            "query": "Potential ethical concerns of AlphaFold 3 in scientific research",
            "question": "What are some potential ethical concerns that arise from the use of AlphaFold 3 in scientific research, particularly in terms of data privacy and biases in predictions?",
            "placement": "root -> Ethical Concerns"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11292590/",
          "description": "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor AlphaFold ...",
          "snippets": [
            "The limited and proprietary nature of AlphaFold's accessibility raises concerns regarding equitable access to cutting-edge technology. Such restrictions can impact scientific transparency and public accountability, which are crucial for the advancement and democratization of scientific research . By addressing these challenges and limitations, the potential of AlphaFold 3 in transforming medical science and research can be more fully realized, ensuring that this revolutionary technology benefits a broader spectrum of the scientific community.",
            "This easy-to-use research tool allows the scientific community to leverage the model's predictive abilities free. Furthermore, Isomorphic Labs is collaborating with pharmaceutical companies to apply AlphaFold 3 to real-world drug design challenges, aiming to develop new treatments that could change patients' lives. This collaborative approach underscores the commitment to harnessing the potential of AlphaFold 3 for advancing medical science and research.",
            "This capability is instrumental in advancing our understanding of how diseases like COVID-19 can be combated through the immune system, potentially leading to more effective treatments and vaccines . By modeling these interactions with high accuracy, AlphaFold 3 aids in the development of therapeutic strategies that are finely tuned to the nuances of immune system behavior . ... With its comprehensive approach to modeling life\u2019s molecules, AlphaFold 3 broadens the scope of scientific inquiry, enabling researchers to explore a wider range of biological molecules and their interactions . This expansion of capabilities accelerates the discovery process and opens new avenues for research that were previously limited by technological constraints.",
            "By predicting the structure of enzymes from soil-borne fungi that affect plant health, researchers can develop strategies to enhance crop resilience and health. This application demonstrates the versatility of AlphaFold in contributing to various scientific fields beyond human health . These real-life examples underscore the transformative potential of AlphaFold in advancing our understanding of complex biological interactions and accelerating the pace of medical and scientific discovery."
          ],
          "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
          "meta": {
            "query": "Potential ethical concerns of AlphaFold 3 in scientific research",
            "question": "What are some potential ethical concerns that arise from the use of AlphaFold 3 in scientific research, particularly in terms of data privacy and biases in predictions?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.thehindu.com/sci-tech/science/how-will-alphafold-3-change-life-sciences-research/article68307452.ece",
          "description": "For now, we need to wait and watch how DeepMind decides to let eager scientists look under the hood and examine AlphaFold 3 more closely, to appreciate its full power. But until then, the model remains one of the best AI-based protein structure prediction models out there, now with the ability ...",
          "snippets": [
            "For now, we need to wait and watch how DeepMind decides to let eager scientists look under the hood and examine AlphaFold 3 more closely, to appreciate its full power. But until then, the model remains one of the best AI-based protein structure prediction models out there, now with the ability to predict interactions with other kinds of biological structures as well.",
            "Nevertheless, AlphaFold 3 predicts protein structures and interactions better than other models right now. Academics and companies can potentially use it to find drug candidates that can bind to proteins and help cure diseases. In fact, DeepMind\u2019s spin-off company Isomorphic Labs is using AlphaFold 3 for this very purpose: drug discovery.",
            "An important implication of this lack of access is that it\u2019s currently impossible to use AlphaFold 3 to find structures of proteins bound to drug candidates. Researchers expressed their disappointment in an open letter signed by more than 600 to date. According to the text, the restriction \u201cdoes not align with the principles of scientific progress, which rely on the ability of the community to evaluate, use, and build upon existing work.\u201d Different groups have also begun a race to crack the model\u2019s code and make open-source versions.",
            "AlphaFold uses machine learning and artificial intelligence (AI) to accurately predict protein structures from an amino acid sequence, seemingly solving the protein-folding problem without learning any of the deeper physical principles that drive this biological process."
          ],
          "title": "How will AlphaFold 3 change life sciences research? - The Hindu",
          "meta": {
            "query": "Potential ethical concerns of AlphaFold 3 in scientific research",
            "question": "What are some potential ethical concerns that arise from the use of AlphaFold 3 in scientific research, particularly in terms of data privacy and biases in predictions?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.nature.com/articles/d41586-024-01463-0",
          "description": "Criticism of our decision to publish AlphaFold3 raises important questions. We welcome readers\u2019 views.",
          "snippets": [
            "Criticism of our decision to publish AlphaFold3 raises important questions. We welcome readers\u2019 views. Criticism of our decision to publish AlphaFold3 raises important questions. We welcome readers\u2019 views.",
            "Nature - Criticism of our decision to publish AlphaFold3 raises important questions. We welcome readers\u2019 views.",
            "The latest iteration of the protein-structure-prediction algorithm AlphaFold has generated a great deal of interest since its release, accompanied by a paper in Nature, earlier this month1. Unlike its predecessor AlphaFold2, AlphaFold3 can predict not just the structures of protein complexes, but also when proteins interact with other kinds of molecule, including DNA and RNA.",
            "But its release has also prompted questions, and criticism, of both the AlphaFold team at Google DeepMind in London and Nature. When AlphaFold2 was published2, the full underlying code was made accessible to all researchers."
          ],
          "title": "AlphaFold3 \u2014 why did Nature publish it without its code?",
          "meta": {
            "query": "Potential ethical concerns of AlphaFold 3 in scientific research",
            "question": "What are some potential ethical concerns that arise from the use of AlphaFold 3 in scientific research, particularly in terms of data privacy and biases in predictions?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.scientificamerican.com/article/one-of-the-biggest-problems-in-biology-has-finally-been-solved/",
          "description": "Google DeepMind CEO Demis Hassabis explains how its AlphaFold AI program predicted the 3-D structure of every known protein",
          "snippets": [
            "Scientific American spoke with Hassabis about developing AlphaFold, some of its most exciting potential applications and the ethical considerations of highly sophisticated AI.",
            "AlphaFold, obviously, is huge in the scientific community. But with language and image AIs, it\u2019s starting to break through into the mainstream. Everyone, of course, knows about language and can appreciate images\u2014you don\u2019t have to have any scientific expertise. But I think we should always be thinking about the ethical issues, and that\u2019s one reason we haven\u2019t released our language-based AI yet.",
            "We had to reengineer things for AlphaFold 2 and put a whole bunch of new ideas in there and also bring onto the team some more specialists\u2014biologists and chemists and biophysicists who worked in protein folding\u2014and combine them with our engineering and machine-learning team. I\u2019ve been working on and thinking about general AI for my entire career, even back at university. I tend to note down scientific problems I think one day could be amenable to the types of algorithms we build, and protein folding was right up there for me always, since the 1990s.",
            "But I think AlphaFold is a very good proof of concept or role model of what could happen. And I think we\u2019re going to see much more of that in the next decade\u2014of AI helping to genuinely accelerate some scientific breakthroughs\u2014and we hope to be part of a lot more."
          ],
          "title": "One of the Biggest Problems in Biology Has Finally Been Solved ...",
          "meta": {
            "query": "Potential ethical concerns of AlphaFold 3 in scientific research",
            "question": "What are some potential ethical concerns that arise from the use of AlphaFold 3 in scientific research, particularly in terms of data privacy and biases in predictions?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.isomorphiclabs.com/articles/alphafold-3-predicts-the-structure-and-interactions-of-all-of-lifes-molecules",
          "description": "We are reimagining the entire drug discovery process from first principles with an AI-first approach.",
          "snippets": [
            "AlphaFold 3 predicts the structure and interactions of all of life\u2019s molecules",
            "Building on the external consultations we carried out for AlphaFold 2, Google DeepMind have now engaged with more than 50 domain experts, in addition to specialist third parties, across biosecurity, research, and industry, to understand the capabilities of successive AlphaFold models and any potential risks. We also participated in community-wide forums and discussions ahead of AlphaFold 3\u2019s launch. AlphaFold Server reflects the ongoing commitment to share the benefits of AlphaFold, including the free database of 200 million protein structures. We\u2019ll continue to work with the scientific community and policy makers to develop and deploy AI technologies responsibly.",
            "Scientists can access the majority of its capabilities, for free, through the newly launched AlphaFold Server, an easy-to-use research tool. To build on AlphaFold 3\u2019s potential for drug design, we at Isomorphic Labs are already collaborating with pharmaceutical companies to apply it to real-world drug design challenges and, ultimately, develop new life-changing treatments for patients.",
            "The impacts of AlphaFold 3 and the free AlphaFold Server will be realised through how they empower scientists to accelerate discovery across open questions in biology and new lines of research. We\u2019re just beginning to tap into AlphaFold 3\u2019s potential and can\u2019t wait to see what the future holds."
          ],
          "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
          "meta": {
            "query": "Potential ethical concerns of AlphaFold 3 in scientific research",
            "question": "What are some potential ethical concerns that arise from the use of AlphaFold 3 in scientific research, particularly in terms of data privacy and biases in predictions?",
            "placement": "root -> Ethical Concerns"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.deeporigin.com/blog/alphafold-3-exciting-advance-yet-unresolved-major-issues-remain",
          "description": "We tested the publicly available AlphaFold 3 instance and have reviewed the paper. Note that access to the full tool is not yet available and is provided only as a server with limitations. Here's what we found.",
          "snippets": [
            "You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy. ... Disclaimer: We tested the publicly available AlphaFold 3 instance and have reviewed the paper. Note that access to the full tool is not yet available and is provided only as a server with limitations.",
            "Gather data, find pockets, dock small molecules with conversational AI. Try for free! ... Disclaimer: We tested the publicly available AlphaFold 3 instance and have reviewed the paper. Note that access to the full tool is not yet available and is provided only as a server with limitations.",
            "For protein-ligand interactions, the paper used PoseBusters benchmark set, composed of 428 protein-ligand structures released to the PDB in 2021 or later, and trained AlphaFold3 using a 2019-09-30 training cutoff. Here we have a time split without homology or ligand similarity splits. This is definitely not the hardest split to use for ML benchmarking. AF3 accuracy on the PoseBusters V1 set is 76.4%, which is 2.8% improvement over their recent technical report. In Extended Data Fig.",
            "AlphaFold 3 is a large system and uses diffusion iterations. Since the system mainly consists of neural networks, its inference is done on GPUs. It is not a fast method. The GPU wall clock time without MSA construction, data processing and post-processing is given in Supplementary information 5.10 Table 8."
          ],
          "title": "AlphaFold 3: Exciting Advance yet Unresolved Major Issues Remain ...",
          "meta": {
            "query": "Data privacy issues with AlphaFold 3",
            "question": "What are some potential ethical concerns that arise from the use of AlphaFold 3 in scientific research, particularly in terms of data privacy and biases in predictions?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.genengnews.com/topics/artificial-intelligence/alphafold-3-angst-limited-accessibility-stirs-outcry-from-researchers/",
          "description": "Researchers are angered by the latest update to Google DeepMind\u2019s renowned protein structure prediction algorithm, which published in Nature without the open access code",
          "snippets": [
            "AlQuraishi added that independently reproducing AlphaFold 3 would be highly valuable to permit training new variants of the system, including potentially training on private data repositories.",
            "\u201cI have no doubt that [the ability to predict molecular interactions with AlphaFold 3] could be a transformative advance for the field,\u201d Wankowicz told GEN Biotechnology. \u201cThat\u2019s why this evokes such a strong response from the scientific community. We want access to it because we know that this is probably really good science.\u201d \u00b7 Nature\u2019s editor-in-chief, Magdalena Skipper, PhD stated that when making a decision on data and code availability, the journal reflects on several factors including \u201cthe potential implications for biosecurity and the ethical challenges this presents.\u201d In such cases, the journal works with authors to provide alternatives that will support reproducibility, such as pseudocode.",
            "Google DeepMind\u2019s renowned protein structure prediction algorithm, AlphaFold, which made a grand leap in solving one of biology\u2019s biggest problems, determining a protein\u2019s 3D structure from its sequence, has received a major update.",
            "In a report published in Nature on May 8, researchers unveiled AlphaFold 3\u2019s expanded predictive capabilities from proteins to a broad spectrum of biomolecular interactions, including DNA, RNA, ligands, and more."
          ],
          "title": "AlphaFold 3 Angst: Limited Accessibility Stirs Outcry from Researchers",
          "meta": {
            "query": "Data privacy issues with AlphaFold 3",
            "question": "What are some potential ethical concerns that arise from the use of AlphaFold 3 in scientific research, particularly in terms of data privacy and biases in predictions?",
            "placement": "root -> Ethical Concerns"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
          "description": "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor ...",
          "snippets": [
            "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor AlphaFold 2, this innovation has astonished the world with its capacity and speed.",
            "The innovative use of diffusion techniques in AlphaFold 3 introduces a risk of \"hallucination,\" where the model might generate plausible but non-existent molecular structures. Efforts to add more training data have been made, yet this issue has not been fully resolved, posing a challenge in relying solely on AI predictions without further empirical verification .",
            "The use of machine learning in drug repurposing has become increasingly important. AlphaFold 3 analyzes data on drug-target interactions and side effects to identify new therapeutic applications for existing drugs.",
            "Acquisition, analysis, or interpretation of data: Jitendra Patel, Jyothi Vybhavi, Dev Desai \u00b7 Drafting of the manuscript: Jitendra Patel, Shiv V. Kantliwala, Jyothi Vybhavi, Renju Ravi, Dev Desai \u00b7 Critical review of the manuscript for important intellectual content: Jitendra Patel, Dev Desai, Harshkumar Patel ... 1.Accurate structure prediction of biomolecular interactions with AlphaFold 3."
          ],
          "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
          "meta": {
            "query": "Data privacy issues with AlphaFold 3",
            "question": "What are some potential ethical concerns that arise from the use of AlphaFold 3 in scientific research, particularly in terms of data privacy and biases in predictions?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://en.wikipedia.org/wiki/AlphaFold",
          "description": "On 15 July 2021, the AlphaFold 2 paper was published in Nature as an advance access publication alongside open source software and a searchable database of species proteomes. As of February 2025, the paper had been cited nearly 32,000 times. AlphaFold 3 was announced on 8 May 2024.",
          "snippets": [
            "AlphaFold 1 (2018) was built on work developed by various teams in the 2010s, work that looked at the large databanks of related DNA sequences now available from many different organisms (most without known 3D structures), to try to find changes at different residues (peptides) that appeared to be correlated, even though the residues were not consecutive in the main chain.",
            "However, the October 2021 update, named AlphaFold-Multimer, included protein complexes in its training data. DeepMind stated this update succeeded about 70% of the time at accurately predicting protein-protein interactions. Announced on 8 May 2024, AlphaFold 3 was co-developed by Google DeepMind and Isomorphic Labs, both subsidiaries of Alphabet.",
            "Open access to source code of several AlphaFold versions (excluding AlphaFold 3) has been provided by DeepMind after requests from the scientific community. The source code of AlphaFold 3 was made available for non-commercial use to the scientific community upon request in November 2024. The AlphaFold Protein Structure Database, a joint project between AlphaFold and EMBL-EBI, was launched on July 22, 2021.",
            "Therefore, it may not perform as well on synthetic proteins or proteins with very low homology to those in the training database. The model's ability to predict multiple native conformations of proteins is limited. AlphaFold 3 version can predict structures of protein complexes with a very limited set of selected cofactors and co- and post-translational modifications.",
            "AlphaFold is an artificial intelligence (AI) program developed by DeepMind, a subsidiary of Alphabet, which performs predictions of protein structure. It is designed using deep learning techniques. AlphaFold 1 (2018) placed first in the overall rankings of the 13th Critical Assessment of Structure ..."
          ],
          "title": "AlphaFold - Wikipedia",
          "meta": {
            "query": "Data privacy issues with AlphaFold 3",
            "question": "What are some potential ethical concerns that arise from the use of AlphaFold 3 in scientific research, particularly in terms of data privacy and biases in predictions?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.forbes.com/sites/robtoews/2021/10/03/alphafold-is-the-most-important-achievement-in-ai-ever/",
          "description": "Machine learning will transform the life sciences in the years ahead.",
          "snippets": [
            "Another database, UniProt, contains the amino acid sequences (without structures) for nearly two hundred million more proteins. The AlphaFold AI model is built with transformers, the same cutting-edge neural network architecture that powers well-known language models like GPT-3 and BERT.",
            "This article is more than 3 years old. ... DeepMind's AlphaFold represents the first time a significant scientific problem has been solved by ...",
            "Before AlphaFold, we knew the 3-D structures for only about 17% of the roughly 20,000 proteins in the human body.",
            "Suddenly, thanks to AlphaFold, we now have 3-D structures for virtually all (98.5%) of the human proteome."
          ],
          "title": "AlphaFold Is The Most Important Achievement In AI\u2014Ever",
          "meta": {
            "query": "Data privacy issues with AlphaFold 3",
            "question": "What are some potential ethical concerns that arise from the use of AlphaFold 3 in scientific research, particularly in terms of data privacy and biases in predictions?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.reddit.com/r/singularity/comments/1cnp5u7/alphafold_3_is_a_fantastic_breakthrough_and/",
          "description": "336 votes, 140 comments. The model itself is closed source and heavily restricted. Yes, the dataset of all known proteins is available, but Deepmind\u2026",
          "snippets": [
            "Posted by u/AlterandPhil - 336 votes and 140 comments",
            "Yes, the dataset of all known proteins is available, but Deepmind has restricted the prediction of custom proteins, predictions of these custom proteins binding to molecules, custom ligands, quaternary structures of custom protein, and many more. The model can only be accessed on the cloud using AlphaFold server and each user is limited to 10 predictions per day.",
            "Sergey Ovchinnikov, an evolutionary biologist at the Massachusetts Institute of Technology in Cambridge, had hoped to develop a web version of AlphaFold3, as he and his colleagues have done for AlphaFold2 shortly after its code was released. But based on the ample information provided in the latest Nature paper, it shouldn\u2019t take long for other teams to create their own versions, he says.",
            "Don't see a problem with this if you believe in any form of a market economy. If Google want to eventually make some sort of money from AlphaFold, they should have the opportunity to do so which probably entails making it closed-sourced."
          ],
          "title": "r/singularity on Reddit: AlphaFold 3 is a Fantastic Breakthrough ...",
          "meta": {
            "query": "Data privacy issues with AlphaFold 3",
            "question": "What are some potential ethical concerns that arise from the use of AlphaFold 3 in scientific research, particularly in terms of data privacy and biases in predictions?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11292590/",
          "description": "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor AlphaFold ...",
          "snippets": [
            "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor AlphaFold 2, this innovation has astonished the world with its capacity and speed.",
            "The innovative use of diffusion techniques in AlphaFold 3 introduces a risk of \"hallucination,\" where the model might generate plausible but non-existent molecular structures. Efforts to add more training data have been made, yet this issue has not been fully resolved, posing a challenge in relying solely on AI predictions without further empirical verification .",
            "The use of machine learning in drug repurposing has become increasingly important. AlphaFold 3 analyzes data on drug-target interactions and side effects to identify new therapeutic applications for existing drugs.",
            "Acquisition, analysis, or interpretation of data: Jitendra Patel, Jyothi Vybhavi, Dev Desai \u00b7 Drafting of the manuscript: Jitendra Patel, Shiv V. Kantliwala, Jyothi Vybhavi, Renju Ravi, Dev Desai \u00b7 Critical review of the manuscript for important intellectual content: Jitendra Patel, Dev Desai, Harshkumar Patel ... 1. Accurate structure prediction of biomolecular interactions with AlphaFold 3."
          ],
          "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
          "meta": {
            "query": "Data privacy issues with AlphaFold 3",
            "question": "What are some potential ethical concerns that arise from the use of AlphaFold 3 in scientific research, particularly in terms of data privacy and biases in predictions?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://github.com/google-deepmind/alphafold3",
          "description": "AlphaFold 3 inference pipeline. Contribute to google-deepmind/alphafold3 development by creating an account on GitHub.",
          "snippets": [
            "Two fundamental flags that control which parts AlphaFold 3 will run are: --run_data_pipeline (defaults to true): whether to run the data pipeline, i.e. genetic and template search. This part is CPU-only, time consuming and could be run on a machine without a GPU. --run_inference (defaults to true): whether to run the inference. This part requires a GPU. See the input documentation. See the output documentation. See the performance documentation. Known issues are documented in the known issues documentation.",
            "You can then run AlphaFold 3 using the following command: docker run -it \\ --volume $HOME/af_input:/root/af_input \\ --volume $HOME/af_output:/root/af_output \\ --volume <MODEL_PARAMETERS_DIR>:/root/models \\ --volume <DATABASES_DIR>:/root/public_databases \\ --gpus all \\ alphafold3 \\ python run_alphafold.py \\ --json_path=/root/af_input/fold_input.json \\ --model_dir=/root/models \\ --output_dir=/root/af_output",
            "The following databases have been: (1) mirrored by Google DeepMind; and (2) in part, included with the inference code package for testing purposes, and are available with reference to the following: BFD (modified), by Steinegger M. and S\u00f6ding J., modified by Google DeepMind, available under a Creative Commons Attribution 4.0 International License. See the Methods section of the AlphaFold proteome paper for details.",
            "This package provides an implementation of the inference pipeline of AlphaFold 3. See below for how to access the model parameters. You may only use AlphaFold 3 model parameters if received directly from Google."
          ],
          "title": "GitHub - google-deepmind/alphafold3: AlphaFold 3 inference pipeline.",
          "meta": {
            "query": "Data privacy issues with AlphaFold 3",
            "question": "What are some potential ethical concerns that arise from the use of AlphaFold 3 in scientific research, particularly in terms of data privacy and biases in predictions?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://academic.oup.com/nar/article/50/D1/D439/6430488",
          "description": "Thus, we only know the 3D structure of a tiny fraction of all proteins currently known to science. The first release of AlphaFold DB contains over 360 000 predicted structures from 21 model-organism proteomes. Having access to these highly accurate models will greatly impact biology, from enabling structure-based drug design to providing data ...",
          "snippets": [
            "Thus, we only know the 3D structure of a tiny fraction of all proteins currently known to science. The first release of AlphaFold DB contains over 360 000 predicted structures from 21 model-organism proteomes. Having access to these highly accurate models will greatly impact biology, from enabling structure-based drug design to providing data for high-throughput structural bioinformatics research that will tackle fundamental biological questions.",
            "This will be followed by another update in 2022 to include structures for most representative sequences from the UniRef90 data set (>100 million structures). Future updates will also aim to overlay annotations onto the predicted structures and display this information on 2D sequence-feature viewers. AlphaFold DB will enable biomedical scientists to use 3D models of protein structures as a core tool, driving research and innovation across multiple fields by providing open access to an ever-growing number of predicted structures.",
            "A structural biology community assessment of AlphaFold 2 applications Biophysics. ... L.J. et al. . Pfam: The protein families database in 2021. Nucleic Acids Res. ... S. et al. . The InterPro protein families and domains database: 20 years on. Nucleic Acids Res. ... Mol* Viewer: modern web app for 3D visualization and analysis of large biomolecular structures.",
            "Mihaly Varadi, Stephen Anyango, Mandar Deshpande, Sreenath Nair, Cindy Natassia, Galabina Yordanova, David Yuan, Oana Stroe, Gemma Wood, Agata Laydon, Augustin \u017d\u00eddek, Tim Green, Kathryn Tunyasuvunakool, Stig Petersen, John Jumper, Ellen Clancy, Richard Green, Ankur Vora, Mira Lutfi, Michael Figurnov, Andrew Cowie, Nicole Hobbs, Pushmeet Kohli, Gerard Kleywegt, Ewan Birney, Demis Hassabis, Sameer Velankar, AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models, Nucleic Acids Research, Volume 50, Issue D1, 7 January 2022, Pages D439\u2013D444, https://doi.org/10.1093/nar/gkab1061"
          ],
          "title": "AlphaFold Protein Structure Database: massively expanding the ...",
          "meta": {
            "query": "Data privacy issues with AlphaFold 3",
            "question": "What are some potential ethical concerns that arise from the use of AlphaFold 3 in scientific research, particularly in terms of data privacy and biases in predictions?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://blog.google/technology/ai/how-we-built-alphafold-3/",
          "description": "Where AlphaFold 2 used a complex ... module, AlphaFold 3 uses a generative model that\u2019s based on diffusion \u2014 similar to our other cutting-edge image generation models, like Imagen \u2014 which greatly simplified how the model handles all the new molecule types. That shift led to a new issue, though: Since so-called \u201cdisordered regions\u201d of proteins weren\u2019t included in the training data, the diffusion ...",
          "snippets": [
            "Where AlphaFold 2 used a complex custom geometry-based module, AlphaFold 3 uses a generative model that\u2019s based on diffusion \u2014 similar to our other cutting-edge image generation models, like Imagen \u2014 which greatly simplified how the model handles all the new molecule types. That shift led to a new issue, though: Since so-called \u201cdisordered regions\u201d of proteins weren\u2019t included in the training data, the diffusion model would try to create an inaccurate \u201cordered\u201d structure with a defined spiral shape, instead of predicting disordered regions.",
            "That meant making a database with all the capabilities would have been impossible. Instead, we\u2019ve released AlphaFold Server, a free tool that lets scientists plug in their own sequences that AlphaFold can then generate molecular complexes for.",
            "In order to get AlphaFold 3 to work with this much wider range of biomolecules, the team vastly expanded the data that the newer model was trained on to include DNA, RNA, small molecules and more. \u201cWe were able to say, \u2018Let's just train on everything that exists in this dataset that helped us so much with proteins and let\u2019s see how far we can get,\u2019\u201d Lindsay says.",
            "Since its launch in 2020, more than 2 million researchers have used Google DeepMind\u2019s AlphaFold 2 model for protein predictions in their work on vaccine development, cancer treatments and more \u2014 helping solve a problem that researchers had been working on for over 50 years."
          ],
          "title": "How we built AlphaFold 3 to predict the structure and interaction ...",
          "meta": {
            "query": "Data privacy issues with AlphaFold 3",
            "question": "What are some potential ethical concerns that arise from the use of AlphaFold 3 in scientific research, particularly in terms of data privacy and biases in predictions?"
          },
          "citation_uuid": -1
        }
      ],
      "cited_info": null
    },
    {
      "utterance": "AlphaFold 3, the latest iteration of Google DeepMind's biomolecular structure predictor AI model, has raised the bar in terms of accuracy and power compared to its predecessor, AlphaFold 2[31]. This new version uses a neural network approach to predict the 3D coordinates of non-hydrogen atoms in a given protein, based on the protein sequence and sequence homology[32]. AlphaFold 3 has been trained on a significantly larger dataset, resulting in a 30% increase in training data compared to the previous version[33]. This expanded training data includes a wider range of biomolecules such as DNA, RNA, and small molecules, allowing for more accurate predictions across different molecular types[37].\n\nOne key improvement in AlphaFold 3 is its ability to predict the structure of almost all biomolecules, including protein-nucleic acid complexes and protein-small molecule complexes, with higher accuracy than traditional methods[34]. The model has shown at least a 50% improvement in predicting protein interactions with other molecule types, and in some cases, it has doubled prediction accuracy for important categories of interactions[35]. With its enhanced predictive capabilities, AlphaFold 3 aims to transform our understanding of the biological world and advance drug discovery efforts[35].\n\nIn terms of predictive accuracy, AlphaFold 3 has set a high standard. AlphaFold 2, for example, demonstrated high accuracy in its predictions, with 88% of its predictions having a root-mean-square deviation of less than 4 \u00c5 for C-alpha atoms, and 76% achieving better than 3 \u00c5 accuracy[36]. This level of precision is crucial in structural biology for understanding protein function and molecular interactions.\n\nIt's worth noting that while DeepMind has not released training data or procedures for AlphaFold 2, an open-source equivalent called OpenFold has been developed by researchers at Columbia University, providing insight into the training process[38]. This transparency can be crucial for advancing the field of structural biology and AI-driven protein structure prediction.\n\nOverall, the advancements in AlphaFold 3, with its broader training data and enhanced predictive accuracy, showcase the potential of AI in revolutionizing the understanding of biomolecular structures and accelerating drug discovery processes.",
      "raw_utterance": "AlphaFold 3, the latest iteration of Google DeepMind's biomolecular structure predictor AI model, has raised the bar in terms of accuracy and power compared to its predecessor, AlphaFold 2[31]. This new version uses a neural network approach to predict the 3D coordinates of non-hydrogen atoms in a given protein, based on the protein sequence and sequence homology[32]. AlphaFold 3 has been trained on a significantly larger dataset, resulting in a 30% increase in training data compared to the previous version[33]. This expanded training data includes a wider range of biomolecules such as DNA, RNA, and small molecules, allowing for more accurate predictions across different molecular types[37].\n\nOne key improvement in AlphaFold 3 is its ability to predict the structure of almost all biomolecules, including protein-nucleic acid complexes and protein-small molecule complexes, with higher accuracy than traditional methods[34]. The model has shown at least a 50% improvement in predicting protein interactions with other molecule types, and in some cases, it has doubled prediction accuracy for important categories of interactions[35]. With its enhanced predictive capabilities, AlphaFold 3 aims to transform our understanding of the biological world and advance drug discovery efforts[35].\n\nIn terms of predictive accuracy, AlphaFold 3 has set a high standard. AlphaFold 2, for example, demonstrated high accuracy in its predictions, with 88% of its predictions having a root-mean-square deviation of less than 4 \u00c5 for C-alpha atoms, and 76% achieving better than 3 \u00c5 accuracy[36]. This level of precision is crucial in structural biology for understanding protein function and molecular interactions.\n\nIt's worth noting that while DeepMind has not released training data or procedures for AlphaFold 2, an open-source equivalent called OpenFold has been developed by researchers at Columbia University, providing insight into the training process[38]. This transparency can be crucial for advancing the field of structural biology and AI-driven protein structure prediction.\n\nOverall, the advancements in AlphaFold 3, with its broader training data and enhanced predictive accuracy, showcase the potential of AI in revolutionizing the understanding of biomolecular structures and accelerating drug discovery processes.",
      "role": "Computational biologist",
      "role_description": " This expert specializes in using computational methods to study biological systems. They will focus on the technical aspects of AlphaFold 3, its data training, and the implications of its predictive accuracy on understanding biomolecular interactions.",
      "queries": [
        "AlphaFold 3 vs previous versions data training methods",
        "AlphaFold 3 vs previous versions predictive accuracy comparison"
      ],
      "utterance_type": "Support",
      "claim_to_make": "What are the key differences between AlphaFold 3 and its previous versions in terms of data training methods and predictive accuracy?",
      "raw_retrieved_info": [
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
          "description": "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor ...",
          "snippets": [
            "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor AlphaFold 2, this innovation has astonished the world with its capacity and speed.",
            "On May 8, 2024, an article was published by Josh Abramson regarding the successful use of AlphaFold 3 (Google DeepMind Technologies Limited, London, United Kingdom) in the accurate structure prediction of biomolecular interactions . In the rapidly evolving landscape of life sciences, the intersection of artificial intelligence (AI) and biology has heralded a new era of discovery and innovation. At the forefront of this revolution is AlphaFold 3, the latest iteration of Google DeepMind's groundbreaking protein folding AI. Leveraging advanced deep learning methodologies, AlphaFold 3 has achie",
            "AlphaFold 3, developed by Isomorphic Labs Limited (London, United Kingdom) and Google DeepMind, represents a significant leap forward in the field of molecular biology through its ability to predict the structure and interactions of biomolecules with unparalleled accuracy . This revolutionary model extends its predictive capabilities beyond proteins to encompass a broad spectrum of biomolecules, including proteins, DNA, RNA, and ligands, thereby offering a comprehensive understanding of the biological world.",
            "In summary, AlphaFold 3's introduction marks a pivotal moment in the understanding of biomolecular interactions and the acceleration of drug discovery processes. Its comprehensive modeling capabilities, combined with its predictive accuracy, set a new standard in the field, promising to unlock transformative scientific advancements ."
          ],
          "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
          "meta": {
            "query": "AlphaFold 3 vs previous versions predictive accuracy comparison",
            "question": "What are the key differences between AlphaFold 3 and its previous versions in terms of data training methods and predictive accuracy?",
            "placement": "root -> Comparisons"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://medium.com/@falk_hoffmann/alphafold3-and-its-improvements-in-comparison-to-alphafold2-96815ffbb044",
          "description": "Predicting protein structures is one of the most important challenges in biochemistry. Highly accurate protein structures are essential for drug discovery purposes. Here, you can find more about the\u2026",
          "snippets": [
            "AlphaFold uses a neural network approach that directly predicts the 3D coordinates of all non-hydrogen atoms for a given protein using the protein sequence and sequence homology. While immediately being the best prediction method in CASP13, it was still not good enough to call the protein structure prediction task successful. A successful in silico prediction method reaches experimental accuracy.",
            "It is interesting to see how open-source models like OpenFold will use those models to improve their accuracy. We can expect several new complex prediction tools soon, most of which will use approaches implemented in AlphaFold3. ... Abramson, J., Adler, J., Dunger, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3.",
            "Are you curious about what this text holds for you?",
            "Soon after AlphaFold2 was published, models with similar architectures appeared to either improve its accuracy or make it faster. Some examples are RosettaFold from the lab of David Baker, OmegaFold or ESMFold from MetaAI. In collaboration with the European Bioinformatics Institute, DeepMind also created the AlphaFold \u2014 EBI database, which contains more than 200 million predicted structures of proteins covering most of the sequences in UniProt."
          ],
          "title": "AlphaFold3 and its improvements in comparison to AlphaFold2 | by ...",
          "meta": {
            "query": "AlphaFold 3 vs previous versions predictive accuracy comparison",
            "question": "What are the key differences between AlphaFold 3 and its previous versions in terms of data training methods and predictive accuracy?",
            "placement": "root -> Comparisons"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10751731/",
          "description": "Statistical significance values ... CAPRI accuracy predictions, as noted at top (**p \u2264 0.01). Recently, an updated version of AlphaFold (v.2.3.0, hereafter denoted as v.2.3) was released, with modifications to the pipeline and deep learning model (DeepMind, 2022). Compared with the previous version, this ...",
          "snippets": [
            "Statistical significance values (Wilcoxon rank\u2010sum test) were calculated between interface energy scores for sets of cases with incorrect versus medium and incorrect versus high CAPRI accuracy predictions, as noted at top (**p \u2264 0.01). Recently, an updated version of AlphaFold (v.2.3.0, hereafter denoted as v.2.3) was released, with modifications to the pipeline and deep learning model (DeepMind, 2022). Compared with the previous version, this version was trained on PDB structures released until September 30, 2021, resulting in a 30% increase in training data.",
            "High resolution antibody\u2013antigen structures provide critical insights into immune recognition and can inform therapeutic design. The challenges of experimental structural determination and the diversity of the immune repertoire underscore the ...",
            "This model has high CAPRI accuracy (I\u2010RMSD = 0.68 \u00c5) and has the highest model confidence of all 25 predictions of this complex (model confidence = 0.88). (c) An example of an acceptable accuracy complex model from AlphaFold, in comparison with the experimentally determined structure (PDB: 6j15; antibody/PD\u20101 complex). This model has acceptable CAPRI accuracy (I\u2010RMSD = 3.35 \u00c5), and has the highest model confidence of all 25 predictions of this complex (model confidence = 0.75).",
            "Figure 1c shows an acceptable CAPRI accuracy prediction with an I\u2010RMSD of 3.55 \u00c5. While the antibody engages the correct site of the antigen in this example, a deviation in positioning of the antibody on the antigen, with respect to the experimentally determined structure, is observed. We compared the AlphaFold benchmarking results with other pipelines and approaches, including AlphaFold in ColabFold (Mirdita et al., 2022)."
          ],
          "title": "Evaluation of AlphaFold antibody\u2013antigen modeling with implications ...",
          "meta": {
            "query": "AlphaFold 3 vs previous versions predictive accuracy comparison",
            "question": "What are the key differences between AlphaFold 3 and its previous versions in terms of data training methods and predictive accuracy?",
            "placement": "root -> Comparisons"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.nature.com/articles/s41586-021-03819-2",
          "description": "Proteins are essential to life, and understanding their structure can facilitate a mechanistic understanding of their function. Through an enormous experimental effort1\u20134, the structures of around 100,000 unique proteins have been determined5, but this represents a small fraction of the billions ...",
          "snippets": [
            "Proteins are essential to life, and understanding their structure can facilitate a mechanistic understanding of their function. Through an enormous experimental effort1\u20134, the structures of around 100,000 unique proteins have been determined5, but this represents a small fraction of the billions of known protein sequences6,7. Structural coverage is bottlenecked by the months to years of painstaking effort required to determine a single protein structure.",
            "Nature - AlphaFold predicts protein structures with an accuracy competitive with experimental structures in the majority of cases using a novel deep learning architecture.",
            "We validated an entirely redesigned version of our neural network-based model, AlphaFold, in the challenging 14th Critical Assessment of protein Structure Prediction (CASP14)15, demonstrating accuracy competitive with experimental structures in a majority of cases and greatly outperforming other methods. Underpinning the latest version of AlphaFold is a novel machine learning approach that incorporates physical and biological knowledge about protein structure, leveraging multi-sequence alignments, into the design of the deep learning algorithm. ... The development of computational methods to predict three-dimensional (3D) protein structures from the protein sequence has proceeded along two complementary paths that focus on either the physical interactions or the evolutionary history.",
            "In particular, we demonstrate a new architecture to jointly embed multiple sequence alignments (MSAs) and pairwise features, a new output representation and associated loss that enable accurate end-to-end structure prediction, a new equivariant attention architecture, use of intermediate losses to achieve iterative refinement of predictions, masked MSA loss to jointly train with the structure, learning from unlabelled protein sequences using self-distillation and self-estimates of accuracy. The AlphaFold network directly predicts the 3D coordinates of all heavy atoms for a given protein using the primary amino acid sequence and aligned sequences of homologues as inputs (Fig."
          ],
          "title": "Highly accurate protein structure prediction with AlphaFold | Nature",
          "meta": {
            "query": "AlphaFold 3 vs previous versions predictive accuracy comparison",
            "question": "What are the key differences between AlphaFold 3 and its previous versions in terms of data training methods and predictive accuracy?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://hyperlab.hits.ai/en/blog/google-deepmind-alphafoldlatest",
          "description": "AlphaFold-latest, the next generation of AlphaFold, has the ability to predict the structure of almost all biomolecules along with proteins compared to previous models. The model can predict a variety of molecular combinations, including protein-nucleic acid complexes and protein-small molecule ...",
          "snippets": [
            "AlphaFold-latest, the next generation of AlphaFold, has the ability to predict the structure of almost all biomolecules along with proteins compared to previous models. The model can predict a variety of molecular combinations, including protein-nucleic acid complexes and protein-small molecule complexes, and shows higher prediction accuracy than traditional docking programs.",
            "AlphaFold-latest is more than 40% more accurate than the best docking programs for predicting the structure of protein-ligand complexes alone, with an accuracy of 37-53% for covalently bound non-proteins such as covalent ligands, glycoproteins, modified amino acids, and modified nucleic acids, which are particularly challenging to predict. Complex protein structures, such as protein multimers and protein-antibody conjugates, have also been reported to show significant accuracy improvements over the previous AlphaFold 2.3.",
            "AlphaFold has steadily evolved from Version 1 (2018), to Version 2 (2020), to AlphaFold-Multimer (2021), to the most recent Version 2.3 (2022), increasing its predictive protein size and accuracy.",
            "What's the biggest change in AlphaFold-latest compared to the last publicly available model, AlphaFold 2.3? ... Even if you're not familiar with artificial intelligence technology, you're probably not familiar with AlphaFold \u00b7 AlphaFold, which predicts three-dimensional structures from protein sequences, has made such an impact on the scientific community that its main developers, Demis Hassabis and John Jumper, were awarded Breakthrough Prize and the Lasker Award in 2023."
          ],
          "title": "Google DeepMind AlphaFold-latest l What's different from previous ...",
          "meta": {
            "query": "AlphaFold 3 vs previous versions predictive accuracy comparison",
            "question": "What are the key differences between AlphaFold 3 and its previous versions in terms of data training methods and predictive accuracy?",
            "placement": "root -> Comparisons"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://biosciences.lbl.gov/2024/01/23/researchers-assess-alphafold-model-accuracy/",
          "description": "AI-based protein structure predictions are best considered to be exceptionally useful hypotheses; experimental measurements remain essential for confirmation of protein structure details.",
          "snippets": [
            "Artificial Intelligence (AI) took the structural biology world by storm when Google parent company Alphabet\u2019s DeepMind AlphaFold software was released in 2021. It was a major breakthrough in three-dimensional protein structure prediction, promising highly accurate models for proteins of unknown conformation.",
            "However, a multi-institutional team led by Tom Terwilliger (pictured, right) from the New Mexico Consortium and including researchers from Berkeley Lab have shown that\u2014as with other similar tools that promise to make quicker work of solving structures\u2014there is still a need for empirical evidence and human contributions. In a study published in Nature Methods, the team performed a rigorous analysis of AlphaFold predictions, comparing them with both high-quality experimental data and experimentally determined structures.",
            "What\u2019s more, Terwilliger noted that not all protein structures are predicted with very high confidence, and lower-confidence predictions are much less accurate than experimentally determined ones. Overlaid on experimental electron density, left to right: a near-perfect AlphaFold prediction, an incorrect one, and a distorted one, all predicted with very high confidence.",
            "Adams said that the level of accuracy needed in the AI prediction is tied directly to what scientific questions are being asked. \u201cIf a scientist is studying the evolution of proteins by making global comparisons, the AlphaFold models are very useful,\u201d he said."
          ],
          "title": "Researchers Assess AlphaFold Model Accuracy - Biosciences Area",
          "meta": {
            "query": "AlphaFold 3 vs previous versions predictive accuracy comparison",
            "question": "What are the key differences between AlphaFold 3 and its previous versions in terms of data training methods and predictive accuracy?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10349958/",
          "description": "Furthermore, detailed analysis ... modeling accuracy. Finally, we benchmarked a recently released version of AlphaFold (v.2.3) and compared its performance to that of the previous version (v.2.2). Our study presents a thorough analysis of AlphaFold\u2019s ability to predict antibody-antigen ...",
          "snippets": [
            "Furthermore, detailed analysis was conducted on the impact of recycling iterations, as well as the use of custom template inputs to evaluate the impact of accurate subunit modeling on antibody-antigen complex modeling accuracy. Finally, we benchmarked a recently released version of AlphaFold (v.2.3) and compared its performance to that of the previous version (v.2.2). Our study presents a thorough analysis of AlphaFold\u2019s ability to predict antibody-antigen complexes, yielding valuable insights for interpreting model accuracy, identifying obstacles in the modeling process, and highlighting potential areas for improvement.",
            "Statistical significance values (Wilcoxon rank-sum test) were calculated between interface energy scores for sets of cases with Incorrect versus Medium and Incorrect versus High CAPRI accuracy predictions, as noted at top (**p \u2264 0.01). Recently, an updated version of AlphaFold (v.2.3.0, hereafter denoted as v.2.3) was released, with modifications to the pipeline and deep learning model37. Compared with the previous version, this version was trained on PDB structures released until September 30, 2021, resulting in a 30% increase in training data.",
            "High resolution antibody-antigen structures provide critical insights into immune recognition and can inform therapeutic design. The challenges of experimental structural determination and the diversity of the immune repertoire underscore the ...",
            "This model has High CAPRI accuracy (I-RMSD=0.68 \u00c5) and has the highest model confidence of all 25 predictions of this complex (model confidence=0.88). c An example of an Acceptable accuracy complex model from AlphaFold, in comparison with the experimentally determined structure (PDB: 6j15; antibody/PD-1 complex). This model has Acceptable CAPRI accuracy (I-RMSD=3.35 \u00c5), and has the highest model confidence of all 25 predictions of this complex (model confidence=0.75)."
          ],
          "title": "Evaluation of AlphaFold Antibody-Antigen Modeling with Implications ...",
          "meta": {
            "query": "AlphaFold 3 vs previous versions predictive accuracy comparison",
            "question": "What are the key differences between AlphaFold 3 and its previous versions in terms of data training methods and predictive accuracy?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://blog.google/technology/ai/google-deepmind-isomorphic-alphafold-3-ai-model/",
          "description": "Our new AI model AlphaFold 3 can predict the structure and interactions of all life\u2019s molecules with unprecedented accuracy.",
          "snippets": [
            "For the interactions of proteins with other molecule types we see at least a 50% improvement compared with existing prediction methods, and for some important categories of interaction we have doubled prediction accuracy. We hope AlphaFold 3 will help transform our understanding of the biological world and drug discovery.",
            "AlphaFold 3 creates capabilities for drug design with predictions for molecules commonly used in drugs, such as ligands and antibodies, that bind to proteins to change how they interact in human health and disease. AlphaFold 3 achieves unprecedented accuracy in predicting drug-like interactions, including the binding of proteins with ligands and antibodies with their target proteins.",
            "In a paper published in Nature, we introduce AlphaFold 3, a revolutionary model that can predict the structure and interactions of all life\u2019s molecules with unprecedented accuracy.",
            "AlphaFold 3\u2019s predictions of molecular interactions surpass the accuracy of all existing systems."
          ],
          "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
          "meta": {
            "query": "AlphaFold 3 vs previous versions predictive accuracy comparison",
            "question": "What are the key differences between AlphaFold 3 and its previous versions in terms of data training methods and predictive accuracy?",
            "placement": "root -> Comparisons"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://en.wikipedia.org/wiki/AlphaFold",
          "description": "AlphaFold 3 was announced on 8 May 2024. It can predict the structure of complexes created by proteins with DNA, RNA, various ligands, and ions. The new prediction method shows a minimum 50% improvement in accuracy for protein interactions with other molecules compared to existing methods.",
          "snippets": [
            "Measured by the root-mean-square deviation (RMS-D) of the placement of the alpha-carbon atoms of the protein backbone chain, which tends to be dominated by the performance of the worst-fitted outliers, 88% of AlphaFold 2's predictions had an RMS deviation of less than 4 \u00c5 for the set of overlapped C-alpha atoms. 76% of predictions achieved better than 3 \u00c5, and 46% had a C-alpha atom RMS accuracy better than 2 \u00c5, with a median RMS deviation in its predictions of 2.1 \u00c5 for a set of overlapped CA atoms.",
            "Moreover, for certain key categories of interactions, the prediction accuracy has effectively doubled. Demis Hassabis and John Jumper of Google DeepMind shared one half of the 2024 Nobel Prize in Chemistry, awarded \"for protein structure prediction,\" while the other half went to David Baker \"for computational protein design.\" Hassabis and Jumper had previously won the Breakthrough Prize in Life Sciences and the Albert Lasker Award for Basic Medical Research in 2023 for their leadership of the AlphaFold project.",
            "It was particularly successful at predicting the most accurate structures for targets rated as most difficult by the competition organizers, where no existing template structures were available from proteins with partially similar sequences. AlphaFold 2 (2020) repeated this placement in the CASP14 competition in November 2020. It achieved a level of accuracy much higher than any other entry.",
            "The inclusion of metagenomic data has improved the quality of the prediction of MSAs. One of the biggest sources of the training data was the custom-built Big Fantastic Database (BFD) of 65,983,866 protein families, represented as MSAs and hidden Markov models (HMMs), covering 2,204,359,010 protein sequences from reference databases, metagenomes, and metatranscriptomes. AlphaFold 2's results at CASP14 were described as \"astounding\" and \"transformational\". However, some researchers noted that the accuracy was insufficient for a third of its predictions, and that it did not reveal the underlying mechanism or rules of protein folding for the protein folding problem remains unsolved.",
            "AlphaFold is an artificial intelligence (AI) program developed by DeepMind, a subsidiary of Alphabet, which performs predictions of protein structure. It is designed using deep learning techniques. AlphaFold 1 (2018) placed first in the overall rankings of the 13th Critical Assessment of Structure ..."
          ],
          "title": "AlphaFold - Wikipedia",
          "meta": {
            "query": "AlphaFold 3 vs previous versions predictive accuracy comparison",
            "question": "What are the key differences between AlphaFold 3 and its previous versions in terms of data training methods and predictive accuracy?",
            "placement": "root -> Comparisons"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://frontlinegenomics.com/alphafold-3-stepping-into-the-future-of-structure-prediction/",
          "description": "In this news highlight, we explore AlphaFold3, compare it to its predecessor and take a look to the future.",
          "snippets": [
            "For years, scientists have been attempting to integrate the latest and greatest AI models into the field, in order to speed up the process and improve accuracy. Enter AlphaFold, an artificial intelligence tool developed by Google\u2019s DeepMind. The first version of the technology was released in 2018, but it was 2020\u2019s AlphaFold 2 that made headlines \u2013 winning the prestigious Critical Assessment of Structure Prediction (CASP) 14 competition.",
            "These improvements to the model have led the company to claim that AlphaFold 3 has the highest accuracy yet. Perhaps the most exciting comparison that can be drawn between AlphaFold 2 and 3 is the latter\u2019s ability to make predictions not just about protein structure, but about interactions between proteins and biological molecules such as DNA, RNA and ligands \u2013 an acknowledgment that no molecules operate on their own.",
            "We\u2019ve all heard about the potential of artificial intelligence in the life sciences field. In 2020, the launch of AlphaFold 2, pioneered by Google DeepMind, took the world by storm and marked a new age in protein structure prediction. But now, AlphaFold 3 is transforming the landscape again.",
            "AlphaFold 2 achieved remarkable success in predicting the 3D structures of proteins from their amino acid sequences. It gained notoriety for its performance in the CASP 14 competition, where it significantly outperformed other methods, demonstrating the potential of powerful AI in solving a decades-long challenge. AlphaFold 2 utilised a deep learning architecture called Evoformer."
          ],
          "title": "AlphaFold 3: Stepping into the future of structure prediction - ...",
          "meta": {
            "query": "AlphaFold 3 vs previous versions predictive accuracy comparison",
            "question": "What are the key differences between AlphaFold 3 and its previous versions in terms of data training methods and predictive accuracy?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://blog.google/technology/ai/how-we-built-alphafold-3/",
          "description": "In order to get AlphaFold 3 to work with this much wider range of biomolecules, the team vastly expanded the data that the newer model was trained on to include DNA, RNA, small molecules and more. \u201cWe were able to say, \u2018Let's just train on everything that exists in this dataset that helped ...",
          "snippets": [
            "In order to get AlphaFold 3 to work with this much wider range of biomolecules, the team vastly expanded the data that the newer model was trained on to include DNA, RNA, small molecules and more. \u201cWe were able to say, \u2018Let's just train on everything that exists in this dataset that helped us so much with proteins and let\u2019s see how far we can get,\u2019\u201d Lindsay says.",
            "Where AlphaFold 2 used a complex custom geometry-based module, AlphaFold 3 uses a generative model that\u2019s based on diffusion \u2014 similar to our other cutting-edge image generation models, like Imagen \u2014 which greatly simplified how the model handles all the new molecule types. That shift led to a new issue, though: Since so-called \u201cdisordered regions\u201d of proteins weren\u2019t included in the training data, the diffusion model would try to create an inaccurate \u201cordered\u201d structure with a defined spiral shape, instead of predicting disordered regions.",
            "So the team turned to AlphaFold 2, which is already extremely good at predicting which interactions would be disordered \u2014 which look like a pile of chaotic spaghetti \u2014 and which ones were not. \u201cWe were able to use those predicted structures from AlphaFold 2 as distillation training for AlphaFold 3, so that AlphaFold 3 could learn to predict disorder,\u201d Lindsay says.",
            "Instead, they got started on AlphaFold 3. This newer model, which the teams at Google DeepMind and Isomorphic Labs launched in May, builds on our previous models by predicting not just protein folding structures, but predicting the structure and interactions of all of life's molecules, including DNA, RNA and ligands (small molecules that bind to proteins)."
          ],
          "title": "How we built AlphaFold 3 to predict the structure and interaction ...",
          "meta": {
            "query": "AlphaFold 3 vs previous versions data training methods",
            "question": "What are the key differences between AlphaFold 3 and its previous versions in terms of data training methods and predictive accuracy?",
            "placement": "root -> Comparisons -> AlphaFold 3 vs previous versions data training methods"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://medium.com/@falk_hoffmann/alphafold3-and-its-improvements-in-comparison-to-alphafold2-96815ffbb044",
          "description": "Predicting protein structures is one of the most important challenges in biochemistry. Highly accurate protein structures are essential for drug discovery purposes. Here, you can find more about the\u2026",
          "snippets": [
            "Are you curious about what this text holds for you?",
            "Similar to the previous versions of AlphaFold, AlphaFold3 is the new SOTA method for protein structure prediction. It is slightly better at single-chain predictions than AlphaFold2, but the main advantage of AlphaFold3 is in the accurate prediction of complexes. Especially remarkable is the improved prediction of antibody-antigen interface predictions in comparison to AlphaFold-multimer v2.3.",
            "Importantly, no physics-based minimisation is needed as performed with AMBER on the side chain atom positions in AlphaFold2. To prevent generating physically plausible structures in unstructured regions during the diffusion process, cross-distillation was used with training data from AlphaFold-Multimer v2.3, which contains loops in those regions.",
            "AlphaFold2 and 3 use relative positional encodings between two tokens. Relative positional encodings have already been used in AlphaFold2 and have the advantage that the quality of the (AlphaFold) model does not decrease on sequences longer than those on which the model was trained."
          ],
          "title": "AlphaFold3 and its improvements in comparison to AlphaFold2 | by ...",
          "meta": {
            "query": "AlphaFold 3 vs previous versions data training methods",
            "question": "What are the key differences between AlphaFold 3 and its previous versions in terms of data training methods and predictive accuracy?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://en.wikipedia.org/wiki/AlphaFold",
          "description": "The overall training was conducted on processing power between 100 and 200 GPUs. AlphaFold 1 (2018) was built on work developed by various teams in the 2010s, work that looked at the large databanks of related DNA sequences now available from many different organisms (most without known 3D ...",
          "snippets": [
            "The overall training was conducted on processing power between 100 and 200 GPUs. AlphaFold 1 (2018) was built on work developed by various teams in the 2010s, work that looked at the large databanks of related DNA sequences now available from many different organisms (most without known 3D structures), to try to find changes at different residues (peptides) that appeared to be correlated, even though the residues were not consecutive in the main chain.",
            "However, the October 2021 update, named AlphaFold-Multimer, included protein complexes in its training data. DeepMind stated this update succeeded about 70% of the time at accurately predicting protein-protein interactions. Announced on 8 May 2024, AlphaFold 3 was co-developed by Google DeepMind and Isomorphic Labs, both subsidiaries of Alphabet.",
            "Therefore, it may not perform as well on synthetic proteins or proteins with very low homology to those in the training database. The model's ability to predict multiple native conformations of proteins is limited. AlphaFold 3 version can predict structures of protein complexes with a very limited set of selected cofactors and co- and post-translational modifications.",
            "It also used more advanced learning methods than previously to develop the inference. The 2020 version of the program (AlphaFold 2, 2020) is significantly different from the original version that won CASP 13 in 2018, according to the team at DeepMind. AlphaFold 1 used a number of separately trained modules to produce a guide potential, which was then combined with a physics-based energy potential.",
            "On 15 July 2021, the AlphaFold 2 paper was published in Nature as an advance access publication alongside open source software and a searchable database of species proteomes. As of February 2025, the paper had been cited nearly 32,000 times. AlphaFold 3 was announced on 8 May 2024. It can predict the structure of complexes created by proteins with DNA, RNA, various ligands, and ions. The new prediction method shows a minimum 50% improvement in accuracy for protein interactions with other molecules compared to existing methods."
          ],
          "title": "AlphaFold - Wikipedia",
          "meta": {
            "query": "AlphaFold 3 vs previous versions data training methods",
            "question": "What are the key differences between AlphaFold 3 and its previous versions in terms of data training methods and predictive accuracy?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://medium.com/@falk_hoffmann/promising-alternatives-to-alphafold-3-how-they-work-and-when-to-use-them-ccbcde490b14",
          "description": "As mentioned in my last text, AlphaFold 3 (AF3) sets the new standard for protein-ligand structure prediction. However, AlphaFold 3 has several limitations. Those include: Those limitations show a\u2026",
          "snippets": [
            "Are you curious about what this text holds for you?",
            "Note that these atom features include more about the chemistry of the ligands than the geometrically focused ligand features in AlphaFold 3. This is a generally different approach: Tools like DiffDock assume to learn from the physics features of the ligand in the training data.",
            "In contrast, AlphaFold 3 assumes to learn the physics directly. If the training data is dense enough, it should be able to learn the physics of the ligands, but embedding physics features can lead to better results (see below for NeuralPlexer).",
            "AlphaFold 3 demonstrates that combining transformers and diffusion models leads to quickly estimating accurate protein structures. However, most of those models do not use physical constraints. Those constraints can increase the quality of the predictions. One docking method that uses physical constraints is DiffDock from Tommi Jaakkola\u2019s lab at MIT. DiffDock builds on the previous success of deep learning-based docking methods like EquiBind from the same group or TANKBind from Galixir Technologies."
          ],
          "title": "Alternatives to AlphaFold 3\u2014 how they work and when to use them ...",
          "meta": {
            "query": "AlphaFold 3 vs previous versions data training methods",
            "question": "What are the key differences between AlphaFold 3 and its previous versions in terms of data training methods and predictive accuracy?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://cen.acs.org/analytical-chemistry/structural-biology/AlphaFold-3-offer-structure-prediction/102/i15",
          "description": "Tool can predict structures of proteins and nucleic acids bound to ions, ligands, and one another",
          "snippets": [
            "While DeepMind has released the code for predecessor model AlphaFold 2, it has not released training data or procedures\u2014a critical part of a machine learning model. In mid-May, researchers led by Mohammed AlQuraishi at Columbia University published OpenFold, an open-source equivalent to AlphaFold 2 that includes that information (Nat. Methods 2024, DOI: 10.1038/s41592-024-02272-z).",
            "In principle, a laboratory at a company or university could train its own variant of OpenFold\u2014for example, using proprietary structure data\u2014and generate predictions that resemble what AlphaFold 2 might predict, without using Google\u2019s servers. A lab might also optimize the model to solve a different type of problem. In an email to C&EN, AlQuraishi writes that his team has already started an effort to reproduce AlphaFold 3.",
            "The new tool can predict the structures and interactions of an array of molecules, including nucleic acids, small-molecule ligands, and macromolecule modifications (Nature 2024, DOI: 10.1038/s41586-024-07487-w). \u201cEvery time I gave an AlphaFold 2 talk . . . people would always ask me, That\u2019s really good, but I have a DNA-binding protein. Could you just tell me how it binds the DNA?\u201d John Jumper, a director at Google DeepMind, said during a press conference. Unlike past versions, AlphaFold 3, which was codeveloped with drug company Isomorphic Labs and first announced in October, can tackle such interactions.",
            "This article was updated on May 16, 2024, to add information about a letter to Nature by structural and computational biologists as well as a paper on an open-source program called OpenFold. The update also added a space to correct the name of AlphaFold 3."
          ],
          "title": "AlphaFold 3 to offer structure prediction via web browser",
          "meta": {
            "query": "AlphaFold 3 vs previous versions data training methods",
            "question": "What are the key differences between AlphaFold 3 and its previous versions in terms of data training methods and predictive accuracy?",
            "placement": "root -> Comparisons -> AlphaFold 3 vs previous versions data training methods"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://frontlinegenomics.com/alphafold-3-stepping-into-the-future-of-structure-prediction/",
          "description": "In this news highlight, we explore AlphaFold3, compare it to its predecessor and take a look to the future.",
          "snippets": [
            "These methods were time consuming and costly, and were a major limiting step in drug discovery and development processes in particular. For years, scientists have been attempting to integrate the latest and greatest AI models into the field, in order to speed up the process and improve accuracy. Enter AlphaFold, an artificial intelligence tool developed by Google\u2019s DeepMind. The first version of the technology was released in 2018, but it was 2020\u2019s AlphaFold 2 that made headlines \u2013 winning the prestigious Critical Assessment of Structure Prediction (CASP) 14 competition.",
            "Perhaps the most exciting comparison that can be drawn between AlphaFold 2 and 3 is the latter\u2019s ability to make predictions not just about protein structure, but about interactions between proteins and biological molecules such as DNA, RNA and ligands \u2013 an acknowledgment that no molecules operate on their own. These interactions are crucial in understanding the underpinnings of life, and in identifying potential drug candidates. This is reflected in AlphaFold 3\u2019s large training set, which includes a wider range of molecules.",
            "But now, AlphaFold 3 is transforming the landscape again. In this news highlight, we explore the new tech, compare it to its predecessor and take a look to the future. Before the AI revolution, protein structure prediction heavily relied on experimental methods, such as X-ray crystallography, NMR spectroscopy and, later, some complex computational methods like homology modelling.",
            "AlphaFold 2 achieved remarkable success in predicting the 3D structures of proteins from their amino acid sequences. It gained notoriety for its performance in the CASP 14 competition, where it significantly outperformed other methods, demonstrating the potential of powerful AI in solving a decades-long challenge."
          ],
          "title": "AlphaFold 3: Stepping into the future of structure prediction - ...",
          "meta": {
            "query": "AlphaFold 3 vs previous versions data training methods",
            "question": "What are the key differences between AlphaFold 3 and its previous versions in terms of data training methods and predictive accuracy?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://github.com/google-deepmind/alphafold/blob/main/docs/technical_note_v2.3.0.md",
          "description": "This technical note describes updates in the code and model weights that were made to produce AlphaFold v2.3.0 including updated training data. We have fine-tuned new AlphaFold-Multimer weights using identical model architecture but a new training cutoff of 2021-09-30. Previously released versions ...",
          "snippets": [
            "This technical note describes updates in the code and model weights that were made to produce AlphaFold v2.3.0 including updated training data. We have fine-tuned new AlphaFold-Multimer weights using identical model architecture but a new training cutoff of 2021-09-30. Previously released versions of AlphaFold and AlphaFold-Multimer were trained using PDB structures with a release date before 2018-04-30, a cutoff date chosen to coincide with the start of the 2018 CASP13 assessment.",
            "Open source code for AlphaFold 2. Contribute to google-deepmind/alphafold development by creating an account on GitHub.",
            "The new training cutoff includes 4\u00d7 the number of electron microscopy structures and in aggregate twice the number of large structures (more than 2,000 residues)1. Due to the significant increase in the number of large structures, we are also able to increase the size of training crops (subsets of the structure used to train AlphaFold) from 384 to 640 residues. These new AlphaFold-Multimer models are expected to be substantially more accurate on large protein complexes even though we use the same model architecture and training methodology as our previously released AlphaFold-Multimer paper.",
            "Since they were developed as baselines, we have emphasized minimal changes to our previous AlphaFold-Multimer system while accommodating larger complexes. In particular, we increase the number of chains used at training time from 8 to 20 and increase the maximum number of MSA sequences from 1,152 to 2,048 for 3 of the 5 AlphaFold-Multimer models."
          ],
          "title": "alphafold/docs/technical_note_v2.3.0.md at main \u00b7 google-deep...",
          "meta": {
            "query": "AlphaFold 3 vs previous versions data training methods",
            "question": "What are the key differences between AlphaFold 3 and its previous versions in terms of data training methods and predictive accuracy?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.nature.com/articles/s41586-021-03819-2",
          "description": "Proteins are essential to life, and understanding their structure can facilitate a mechanistic understanding of their function. Through an enormous experimental effort1\u20134, the structures of around 100,000 unique proteins have been determined5, but this represents a small fraction of the billions ...",
          "snippets": [
            "Proteins are essential to life, and understanding their structure can facilitate a mechanistic understanding of their function. Through an enormous experimental effort1\u20134, the structures of around 100,000 unique proteins have been determined5, but this represents a small fraction of the billions of known protein sequences6,7. Structural coverage is bottlenecked by the months to years of painstaking effort required to determine a single protein structure.",
            "In particular, we demonstrate a new architecture to jointly embed multiple sequence alignments (MSAs) and pairwise features, a new output representation and associated loss that enable accurate end-to-end structure prediction, a new equivariant attention architecture, use of intermediate losses to achieve iterative refinement of predictions, masked MSA loss to jointly train with the structure, learning from unlabelled protein sequences using self-distillation and self-estimates of accuracy. The AlphaFold network directly predicts the 3D coordinates of all heavy atoms for a given protein using the primary amino acid sequence and aligned sequences of homologues as inputs (Fig. 1e; see Methods for details of inputs including databases, MSA construction and use of templates).",
            "This creates a strong bias for atoms to be correct relative to the local frame of each residue and hence correct with respect to its side-chain interactions, as well as providing the main source of chirality for AlphaFold (Supplementary Methods 1.9.3 and Supplementary Fig. 9). The AlphaFold architecture is able to train to high accuracy using only supervised learning on PDB data, but we are able to enhance accuracy (Fig.",
            "Nature - AlphaFold predicts protein structures with an accuracy competitive with experimental structures in the majority of cases using a novel deep learning architecture."
          ],
          "title": "Highly accurate protein structure prediction with AlphaFold | Nature",
          "meta": {
            "query": "AlphaFold 3 vs previous versions data training methods",
            "question": "What are the key differences between AlphaFold 3 and its previous versions in terms of data training methods and predictive accuracy?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://hyperlab.hits.ai/en/blog/google-deepmind-alphafoldlatest",
          "description": "AlphaFold-latest, the next generation of AlphaFold, has the ability to predict the structure of almost all biomolecules along with proteins compared to previous models. The model can predict a variety of molecular combinations, including protein-nucleic acid complexes and protein-small molecule ...",
          "snippets": [
            "AlphaFold-latest, the next generation of AlphaFold, has the ability to predict the structure of almost all biomolecules along with proteins compared to previous models. The model can predict a variety of molecular combinations, including protein-nucleic acid complexes and protein-small molecule complexes, and shows higher prediction accuracy than traditional docking programs.",
            "Complex protein structures, such as protein multimers and protein-antibody conjugates, have also been reported to show significant accuracy improvements over the previous AlphaFold 2.3. Comparison of structure prediction performance on 428 protein-small molecule complexes from the [PoseBusters benchmark]. Deep learning models including EquiBind, DeepDock, TankBind, Uni-Mol, DiffDock, etc. docking programs such as Gold and Vina are compared to AlphaFold-latest. The AlphaFold-latest model was trained on data prior to 2019-09-30.",
            "Since the opening of the AlphaFold Database, it has become commonplace to use the \"AlphaFold predicted structure of a target protein\" in drug discovery projects. AlphaFold progressively predicts the structure of a multi-domain protein (CASP14 T1091) [Nature 596: 583 (2021), CC BY 4.0 \u00b7 AlphaFold has steadily evolved from Version 1 (2018), to Version 2 (2020), to AlphaFold-Multimer (2021), to the most recent Version 2.3 (2022), increasing its predictive protein size and accuracy.",
            "When comparing Google DeepMind's AlphaFold-latest to the last publicly available model, AlphaFold 2.3, the biggest change is that it can now predict almost all biomolecular structures, including proteins, small molecules, DNA and RNA, ions, and modified amino acids. Biomolecule structures predicted by AlphaFold-latest."
          ],
          "title": "Google DeepMind AlphaFold-latest l What's different from previous ...",
          "meta": {
            "query": "AlphaFold 3 vs previous versions data training methods",
            "question": "What are the key differences between AlphaFold 3 and its previous versions in terms of data training methods and predictive accuracy?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.drugdiscoverytrends.com/meet-alphafold-3-which-can-accurately-model-more-than-99-of-molecular-types-in-the-protein-data-bank/",
          "description": "AlphaFold 3 by DeepMind accurately predicts protein structures and interactions, transforming drug discovery and structural biology.",
          "snippets": [
            "A paper introducing the model, titled \u201cAccurate structure prediction of biomolecular 2 interactions with AlphaFold 3,\u201d notes that it can accurately predict \u201ccomplexes containing nearly all molecular types present in the Protein Data Bank,\u201d a widely used repository of 3D structural data for large biological molecules. The PDB was also a core resource for training and evaluating AlphaFold 3 and its predecessors. A team of researchers using the first iteration of the model placed first in the 13th Critical Assessment of Structure Prediction (CASP) competition in December 2018. Two years later, a team using AlphaFold 2 did the same at CASP 14. A 2021 paper in Nature describes the \u201credesigned version\u201d of the neural network-based model.AlphaFold 3\u2019s predictions are highly accurate.",
            "This technique allows AlphaFold 3 to learn from the successes and failures of its predecessor, ultimately leading to more accurate predictions. Additionally, the model has been trained on data that represent disordered regions as extended loops, enabling it to better capture the flexibility and variability of these regions.",
            "This capability could significantly streamline the drug design process, as the authors note that \u201cAF3 is able to accurately predict the binding modes of small molecules to proteins, which has potential applications in drug discovery.\u201d By providing accurate insights into protein-ligand interactions, AlphaFold 3 could drastically reduce the time and cost associated with experimental methods, allowing researchers to focus their efforts on the most promising drug candidates.",
            "DeepMind has made AlphaFold 3\u2019s methodology, code and protein structure predictions freely accessible to the scientific community. This open science initiative aims to accelerate scientific research through access to high-quality protein structure predictions."
          ],
          "title": "AlphaFold 3 offers even more accurate protein structure prediction",
          "meta": {
            "query": "AlphaFold 3 vs previous versions data training methods",
            "question": "What are the key differences between AlphaFold 3 and its previous versions in terms of data training methods and predictive accuracy?"
          },
          "citation_uuid": -1
        }
      ],
      "cited_info": null
    },
    {
      "utterance": "Ensuring that the predictions generated by AlphaFold 3 are used responsibly and ethically in scientific research is crucial given its potential impact on various fields. AlphaFold 3, the latest version of the biomolecular structure predictor AI model developed by Google DeepMind, has been hailed for its accuracy and speed in predicting molecule shapes [39][40]. This innovation has the potential to revolutionize protein modeling and design, as it can predict the joint structure of complexes including proteins, nucleic acids, small molecules, ions, and modified residues [41]. \n\nWhile AlphaFold 3 has shown remarkable capabilities in predicting the structure and interactions of life's molecules, it's important to consider potential biases and unintended consequences in its applications [42]. The accuracy of predictions by AI-based protein structure prediction methods like AlphaFold can vary and may not account for factors like ligands or environmental modifications [43]. Additionally, the limited accessibility of AlphaFold raises concerns about equitable access to cutting-edge technology, impacting scientific transparency and public accountability in research [44].\n\nAs the scientific community embraces AlphaFold's advancements, it's essential to address ethical considerations surrounding its use. The predictive power of AlphaFold 3 in determining protein structures has significantly influenced research in fields like biochemistry, genetics, and medical sciences [45]. The ability of AlphaFold 3 to predict the structure and interactions of various molecules, including DNA, RNA, and ligands, opens up new avenues for research beyond protein folding [46]. \n\nTo promote responsible and ethical use of AlphaFold 3, efforts are being made to equip scientists worldwide with the necessary tools through educational initiatives and partnerships [47]. This includes expanding free courses and collaborations with organizations in the Global South to accelerate research in underfunded areas such as neglected diseases and food security. By working closely with the scientific community and policymakers, the aim is to develop and deploy AI technologies, including AlphaFold 3, responsibly [47].\n\nIn conclusion, while AlphaFold 3 offers groundbreaking capabilities in predicting molecular structures, it is essential to navigate potential biases and unintended consequences in its application. By fostering transparency, accessibility, and responsible deployment of AI technologies like AlphaFold 3, we can harness its potential for scientific advancement while upholding ethical standards in research.",
      "raw_utterance": "Ensuring that the predictions generated by AlphaFold 3 are used responsibly and ethically in scientific research is crucial given its potential impact on various fields. AlphaFold 3, the latest version of the biomolecular structure predictor AI model developed by Google DeepMind, has been hailed for its accuracy and speed in predicting molecule shapes [39][40]. This innovation has the potential to revolutionize protein modeling and design, as it can predict the joint structure of complexes including proteins, nucleic acids, small molecules, ions, and modified residues [41]. \n\nWhile AlphaFold 3 has shown remarkable capabilities in predicting the structure and interactions of life's molecules, it's important to consider potential biases and unintended consequences in its applications [42]. The accuracy of predictions by AI-based protein structure prediction methods like AlphaFold can vary and may not account for factors like ligands or environmental modifications [43]. Additionally, the limited accessibility of AlphaFold raises concerns about equitable access to cutting-edge technology, impacting scientific transparency and public accountability in research [44].\n\nAs the scientific community embraces AlphaFold's advancements, it's essential to address ethical considerations surrounding its use. The predictive power of AlphaFold 3 in determining protein structures has significantly influenced research in fields like biochemistry, genetics, and medical sciences [45]. The ability of AlphaFold 3 to predict the structure and interactions of various molecules, including DNA, RNA, and ligands, opens up new avenues for research beyond protein folding [46]. \n\nTo promote responsible and ethical use of AlphaFold 3, efforts are being made to equip scientists worldwide with the necessary tools through educational initiatives and partnerships [47]. This includes expanding free courses and collaborations with organizations in the Global South to accelerate research in underfunded areas such as neglected diseases and food security. By working closely with the scientific community and policymakers, the aim is to develop and deploy AI technologies, including AlphaFold 3, responsibly [47].\n\nIn conclusion, while AlphaFold 3 offers groundbreaking capabilities in predicting molecular structures, it is essential to navigate potential biases and unintended consequences in its application. By fostering transparency, accessibility, and responsible deployment of AI technologies like AlphaFold 3, we can harness its potential for scientific advancement while upholding ethical standards in research.",
      "role": "Ethicist",
      "role_description": " This expert focuses on the ethical implications of technology in research and development. They will explore the ethical considerations surrounding the use of AI like AlphaFold 3 in scientific research, including issues of data privacy, accessibility, and potential biases in the predictions generated.",
      "queries": [
        "Responsible use of AlphaFold 3 predictions in scientific research",
        "Ethical considerations of AlphaFold 3 predictions"
      ],
      "utterance_type": "Support",
      "claim_to_make": "How can we ensure that the predictions generated by AlphaFold 3 are used responsibly and ethically in scientific research, especially in terms of potential biases and unintended consequences?",
      "raw_retrieved_info": [
        {
          "url": "https://www.analyticsvidhya.com/blog/2024/05/deepmind-ai-alphafold/",
          "description": "Without the bottleneck of protein structure prediction, researchers can focus on more difficult biological questions, resulting in quicker development of new science. While AlphaFold 3 offers immense benefits, its power requires careful consideration of some ethical issues:",
          "snippets": [
            "AlphaFold 3\u2019s impact goes far beyond predicting molecule shapes. It can potentially revolutionize various fields, accelerate research, and raise ethical considerations.",
            "AlphaFold 3, the AI revolutionizing molecular understanding beyond proteins. Explore its power to predict DNA, RNA, and drug structures!",
            "Challenge: Predicting their shapes has been tough. AlphaFold 3: Goes beyond proteins to explore molecules that matter!",
            "AlphaFold 3 is a giant leap forward in understanding the building blocks of life. Developed by DeepMind (a subsidiary of Alphabet), it\u2019s an AI model that can predict the 3D structures of various molecules, not just proteins, like its predecessor, AlphaFold 2."
          ],
          "title": "AlphaFold 3: The Next Generation in Molecular Prediction",
          "meta": {
            "query": "Ethical considerations of AlphaFold 3 predictions",
            "question": "How can we ensure that the predictions generated by AlphaFold 3 are used responsibly and ethically in scientific research, especially in terms of potential biases and unintended consequences?",
            "placement": "root"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
          "description": "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor ...",
          "snippets": [
            "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor AlphaFold 2, this innovation has astonished the world with its capacity and speed.",
            "It takes humans years to determine the structure of various proteins and how the shape works with the receptors but AlphaFold 3 predicts the same structure in seconds. The version's utility is unimaginable in the field of drug discoveries, vaccines, enzymatic processes, and determining the rate and effect of different biological processes.",
            "The integration of AI models like AlphaFold 3, bolstered by rigorous validation against high-standard research publications, is set to catalyze further innovations and offer a glimpse into the future of biomedicine. Keywords: google deepmind, predictive biochemistry, artificial intelligence, protein structure, structural biology, deep learning, machine learning, deepmind, alphafold 3",
            "On May 8, 2024, an article was published by Josh Abramson regarding the successful use of AlphaFold 3 (Google DeepMind Technologies Limited, London, United Kingdom) in the accurate structure prediction of biomolecular interactions ."
          ],
          "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
          "meta": {
            "query": "Ethical considerations of AlphaFold 3 predictions",
            "question": "How can we ensure that the predictions generated by AlphaFold 3 are used responsibly and ethically in scientific research, especially in terms of potential biases and unintended consequences?",
            "placement": "root"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.scientificamerican.com/article/one-of-the-biggest-problems-in-biology-has-finally-been-solved/",
          "description": "Google DeepMind CEO Demis Hassabis explains how its AlphaFold AI program predicted the 3-D structure of every known protein",
          "snippets": [
            "If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today. Scientific American spoke with Hassabis about developing AlphaFold, some of its most exciting potential applications and the ethical considerations of highly sophisticated AI.",
            "But last year an artificial-intelligence program called AlphaFold, developed by the Alphabet-owned company DeepMind, predicted the 3-D structures of almost every known protein\u2014about 200 million in all.",
            "AlphaFold, obviously, is huge in the scientific community. But with language and image AIs, it\u2019s starting to break through into the mainstream. Everyone, of course, knows about language and can appreciate images\u2014you don\u2019t have to have any scientific expertise. But I think we should always be thinking about the ethical issues, and that\u2019s one reason we haven\u2019t released our language-based AI yet.",
            "The end goal was to develop things like AlphaFold. It\u2019s been a mammoth project\u2014about five or six years\u2019 worth of work before CASP14 [the 14th Critical Assessment of Structure Prediction, a protein-folding competition]. We had an earlier version at the CASP13 competition, and that was AlphaFold 1."
          ],
          "title": "One of the Biggest Problems in Biology Has Finally Been Solved ...",
          "meta": {
            "query": "Ethical considerations of AlphaFold 3 predictions",
            "question": "How can we ensure that the predictions generated by AlphaFold 3 are used responsibly and ethically in scientific research, especially in terms of potential biases and unintended consequences?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.nature.com/articles/s41586-024-07487-w",
          "description": "AlphaFold 3 has a substantially updated architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and modified residues with greatly improved accuracy over many previous specialized tools.",
          "snippets": [
            "The introduction of AlphaFold 21 has spurred a revolution in modelling the structure of proteins and their interactions, enabling a huge range of applications in protein modelling and design2\u20136. Here we describe our AlphaFold 3 model with a substantially updated diffusion-based architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and modified residues.",
            "Nature - AlphaFold 3 has a substantially updated architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and...",
            "The introduction of AlphaFold 21 has spurred a revolution in modelling the structure of proteins and their interactions, enabling a huge range of applications in protein modelling and design2,3,4,5,6. Here we describe our AlphaFold 3 model with a substantially updated diffusion-based architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and modified residues.",
            "The new AlphaFold model demonstrates substantially improved accuracy over many previous specialized tools: far greater accuracy for protein\u2013ligand interactions compared with state-of-the-art docking tools, much higher accuracy for protein\u2013nucleic acid interactions compared with nucleic-acid-specific predictors and substantially higher antibody\u2013antigen prediction accuracy compared with AlphaFold-Multimer v.2.37,8. Together, these results show that high-accuracy modelling across biomolecular space is possible within a single unified deep-learning framework. ... Accurate models of biological complexes are critical to our understanding of cellular functions and for the rational design of therapeutics2,3,4,9."
          ],
          "title": "Accurate structure prediction of biomolecular interactions with ...",
          "meta": {
            "query": "Ethical considerations of AlphaFold 3 predictions",
            "question": "How can we ensure that the predictions generated by AlphaFold 3 are used responsibly and ethically in scientific research, especially in terms of potential biases and unintended consequences?",
            "placement": "root"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.isomorphiclabs.com/articles/alphafold-3-predicts-the-structure-and-interactions-of-all-of-lifes-molecules",
          "description": "We are reimagining the entire drug discovery process from first principles with an AI-first approach.",
          "snippets": [
            "AlphaFold 3 predicts the structure and interactions of all of life\u2019s molecules",
            "For the interactions of proteins with other molecule types we see at least a 50% improvement compared with existing prediction methods, and for some important categories of interaction we have doubled prediction accuracy. ... We hope AlphaFold 3 will help transform our understanding of the biological world and drug discovery.",
            "Our new model builds on the foundations of AlphaFold 2, which in 2020 made a fundamental breakthrough in protein structure prediction. So far, millions of researchers globally have used AlphaFold 2 to make discoveries in areas including malaria vaccines, cancer treatments, and enzyme design.",
            "At the core of the model is an improved version of our Evoformer module \u2013 a deep learning architecture that underpinned AlphaFold 2\u2019s incredible performance. After processing the inputs, AlphaFold 3 assembles its predictions using a diffusion network, akin to those found in AI image generators."
          ],
          "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
          "meta": {
            "query": "Ethical considerations of AlphaFold 3 predictions",
            "question": "How can we ensure that the predictions generated by AlphaFold 3 are used responsibly and ethically in scientific research, especially in terms of potential biases and unintended consequences?",
            "placement": "root"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.nature.com/articles/s41592-023-02087-4",
          "description": "An analysis of AlphaFold protein structure predictions shows that while in many cases the predictions are highly accurate, there are also many instances where the predicted structures or parts of predicted structures do not agree with experimentally resolved data.",
          "snippets": [
            "Artificial intelligence-based protein structure prediction methods such as AlphaFold have revolutionized structural biology. The accuracies of these predictions vary, however, and they do not take into account ligands, covalent modifications or other environmental factors.",
            "Nature Methods - An analysis of AlphaFold protein structure predictions shows that while in many cases the predictions are highly accurate, there are also many instances where the predicted...",
            "The small fraction of residues with predictions under 80 may lead to some uncertainty in the error estimates for moderate- and low-confidence predictions in Table 1. The median r.m.s.d. between AlphaFold predictions and deposited models in the PDB in our analysis (1.0 \u00c5; Fig. 2c) was considerably lower than that obtained in a large-scale analysis of recent structures by DeepMind1 (2.3 \u00c5 for all C\u03b1 atoms, 1.5 \u00c5 excluding the largest 5% of differences), perhaps due to the high confidence in prediction in our sample.",
            "In many cases, AlphaFold predictions matched experimental maps remarkably closely. In other cases, even very high-confidence predictions differed from experimental maps on a global scale through distortion and domain orientation, and on a local scale in backbone and side-chain conformation. We suggest considering AlphaFold predictions as exceptionally useful hypotheses."
          ],
          "title": "AlphaFold predictions are valuable hypotheses and accelerate but ...",
          "meta": {
            "query": "Ethical considerations of AlphaFold 3 predictions",
            "question": "How can we ensure that the predictions generated by AlphaFold 3 are used responsibly and ethically in scientific research, especially in terms of potential biases and unintended consequences?",
            "placement": "root"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://medium.com/meta-multiomics/alphafold-3-a-leap-forward-in-biomolecular-structure-prediction-opportunities-and-limitations-924350af1181",
          "description": "AlphaFold 3 (AF3) represents a monumental stride in the domain of protein structure prediction, establishing new paradigms in accuracy and\u2026",
          "snippets": [
            "The latest release of DeepMind\u2019s AlphaFold 3 (AF3) represents a monumental stride in the domain of protein structure prediction, establishing new paradigms in accuracy and applicability that far\u2026",
            "Toxicity and Side Effects: Predicting adverse reactions and interactions with other drugs involves different types of models and experimental validations that consider the drug\u2019s behavior in complex biological systems. While AlphaFold 3 (AF3) brings unprecedented precision to protein structure prediction, its utility in drug discovery is largely confined to the post-translational landscape.",
            "The latest release of DeepMind\u2019s AlphaFold 3 (AF3) represents a monumental stride in the domain of protein structure prediction, establishing new paradigms in accuracy and applicability that far surpass its predecessor, AlphaFold 2 (AF2).",
            "I have highlighted the core advancements of AF3, illustrating its superior architecture, broadened predictive capabilities, and its implications for scientific research in this blog. I also talk about the significant limitations of AlphaFold 3 and how companies such as Cognit.AI which is working on simulation of gene regulatory network in a human cell, in-silico can complement in application areas like drug discovery for complex diseases."
          ],
          "title": "AlphaFold 3: A Leap Forward in Biomolecular Structure Prediction ...",
          "meta": {
            "query": "Ethical considerations of AlphaFold 3 predictions",
            "question": "How can we ensure that the predictions generated by AlphaFold 3 are used responsibly and ethically in scientific research, especially in terms of potential biases and unintended consequences?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0022283624004388",
          "description": "DeepMind\u2019s AlphaFold3 webserver offers exciting new opportunities to make structural predictions of heterogeneous macromolecular systems. Here we atte\u2026",
          "snippets": [
            "DeepMind\u2019s AlphaFold3 webserver offers exciting new opportunities to make structural predictions of heterogeneous macromolecular systems. Here we attempt to apply AlphaFold3 to large RNA molecules whose 3D atomic structures are unknown but whose physical dimensions have been studied experimentally.",
            "For two RNAs whose shapes have been imaged experimentally, the computed anisotropies of the AlphaFold3-predicted structures are too low, indicating that they are excessively spherical; extending this analysis to larger RNAs shows that they become progressively more spherical with increasing length.",
            "Overall, the results suggest that AlphaFold3 is capable of producing plausible models for RNAs up to \u223c2000 nucleotides in length, but that thousands of predictions may be required to obtain models free of geometric problems.",
            "The authors thank members of the Elcock group for their help with performing predictions on the AlphaFold3 webserver and the reviewers of this manuscript for a number of insightful comments. This research was supported by the University of Iowa."
          ],
          "title": "Structure Prediction of Large RNAs with AlphaFold3 Highlights its ...",
          "meta": {
            "query": "Ethical considerations of AlphaFold 3 predictions",
            "question": "How can we ensure that the predictions generated by AlphaFold 3 are used responsibly and ethically in scientific research, especially in terms of potential biases and unintended consequences?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11292590/",
          "description": "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor AlphaFold ...",
          "snippets": [
            "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor AlphaFold 2, this innovation has astonished the world with its capacity and speed.",
            "35. An overview of antiviral peptides and rational biodesign considerations. Lee YJ, Shirkey JD, Park J, Bisht K, Cowan AJ. Biodes Res. 2022;2022:9898241. [PMC free article] [PubMed] [Google Scholar] 36. AlphaFold-Multimer predicts cross-kingdom interactions at the plant-pathogen interface.",
            "It takes humans years to determine the structure of various proteins and how the shape works with the receptors but AlphaFold 3 predicts the same structure in seconds. The version's utility is unimaginable in the field of drug discoveries, vaccines, enzymatic processes, and determining the rate and effect of different biological processes.",
            "The integration of AI models like AlphaFold 3, bolstered by rigorous validation against high-standard research publications, is set to catalyze further innovations and offer a glimpse into the future of biomedicine. Keywords: google deepmind, predictive biochemistry, artificial intelligence, protein structure, structural biology, deep learning, machine learning, deepmind, alphafold 3"
          ],
          "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
          "meta": {
            "query": "Ethical considerations of AlphaFold 3 predictions",
            "question": "How can we ensure that the predictions generated by AlphaFold 3 are used responsibly and ethically in scientific research, especially in terms of potential biases and unintended consequences?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10776388/",
          "description": "Artificial intelligence-based protein structure prediction methods such as AlphaFold have revolutionized structural biology. The accuracies of these predictions vary, however, and they do not take into account ligands, covalent modifications or ...",
          "snippets": [
            "The small fraction of residues with predictions under 80 may lead to some uncertainty in the error estimates for moderate- and low-confidence predictions in Table 1. The median r.m.s.d. between AlphaFold predictions and deposited models in the PDB in our analysis (1.0 \u00c5; Fig. 2c) was considerably lower than that obtained in a large-scale analysis of recent structures by DeepMind1 (2.3 \u00c5 for all C\u03b1 atoms, 1.5 \u00c5 excluding the largest 5% of differences), perhaps due to the high confidence in prediction in our sample.",
            "In many cases, AlphaFold predictions matched experimental maps remarkably closely. In other cases, even very high-confidence predictions differed from experimental maps on a global scale through distortion and domain orientation, and on a local scale in backbone and side-chain conformation. We suggest considering AlphaFold predictions as exceptionally useful hypotheses.",
            "We further suggest that it is important to consider the confidence in prediction when interpreting AlphaFold predictions and to carry out experimental structure determination to verify structural details, particularly those that involve interactions not included in the prediction.",
            "AlphaFold predictions are produced with residue-specific confidence metrics (pLDDT, the predicted value of the local distance difference test), which are estimates of the local accuracy of the prediction1. Residues with pLDDT values of greater than 90 are considered to be predicted with very high confidence and those with values of 70 or greater have moderate-to-high confidence."
          ],
          "title": "AlphaFold predictions are valuable hypotheses and accelerate but ...",
          "meta": {
            "query": "Ethical considerations of AlphaFold 3 predictions",
            "question": "How can we ensure that the predictions generated by AlphaFold 3 are used responsibly and ethically in scientific research, especially in terms of potential biases and unintended consequences?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
          "description": "The complexity of drug interactions and physiological responses often requires more than accurate structural predictions to achieve effective therapeutic results [24,37]. ... The limited and proprietary nature of AlphaFold's accessibility raises concerns regarding equitable access to cutting-edge technology. Such restrictions can impact scientific transparency and public accountability, which are crucial for the advancement and democratization of scientific research ...",
          "snippets": [
            "The complexity of drug interactions and physiological responses often requires more than accurate structural predictions to achieve effective therapeutic results . ... The limited and proprietary nature of AlphaFold's accessibility raises concerns regarding equitable access to cutting-edge technology. Such restrictions can impact scientific transparency and public accountability, which are crucial for the advancement and democratization of scientific research .",
            "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor ...",
            "AlphaFold 3 is reported to be 50% more accurate than the best traditional methods on the PoseBusters benchmark, marking it as the first AI system to outperform physics-based tools in biomolecular structure prediction . This leap in predictive accuracy offers a new lens through which to view the molecular underpinnings of life, from drug interactions to the human immune response. ... AlphaFold 3's nuanced understanding of protein-ligand interactions holds immense potential for revolutionizing drug discovery . By accurately predicting the binding sites and optimal shapes for potential drug molecules, AlphaFold 3 significantly streamlines the drug design process. This efficiency could drastically reduce the time and cost associated with experimental methods, allowing researchers to focus on the most promising drug candidates.",
            "AlphaFold 3 can predict complex molecular structures in a fraction of the time, dramatically reducing both the time and financial costs associated with drug development . This efficiency allows researchers to focus on the most promising drug targets and biological questions without the burden of lengthy and expensive traditional methods . ... AlphaFold 3's ability to predict interactions between the spike protein of common viruses and antibodies provides critical insights into immune response mechanisms."
          ],
          "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
          "meta": {
            "query": "Responsible use of AlphaFold 3 predictions in scientific research",
            "question": "How can we ensure that the predictions generated by AlphaFold 3 are used responsibly and ethically in scientific research, especially in terms of potential biases and unintended consequences?",
            "placement": "root"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.isomorphiclabs.com/articles/alphafold-3-predicts-the-structure-and-interactions-of-all-of-lifes-molecules",
          "description": "We are reimagining the entire drug discovery process from first principles with an AI-first approach.",
          "snippets": [
            "AlphaFold 3 predicts the structure and interactions of all of life\u2019s molecules",
            "We\u2019ll continue to work with the scientific community and policy makers to develop and deploy AI technologies responsibly. ... 7R6R - DNA binding protein: AlphaFold 3\u2019s prediction for a molecular complex featuring a protein (blue) bound to a double helix of DNA (pink) is a near-perfect match to the true molecular structure discovered through painstaking experiments (gray).",
            "Our new model builds on the foundations of AlphaFold 2, which in 2020 made a fundamental breakthrough in protein structure prediction. So far, millions of researchers globally have used AlphaFold 2 to make discoveries in areas including malaria vaccines, cancer treatments, and enzyme design. AlphaFold has been cited more than 20,000 times and its scientific impact recognized through many prizes, most recently the Breakthrough Prize in Life Sciences.",
            "As a single model that computes entire molecular complexes in a holistic way, it\u2019s uniquely able to unify scientific insights. ... 7BBV - Enzyme: AlphaFold 3\u2019s prediction for a molecular complex featuring an enzyme protein (blue), an ion (yellow sphere) and simple sugars (yellow), along with the true structure (gray). This enzyme is found in a soil-borne fungus (Verticillium dahliae) that damages a wide range of plants. Insights into how this enzyme interacts with plant cells could help researchers develop healthier, more resilient crops."
          ],
          "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
          "meta": {
            "query": "Responsible use of AlphaFold 3 predictions in scientific research",
            "question": "How can we ensure that the predictions generated by AlphaFold 3 are used responsibly and ethically in scientific research, especially in terms of potential biases and unintended consequences?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10011655/",
          "description": "Three-dimensional protein structure is directly correlated with its function and its determination is critical to understanding biological processes and addressing human health and life science problems in general. Although new protein structures ...",
          "snippets": [
            "Due to the difficulty of determining protein structures by experimental methods, their predictions have been one of the central problems of the scientific community. The advent of AlphaFold2 and the release of millions of protein structures predicted with high accuracy and available in AlphaFold DB allowed an unprecedented expansion of different research fields in life science, impacting the most biological sciences, followed by biochemistry and cell biology, genetics, medical and health sciences and chemical sciences (Varadi and Velankar, 2022).",
            "For this, ESM Metagenomic Atlas is an important 3D protein structures resource to be deeply investigated by the scientific community (Lin et al., 2022). Finally, the efforts to better predict how mutations affect protein structure using these new approaches are essential to gain insights in human genetic disease and further improve disease management and prediction. Today, these methods do not outperform AlphaFold2, but with the improvement of deep language models and the enrichment of these models with biological information through multi-task learning, they promise to revolutionize the protein structural biology.",
            "Keywords: protein structure prediction, AlphaFold, template-based modeling, free modeling, protein language model \u00b7 Protein is the term proposed by the Swedish chemist Jacob Berzelius to compounds containing nitrogen and constituted by a combination of amino acids linked by a bond, called peptide bond (Fruton, 1985; Wisniak, 2000; Lehninger et al., 2005; Voet et al., 2014). They are responsible for housekeeping and specific functions essential to life, such as cell structural support, immune protection, enzymatic catalysis, cell signal transduction to transcription and translation regulation (Pearce and Zhang, 2021).",
            "In the same year, in a partnership between DeepMind and the EMBL-European Bioinformatics Institute (EMBL-EBI), the AlphaFold Protein Structure Database (AlphaFold DB\u2014Available in https://alphafold.ebi.ac.uk) was created, making available over 360,000 predicted structures from 21 organism proteomes (Varadi et al., 2022). Today, AlphaFold DB has over 200 million entries from the human and 47 other organism proteomes, with the structure predictions and their respective analyses freely available to the scientific community."
          ],
          "title": "Before and after AlphaFold2: An overview of protein structure ...",
          "meta": {
            "query": "Responsible use of AlphaFold 3 predictions in scientific research",
            "question": "How can we ensure that the predictions generated by AlphaFold 3 are used responsibly and ethically in scientific research, especially in terms of potential biases and unintended consequences?",
            "placement": "root"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.nature.com/articles/s41586-024-07487-w",
          "description": "AlphaFold 3 has a substantially updated architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and modified residues with greatly improved accuracy over many previous specialized tools.",
          "snippets": [
            "The introduction of AlphaFold 21 has spurred a revolution in modelling the structure of proteins and their interactions, enabling a huge range of applications in protein modelling and design2\u20136. Here we describe our AlphaFold 3 model with a substantially updated diffusion-based architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and modified residues.",
            "Nature - AlphaFold 3 has a substantially updated architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and...",
            "Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493\u2013500 (2024). https://doi.org/10.1038/s41586-024-07487-w ... Sorry, a shareable link is not currently available for this article. ... Maximilian G. Schuh ... Stephan A. Sieber ... Hashim M. Al-Hashimi \u00b7 Nature Structural & Molecular Biology News & Views 08 Jul 2024 ... Matthew I. J. Raybould \u00b7 Charlotte M. Deane ... Sign up for the Nature Briefing: Translational Research newsletter \u2014 top stories in biotechnology, drug discovery and pharma.",
            "The new AlphaFold model demonstrates substantially improved accuracy over many previous specialized tools: far greater accuracy for protein\u2013ligand interactions compared with state-of-the-art docking tools, much higher accuracy for protein\u2013nucleic acid interactions compared with nucleic-acid-specific predictors and substantially higher antibody\u2013antigen prediction accuracy compared with AlphaFold-Multimer v.2.37,8. Together, these results show that high-accuracy modelling across biomolecular space is possible within a single unified deep-learning framework. ... Accurate models of biological complexes are critical to our understanding of cellular functions and for the rational design of therapeutics2,3,4,9."
          ],
          "title": "Accurate structure prediction of biomolecular interactions with ...",
          "meta": {
            "query": "Responsible use of AlphaFold 3 predictions in scientific research",
            "question": "How can we ensure that the predictions generated by AlphaFold 3 are used responsibly and ethically in scientific research, especially in terms of potential biases and unintended consequences?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://medium.com/meta-multiomics/alphafold-3-a-leap-forward-in-biomolecular-structure-prediction-opportunities-and-limitations-924350af1181",
          "description": "AlphaFold 3 (AF3) represents a monumental stride in the domain of protein structure prediction, establishing new paradigms in accuracy and\u2026",
          "snippets": [
            "The latest release of DeepMind\u2019s AlphaFold 3 (AF3) represents a monumental stride in the domain of protein structure prediction, establishing new paradigms in accuracy and applicability that far\u2026",
            "The latest release of DeepMind\u2019s AlphaFold 3 (AF3) represents a monumental stride in the domain of protein structure prediction, establishing new paradigms in accuracy and applicability that far surpass its predecessor, AlphaFold 2 (AF2). I have highlighted the core advancements of AF3, illustrating its superior architecture, broadened predictive capabilities, and its implications for scientific research in this blog.",
            "The AF3 advancement is poised to transform various aspects of biological research and drug discovery. However, as with any tool, AF3 has its limitations. It serves as a component within a larger ecosystem of drug development, which involves multiple stages from molecular discovery to clinical trials. This scientific review analyzes how AF3 interfaces with these processes and where companies like Cognit can integrate and enhance the pathway from computational models to therapeutic solutions. AF3 excels in predicting the three-dimensional structures of proteins, including complex formations between proteins and other biomolecules such as nucleic acids, small molecules (ligands), and ions.",
            "Architecture and Training Procedure: AlphaFold 3 introduces a new diffusion-based architecture, replacing the AlphaFold 2 Evoformer with the simpler Pairformer Module. This change allows for more efficient processing of multiple sequence alignments (MSAs) and focuses on raw atomic coordinates prediction rather than relying heavily on rotational frames or equivariance."
          ],
          "title": "AlphaFold 3: A Leap Forward in Biomolecular Structure Prediction ...",
          "meta": {
            "query": "Responsible use of AlphaFold 3 predictions in scientific research",
            "question": "How can we ensure that the predictions generated by AlphaFold 3 are used responsibly and ethically in scientific research, especially in terms of potential biases and unintended consequences?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://blog.google/technology/ai/how-we-built-alphafold-3/",
          "description": "Since its launch in 2020, more than 2 million researchers have used Google DeepMind\u2019s AlphaFold 2 model for protein predictions in their work on vaccine development, cancer treatments and more \u2014 helping solve a problem that researchers had been working on for over 50 years.",
          "snippets": [
            "Instead, they got started on AlphaFold 3. This newer model, which the teams at Google DeepMind and Isomorphic Labs launched in May, builds on our previous models by predicting not just protein folding structures, but predicting the structure and interactions of all of life's molecules, including DNA, RNA and ligands (small molecules that bind to proteins). \u201cWith AlphaFold 2, we made enormous progress on this decades-old open problem of protein folding, but if you look at recent high-impact research, researchers are moving beyond that,\u201d says Jonas Adler, research scientist at Google DeepMind.",
            "An example of a prediction from AlphaFold 3 with ordered \u201cfusilli\u201d regions in blue and disordered \u201cspaghetti\u201d regions in orange. The colors represent the model\u2019s confidence of predicted accuracy. The team is looking forward to seeing how researchers will use AlphaFold 3 to advance fields like genomics research, drug design and more.",
            "\u201cIt\u2019s like Google Maps for molecular complexes,\u201d says Lindsay Willmore, research engineer at Google DeepMind. \u201cAny user who doesn't know how to code at all can just copy and paste the sequences of their proteins, DNA, RNA or the name of their small molecule, press a button and wait a few minutes. Their structure and the confidence metrics will come out so that they're able to look at and evaluate their prediction.\u201d \u00b7 In order to get AlphaFold 3 to work with this much wider range of biomolecules, the team vastly expanded the data that the newer model was trained on to include DNA, RNA, small molecules and more.",
            "That meant making a database with all the capabilities would have been impossible. Instead, we\u2019ve released AlphaFold Server, a free tool that lets scientists plug in their own sequences that AlphaFold can then generate molecular complexes for. Since launching in May, researchers have already used it to generate over 1 million structures."
          ],
          "title": "How we built AlphaFold 3 to predict the structure and interaction ...",
          "meta": {
            "query": "Responsible use of AlphaFold 3 predictions in scientific research",
            "question": "How can we ensure that the predictions generated by AlphaFold 3 are used responsibly and ethically in scientific research, especially in terms of potential biases and unintended consequences?",
            "placement": "root"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.nature.com/articles/s41592-023-02087-4",
          "description": "An analysis of AlphaFold protein structure predictions shows that while in many cases the predictions are highly accurate, there are also many instances where the predicted structures or parts of predicted structures do not agree with experimentally resolved data.",
          "snippets": [
            "Artificial intelligence-based protein structure prediction methods such as AlphaFold have revolutionized structural biology. The accuracies of these predictions vary, however, and they do not take into account ligands, covalent modifications or other environmental factors.",
            "Nature Methods - An analysis of AlphaFold protein structure predictions shows that while in many cases the predictions are highly accurate, there are also many instances where the predicted...",
            "To analyze the local side-chain structure and remove confounding effects from domain shifts or distortions, we grafted the side chain from each residue in an AlphaFold prediction onto the corresponding main-chain atom residues of the deposited model. This yielded a composite model with the main-chain coordinates of the deposited models and side-chain conformations corresponding to the AlphaFold predictions. Figure 3a shows a local portion of PDB entry 7vgm, and Fig.",
            "Figure 3d shows the deposited model for 7vgm along with the density map obtained for PDB entry 7vgm, and Fig. 3e shows the AlphaFold model superimposed on the same density map. Even though the density map was obtained with the AlphaFold prediction and without reference to the deposited model, all the side chains in the deposited model match the map closely."
          ],
          "title": "AlphaFold predictions are valuable hypotheses and accelerate but ...",
          "meta": {
            "query": "Responsible use of AlphaFold 3 predictions in scientific research",
            "question": "How can we ensure that the predictions generated by AlphaFold 3 are used responsibly and ethically in scientific research, especially in terms of potential biases and unintended consequences?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://blog.google/technology/ai/google-deepmind-isomorphic-alphafold-3-ai-model/",
          "description": "We\u2019ll also be expanding our free ... and research, including on underfunded areas such as neglected diseases and food security. We\u2019ll continue to work with the scientific community and policy makers to develop and deploy AI technologies responsibly. 7BBV - Enzyme: AlphaFold 3\u2019s prediction for a molecular ...",
          "snippets": [
            "We\u2019ll also be expanding our free AlphaFold education online course with EMBL-EBI and partnerships with organizations in the Global South to equip scientists with the tools they need to accelerate adoption and research, including on underfunded areas such as neglected diseases and food security. We\u2019ll continue to work with the scientific community and policy makers to develop and deploy AI technologies responsibly. 7BBV - Enzyme: AlphaFold 3\u2019s prediction for a molecular complex featuring an enzyme protein (blue), an ion (yellow sphere) and simple sugars (yellow), along with the true structure (gray).",
            "Our new AI model AlphaFold 3 can predict the structure and interactions of all life\u2019s molecules with unprecedented accuracy.",
            "Our new model builds on the foundations of AlphaFold 2, which in 2020 made a fundamental breakthrough in protein structure prediction. So far, millions of researchers globally have used AlphaFold 2 to make discoveries in areas including malaria vaccines, cancer treatments and enzyme design. AlphaFold has been cited more than 20,000 times and its scientific impact recognized through many prizes, most recently the Breakthrough Prize in Life Sciences.",
            "AlphaFold 3 is 50% more accurate than the best traditional methods on the PoseBusters benchmark without needing the input of any structural information, making AlphaFold 3 the first AI system to surpass physics-based tools for biomolecular structure prediction. The ability to predict antibody-protein binding is critical to understanding aspects of the human immune response and the design of new antibodies \u2014 a growing class of therapeutics."
          ],
          "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
          "meta": {
            "query": "Responsible use of AlphaFold 3 predictions in scientific research",
            "question": "How can we ensure that the predictions generated by AlphaFold 3 are used responsibly and ethically in scientific research, especially in terms of potential biases and unintended consequences?",
            "placement": "root"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0022283624004388",
          "description": "DeepMind\u2019s AlphaFold3 webserver offers exciting new opportunities to make structural predictions of heterogeneous macromolecular systems. Here we atte\u2026",
          "snippets": [
            "The authors thank members of the Elcock group for their help with performing predictions on the AlphaFold3 webserver and the reviewers of this manuscript for a number of insightful comments. This research was supported by the University of Iowa.",
            "DeepMind\u2019s AlphaFold3 webserver offers exciting new opportunities to make structural predictions of heterogeneous macromolecular systems. Here we attempt to apply AlphaFold3 to large RNA molecules whose 3D atomic structures are unknown but whose physical dimensions have been studied experimentally.",
            "The hydrodynamic radii computed from the AlphaFold3 models are too large in comparison with experimental data obtained under low salt conditions but are in better agreement with experimental data obtained in the presence of polyvalent cations.",
            "Restricting attention to those RNAs for which non-clashing models can be obtained, we find that hydrodynamic radii computed from the AlphaFold3 models are much larger than those reported experimentally under low salt conditions but are in better agreement with those reported in the presence of polyvalent cations."
          ],
          "title": "Structure Prediction of Large RNAs with AlphaFold3 Highlights its ...",
          "meta": {
            "query": "Responsible use of AlphaFold 3 predictions in scientific research",
            "question": "How can we ensure that the predictions generated by AlphaFold 3 are used responsibly and ethically in scientific research, especially in terms of potential biases and unintended consequences?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10136805/",
          "description": "Elucidation of the tertiary structure of proteins is an important task for biological and medical studies. AlphaFold, a modern deep-learning algorithm, enables the prediction of protein structure to a high level of accuracy. It has been applied in ...",
          "snippets": [
            "Elucidation of the tertiary structure of proteins is an important task for biological and medical studies. AlphaFold, a modern deep-learning algorithm, enables the prediction of protein structure to a high level of accuracy. It has been applied in numerous studies in various areas of biology and medicine.",
            "AlphaFold is not designed for the prediction of post-translational modifications (PTMs) of proteins, such as protein glycosylation. This fact has attracted the attention of the scientific community, with recent studies demonstrating the relevance and importance of glycosylation in the SARS-CoV-2 spike protein or in human proteins.",
            "In CASP14, AlphaFold2 structures had a median backbone accuracy of 0.96 \u00c5 RMSD95 (C\u03b1 root-mean-square deviation at 95% residue coverage) and an all-atom accuracy of 1.5 \u00c5 RMSD95. The corresponding values for the prediction of the best alternative method were 2.8 \u00c5 and 3.5 \u00c5 . The high level of accuracy of AlphaFold2 predictions boosted the popularity of this technique.",
            "The accuracy of predicted structures can be assessed using computational techniques  and via experimental methods, e.g., optical spectroscopy or measurement of solution residual dipolar couplings data (RDCs) . A meticulous evaluation of the concordance of AF2 models of the SARS-CoV-2 homodimeric 3C-like protease (Mpro) with residual dipolar couplings (RDCs) measured in solution for 15N\u20131HN and 13C\u2032\u20131HN atom pairs indicated the close agreement of AlphaFold predictions with experimental data (Figure 2) ."
          ],
          "title": "Using AlphaFold Predictions in Viral Research - PMC",
          "meta": {
            "query": "Responsible use of AlphaFold 3 predictions in scientific research",
            "question": "How can we ensure that the predictions generated by AlphaFold 3 are used responsibly and ethically in scientific research, especially in terms of potential biases and unintended consequences?"
          },
          "citation_uuid": -1
        }
      ],
      "cited_info": null
    },
    {
      "utterance": "The adoption of AlphaFold 3 in the drug discovery process is set to revolutionize the timeline and cost of bringing new drugs to market. With the ability to predict protein structures in seconds, a task that typically takes years for humans to accomplish, AlphaFold 3 offers unparalleled speed and accuracy in understanding the shape and interactions of various molecules[48][51]. This capability is crucial in drug discovery, as it allows researchers to design drug candidates with improved efficacy and reduced side effects, ultimately expediting the drug development process[50].\n\nFurthermore, AlphaFold 3's ability to predict how ligands bind to target proteins facilitates rational drug design, guiding researchers in creating structures that are more effective in treating diseases[50]. This breakthrough not only accelerates the drug discovery process but also has the potential to reduce overall development costs, making it a game-changer in the pharmaceutical industry[50].\n\nWhile AlphaFold 3 provides a powerful tool for identifying promising compounds faster, it is important to note that traditional challenges in drug development still exist[52]. However, AlphaFold 3 represents a significant piece of the puzzle in improving the success of drug development efforts[52]. By offering a broader understanding of the context in which drug targets operate, AlphaFold 3 enables more effective drugs to be developed and tested in the clinic[49].\n\nOverall, the impact of AlphaFold 3 on drug discovery and biological understanding is immense, with its potential to revolutionize various fields, accelerate research, and raise ethical considerations[57]. As DeepMind and Isomorphic Labs continue to enhance the capabilities of AlphaFold, its value in drug R&D is expected to grow, potentially leading to significant commercial benefits and advancements in medical treatments[53][55]. The restricted access to AlphaFold 3 further underscores its groundbreaking potential and the importance of utilizing advanced AI tools in drug discovery processes[54].\n\nIn conclusion, the adoption of AlphaFold 3 in the drug discovery process is poised to transform the industry by significantly reducing the time and cost required to bring new drugs to market. Its ability to predict protein structures rapidly and accurately has the potential to revolutionize drug design and development, offering new opportunities for creating more effective and targeted therapeutics[56].",
      "raw_utterance": "The adoption of AlphaFold 3 in the drug discovery process is set to revolutionize the timeline and cost of bringing new drugs to market. With the ability to predict protein structures in seconds, a task that typically takes years for humans to accomplish, AlphaFold 3 offers unparalleled speed and accuracy in understanding the shape and interactions of various molecules[48][51]. This capability is crucial in drug discovery, as it allows researchers to design drug candidates with improved efficacy and reduced side effects, ultimately expediting the drug development process[50].\n\nFurthermore, AlphaFold 3's ability to predict how ligands bind to target proteins facilitates rational drug design, guiding researchers in creating structures that are more effective in treating diseases[50]. This breakthrough not only accelerates the drug discovery process but also has the potential to reduce overall development costs, making it a game-changer in the pharmaceutical industry[50].\n\nWhile AlphaFold 3 provides a powerful tool for identifying promising compounds faster, it is important to note that traditional challenges in drug development still exist[52]. However, AlphaFold 3 represents a significant piece of the puzzle in improving the success of drug development efforts[52]. By offering a broader understanding of the context in which drug targets operate, AlphaFold 3 enables more effective drugs to be developed and tested in the clinic[49].\n\nOverall, the impact of AlphaFold 3 on drug discovery and biological understanding is immense, with its potential to revolutionize various fields, accelerate research, and raise ethical considerations[57]. As DeepMind and Isomorphic Labs continue to enhance the capabilities of AlphaFold, its value in drug R&D is expected to grow, potentially leading to significant commercial benefits and advancements in medical treatments[53][55]. The restricted access to AlphaFold 3 further underscores its groundbreaking potential and the importance of utilizing advanced AI tools in drug discovery processes[54].\n\nIn conclusion, the adoption of AlphaFold 3 in the drug discovery process is poised to transform the industry by significantly reducing the time and cost required to bring new drugs to market. Its ability to predict protein structures rapidly and accurately has the potential to revolutionize drug design and development, offering new opportunities for creating more effective and targeted therapeutics[56].",
      "role": "Pharmaceutical industry representative",
      "role_description": " This expert works in the pharmaceutical industry and has experience in drug discovery. They will discuss how AlphaFold 3 can impact the process of identifying and designing new drugs, potentially speeding up the development of novel therapeutics.",
      "queries": [
        "AlphaFold 3 adoption impact on drug discovery timeline and cost",
        "Effects of using AlphaFold 3 in drug discovery process"
      ],
      "utterance_type": "Support",
      "claim_to_make": "How do you think the adoption of AlphaFold 3 in the drug discovery process will affect the overall timeline and cost of bringing new drugs to market?",
      "raw_retrieved_info": [
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
          "description": "It takes humans years to determine ... with the receptors but AlphaFold 3 predicts the same structure in seconds. The version's utility is unimaginable in the field of drug discoveries, vaccines, enzymatic processes, and determining the rate and effect of different biological ...",
          "snippets": [
            "It takes humans years to determine the structure of various proteins and how the shape works with the receptors but AlphaFold 3 predicts the same structure in seconds. The version's utility is unimaginable in the field of drug discoveries, vaccines, enzymatic processes, and determining the rate and effect of different biological processes.",
            "Machine learning, particularly through platforms like AlphaFold 3, has revolutionized the identification and optimization of lead compounds in drug discovery . By analyzing extensive chemical libraries, AlphaFold 3 identifies promising drug candidates based on their predicted biological activity and physicochemical properties, significantly accelerating the drug development process. ... AlphaFold 3's ability to predict drug-target interactions with unprecedented accuracy is a cornerstone of its application in drug discovery. This AI model predicts how new drug candidates will interact with biological targets, aiding in the design of more effective and selective drugs.",
            "This example highlights how predictive models can optimize vaccine formulations to enhance their effectiveness [21,32-34]. ... AlphaFold's impact is notable in drug discovery, particularly for viral diseases. The platform has been used to identify potential inhibitors for the non-structural protein 6 (NSP6) of SARS-CoV-2, with candidates recommended for biological testing. This approach not only accelerates the identification of viable drug candidates but also refines the drug development process by focusing on the most promising targets .",
            "AlphaFold 3's integration into drug discovery processes signifies a transformative shift, particularly with its ability to predict interactions at the atomic level. This precision facilitates the development of drugs that are not only more effective but also specifically targeted, reducing the time and costs associated with traditional drug development methods."
          ],
          "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
          "meta": {
            "query": "Effects of using AlphaFold 3 in drug discovery process",
            "question": "How do you think the adoption of AlphaFold 3 in the drug discovery process will affect the overall timeline and cost of bringing new drugs to market?",
            "placement": "root -> Adoption Impact -> Effects of using AlphaFold 3 in drug discovery process"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.isomorphiclabs.com/articles/rational-drug-design-with-alphafold-3",
          "description": "We are reimagining the entire drug discovery process from first principles with an AI-first approach.",
          "snippets": [
            "We believe that this broader understanding of the context within which drug targets operate will translate into more effective drugs in the clinic. ... To demonstrate the potential for rational structure-based drug design with AlphaFold 3, we examined TIM-3, an immune checkpoint protein identified as a potential target for cancer immunotherapy following a 2021 publication. ... The study focused on the discovery and design of small molecules capable of binding TIM-3 with high affinity.",
            "This builds upon Google DeepMind\u2019s foundational work of predicting the structure of proteins with AlphaFold 2, to now include how multiple proteins, DNA, RNA, and small molecule ligands come together and interact, as well as predicting the structural impact of post-translational modifications and ions on these molecular systems. This model is a powerful unified framework for structure prediction, encompassing unprecedented breadth and accuracy. ... This breakthrough opens up exciting possibilities for drug discovery, allowing us to rationally develop therapeutics against targets that were previously difficult or deemed intractable to modulate.",
            "But AlphaFold 3 is one of the many AI-powered breakthroughs we\u2019re working on which are needed to transform drug discovery - structural understanding is just a part of the picture. We\u2019re combining AlphaFold 3 with our other proprietary AI models in our platform that help us understand more about the properties, function, and dynamics of molecular systems.",
            "We used the raw sequence of the protein, and the SMILES representation of each ligand, without giving AlphaFold 3 any additional information about the pose, structure, or pocket. Excitingly, the predicted structures were in agreement with the published experimental structures. The pocket discovered by the study was also found by AlphaFold 3."
          ],
          "title": "Rational drug design with AlphaFold 3 - Isomorphic Labs",
          "meta": {
            "query": "Effects of using AlphaFold 3 in drug discovery process",
            "question": "How do you think the adoption of AlphaFold 3 in the drug discovery process will affect the overall timeline and cost of bringing new drugs to market?",
            "placement": "root -> Adoption Impact -> Effects of using AlphaFold 3 in drug discovery process"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11292590/",
          "description": "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor AlphaFold ...",
          "snippets": [
            "It takes humans years to determine the structure of various proteins and how the shape works with the receptors but AlphaFold 3 predicts the same structure in seconds. The version's utility is unimaginable in the field of drug discoveries, vaccines, enzymatic processes, and determining the rate and effect of different biological processes.",
            "Machine learning, particularly through platforms like AlphaFold 3, has revolutionized the identification and optimization of lead compounds in drug discovery . By analyzing extensive chemical libraries, AlphaFold 3 identifies promising drug candidates based on their predicted biological activity and physicochemical properties, significantly accelerating the drug development process. ... AlphaFold 3's ability to predict drug-target interactions with unprecedented accuracy is a cornerstone of its application in drug discovery. This AI model predicts how new drug candidates will interact with biological targets, aiding in the design of more effective and selective drugs.",
            "This example highlights how predictive models can optimize vaccine formulations to enhance their effectiveness [21,32-34]. ... AlphaFold's impact is notable in drug discovery, particularly for viral diseases. The platform has been used to identify potential inhibitors for the non-structural protein 6 (NSP6) of SARS-CoV-2, with candidates recommended for biological testing. This approach not only accelerates the identification of viable drug candidates but also refines the drug development process by focusing on the most promising targets .",
            "AlphaFold 3's integration into drug discovery processes signifies a transformative shift, particularly with its ability to predict interactions at the atomic level. This precision facilitates the development of drugs that are not only more effective but also specifically targeted, reducing the time and costs associated with traditional drug development methods."
          ],
          "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
          "meta": {
            "query": "Effects of using AlphaFold 3 in drug discovery process",
            "question": "How do you think the adoption of AlphaFold 3 in the drug discovery process will affect the overall timeline and cost of bringing new drugs to market?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.drugdiscoverytrends.com/laying-groundwork-alphafold-3-drug-discovery/",
          "description": "With the right approach, AlphaFold 3 promises to streamline drug discovery with advanced biomolecular predictions.",
          "snippets": [
            "Drug developers don\u2019t need to become AI experts to be able to effectively wield its powers. He drew an analogy to electricity. \u201cYou know that flicking on a light switch will turn on the light, even if you can\u2019t explain the electrodynamics behind it. The same applies to AI,\u201d he said. \u201cBut you do know how to use it.\u201d \u00b7 Filed Under: Data science, Drug Discovery, machine learning and AI Tagged With: AI in Pharma, AI tools, AlphaFold 3, biopharma innovation, drug discovery, pharmaceutical R&D, protein structure prediction",
            "Despite this challenge and the significant costs of building the necessary foundation, AlphaFold is an order of magnitude \u2014 or two \u2014 less expensive than traditional methods in medicinal chemistry. \u201cWe\u2019re talking about a completely game-changing technology as far as drug discovery is concerned,\u201d Bangert said.",
            "\u201cAlphaFold itself is like the heart but you need the lungs and the liver and the kidneys and blood vessels and all that as well,\u201d Bangert said. Deploying AlphaFold 3 at a production scale to accelerate drug discovery involves assembling an ecosystem of IT infrastructure, data pipelines and domain expertise.",
            "\u201cAnd you tried that out in the lab physically and you had to go through a few thousand physical tests with each new attempt.\u201d Drug developers can now conduct these experiments computationally at a fraction of the cost using AlphaFold, compared to the time-consuming and resource-intensive process of traditional methods."
          ],
          "title": "Laying the groundwork to tap AlphaFold 3's potential in drug ...",
          "meta": {
            "query": "Effects of using AlphaFold 3 in drug discovery process",
            "question": "How do you think the adoption of AlphaFold 3 in the drug discovery process will affect the overall timeline and cost of bringing new drugs to market?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://news.mit.edu/2022/alphafold-potential-protein-drug-0906",
          "description": "Using protein structures generated by the AI software AlphaFold, MIT researchers investigated whether existing computational models could identify the mechanisms of action of antibacterial compounds.",
          "snippets": [
            "Study finds computer models that predict molecular interactions need improvement before they can help identify drug mechanisms of action. ... Caption: Using protein structures generated by the AI software AlphaFold, MIT researchers investigated whether existing computational models could identify the mechanisms of action of antibacterial compounds.",
            "\u201cAlphaFold appears to do roughly as well as experimentally determined structures, but we need to do a better job with molecular docking models if we\u2019re going to utilize AlphaFold effectively and extensively in drug discovery,\u201d Collins says.",
            "The new study is part of an effort recently launched by Collins\u2019 lab called the Antibiotics-AI Project, which has the goal of using artificial intelligence to discover and design new antibiotics. AlphaFold, an AI software developed by DeepMind and Google, has accurately predicted protein structures from their amino acid sequences. This technology has generated excitement among researchers looking for new antibiotics, who hope that they could use the AlphaFold structures to find drugs that bind to specific bacterial proteins.",
            "\u201cBreakthroughs such as AlphaFold are expanding the possibilities for in silico drug discovery efforts, but these developments need to be coupled with additional advances in other aspects of modeling that are part of drug discovery efforts,\u201d Collins says."
          ],
          "title": "Analyzing the potential of AlphaFold in drug discovery | MIT News ...",
          "meta": {
            "query": "Effects of using AlphaFold 3 in drug discovery process",
            "question": "How do you think the adoption of AlphaFold 3 in the drug discovery process will affect the overall timeline and cost of bringing new drugs to market?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.theatlantic.com/sponsored/google/ai-powered-future-drug-discovery/3962/",
          "description": "But now, AI systems are poised ... process. One area in which AlphaFold 3 shows particular promise is the rational design of drugs. AlphaFold 3 can efficiently predict how ligands, a structural component of many drugs, will bind to a target protein, thereby guiding researchers in designing drug candidate structures for improved efficacy and reduced side effects. This not only hastens the drug discovery process but ...",
          "snippets": [
            "But now, AI systems are poised to dramatically accelerate this painstaking process. One area in which AlphaFold 3 shows particular promise is the rational design of drugs. AlphaFold 3 can efficiently predict how ligands, a structural component of many drugs, will bind to a target protein, thereby guiding researchers in designing drug candidate structures for improved efficacy and reduced side effects. This not only hastens the drug discovery process but also has the potential to ultimately impact the overall cost of development.",
            "These stories are meant to help you explore, understand and get even more curious about it, and remind you that as long as we\u2019re willing to confront the complexities, there will always be something new to discover. ... The pioneering AI model AlphaFold can predict the structure and interactions of molecules with unprecedented accuracy. By Alasdair Lane \u2022 Illustrations by Petra P\u00e9terffy \u00b7 At the heart of every biological process, from the replication of cells to the functioning of the human brain, lies the intricate world of proteins.",
            "AlphaFold 3 also has the ability to predict antibody-protein binding, which can help researchers understand immune response and design new antibodies. Antibodies are examples of therapeutic proteins that can be used to treat diseases like cancer. But discovering new ones by traditional means is an arduous task. With trillions of possible structures, finding the ones that effectively stick to a target of interest is like searching for a needle in a haystack, experts say.",
            "In 2021, Hassabis founded Isomorphic Labs as an offshoot of Google DeepMind to specifically focus on rational drug design and apply AI to redefine the drug discovery process from first principles. The latest version, AlphaFold 3, developed by Google DeepMind and Isomorphic Labs, is reshaping the field of structural biology and providing invaluable insights for drug design."
          ],
          "title": "The AI-Powered Future of Drug Discovery - Sponsor Content - Google",
          "meta": {
            "query": "Effects of using AlphaFold 3 in drug discovery process",
            "question": "How do you think the adoption of AlphaFold 3 in the drug discovery process will affect the overall timeline and cost of bringing new drugs to market?",
            "placement": "root -> Adoption Impact -> Effects of using AlphaFold 3 in drug discovery process"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.isomorphiclabs.com/articles/alphafold-3-predicts-the-structure-and-interactions-of-all-of-lifes-molecules",
          "description": "We are reimagining the entire drug discovery process from first principles with an AI-first approach.",
          "snippets": [
            "AlphaFold 3 predicts the structure and interactions of all of life\u2019s molecules",
            "This new window on the molecules of life reveals how they\u2019re all connected and helps understand how those connections affect biological functions \u2013 such as the actions of drugs, the production of hormones, and the health-preserving process of DNA repair. The impacts of AlphaFold 3 and the free AlphaFold Server will be realised through how they empower scientists to accelerate discovery across open questions in biology and new lines of research.",
            "We hope AlphaFold 3 will help transform our understanding of the biological world and drug discovery. Scientists can access the majority of its capabilities, for free, through the newly launched AlphaFold Server, an easy-to-use research tool.",
            "To build on AlphaFold 3\u2019s potential for drug design, we at Isomorphic Labs are already collaborating with pharmaceutical companies to apply it to real-world drug design challenges and, ultimately, develop new life-changing treatments for patients. ... Our new model builds on the foundations of AlphaFold 2, which in 2020 made a fundamental breakthrough in protein structure prediction. So far, millions of researchers globally have used AlphaFold 2 to make discoveries in areas including malaria vaccines, cancer treatments, and enzyme design."
          ],
          "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
          "meta": {
            "query": "Effects of using AlphaFold 3 in drug discovery process",
            "question": "How do you think the adoption of AlphaFold 3 in the drug discovery process will affect the overall timeline and cost of bringing new drugs to market?",
            "placement": "root -> Adoption Impact -> Effects of using AlphaFold 3 in drug discovery process"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.pharmavoice.com/news/google-alphafold-3-drug-discovery-pharma-buzz/716496/",
          "description": "The \u201cNobel Prize-worthy invention\u201d could be worth hundreds of billions commercially \u2014 and have a deep impact on drug R&D.",
          "snippets": [
            "And while AlphaFold 3 could identify promising compounds faster, the usual hurdles to market will remain. \u201cThis isn't necessarily a Holy Grail to instantly make the drug development process more successful,\u201d Bangert said. \u201cYou're still going to have the traditional challenges, but this is a piece of that puzzle that's fitting better now.\u201d \u00b7 AI has secured a footing in drug discovery.",
            "The artificial intelligence program AlphaFold 3, rolled out by Google DeepMind and Isomorphic Labs earlier this month, has been called \u201cgroundbreaking,\u201d holding transformative potential in drug discovery.",
            "However, AlphaFold and competing programs, such as RoseTTaFold, now make the process quicker and easier. \u201cInstead of trialing a hundred options in the lab, physically, I can trial tens of thousands of options in silico,\u201d he said. \u201cWhile it still costs money, it's a small fraction and, of course, it's almost instantaneous.\u201d \u00b7 If a company typically takes ten years to get a drug across the finish line, this technology will allow them to do it in seven, he said.",
            "It\u2019s hard to find the downside of AlphaFold 3, Bangert said. \u201cThis is actually one of those rare examples where I genuinely can't think of a drawback, mainly because this protein folding problem is so early in the process of drug development,\u201d he said."
          ],
          "title": "Why AlphaFold 3 is stirring up so much buzz in pharma | PharmaVoice",
          "meta": {
            "query": "Effects of using AlphaFold 3 in drug discovery process",
            "question": "How do you think the adoption of AlphaFold 3 in the drug discovery process will affect the overall timeline and cost of bringing new drugs to market?",
            "placement": "root -> Adoption Impact -> Effects of using AlphaFold 3 in drug discovery process"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.nature.com/articles/d41586-023-02984-w",
          "description": "Nature - Questions remain about whether the AI tool for predicting protein structures can really shake up the pharmaceutical industry.",
          "snippets": [
            "Questions remain about whether the AI tool for predicting protein structures can really shake up the pharmaceutical industry. Questions remain about whether the AI tool for predicting protein structures can really shake up the pharmaceutical industry.",
            "After Google Deepmind\u2019s AlphaFold proved that it could predict the 3D shapes of proteins with high accuracy in 2020, chemists became excited about the promise of using the open-source artificial-intelligence (AI) programme to discover drugs more quickly and cheaply."
          ],
          "title": "AlphaFold touted as next big thing for drug discovery \u2014 but is it?",
          "meta": {
            "query": "Effects of using AlphaFold 3 in drug discovery process",
            "question": "How do you think the adoption of AlphaFold 3 in the drug discovery process will affect the overall timeline and cost of bringing new drugs to market?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.labiotech.eu/in-depth/alpha-fold-3-drug-discovery/",
          "description": "Find out how Google DeepMind's AlphaFold3 platform could help scientists revolutionize the field of drug discovery.",
          "snippets": [
            "As DeepMind and Isomorphic Labs said in their joint release about AlphaFold3, it\u2019s only by seeing how proteins, DNA, and other molecules interact together, across millions of types of combinations, that we can \u201cstart to truly understand life\u2019s processes.\u201d \u00b7 To learn how to puzzle out the precise atomic structures of molecules, AlphaFold3 uses a diffusion model, similar to ones used for popular text-to-image generation models such as OpenAI\u2019s DALL-E 3.",
            "The withholding of the code was largely down to commercial reasons, as co-developer Isomorphic Labs, a DeepMind spinoff company, is using AlphaFold3 internally to speed up its drug discovery efforts. The company currently has partnerships potentially worth $3 billion with Eli Lilly and Novartis aimed at developing multiple drugs.",
            "A critical first step in this process is the ability to produce target proteins, often in pre-formed complexes, to study such interactions effectively.\u201d \u00b7 As an example, Tan said that cell and gene therapy is an area where AlphaFold3 could make a key difference.",
            "This makes AlphaFold3 the perfect tool for drug discovery, ultimately enabling scientists to simulate vital molecular interactions with unprecedented speed and precision, and offering a faster, more cost-effective alternative to traditional lab methods."
          ],
          "title": "AlphaFold3: Revolutionizing drug discovery and development",
          "meta": {
            "query": "Effects of using AlphaFold 3 in drug discovery process",
            "question": "How do you think the adoption of AlphaFold 3 in the drug discovery process will affect the overall timeline and cost of bringing new drugs to market?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.drugdiscoverytrends.com/laying-groundwork-alphafold-3-drug-discovery/",
          "description": "With the right approach, AlphaFold 3 promises to streamline drug discovery with advanced biomolecular predictions.",
          "snippets": [
            "In its most recent update, AlphaFold 3 adopts a diffusion-based approach, which enables the model to learn protein structure at multiple scales and directly predict raw atom coordinates.",
            "Despite this challenge and the significant costs of building the necessary foundation, AlphaFold is an order of magnitude \u2014 or two \u2014 less expensive than traditional methods in medicinal chemistry. \u201cWe\u2019re talking about a completely game-changing technology as far as drug discovery is concerned,\u201d Bangert said.",
            "\u201cAlphaFold itself is like the heart but you need the lungs and the liver and the kidneys and blood vessels and all that as well,\u201d Bangert said. Deploying AlphaFold 3 at a production scale to accelerate drug discovery involves assembling an ecosystem of IT infrastructure, data pipelines and domain expertise.",
            "Filed Under: Data science, Drug Discovery, machine learning and AI Tagged With: AI in Pharma, AI tools, AlphaFold 3, biopharma innovation, drug discovery, pharmaceutical R&D, protein structure prediction"
          ],
          "title": "Laying the groundwork to tap AlphaFold 3's potential in drug ...",
          "meta": {
            "query": "AlphaFold 3 adoption impact on drug discovery timeline and cost",
            "question": "How do you think the adoption of AlphaFold 3 in the drug discovery process will affect the overall timeline and cost of bringing new drugs to market?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.pharmavoice.com/news/google-alphafold-3-drug-discovery-pharma-buzz/716496/",
          "description": "The \u201cNobel Prize-worthy invention\u201d could be worth hundreds of billions commercially \u2014 and have a deep impact on drug R&D.",
          "snippets": [
            "The \u201cNobel Prize-worthy invention\u201d could be worth hundreds of billions commercially \u2014 and have a deep impact on drug R&D. ... This audio is auto-generated. Please let us know if you have feedback. The artificial intelligence program AlphaFold 3, rolled out by Google DeepMind and Isomorphic Labs earlier this month, has been called \u201cgroundbreaking,\u201d holding transformative potential in drug discovery.",
            "And while AlphaFold 3 could identify promising compounds faster, the usual hurdles to market will remain. \u201cThis isn't necessarily a Holy Grail to instantly make the drug development process more successful,\u201d Bangert said. \u201cYou're still going to have the traditional challenges, but this is a piece of that puzzle that's fitting better now.\u201d \u00b7 AI has secured a footing in drug discovery.",
            "It\u2019s hard to find the downside of AlphaFold 3, Bangert said. \u201cThis is actually one of those rare examples where I genuinely can't think of a drawback, mainly because this protein folding problem is so early in the process of drug development,\u201d he said. \u201cThis is prior to doing any chemical experimentation, certainly prior to any kind of clinical trials, that even if you did make a mistake, it wouldn't matter because you wouldn't be impacting anything.",
            "\u201cSo far, millions of researchers globally have used AlphaFold 2 to make discoveries in areas including malaria vaccines, cancer treatments, and enzyme design,\u201d according to the Google AlphaFold 3 announcement. \u201cAlphaFold has been cited more than 20,000 times and its scientific impact recognized through many prizes, most recently the Breakthrough Prize in Life Sciences.\u201d"
          ],
          "title": "Why AlphaFold 3 is stirring up so much buzz in pharma | PharmaVoice",
          "meta": {
            "query": "AlphaFold 3 adoption impact on drug discovery timeline and cost",
            "question": "How do you think the adoption of AlphaFold 3 in the drug discovery process will affect the overall timeline and cost of bringing new drugs to market?",
            "placement": "root -> Adoption Impact -> AlphaFold 3 adoption impact on drug discovery timeline and cost"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.nature.com/articles/d41586-024-01383-z",
          "description": "Latest version of the AI models how proteins interact with other molecules \u2014 but DeepMind restricts access to the tool.",
          "snippets": [
            "Latest version of the AI models how proteins interact with other molecules \u2014 but DeepMind restricts access to the tool. Latest version of the AI models how proteins interact with other molecules \u2014 but DeepMind restricts access to the tool.",
            "Nature - Latest version of the AI models how proteins interact with other molecules \u2014 but DeepMind restricts access to the tool.",
            "Since the powerhouse artificial intelligence (AI) tool AlphaFold2 was released in 2021, scientists have used the protein-structure-prediction model to map one of our cells\u2019 biggest machines, discover drugs and chart the universe of every known protein."
          ],
          "title": "Major AlphaFold upgrade offers boost for drug discovery",
          "meta": {
            "query": "AlphaFold 3 adoption impact on drug discovery timeline and cost",
            "question": "How do you think the adoption of AlphaFold 3 in the drug discovery process will affect the overall timeline and cost of bringing new drugs to market?",
            "placement": "root -> Adoption Impact -> AlphaFold 3 adoption impact on drug discovery timeline and cost"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11292590/",
          "description": "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor AlphaFold ...",
          "snippets": [
            "This expansion is crucial for drug discovery as it includes many drugs under the ligand category. Additionally, AlphaFold 3 can model chemical modifications to these molecules, which play a significant role in the healthy functioning of cells. Disruptions in these processes can lead to disease, thus highlighting the model's potential in understanding and addressing medical conditions [9-11]. Impact on Drug Discovery and Biological Understanding",
            "Researchers are excited about the prospect of speedier drug discovery, facilitated by the greater range of predictive abilities offered by AlphaFold 3 . ... To maximize the impact of AlphaFold 3 on scientific research and drug discovery, its capabilities are made accessible to scientists through the AlphaFold Server.",
            "This section delves into the core of AlphaFold 3's capabilities, shedding light on its profound impact on our understanding of biomolecular interactions . ... AlphaFold 3's methodology allows for the generation of joint 3D structures of molecules, facilitating a comprehensive view of how various biomolecules, including proteins, DNA, RNA, and ligands, interact within a cellular context. This capability is crucial for drug discovery, as many drugs fall under the ligand category.",
            "By integrating these advanced predictive tools, AlphaFold 3 not only streamlines the drug discovery process but also opens up new possibilities for innovative therapeutic approaches, ultimately aiming to improve patient outcomes and advance the field of medical science. ... AlphaFold's capabilities extend into the realm of viral research, significantly impacting the development of therapies."
          ],
          "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
          "meta": {
            "query": "AlphaFold 3 adoption impact on drug discovery timeline and cost",
            "question": "How do you think the adoption of AlphaFold 3 in the drug discovery process will affect the overall timeline and cost of bringing new drugs to market?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
          "description": "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor ...",
          "snippets": [
            "This expansion is crucial for drug discovery as it includes many drugs under the ligand category. Additionally, AlphaFold 3 can model chemical modifications to these molecules, which play a significant role in the healthy functioning of cells. Disruptions in these processes can lead to disease, thus highlighting the model's potential in understanding and addressing medical conditions [9-11]. Impact on Drug Discovery and Biological Understanding",
            "Researchers are excited about the prospect of speedier drug discovery, facilitated by the greater range of predictive abilities offered by AlphaFold 3 . ... To maximize the impact of AlphaFold 3 on scientific research and drug discovery, its capabilities are made accessible to scientists through the AlphaFold Server.",
            "This section delves into the core of AlphaFold 3's capabilities, shedding light on its profound impact on our understanding of biomolecular interactions . ... AlphaFold 3's methodology allows for the generation of joint 3D structures of molecules, facilitating a comprehensive view of how various biomolecules, including proteins, DNA, RNA, and ligands, interact within a cellular context. This capability is crucial for drug discovery, as many drugs fall under the ligand category.",
            "By integrating these advanced predictive tools, AlphaFold 3 not only streamlines the drug discovery process but also opens up new possibilities for innovative therapeutic approaches, ultimately aiming to improve patient outcomes and advance the field of medical science. ... AlphaFold's capabilities extend into the realm of viral research, significantly impacting the development of therapies."
          ],
          "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
          "meta": {
            "query": "AlphaFold 3 adoption impact on drug discovery timeline and cost",
            "question": "How do you think the adoption of AlphaFold 3 in the drug discovery process will affect the overall timeline and cost of bringing new drugs to market?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.labiotech.eu/in-depth/alpha-fold-3-drug-discovery/",
          "description": "Find out how Google DeepMind's AlphaFold3 platform could help scientists revolutionize the field of drug discovery.",
          "snippets": [
            "The sheer potential of DeepMind\u2019s AlphaFold technology, reinforced by the awarding of the 2024 Nobel Prize in Chemistry to its developers Demis Hassabis and John Jumper, shows just how much of an impact AI can really have on molecular biology and overall drug development.",
            "Ultimately, AlphaFold3\u2019s impact on drug discovery and development is expected to be substantial.",
            "Building on the foundations of its hugely successful AlphaFold2, which made a fundamental breakthrough in protein structure prediction in 2020, Google DeepMind and its sister company Isomorphic Labs launched AlphaFold3 in May.",
            "After controversially withholding the code for six months, DeepMind finally \u2013 and somewhat unexpectedly \u2013 open-sourced its platform early last week, meaning academic researchers all over the world can access both the code and training weights for the first time for non-commercial applications. This decision marks a significant advance that could massively accelerate scientific discovery and drug development. So, with the already unavoidable acclaim for AlphaFold3, can the platform really usher in a new era for drug discovery and molecular biology?"
          ],
          "title": "AlphaFold3: Revolutionizing drug discovery and development",
          "meta": {
            "query": "AlphaFold 3 adoption impact on drug discovery timeline and cost",
            "question": "How do you think the adoption of AlphaFold 3 in the drug discovery process will affect the overall timeline and cost of bringing new drugs to market?",
            "placement": "root -> Adoption Impact -> AlphaFold 3 adoption impact on drug discovery timeline and cost"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://news.mit.edu/2022/alphafold-potential-protein-drug-0906",
          "description": "Using protein structures generated by the AI software AlphaFold, MIT researchers investigated whether existing computational models could identify the mechanisms of action of antibacterial compounds.",
          "snippets": [
            "Caption: Using protein structures generated by the AI software AlphaFold, MIT researchers investigated whether existing computational models could identify the mechanisms of action of antibacterial compounds.",
            "A new study from MIT reveals the potential and limitations of one such computational approach. Using protein structures generated by an artificial intelligence program called AlphaFold, the researchers explored whether existing models could accurately predict the interactions between bacterial proteins and antibacterial compounds.",
            "In their new study, the researchers were able to improve the performance of these types of models, known as molecular docking simulations, by applying machine-learning techniques to refine the results. However, more improvement will be necessary to fully take advantage of the protein structures provided by AlphaFold, the researchers say.",
            "AlphaFold, an AI software developed by DeepMind and Google, has accurately predicted protein structures from their amino acid sequences."
          ],
          "title": "Analyzing the potential of AlphaFold in drug discovery | MIT News ...",
          "meta": {
            "query": "AlphaFold 3 adoption impact on drug discovery timeline and cost",
            "question": "How do you think the adoption of AlphaFold 3 in the drug discovery process will affect the overall timeline and cost of bringing new drugs to market?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.nature.com/articles/d41586-023-02984-w",
          "description": "Nature - Questions remain about whether the AI tool for predicting protein structures can really shake up the pharmaceutical industry.",
          "snippets": [
            "Questions remain about whether the AI tool for predicting protein structures can really shake up the pharmaceutical industry. Questions remain about whether the AI tool for predicting protein structures can really shake up the pharmaceutical industry.",
            "After Google Deepmind\u2019s AlphaFold proved that it could predict the 3D shapes of proteins with high accuracy in 2020, chemists became excited about the promise of using the open-source artificial-intelligence (AI) programme to discover drugs more quickly and cheaply."
          ],
          "title": "AlphaFold touted as next big thing for drug discovery \u2014 but is it?",
          "meta": {
            "query": "AlphaFold 3 adoption impact on drug discovery timeline and cost",
            "question": "How do you think the adoption of AlphaFold 3 in the drug discovery process will affect the overall timeline and cost of bringing new drugs to market?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.isomorphiclabs.com/articles/rational-drug-design-with-alphafold-3",
          "description": "We are reimagining the entire drug discovery process from first principles with an AI-first approach.",
          "snippets": [
            "This builds upon Google DeepMind\u2019s foundational work of predicting the structure of proteins with AlphaFold 2, to now include how multiple proteins, DNA, RNA, and small molecule ligands come together and interact, as well as predicting the structural impact of post-translational modifications and ions on these molecular systems. This model is a powerful unified framework for structure prediction, encompassing unprecedented breadth and accuracy. ... This breakthrough opens up exciting possibilities for drug discovery, allowing us to rationally develop therapeutics against targets that were previously difficult or deemed intractable to modulate.",
            "To demonstrate the potential for rational structure-based drug design with AlphaFold 3, we examined TIM-3, an immune checkpoint protein identified as a potential target for cancer immunotherapy following a 2021 publication. ... The study focused on the discovery and design of small molecules capable of binding TIM-3 with high affinity.",
            "We used the raw sequence of the protein, and the SMILES representation of each ligand, without giving AlphaFold 3 any additional information about the pose, structure, or pocket. Excitingly, the predicted structures were in agreement with the published experimental structures. The pocket discovered by the study was also found by AlphaFold 3.",
            "But AlphaFold 3 is one of the many AI-powered breakthroughs we\u2019re working on which are needed to transform drug discovery - structural understanding is just a part of the picture. We\u2019re combining AlphaFold 3 with our other proprietary AI models in our platform that help us understand more about the properties, function, and dynamics of molecular systems."
          ],
          "title": "Rational drug design with AlphaFold 3 - Isomorphic Labs",
          "meta": {
            "query": "AlphaFold 3 adoption impact on drug discovery timeline and cost",
            "question": "How do you think the adoption of AlphaFold 3 in the drug discovery process will affect the overall timeline and cost of bringing new drugs to market?",
            "placement": "root -> Adoption Impact -> AlphaFold 3 adoption impact on drug discovery timeline and cost"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.analyticsvidhya.com/blog/2024/05/deepmind-ai-alphafold/",
          "description": "AlphaFold 3, the AI revolutionizing molecular understanding beyond proteins. Explore its power to predict DNA, RNA, and drug structures!",
          "snippets": [
            "AlphaFold 3\u2019s impact goes far beyond predicting molecule shapes. It can potentially revolutionize various fields, accelerate research, and raise ethical considerations.",
            "AlphaFold 3 is a giant leap forward in understanding the building blocks of life. Developed by DeepMind (a subsidiary of Alphabet), it\u2019s an AI model that can predict the 3D structures of various molecules, not just proteins, like its predecessor, AlphaFold 2.",
            "Deep Learning (The Secret Weapon): Deep learning is a special type of AI technique that allows AlphaFold 3 to learn independently. Think of it like giving the student tons of practice problems to solve. By analyzing vast amounts of data on known protein structures, AlphaFold 3 can identify hidden rules and relationships.",
            "DNA: The blueprint of life, holding the genetic code within its double helix structure. AlphaFold 3 can predict this complex shape, providing insights into how DNA interacts with proteins and regulates cellular processes."
          ],
          "title": "AlphaFold 3 Will Change the Biological World and Drug Discovery",
          "meta": {
            "query": "AlphaFold 3 adoption impact on drug discovery timeline and cost",
            "question": "How do you think the adoption of AlphaFold 3 in the drug discovery process will affect the overall timeline and cost of bringing new drugs to market?",
            "placement": "root -> Adoption Impact -> AlphaFold 3 adoption impact on drug discovery timeline and cost"
          },
          "citation_uuid": -1
        }
      ],
      "cited_info": null
    }
  ],
  "experts": [
    {
      "topic": "AlphaFold 3",
      "role_name": "Pharmaceutical company representative",
      "role_description": "A representative from a pharmaceutical company that has partnered with AlphaFold 3, such as Isomorphic Labs, Eli Lilly, or Novartis. They will share insights on how partnerships with AlphaFold 3 have accelerated their drug design processes, led to the development of innovative treatments, and the impact on their research collaborations."
    },
    {
      "topic": "AlphaFold 3",
      "role_name": "Biomedical researcher specializing in protein structure prediction",
      "role_description": "An expert in the field of protein structure prediction who can provide technical insights into the use of AlphaFold 3. They will focus on the expanded training data of AlphaFold 3, the accuracy and scope of protein structure predictions, and the implications of predicting complex biomolecular structures. They will also discuss how partnerships with pharmaceutical companies can further enhance drug discovery efforts."
    }
  ],
  "knowledge_base": {
    "topic": "AlphaFold 3",
    "tree": {
      "name": "root",
      "content": [
        39,
        40,
        41,
        42,
        43,
        44,
        45,
        46,
        47
      ],
      "children": [
        {
          "name": "History",
          "content": [],
          "children": [
            {
              "name": "Development",
              "content": [
                1,
                2,
                3,
                4,
                5,
                6,
                7,
                8,
                9,
                10
              ],
              "children": [],
              "parent": "History",
              "synthesize_output": "AlphaFold 3, developed by Google DeepMind and Isomorphic Labs, represents a significant advancement in the field of computational structural biology[10]. Building on previous models, AlphaFold 3 was launched in May and is capable of predicting the structure and interactions of a wide range of biomolecules, including proteins, DNA, RNA, and small molecules such as ligands[6].\n\nIn order to expand the capabilities of AlphaFold 3 to predict complex biomolecular structures, the development team significantly increased the amount and diversity of data used to train the model. This allowed AlphaFold 3 to accurately predict protein-molecule complexes containing various molecular types found in the Protein Data Bank[3]. The model code and weights for AlphaFold 3 were made available for academic use in November 2024 to further advance research in the field[4].\n\nThe development of AlphaFold 3 has revolutionized research by simplifying the prediction of 3D protein structures and interactions, including scenarios where a protein is bound to another molecule[7]. The model's ability to predict a wide range of biomolecular complexes has the potential to streamline drug discovery processes and accelerate scientific breakthroughs in life science research[5][8].\n\nDespite initial criticism for limited access to the model code, AlphaFold 3 has garnered praise for its groundbreaking technology and transformative potential in various research fields[9]. The AI program's ability to predict complex biomolecular structures with high accuracy has positioned AlphaFold 3 as a leading tool in computational structural biology[1].",
              "need_regenerate_synthesize_output": false
            },
            {
              "name": "Milestones",
              "content": [
                16
              ],
              "children": [],
              "parent": "History",
              "synthesize_output": "Milestones\n\nAlphaFold 3 has achieved increased predictive accuracy through advancements in data training methods[16]. The modified residues dataset used in AlphaFold 3 is filtered similarly to other polymer test sets, containing only modified residues in polymer chains with low homology to the training set. This approach has led to improved protein complex accuracy relative to previous versions such as AlphaFold-Multimer (v.2.3). Additionally, the model has shown enhanced capabilities in predicting protein, DNA, and RNA structures with covalent modifications, including the impact of phosphorylation on predictions. These advancements in data training methods have contributed significantly to the improved predictive accuracy of AlphaFold 3.",
              "need_regenerate_synthesize_output": false
            }
          ],
          "parent": "root",
          "synthesize_output": null,
          "need_regenerate_synthesize_output": true
        },
        {
          "name": "Impact",
          "content": [],
          "children": [
            {
              "name": "Scientific community",
              "content": [],
              "children": [
                {
                  "name": "How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry?",
                  "content": [],
                  "children": [
                    {
                      "name": "Partnerships for AlphaFold 3 Integration",
                      "content": [
                        73,
                        74,
                        75,
                        76
                      ],
                      "children": [],
                      "parent": "How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry?",
                      "synthesize_output": "Partnerships for AlphaFold 3 Integration\n\nIsomorphic Labs has been actively leveraging AlphaFold 3 through strategic collaborations with pharmaceutical partners to enhance drug design processes[73]. This partnership approach not only accelerates drug development cycles but also ensures that new treatments are both innovative and effective, addressing previously intractable disease targets.\n\nStartups with roughly $5\u201310 million in VC funding have been able to develop new drugs thanks to AlphaFold, covering the costs of infrastructure, talent acquisition, and initial research[74]. On the other hand, Big Pharma companies tend to accumulate vast datasets over the years while forging partnerships with organizations, highlighting the broad impact of these collaborations on the industry.\n\nIn addition to these partnerships, Isomorphic Labs has actively participated in community-wide forums and discussions ahead of AlphaFold 3\u2019s launch[75]. The company's ongoing commitment is reflected in the AlphaFold Server, which provides a free database of 200 million protein structures. Moreover, Isomorphic Labs is expanding its free AlphaFold education online course in collaboration with EMBL-EBI and other organizations in the Global South to equip scientists with the necessary tools for accelerated adoption and research in areas such as neglected diseases and food security.\n\nThe withholding of the code for AlphaFold 3 was primarily driven by commercial reasons, as Isomorphic Labs is using AlphaFold3 internally to speed up its drug discovery efforts and has established partnerships potentially worth $3 billion with Eli Lilly and Novartis for the development of multiple drugs[76]. These partnerships showcase the significant impact of integrating AlphaFold 3 into drug design processes through collaborations with industry leaders.",
                      "need_regenerate_synthesize_output": false
                    },
                    {
                      "name": "Strategies for AlphaFold 3 Integration",
                      "content": [
                        77,
                        78,
                        79,
                        80,
                        81
                      ],
                      "children": [],
                      "parent": "How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry?",
                      "synthesize_output": "AlphaFold 3 has implemented several strategies to enhance its integration into the scientific community and drug discovery processes. One key strategy is the development of the AlphaFold Server, which allows scientists to access the majority of its capabilities for free. This user-friendly research tool enables researchers to leverage AlphaFold 3's advanced capabilities in predicting protein structures with high accuracy[78].\n\nAdditionally, AlphaFold 3 has expanded its capabilities to predict the structures of a wide range of biomolecules beyond just proteins. By training the model on a diverse dataset that includes DNA, RNA, small molecules, and more, AlphaFold 3 has significantly increased its versatility in predicting the complex 3D structures of various biomolecules[80].\n\nMoreover, the introduction of AlphaFold 21 has revolutionized the field of protein structure prediction and modeling. The updated diffusion-based architecture of AlphaFold 3 allows for the prediction of joint structures of complexes involving proteins, nucleic acids, small molecules, ions, and modified residues. This advancement has opened up a vast array of applications in protein modeling and design, further enhancing the utility of AlphaFold 3 in scientific research and drug development[81].",
                      "need_regenerate_synthesize_output": false
                    },
                    {
                      "name": "Implications of AlphaFold 3 on Protein Design",
                      "content": [
                        59,
                        60,
                        61,
                        62,
                        63
                      ],
                      "children": [],
                      "parent": "How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry?",
                      "synthesize_output": "AlphaFold 3's enhanced predictive accuracy has significant implications for designing novel proteins with improved stability and functionality. The updated diffusion-based architecture of AlphaFold 3 allows for the prediction of complex structures involving proteins, nucleic acids, small molecules, ions, and modified residues[59]. This advancement enables researchers to gain detailed insights into how molecules interact and influence biological functions, paving the way for groundbreaking advancements in medical science and research[61].\n\nFurthermore, the inclusion of metagenomic data in AlphaFold 3 has improved the quality of predictions, particularly in predicting mutations that affect protein structure, which is crucial for gaining insights into human genetic diseases and improving disease management and prediction[60]. By accurately modeling large biomolecules such as proteins, DNA, RNA, and small molecules, AlphaFold 3 can reveal how these molecules fit together and how chemical modifications control the healthy functioning of cells, ultimately leading to the potential for improved treatments, especially in understanding immune-system processes related to coronaviruses like COVID-19[62].",
                      "need_regenerate_synthesize_output": false
                    }
                  ],
                  "parent": "Scientific community",
                  "synthesize_output": null,
                  "need_regenerate_synthesize_output": true
                },
                {
                  "name": "Benefits of AlphaFold 3 in drug discovery",
                  "content": [],
                  "children": [
                    {
                      "name": "Impact on protein engineering and design",
                      "content": [
                        58
                      ],
                      "children": [],
                      "parent": "Benefits of AlphaFold 3 in drug discovery",
                      "synthesize_output": "AlphaFold 3's enhanced predictive accuracy and expanded capabilities have the potential to greatly impact the field of protein engineering and design. By providing more accurate and reliable structural information for designing novel proteins with specific functions[58], AlphaFold 3 can revolutionize the process of protein engineering.\n\nWith the ability to predict the 3D coordinates of non-hydrogen atoms for various biomolecules, including proteins, DNA, RNA, and small molecules, AlphaFold 3 enables researchers to have a better understanding of protein interactions and structural features. This newfound knowledge can lead to the design of proteins with improved stability, functionality, and specificity, which is crucial for developing new therapeutic agents, enzymes, and biomaterials.\n\nBy leveraging AlphaFold 3's advancements in biomolecular structure prediction, protein engineers can accelerate the process of designing custom proteins tailored for specific applications in biotechnology, medicine, and other fields. The superior accuracy and speed of AlphaFold 3 make it a powerful tool for protein engineers looking to push the boundaries of protein design and create innovative solutions for various industries.",
                      "need_regenerate_synthesize_output": false
                    },
                    {
                      "name": "Accelerating drug discovery processes",
                      "content": [
                        67,
                        68,
                        69,
                        70,
                        71,
                        72
                      ],
                      "children": [],
                      "parent": "Benefits of AlphaFold 3 in drug discovery",
                      "synthesize_output": "AlphaFold 3 has the potential to significantly accelerate drug discovery processes and identify new disease targets in the pharmaceutical industry. The model goes beyond predicting the structure of proteins to include how multiple proteins, DNA, RNA, and small molecule ligands interact, as well as the structural impact of post-translational modifications and ions on these molecular systems[67].\n\nThis expanded capability is crucial for drug discovery, as it encompasses many drugs under the ligand category and can model chemical modifications to these molecules that are essential for healthy cellular functioning[69]. The insights provided by AlphaFold 3 enable scientists to understand how molecules are interconnected and how these connections influence biological functions, such as drug actions, hormone production, and DNA repair processes[68].\n\nFurthermore, the creation of Isomorphic Labs by Google's parent company Alphabet, which takes an AI-first approach to drug discovery, underscores the potential impact of AlphaFold 3 on accelerating the drug development process. Researchers at Isomorphic Labs have contributed to the development of AlphaFold 3 and will have exclusive access to the model for commercial use, emphasizing its significance in advancing pharmaceutical research[70].\n\nDespite the challenges and costs associated with developing this technology, AlphaFold 3 offers a more cost-effective alternative to traditional methods in medicinal chemistry. This game-changing technology is poised to revolutionize drug discovery by providing unprecedented insights into molecular structures and interactions, ultimately facilitating the development of novel therapeutics[71].",
                      "need_regenerate_synthesize_output": false
                    },
                    {
                      "name": "Integration in drug discovery process",
                      "content": [
                        17,
                        18,
                        19,
                        20,
                        21
                      ],
                      "children": [],
                      "parent": "Benefits of AlphaFold 3 in drug discovery",
                      "synthesize_output": "Integration in drug discovery process\n\nAlphaFold 3 has the potential to revolutionize the drug discovery process in the pharmaceutical industry by addressing challenges and limitations, ensuring broader benefits for the scientific community[17]. By significantly reducing drug discovery time through simulating and predicting the action of substances on proteins, AlphaFold 3 can expedite the development of drugs for currently untreatable diseases, potentially leading to their cure[20]. This groundbreaking technology offers a transformative shift in drug discovery, particularly with its ability to predict interactions at the atomic level, making it a game-changing advancement in medicinal chemistry[18].\n\nBuilding upon the foundational work of predicting protein structures with AlphaFold 2, AlphaFold 3 now includes the prediction of how multiple proteins, DNA, RNA, and small molecule ligands interact, as well as predicting the structural impact of post-translational modifications and ions on these molecular systems[19]. This unified framework for structure prediction offers unprecedented breadth and accuracy, opening up exciting possibilities for drug discovery. It allows researchers to rationally develop therapeutics against targets that were previously challenging or deemed intractable to modulate[19].",
                      "need_regenerate_synthesize_output": false
                    }
                  ],
                  "parent": "Scientific community",
                  "synthesize_output": "AlphaFold 3 offers significant benefits in the field of drug discovery. By integrating this revolutionary technology into the drug discovery process, AlphaFold 3 has the potential to transform medical science and research, benefiting a broader spectrum of the scientific community[17]. The integration of AlphaFold 3 into drug discovery processes signifies a transformative shift, particularly with its ability to predict interactions at the atomic level[17].\n\nDespite the challenges and costs of building the necessary foundation, AlphaFold is significantly less expensive than traditional methods in medicinal chemistry, making it a game-changing technology in drug discovery[18]. This technology builds upon Google DeepMind's foundational work of predicting protein structures with AlphaFold 2, now expanding to predict how multiple proteins, DNA, RNA, and small molecule ligands interact. This breakthrough allows for the rational development of therapeutics against previously difficult targets, opening up exciting possibilities for drug discovery[19].\n\nAlphaFold 3 can drastically reduce drug discovery time by simulating and predicting the action of substances on proteins, leading to the development of drugs for currently untreatable diseases[20]. Additionally, the integration of AlphaFold 3 in drug discovery processes holds transformative potential, making it a groundbreaking technology in the field[21].",
                  "need_regenerate_synthesize_output": true
                }
              ],
              "parent": "Impact",
              "synthesize_output": null,
              "need_regenerate_synthesize_output": true
            },
            {
              "name": "Drug discovery",
              "content": [
                65,
                66,
                22,
                23,
                24,
                25
              ],
              "children": [],
              "parent": "Impact",
              "synthesize_output": "AlphaFold 3's integration into the drug discovery process within the pharmaceutical industry has the potential to revolutionize the field. By making its capabilities accessible through the AlphaFold Server, scientists can leverage the model's predictive abilities for free, facilitating research and development efforts[22][25]. Isomorphic Labs, in collaboration with pharmaceutical companies, is already applying AlphaFold 3 to real-world drug design challenges, with the goal of developing innovative treatments that could significantly impact patients' lives[22][25].\n\nDespite the commercial restrictions that currently limit pharmaceutical applications, DeepMind's decision to make AlphaFold 3 open-source will undoubtedly advance academic research and enhance scientists' understanding of disease mechanisms and drug interactions[23]. The platform's advanced tools are particularly valuable in overcoming data challenges related to integrity and interoperability, albeit requiring meticulous attention to detail and significant capital investment[24].\n\nAlphaFold 3's capabilities, as detailed in the journal Nature, have the potential to expedite the identification of promising drug targets, potentially reducing time-to-market significantly[65]. By accurately predicting 3-D protein structures, AlphaFold 3 aids in understanding how shape influences protein function, a critical aspect in disease identification and drug development[65]. Isomorphic Labs, utilizing AlphaFold 3 alongside in-house AI models, is actively involved in accelerating drug design processes for both internal projects and collaborations with pharmaceutical partners[66]. The integration of AlphaFold 3 not only accelerates the identification of new disease targets but also enhances the success rate of drug design efforts, paving the way for the development of novel treatment approaches[66].",
              "need_regenerate_synthesize_output": false
            }
          ],
          "parent": "root",
          "synthesize_output": null,
          "need_regenerate_synthesize_output": true
        },
        {
          "name": "Ethical Concerns",
          "content": [
            26,
            27,
            28,
            29,
            30
          ],
          "children": [],
          "parent": "root",
          "synthesize_output": "Ethical Concerns\n\nThe limited and proprietary nature of AlphaFold's accessibility raises concerns regarding equitable access to cutting-edge technology[26]. Such restrictions can impact scientific transparency and public accountability, which are crucial for the advancement and democratization of scientific research. Researchers and policymakers must work together to establish guidelines and regulations that mitigate the risks associated with the misuse of AlphaFold 3[27]. This includes implementing safeguards to prevent the technology from falling into the wrong hands and promoting ethical research practices. Developed with Isomorphic Labs, a sister company of Alphabet, the software is accessible through the AlphaFold Server for global non-commercial research, but AlphaFold 3 will not be open-sourced like its predecessors[28]. One major ethical concern is the potential for bias in AI models. AlQuraishi also mentioned that independently reproducing AlphaFold 3 would be highly valuable to permit training new variants of the system, including potentially training on private data repositories[30]. By addressing these challenges and limitations, the potential of AlphaFold 3 in transforming medical science and research can be more fully realized, ensuring that this revolutionary technology benefits a broader spectrum of the scientific community.",
          "need_regenerate_synthesize_output": false
        },
        {
          "name": "Comparisons",
          "content": [
            32,
            33,
            34,
            35,
            36,
            31
          ],
          "children": [
            {
              "name": "AlphaFold 3 vs previous versions data training methods",
              "content": [
                37,
                38
              ],
              "children": [],
              "parent": "Comparisons",
              "synthesize_output": "AlphaFold 3 differs from its predecessors, such as AlphaFold 2, in terms of data training methods and predictive accuracy. While DeepMind has not released the training data or procedures for AlphaFold 2, the team vastly expanded the data that AlphaFold 3 was trained on to include DNA, RNA, small molecules, and more[37]. This approach allowed AlphaFold 3 to train on a wider range of biomolecules, enhancing its predictive accuracy. Additionally, in mid-May, researchers at Columbia University published OpenFold, an open-source equivalent to AlphaFold 2 that includes the training data and procedures, providing a valuable resource for the scientific community[38].",
              "need_regenerate_synthesize_output": false
            },
            {
              "name": "AlphaFold 3 vs previous versions predictive accuracy comparison",
              "content": [
                64
              ],
              "children": [],
              "parent": "Comparisons",
              "synthesize_output": "AlphaFold 3, developed by Isomorphic Labs, has significantly enhanced predictive accuracy compared to its previous versions. By utilizing AlphaFold 3, researchers are able to accelerate and improve the success of drug design by gaining a deeper understanding of how to approach new disease targets and by developing novel ways to pursue existing targets that were previously challenging to tackle[64].\n\nOne of the specific implications of AlphaFold 3's improved predictive accuracy is its impact on designing novel proteins with enhanced stability and functionality. For example, AlphaFold 3's prediction for a molecular complex featuring a protein, a strand of RNA, and two ions closely matched the true structure. This level of accuracy opens up new possibilities for designing proteins that are not only structurally sound but also optimized for specific functions, leading to advancements in drug discovery and development[64].",
              "need_regenerate_synthesize_output": false
            }
          ],
          "parent": "root",
          "synthesize_output": "AlphaFold 3, the latest version of the biomolecular structure predictor artificial intelligence model developed by Google DeepMind Technologies Limited, has showcased significant improvements in accuracy and predictive power compared to its predecessors [31]. One key aspect that sets AlphaFold 3 apart from its previous versions is its enhanced data training methods. AlphaFold 3 utilizes a neural network approach to directly predict the 3D coordinates of all non-hydrogen atoms for a given protein, using the protein sequence and sequence homology [32]. This updated version of AlphaFold was trained on a significantly larger dataset, including DNA, RNA, small molecules, and more, in order to expand its capabilities to predict the structures of a wider range of biomolecules [37].\n\nIn terms of predictive accuracy, AlphaFold 3 has shown remarkable advancements. The model can now predict the structure of almost all biomolecules, including protein-nucleic acid complexes and protein-small molecule complexes, with higher accuracy compared to traditional docking programs [34]. In interactions of proteins with other molecule types, AlphaFold 3 has demonstrated at least a 50% improvement over existing prediction methods, doubling prediction accuracy in some important categories of interaction [35]. Additionally, when measured by the root-mean-square deviation (RMS-D) of the placement of alpha-carbon atoms of the protein backbone chain, AlphaFold 3 has achieved impressive results, with a significant percentage of predictions achieving high accuracy levels [36].\n\nWhile previous versions of AlphaFold have also been highly successful, AlphaFold 3's advancements in data training methods and predictive accuracy have positioned it as a cutting-edge tool in the field of biomolecular structure prediction. The continued evolution of AlphaFold technology holds great promise for transforming our understanding of the biological world and enhancing drug discovery efforts [35].",
          "need_regenerate_synthesize_output": false
        },
        {
          "name": "Adoption Impact",
          "content": [],
          "children": [
            {
              "name": "AlphaFold 3 adoption impact on drug discovery timeline and cost",
              "content": [
                53,
                54,
                55,
                56,
                57
              ],
              "children": [],
              "parent": "Adoption Impact",
              "synthesize_output": "The adoption of AlphaFold 3 in the drug discovery process is expected to have a significant impact on the overall timeline and cost of bringing new drugs to market. The artificial intelligence program, developed by Google DeepMind and Isomorphic Labs, has been described as \"groundbreaking\" and holds transformative potential in drug discovery[53].\n\nAlphaFold 3 builds upon the foundational work of predicting protein structures with AlphaFold 2 and now includes modeling how proteins interact with other molecules, DNA, RNA, small molecule ligands, and predicting the structural impact of post-translational modifications and ions on molecular systems[56]. This advanced model provides unprecedented breadth and accuracy in structure prediction, allowing for the rational development of therapeutics against previously difficult or intractable targets in drug discovery.\n\nThe sheer potential of AlphaFold technology was recognized with the awarding of the 2024 Nobel Prize in Chemistry to its developers, Demis Hassabis and John Jumper, highlighting the significant impact AI can have on molecular biology and drug development[55]. Furthermore, AlphaFold 3's impact extends beyond predicting molecule shapes and has the potential to revolutionize various fields, accelerate research, and raise ethical considerations[57].\n\nWith the adoption of AlphaFold 3, the drug discovery process is expected to become more efficient and effective, potentially reducing the timeline and cost associated with bringing new drugs to market. This breakthrough technology opens up exciting possibilities for developing therapeutics and targeting challenging molecular structures, ultimately leading to advancements in the pharmaceutical industry.",
              "need_regenerate_synthesize_output": false
            },
            {
              "name": "Effects of using AlphaFold 3 in drug discovery process",
              "content": [
                48,
                49,
                50,
                51,
                52
              ],
              "children": [],
              "parent": "Adoption Impact",
              "synthesize_output": "The adoption of AlphaFold 3 in the drug discovery process is poised to have significant effects on the overall timeline and cost of bringing new drugs to market. AlphaFold 3 has the capability to predict the structure of various proteins and their interactions in a matter of seconds, a task that would typically take humans years to accomplish[48]. This accelerated process can lead to quicker identification of promising compounds and potential drug candidates.\n\nOne area where AlphaFold 3 shows particular promise is in the rational design of drugs. By efficiently predicting how ligands, which are a structural component of many drugs, will bind to a target protein, AlphaFold 3 can guide researchers in designing drug candidate structures that offer improved efficacy and reduced side effects[50]. This not only speeds up the drug discovery process but also has the potential to impact the overall cost of drug development.\n\nMoreover, AlphaFold 3's ability to provide a broader understanding of the context within which drug targets operate can lead to the development of more effective drugs for clinical use. For example, in a study focusing on the immune checkpoint protein TIM-3, AlphaFold 3 was used to design small molecules capable of binding to TIM-3 with high affinity, showcasing the potential for rational structure-based drug design with this technology[49].\n\nWhile the adoption of AlphaFold 3 in drug discovery processes is promising, it is important to note that it is not a solution that will instantly make the drug development process more successful. Traditional challenges in drug development will still need to be addressed, but AlphaFold 3 provides a valuable piece of the puzzle that can contribute to more efficient and effective drug discovery[52]. Overall, the integration of AlphaFold 3 in the drug discovery process has the potential to revolutionize the field and lead to the development of novel and impactful medications.",
              "need_regenerate_synthesize_output": false
            }
          ],
          "parent": "root",
          "synthesize_output": null,
          "need_regenerate_synthesize_output": true
        },
        {
          "name": "Advancements in data training methods",
          "content": [
            11,
            12,
            13,
            14,
            15
          ],
          "children": [],
          "parent": "root",
          "synthesize_output": "Advancements in data training methods have played a crucial role in enhancing the predictive accuracy of AlphaFold 3. In order to widen the range of biomolecules that the model can predict, the AlphaFold team significantly expanded the data used for training the newer model to include DNA, RNA, small molecules, and more[11]. This approach allowed the model to be trained on a more diverse set of molecular structures, leading to improved accuracy in predicting the structures of complexes formed by proteins with DNA, RNA, ligands, and ions[12].\n\nThe introduction of AlphaFold 3 brought about a revolution in protein structure modeling and design, enabling a wide range of applications in this field[13]. The model features a substantially updated diffusion-based architecture that can predict the joint structure of complexes involving proteins, nucleic acids, small molecules, ions, and modified residues. To address the issue of hallucination in generative models, a cross-distillation method was implemented to augment the training data with predicted structures, resulting in the development of AlphaFold-Multimer (v.2.3)[14].\n\nRecent advancements in machine learning methods and algorithmic approaches have also contributed to the improved accuracy of protein structure prediction models like AlphaFold 3. The latest version of the AlphaFold model, known as \"AlphaFold-latest,\" has expanded on the functionalities of its predecessor, AlphaFold 2, showcasing the ongoing progress in the field of protein structure prediction[15].",
          "need_regenerate_synthesize_output": false
        }
      ],
      "parent": null,
      "synthesize_output": "A wide range of predictors for various specific interaction types has been developed, as well as one generalist method developed concurrently with the present work, but the accuracy of such deep-learning attempts has been mixed and often below that of physics-inspired methods[1]. AlphaFold has revealed millions of intricate 3D protein structures, and is helping scientists understand how all of life\u2019s molecules interact[2]. \u201cAny user who doesn't know how to code at all can just copy and paste the sequences of their proteins, DNA, RNA or the name of their small molecule, press a button and wait a few minutes. Their structure and the confidence metrics will come out so that they're able to look at and evaluate their prediction.\u201d In order to get AlphaFold 3 to work with this much wider range of biomolecules, the team vastly expanded the data that the newer model was trained on to include DNA, RNA, small molecules and more[3].\n\nThe artificial intelligence program AlphaFold 3, rolled out by Google DeepMind and Isomorphic Labs, has been called \u201cgroundbreaking,\u201d holding transformative potential in drug discovery[4]. Instead of focusing solely on protein folding structures, AlphaFold 3 predicts the structure and interactions of all of life's molecules, including DNA, RNA, and ligands[5]. By accurately predicting protein-molecule complexes containing DNA, RNA, and more, AlphaFold 3 has revolutionized research by making it simple to predict the 3D structures of proteins and other biomolecular complexes[6].",
      "need_regenerate_synthesize_output": false
    },
    "info_uuid_to_info_dict": {
      "1": {
        "url": "https://www.nature.com/articles/s41586-024-07487-w",
        "description": "A wide range of predictors for ... present work29, but the accuracy of such deep-learning attempts has been mixed and often below that of physics-inspired methods30,31. Almost all of these methods are also highly specialized to particular interaction types and cannot predict the structure of general biomolecular complexes containing many types of entities. Here we present AlphaFold 3 (AF3)\u2014a ...",
        "snippets": [
          "A wide range of predictors for various specific interaction types has been developed16,17,18,19,20,21,22,23,24,25,26,27,28, as well as one generalist method developed concurrently with the present work29, but the accuracy of such deep-learning attempts has been mixed and often below that of physics-inspired methods30,31. Almost all of these methods are also highly specialized to particular interaction types and cannot predict the structure of general biomolecular complexes containing many types of entities. Here we present AlphaFold 3 (AF3)\u2014a model that is capable of high-accuracy prediction of complexes containing nearly all molecular types present in the Protein Data Bank32 (PDB) (Fig."
        ],
        "title": "Accurate structure prediction of biomolecular interactions with ...",
        "meta": {
          "query": "How does AlphaFold 3 work?",
          "question": "Background information about AlphaFold 3",
          "placement": "root -> History -> Development"
        },
        "citation_uuid": 1
      },
      "2": {
        "url": "https://deepmind.google/technologies/alphafold/",
        "description": "Access the AlphaFold 3 model code and weights for academic use. ... Inside every cell of your body, billions of tiny machines \u2013 proteins \u2013 are hard at work.",
        "snippets": [
          "AlphaFold has revealed millions of intricate 3D protein structures, and is helping scientists understand how all of life\u2019s molecules interact."
        ],
        "title": "AlphaFold - Google DeepMind",
        "meta": {
          "query": "How does AlphaFold 3 work?",
          "question": "Background information about AlphaFold 3",
          "placement": "root -> History -> Development"
        },
        "citation_uuid": 2
      },
      "3": {
        "url": "https://blog.google/technology/ai/how-we-built-alphafold-3/",
        "description": "\u201cAny user who doesn't know how to code at all can just copy and paste the sequences of their proteins, DNA, RNA or the name of their small molecule, press a button and wait a few minutes. Their structure and the confidence metrics will come out so that they're able to look at and evaluate their prediction.\u201d \u00b7 In order to get AlphaFold 3 to work ...",
        "snippets": [
          "\u201cAny user who doesn't know how to code at all can just copy and paste the sequences of their proteins, DNA, RNA or the name of their small molecule, press a button and wait a few minutes. Their structure and the confidence metrics will come out so that they're able to look at and evaluate their prediction.\u201d \u00b7 In order to get AlphaFold 3 to work with this much wider range of biomolecules, the team vastly expanded the data that the newer model was trained on to include DNA, RNA, small molecules and more."
        ],
        "title": "How we built AlphaFold 3 to predict the structure and interaction ...",
        "meta": {
          "query": "How does AlphaFold 3 work?",
          "question": "Background information about AlphaFold 3",
          "placement": "root -> History -> Development"
        },
        "citation_uuid": 3
      },
      "4": {
        "url": "https://www.isomorphiclabs.com/articles/alphafold-3-predicts-the-structure-and-interactions-of-all-of-lifes-molecules",
        "description": "Update November 11, 2024: As of ... 3 model code and weights for academic use to help advance research. Learn more about AlphaFold tools. ... Inside every plant, animal, and human cell are billions of molecular machines. They\u2019re made up of proteins, DNA, and other molecules, but no single piece works on its ...",
        "snippets": [
          "Update November 11, 2024: As of November 2024, we have released AlphaFold 3 model code and weights for academic use to help advance research. Learn more about AlphaFold tools. ... Inside every plant, animal, and human cell are billions of molecular machines. They\u2019re made up of proteins, DNA, and other molecules, but no single piece works on its own."
        ],
        "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
        "meta": {
          "query": "How does AlphaFold 3 work?",
          "question": "Background information about AlphaFold 3",
          "placement": "root -> History -> Development"
        },
        "citation_uuid": 4
      },
      "5": {
        "url": "https://www.pharmavoice.com/news/google-alphafold-3-drug-discovery-pharma-buzz/716496/",
        "description": "But while researchers have had ... workers to carry out earlier-stage research, the technology may reduce that need. Rather than posing a threat to existing jobs, the AI program could become a pressure release valve for an area often stretched too thin, Bangert said. Given its potential in life science research, DeepMind and Isomorphic\u2019s CEO said this month the platform could eventually be a \u201cmulti-hundred billion\u201d dollar business. And while AlphaFold 3 could identify ...",
        "snippets": [
          "But while researchers have had difficulties finding qualified workers to carry out earlier-stage research, the technology may reduce that need. Rather than posing a threat to existing jobs, the AI program could become a pressure release valve for an area often stretched too thin, Bangert said. Given its potential in life science research, DeepMind and Isomorphic\u2019s CEO said this month the platform could eventually be a \u201cmulti-hundred billion\u201d dollar business. And while AlphaFold 3 could identify promising compounds faster, the usual hurdles to market will remain."
        ],
        "title": "Why AlphaFold 3 is stirring up so much buzz in pharma | PharmaVoice",
        "meta": {
          "query": "How does AlphaFold 3 work?",
          "question": "Background information about AlphaFold 3",
          "placement": "root -> History -> Development"
        },
        "citation_uuid": 5
      },
      "6": {
        "url": "https://blog.google/technology/ai/how-we-built-alphafold-3/",
        "description": "Instead, they got started on AlphaFold 3. This newer model, which the teams at Google DeepMind and Isomorphic Labs launched in May, builds on our previous models by predicting not just protein folding structures, but predicting the structure and interactions of all of life's molecules, including ...",
        "snippets": [
          "Instead, they got started on AlphaFold 3. This newer model, which the teams at Google DeepMind and Isomorphic Labs launched in May, builds on our previous models by predicting not just protein folding structures, but predicting the structure and interactions of all of life's molecules, including DNA, RNA and ligands (small molecules that bind to proteins)."
        ],
        "title": "How we built AlphaFold 3 to predict the structure and interaction ...",
        "meta": {
          "query": "What is AlphaFold 3?",
          "question": "Background information about AlphaFold 3",
          "placement": "root -> History -> Development"
        },
        "citation_uuid": 6
      },
      "7": {
        "url": "https://www.nature.com/articles/d41586-024-01385-x",
        "description": "Deepmind\u2019s AlphaFold has revolutionized research by making it simple to predict the 3D structures of proteins, but it has lacked the ability to predict situations where a protein is bound to another molecule. Now, the AI has been upgraded to AlphaFold 3 and can accurately predict protein-molecule ...",
        "snippets": [
          "Deepmind\u2019s AlphaFold has revolutionized research by making it simple to predict the 3D structures of proteins, but it has lacked the ability to predict situations where a protein is bound to another molecule. Now, the AI has been upgraded to AlphaFold 3 and can accurately predict protein-molecule complexes containing DNA, RNA and more."
        ],
        "title": "Alphafold 3.0: the AI protein predictor gets an upgrade",
        "meta": {
          "query": "What is AlphaFold 3?",
          "question": "Background information about AlphaFold 3",
          "placement": "root -> History -> Development"
        },
        "citation_uuid": 7
      },
      "8": {
        "url": "https://www.pharmavoice.com/news/google-alphafold-3-drug-discovery-pharma-buzz/716496/",
        "description": "The \u201cNobel Prize-worthy invention\u201d could be worth hundreds of billions commercially \u2014 and have a deep impact on drug R&D.",
        "snippets": [
          "This audio is auto-generated. Please let us know if you have feedback. The artificial intelligence program AlphaFold 3, rolled out by Google DeepMind and Isomorphic Labs earlier this month, has been called \u201cgroundbreaking,\u201d holding transformative potential in drug discovery."
        ],
        "title": "Why AlphaFold 3 is stirring up so much buzz in pharma | PharmaVoice",
        "meta": {
          "query": "What is AlphaFold 3?",
          "question": "Background information about AlphaFold 3",
          "placement": "root -> History -> Development"
        },
        "citation_uuid": 8
      },
      "9": {
        "url": "https://venturebeat.com/ai/google-deepmind-open-sources-alphafold-3-ushering-in-a-new-era-for-drug-discovery-and-molecular-biology/",
        "description": "When AlphaFold 3 debuted in May, DeepMind\u2019s decision to withhold the code while offering limited access through a web interface drew criticism from researchers. The controversy exposed a key challenge in AI research: how to balance open science with commercial interests, particularly as companies like DeepMind\u2019s sister organization Isomorphic ...",
        "snippets": [
          "When AlphaFold 3 debuted in May, DeepMind\u2019s decision to withhold the code while offering limited access through a web interface drew criticism from researchers. The controversy exposed a key challenge in AI research: how to balance open science with commercial interests, particularly as companies like DeepMind\u2019s sister organization Isomorphic Labs work to develop new drugs using these advances."
        ],
        "title": "Google DeepMind open-sources AlphaFold 3, ushering in a new era ...",
        "meta": {
          "query": "What is AlphaFold 3?",
          "question": "Background information about AlphaFold 3",
          "placement": "root -> History -> Development"
        },
        "citation_uuid": 9
      },
      "10": {
        "url": "https://www.sciencedirect.com/science/article/pii/S0969212624003356",
        "description": "Computational structural biology aims to accurately predict biomolecular complexes with AlphaFold 3 spearheading the field. However, challenges loom f\u2026",
        "snippets": [
          "Author links open overlay panelToni K. Tr\u00e4ger 1 2, Christian T\u00fcting 1 2, Panagiotis L. Kastritis 1 2 3 4Show more ... Computational structural biology aims to accurately predict biomolecular complexes with AlphaFold 3 spearheading the field."
        ],
        "title": "The human touch: Utilizing AlphaFold 3 to analyze structures of ...",
        "meta": {
          "query": "What is AlphaFold 3?",
          "question": "Background information about AlphaFold 3",
          "placement": "root -> History -> Development"
        },
        "citation_uuid": 10
      },
      "11": {
        "url": "https://blog.google/technology/ai/how-we-built-alphafold-3/",
        "description": "In order to get AlphaFold 3 to work with this much wider range of biomolecules, the team vastly expanded the data that the newer model was trained on to include DNA, RNA, small molecules and more. \u201cWe were able to say, \u2018Let's just train on everything that exists in this dataset that helped ...",
        "snippets": [
          "In order to get AlphaFold 3 to work with this much wider range of biomolecules, the team vastly expanded the data that the newer model was trained on to include DNA, RNA, small molecules and more. \u201cWe were able to say, \u2018Let's just train on everything that exists in this dataset that helped us so much with proteins and let\u2019s see how far we can get,\u2019\u201d Lindsay says."
        ],
        "title": "How we built AlphaFold 3 to predict the structure and interaction ...",
        "meta": {
          "query": "Advancements in data training methods for AlphaFold 3",
          "question": "What advancements in data training methods have contributed to the increased predictive accuracy of AlphaFold 3?",
          "placement": "root -> Advancements in data training methods"
        },
        "citation_uuid": 11
      },
      "12": {
        "url": "https://en.wikipedia.org/wiki/AlphaFold",
        "description": "On 15 July 2021, the AlphaFold ... as an advance access publication alongside open source software and a searchable database of species proteomes. As of February 2025, the paper had been cited nearly 32,000 times. AlphaFold 3 was announced on 8 May 2024. It can predict the structure of complexes created by proteins with DNA, RNA, various ligands, and ions. The new prediction method shows a minimum ...",
        "snippets": [
          "On 15 July 2021, the AlphaFold 2 paper was published in Nature as an advance access publication alongside open source software and a searchable database of species proteomes. As of February 2025, the paper had been cited nearly 32,000 times. AlphaFold 3 was announced on 8 May 2024. It can predict the structure of complexes created by proteins with DNA, RNA, various ligands, and ions. The new prediction method shows a minimum 50% improvement in accuracy for protein interactions with other molecules compared to existing methods."
        ],
        "title": "AlphaFold - Wikipedia",
        "meta": {
          "query": "Advancements in data training methods for AlphaFold 3",
          "question": "What advancements in data training methods have contributed to the increased predictive accuracy of AlphaFold 3?",
          "placement": "root -> Advancements in data training methods"
        },
        "citation_uuid": 12
      },
      "13": {
        "url": "https://www.nature.com/articles/s41586-024-07487-w",
        "description": "AlphaFold 3 has a substantially updated architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and modified residues with greatly improved accuracy over many previous specialized tools.",
        "snippets": [
          "The introduction of AlphaFold 21 has spurred a revolution in modelling the structure of proteins and their interactions, enabling a huge range of applications in protein modelling and design2\u20136. Here we describe our AlphaFold 3 model with a substantially updated diffusion-based architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and modified residues."
        ],
        "title": "Accurate structure prediction of biomolecular interactions with ...",
        "meta": {
          "query": "Advancements in data training methods for AlphaFold 3",
          "question": "What advancements in data training methods have contributed to the increased predictive accuracy of AlphaFold 3?",
          "placement": "root -> Advancements in data training methods"
        },
        "citation_uuid": 13
      },
      "14": {
        "url": "https://towardsdatascience.com/how-alphafold-3-is-like-dalle-2-and-other-learnings-1f809010afc7/",
        "description": "Understanding AI applications in bio for machine learning engineers",
        "snippets": [
          "Generative models are very exciting but they come with the baggage of hallucination. Researchers found the model would invent plausible-looking structures in unstructured regions. To overcome this, a cross-distillation method was used to augment the training data with predicted structures AlphaFold-Multimer (v.2.3)."
        ],
        "title": "How AlphaFold 3 Is Like DALLE 2 and Other Learnings | Towards Data ...",
        "meta": {
          "query": "Advancements in data training methods for AlphaFold 3",
          "question": "What advancements in data training methods have contributed to the increased predictive accuracy of AlphaFold 3?",
          "placement": "root -> Advancements in data training methods"
        },
        "citation_uuid": 14
      },
      "15": {
        "url": "https://bjbas.springeropen.com/articles/10.1186/s43088-024-00503-y",
        "description": "Breakthrough achievements in protein structure prediction have occurred recently, mostly due to the advent of sophisticated machine learning methods and significant advancements in algorithmic approaches. The most recent version of the AlphaFold model, known as \u201cAlphaFold-latest,\u201d which ...",
        "snippets": [
          "Breakthrough achievements in protein structure prediction have occurred recently, mostly due to the advent of sophisticated machine learning methods and significant advancements in algorithmic approaches. The most recent version of the AlphaFold model, known as \u201cAlphaFold-latest,\u201d which expands the functionalities of the groundbreaking AlphaFold2, is the subject of this article."
        ],
        "title": "AlphaFold-latest: revolutionizing protein structure prediction ...",
        "meta": {
          "query": "Advancements in data training methods for AlphaFold 3",
          "question": "What advancements in data training methods have contributed to the increased predictive accuracy of AlphaFold 3?",
          "placement": "root -> Advancements in data training methods"
        },
        "citation_uuid": 15
      },
      "16": {
        "url": "https://www.nature.com/articles/s41586-024-07487-w",
        "description": "The modified residues dataset is ... to the training set (Methods). See Extended Data Table 1 for detailed results, and Extended Data Fig. 6 for examples of predicted protein, DNA and RNA structures with covalent modifications, including analysis of the impact of phosphorylation on predictions. While expanding in modelling abilities, AF3 has also improved in protein complex accuracy relative to AlphaFold-Multimer (v.2.3)7...",
        "snippets": [
          "The modified residues dataset is filtered similarly to our other polymer test sets: it contains only modified residues in polymer chains with low homology to the training set (Methods). See Extended Data Table 1 for detailed results, and Extended Data Fig. 6 for examples of predicted protein, DNA and RNA structures with covalent modifications, including analysis of the impact of phosphorylation on predictions. While expanding in modelling abilities, AF3 has also improved in protein complex accuracy relative to AlphaFold-Multimer (v.2.3)7,8."
        ],
        "title": "Accurate structure prediction of biomolecular interactions with ...",
        "meta": {
          "query": "How has data training improved AlphaFold 3 predictive accuracy?",
          "question": "What advancements in data training methods have contributed to the increased predictive accuracy of AlphaFold 3?",
          "placement": "root -> History -> Milestones"
        },
        "citation_uuid": 16
      },
      "17": {
        "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
        "description": "By addressing these challenges ... more fully realized, ensuring that this revolutionary technology benefits a broader spectrum of the scientific community. ... AlphaFold 3's integration into drug discovery processes signifies a transformative shift, particularly with its ability ...",
        "snippets": [
          "By addressing these challenges and limitations, the potential of AlphaFold 3 in transforming medical science and research can be more fully realized, ensuring that this revolutionary technology benefits a broader spectrum of the scientific community. ... AlphaFold 3's integration into drug discovery processes signifies a transformative shift, particularly with its ability to predict interactions at the atomic level."
        ],
        "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
        "meta": {
          "query": "Benefits of AlphaFold 3 in drug discovery",
          "question": "How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry?",
          "placement": "root -> Impact -> Scientific community -> Benefits of AlphaFold 3 in drug discovery -> Integration in drug discovery process"
        },
        "citation_uuid": 17
      },
      "18": {
        "url": "https://www.drugdiscoverytrends.com/laying-groundwork-alphafold-3-drug-discovery/",
        "description": "With the right approach, AlphaFold 3 promises to streamline drug discovery with advanced biomolecular predictions.",
        "snippets": [
          "Despite this challenge and the significant costs of building the necessary foundation, AlphaFold is an order of magnitude \u2014 or two \u2014 less expensive than traditional methods in medicinal chemistry. \u201cWe\u2019re talking about a completely game-changing technology as far as drug discovery is concerned,\u201d Bangert said."
        ],
        "title": "Laying the groundwork to tap AlphaFold 3's potential in drug ...",
        "meta": {
          "query": "Benefits of AlphaFold 3 in drug discovery",
          "question": "How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry?",
          "placement": "root -> Impact -> Scientific community -> Benefits of AlphaFold 3 in drug discovery -> Integration in drug discovery process"
        },
        "citation_uuid": 18
      },
      "19": {
        "url": "https://www.isomorphiclabs.com/articles/rational-drug-design-with-alphafold-3",
        "description": "We are reimagining the entire drug discovery process from first principles with an AI-first approach.",
        "snippets": [
          "This builds upon Google DeepMind\u2019s foundational work of predicting the structure of proteins with AlphaFold 2, to now include how multiple proteins, DNA, RNA, and small molecule ligands come together and interact, as well as predicting the structural impact of post-translational modifications and ions on these molecular systems. This model is a powerful unified framework for structure prediction, encompassing unprecedented breadth and accuracy. ... This breakthrough opens up exciting possibilities for drug discovery, allowing us to rationally develop therapeutics against targets that were previously difficult or deemed intractable to modulate."
        ],
        "title": "Rational drug design with AlphaFold 3 - Isomorphic Labs",
        "meta": {
          "query": "Benefits of AlphaFold 3 in drug discovery",
          "question": "How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry?",
          "placement": "root -> Impact -> Scientific community -> Benefits of AlphaFold 3 in drug discovery -> Integration in drug discovery process"
        },
        "citation_uuid": 19
      },
      "20": {
        "url": "https://www.analyticsvidhya.com/blog/2024/05/deepmind-ai-alphafold/",
        "description": "Drug Discovery: First, as demonstrated above, AlphaFold 3 can drastically reduce drug discovery time by simulating and predicting the action of substances on proteins. This can result in the development of drugs for currently untreatable diseases, potentially curing them. Materials Science: Materials science, in turn, can similarly benefit ...",
        "snippets": [
          "Drug Discovery: First, as demonstrated above, AlphaFold 3 can drastically reduce drug discovery time by simulating and predicting the action of substances on proteins. This can result in the development of drugs for currently untreatable diseases, potentially curing them. Materials Science: Materials science, in turn, can similarly benefit from predictions about the action of molecules by designing new materials based on predicted properties."
        ],
        "title": "AlphaFold 3 Will Change the Biological World and Drug Discovery",
        "meta": {
          "query": "Benefits of AlphaFold 3 in drug discovery",
          "question": "How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry?",
          "placement": "root -> Impact -> Scientific community -> Benefits of AlphaFold 3 in drug discovery -> Integration in drug discovery process"
        },
        "citation_uuid": 20
      },
      "21": {
        "url": "https://www.pharmavoice.com/news/google-alphafold-3-drug-discovery-pharma-buzz/716496/",
        "description": "The \u201cNobel Prize-worthy invention\u201d could be worth hundreds of billions commercially \u2014 and have a deep impact on drug R&D.",
        "snippets": [
          "The artificial intelligence program AlphaFold 3, rolled out by Google DeepMind and Isomorphic Labs earlier this month, has been called \u201cgroundbreaking,\u201d holding transformative potential in drug discovery."
        ],
        "title": "Why AlphaFold 3 is stirring up so much buzz in pharma | PharmaVoice",
        "meta": {
          "query": "Benefits of AlphaFold 3 in drug discovery",
          "question": "How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry?",
          "placement": "root -> Impact -> Scientific community -> Benefits of AlphaFold 3 in drug discovery -> Integration in drug discovery process"
        },
        "citation_uuid": 21
      },
      "22": {
        "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
        "description": "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor ...",
        "snippets": [
          "To maximize the impact of AlphaFold 3 on scientific research and drug discovery, its capabilities are made accessible to scientists through the AlphaFold Server. This easy-to-use research tool allows the scientific community to leverage the model's predictive abilities free. Furthermore, Isomorphic Labs is collaborating with pharmaceutical companies to apply AlphaFold 3 to real-world drug design challenges, aiming to develop new treatments that could change patients' lives."
        ],
        "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
        "meta": {
          "query": "AlphaFold 3 integration in drug discovery process pharmaceutical industry",
          "question": "How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry?",
          "placement": "root -> Impact -> Drug discovery"
        },
        "citation_uuid": 22
      },
      "23": {
        "url": "https://www.labiotech.eu/in-depth/alpha-fold-3-drug-discovery/",
        "description": "Find out how Google DeepMind's AlphaFold3 platform could help scientists revolutionize the field of drug discovery.",
        "snippets": [
          "Ultimately, AlphaFold3\u2019s impact on drug discovery and development is expected to be substantial. And, while commercial restrictions currently limit pharmaceutical applications, DeepMind\u2019s decision to make the platform open-source means that academic research will inevitably be able to advance scientists\u2019 understanding of disease mechanisms and drug interactions."
        ],
        "title": "AlphaFold3: Revolutionizing drug discovery and development",
        "meta": {
          "query": "AlphaFold 3 integration in drug discovery process pharmaceutical industry",
          "question": "How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry?",
          "placement": "root -> Impact -> Drug discovery"
        },
        "citation_uuid": 23
      },
      "24": {
        "url": "https://www.drugdiscoverytrends.com/laying-groundwork-alphafold-3-drug-discovery/",
        "description": "With the right approach, AlphaFold 3 promises to streamline drug discovery with advanced biomolecular predictions.",
        "snippets": [
          "Some 70% acknowledged AI\u2019s potential in the industry but noted struggles with data integrity and interoperability. The survey found that 63% of respondents were concerned about poor data quality. Given these data challenges, implementing advanced tools like AlphaFold requires meticulous attention to detail and a significant capital outlay. \u201cThe pipeline of tools that you require both before and after AlphaFold to make this into a commercial proposition for a pharmaceutical company or a healthcare company is fairly serious,\u201d Bangert stressed."
        ],
        "title": "Laying the groundwork to tap AlphaFold 3's potential in drug ...",
        "meta": {
          "query": "AlphaFold 3 integration in drug discovery process pharmaceutical industry",
          "question": "How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry?",
          "placement": "root -> Impact -> Drug discovery"
        },
        "citation_uuid": 24
      },
      "25": {
        "url": "https://www.analyticsvidhya.com/blog/2024/05/deepmind-ai-alphafold/",
        "description": "AlphaFold 3, the AI revolutionizing molecular understanding beyond proteins. Explore its power to predict DNA, RNA, and drug structures!",
        "snippets": [
          "Scientists can access most of its capabilities for free through the newly launched AlphaFold Server, an easy-to-use research tool. To build on AlphaFold 3\u2019s potential for drug design, Isomorphic Labs is already collaborating with pharmaceutical companies to apply it to real-world drug design challenges and, ultimately, develop new life-changing treatments for patients."
        ],
        "title": "AlphaFold 3 Will Change the Biological World and Drug Discovery",
        "meta": {
          "query": "AlphaFold 3 integration in drug discovery process pharmaceutical industry",
          "question": "How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry?",
          "placement": "root -> Impact -> Drug discovery"
        },
        "citation_uuid": 25
      },
      "26": {
        "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
        "description": "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor ...",
        "snippets": [
          "The limited and proprietary nature of AlphaFold's accessibility raises concerns regarding equitable access to cutting-edge technology. Such restrictions can impact scientific transparency and public accountability, which are crucial for the advancement and democratization of scientific research . By addressing these challenges and limitations, the potential of AlphaFold 3 in transforming medical science and research can be more fully realized, ensuring that this revolutionary technology benefits a broader spectrum of the scientific community."
        ],
        "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
        "meta": {
          "query": "Potential ethical concerns of AlphaFold 3 in scientific research",
          "question": "What are some potential ethical concerns that arise from the use of AlphaFold 3 in scientific research, particularly in terms of data privacy and biases in predictions?",
          "placement": "root -> Ethical Concerns"
        },
        "citation_uuid": 26
      },
      "27": {
        "url": "https://sidecarglobal.com/blog/the-breakthrough-of-alphafold-3-revolutionizing-biological-research",
        "description": "Discover the groundbreaking capabilities of AlphaFold 3 in biological research. Learn how this advanced AI model revolutionizes drug discovery, personalized medicine, and fundamental research by accurately predicting the structure and interactions of biological molecules.",
        "snippets": [
          "Researchers and policymakers must work together to establish guidelines and regulations that mitigate the risks associated with the misuse of AlphaFold 3. This includes implementing safeguards to prevent the technology from falling into the wrong hands and promoting ethical research practices. One of the significant advantages of AlphaFold 3 is the potential for collaborative research. By open-sourcing the model and its data, researchers worldwide can access and build upon its capabilities. This collaborative approach can accelerate scientific discovery and innovation, leading to more rapid advancements in various fields."
        ],
        "title": "The Breakthrough of AlphaFold 3: Revolutionizing Biological Research",
        "meta": {
          "query": "Potential ethical concerns of AlphaFold 3 in scientific research",
          "question": "What are some potential ethical concerns that arise from the use of AlphaFold 3 in scientific research, particularly in terms of data privacy and biases in predictions?",
          "placement": "root -> Ethical Concerns"
        },
        "citation_uuid": 27
      },
      "28": {
        "url": "https://mexicobusiness.news/health/news/google-deepmind-tackles-drug-discovery-alphafold-3",
        "description": "AlphaFold 3 aims to transform drug discovery with advanced biomolecular structure prediction technology, but ethical concerns persist.",
        "snippets": [
          "Developed with Isomorphic Labs, a sister company of Alphabet, the software is accessible through the AlphaFold Server for global non-commercial research. However, AlphaFold 3 will not be open-sourced like its predecessors. This approach allows AlphaFold 3 to create plausible protein structures by learning patterns from verified data, similar to how image generators produce realistic visuals, states Wired. While powerful, AlphaFold 3 raises significant ethical concerns that must be addressed. One major issue is the potential for bias in AI models."
        ],
        "title": "Google DeepMind Tackles Drug Discovery With AlphaFold 3",
        "meta": {
          "query": "Potential ethical concerns of AlphaFold 3 in scientific research",
          "question": "What are some potential ethical concerns that arise from the use of AlphaFold 3 in scientific research, particularly in terms of data privacy and biases in predictions?",
          "placement": "root -> Ethical Concerns"
        },
        "citation_uuid": 28
      },
      "29": {
        "url": "https://www.isomorphiclabs.com/articles/alphafold-3-predicts-the-structure-and-interactions-of-all-of-lifes-molecules",
        "description": "We are reimagining the entire drug discovery process from first principles with an AI-first approach.",
        "snippets": [
          "AlphaFold 3 predicts the structure and interactions of all of life\u2019s molecules"
        ],
        "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
        "meta": {
          "query": "Potential ethical concerns of AlphaFold 3 in scientific research",
          "question": "What are some potential ethical concerns that arise from the use of AlphaFold 3 in scientific research, particularly in terms of data privacy and biases in predictions?",
          "placement": "root -> Ethical Concerns"
        },
        "citation_uuid": 29
      },
      "30": {
        "url": "https://www.genengnews.com/topics/artificial-intelligence/alphafold-3-angst-limited-accessibility-stirs-outcry-from-researchers/",
        "description": "Researchers are angered by the latest update to Google DeepMind\u2019s renowned protein structure prediction algorithm, which published in Nature without the open access code",
        "snippets": [
          "AlQuraishi added that independently reproducing AlphaFold 3 would be highly valuable to permit training new variants of the system, including potentially training on private data repositories."
        ],
        "title": "AlphaFold 3 Angst: Limited Accessibility Stirs Outcry from Researchers",
        "meta": {
          "query": "Data privacy issues with AlphaFold 3",
          "question": "What are some potential ethical concerns that arise from the use of AlphaFold 3 in scientific research, particularly in terms of data privacy and biases in predictions?",
          "placement": "root -> Ethical Concerns"
        },
        "citation_uuid": 30
      },
      "31": {
        "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
        "description": "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor ...",
        "snippets": [
          "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor AlphaFold 2, this innovation has astonished the world with its capacity and speed."
        ],
        "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
        "meta": {
          "query": "AlphaFold 3 vs previous versions predictive accuracy comparison",
          "question": "What are the key differences between AlphaFold 3 and its previous versions in terms of data training methods and predictive accuracy?",
          "placement": "root -> Comparisons"
        },
        "citation_uuid": 31
      },
      "32": {
        "url": "https://medium.com/@falk_hoffmann/alphafold3-and-its-improvements-in-comparison-to-alphafold2-96815ffbb044",
        "description": "Predicting protein structures is one of the most important challenges in biochemistry. Highly accurate protein structures are essential for drug discovery purposes. Here, you can find more about the\u2026",
        "snippets": [
          "AlphaFold uses a neural network approach that directly predicts the 3D coordinates of all non-hydrogen atoms for a given protein using the protein sequence and sequence homology. While immediately being the best prediction method in CASP13, it was still not good enough to call the protein structure prediction task successful. A successful in silico prediction method reaches experimental accuracy."
        ],
        "title": "AlphaFold3 and its improvements in comparison to AlphaFold2 | by ...",
        "meta": {
          "query": "AlphaFold 3 vs previous versions predictive accuracy comparison",
          "question": "What are the key differences between AlphaFold 3 and its previous versions in terms of data training methods and predictive accuracy?",
          "placement": "root -> Comparisons"
        },
        "citation_uuid": 32
      },
      "33": {
        "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10751731/",
        "description": "Statistical significance values ... CAPRI accuracy predictions, as noted at top (**p \u2264 0.01). Recently, an updated version of AlphaFold (v.2.3.0, hereafter denoted as v.2.3) was released, with modifications to the pipeline and deep learning model (DeepMind, 2022). Compared with the previous version, this ...",
        "snippets": [
          "Statistical significance values (Wilcoxon rank\u2010sum test) were calculated between interface energy scores for sets of cases with incorrect versus medium and incorrect versus high CAPRI accuracy predictions, as noted at top (**p \u2264 0.01). Recently, an updated version of AlphaFold (v.2.3.0, hereafter denoted as v.2.3) was released, with modifications to the pipeline and deep learning model (DeepMind, 2022). Compared with the previous version, this version was trained on PDB structures released until September 30, 2021, resulting in a 30% increase in training data."
        ],
        "title": "Evaluation of AlphaFold antibody\u2013antigen modeling with implications ...",
        "meta": {
          "query": "AlphaFold 3 vs previous versions predictive accuracy comparison",
          "question": "What are the key differences between AlphaFold 3 and its previous versions in terms of data training methods and predictive accuracy?",
          "placement": "root -> Comparisons"
        },
        "citation_uuid": 33
      },
      "34": {
        "url": "https://hyperlab.hits.ai/en/blog/google-deepmind-alphafoldlatest",
        "description": "AlphaFold-latest, the next generation of AlphaFold, has the ability to predict the structure of almost all biomolecules along with proteins compared to previous models. The model can predict a variety of molecular combinations, including protein-nucleic acid complexes and protein-small molecule ...",
        "snippets": [
          "AlphaFold-latest, the next generation of AlphaFold, has the ability to predict the structure of almost all biomolecules along with proteins compared to previous models. The model can predict a variety of molecular combinations, including protein-nucleic acid complexes and protein-small molecule complexes, and shows higher prediction accuracy than traditional docking programs."
        ],
        "title": "Google DeepMind AlphaFold-latest l What's different from previous ...",
        "meta": {
          "query": "AlphaFold 3 vs previous versions predictive accuracy comparison",
          "question": "What are the key differences between AlphaFold 3 and its previous versions in terms of data training methods and predictive accuracy?",
          "placement": "root -> Comparisons"
        },
        "citation_uuid": 34
      },
      "35": {
        "url": "https://blog.google/technology/ai/google-deepmind-isomorphic-alphafold-3-ai-model/",
        "description": "Our new AI model AlphaFold 3 can predict the structure and interactions of all life\u2019s molecules with unprecedented accuracy.",
        "snippets": [
          "For the interactions of proteins with other molecule types we see at least a 50% improvement compared with existing prediction methods, and for some important categories of interaction we have doubled prediction accuracy. We hope AlphaFold 3 will help transform our understanding of the biological world and drug discovery."
        ],
        "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
        "meta": {
          "query": "AlphaFold 3 vs previous versions predictive accuracy comparison",
          "question": "What are the key differences between AlphaFold 3 and its previous versions in terms of data training methods and predictive accuracy?",
          "placement": "root -> Comparisons"
        },
        "citation_uuid": 35
      },
      "36": {
        "url": "https://en.wikipedia.org/wiki/AlphaFold",
        "description": "AlphaFold 3 was announced on 8 May 2024. It can predict the structure of complexes created by proteins with DNA, RNA, various ligands, and ions. The new prediction method shows a minimum 50% improvement in accuracy for protein interactions with other molecules compared to existing methods.",
        "snippets": [
          "Measured by the root-mean-square deviation (RMS-D) of the placement of the alpha-carbon atoms of the protein backbone chain, which tends to be dominated by the performance of the worst-fitted outliers, 88% of AlphaFold 2's predictions had an RMS deviation of less than 4 \u00c5 for the set of overlapped C-alpha atoms. 76% of predictions achieved better than 3 \u00c5, and 46% had a C-alpha atom RMS accuracy better than 2 \u00c5, with a median RMS deviation in its predictions of 2.1 \u00c5 for a set of overlapped CA atoms."
        ],
        "title": "AlphaFold - Wikipedia",
        "meta": {
          "query": "AlphaFold 3 vs previous versions predictive accuracy comparison",
          "question": "What are the key differences between AlphaFold 3 and its previous versions in terms of data training methods and predictive accuracy?",
          "placement": "root -> Comparisons"
        },
        "citation_uuid": 36
      },
      "37": {
        "url": "https://blog.google/technology/ai/how-we-built-alphafold-3/",
        "description": "In order to get AlphaFold 3 to work with this much wider range of biomolecules, the team vastly expanded the data that the newer model was trained on to include DNA, RNA, small molecules and more. \u201cWe were able to say, \u2018Let's just train on everything that exists in this dataset that helped ...",
        "snippets": [
          "In order to get AlphaFold 3 to work with this much wider range of biomolecules, the team vastly expanded the data that the newer model was trained on to include DNA, RNA, small molecules and more. \u201cWe were able to say, \u2018Let's just train on everything that exists in this dataset that helped us so much with proteins and let\u2019s see how far we can get,\u2019\u201d Lindsay says."
        ],
        "title": "How we built AlphaFold 3 to predict the structure and interaction ...",
        "meta": {
          "query": "AlphaFold 3 vs previous versions data training methods",
          "question": "What are the key differences between AlphaFold 3 and its previous versions in terms of data training methods and predictive accuracy?",
          "placement": "root -> Comparisons -> AlphaFold 3 vs previous versions data training methods"
        },
        "citation_uuid": 37
      },
      "38": {
        "url": "https://cen.acs.org/analytical-chemistry/structural-biology/AlphaFold-3-offer-structure-prediction/102/i15",
        "description": "Tool can predict structures of proteins and nucleic acids bound to ions, ligands, and one another",
        "snippets": [
          "While DeepMind has released the code for predecessor model AlphaFold 2, it has not released training data or procedures\u2014a critical part of a machine learning model. In mid-May, researchers led by Mohammed AlQuraishi at Columbia University published OpenFold, an open-source equivalent to AlphaFold 2 that includes that information (Nat. Methods 2024, DOI: 10.1038/s41592-024-02272-z)."
        ],
        "title": "AlphaFold 3 to offer structure prediction via web browser",
        "meta": {
          "query": "AlphaFold 3 vs previous versions data training methods",
          "question": "What are the key differences between AlphaFold 3 and its previous versions in terms of data training methods and predictive accuracy?",
          "placement": "root -> Comparisons -> AlphaFold 3 vs previous versions data training methods"
        },
        "citation_uuid": 38
      },
      "39": {
        "url": "https://www.analyticsvidhya.com/blog/2024/05/deepmind-ai-alphafold/",
        "description": "Without the bottleneck of protein structure prediction, researchers can focus on more difficult biological questions, resulting in quicker development of new science. While AlphaFold 3 offers immense benefits, its power requires careful consideration of some ethical issues:",
        "snippets": [
          "AlphaFold 3\u2019s impact goes far beyond predicting molecule shapes. It can potentially revolutionize various fields, accelerate research, and raise ethical considerations."
        ],
        "title": "AlphaFold 3: The Next Generation in Molecular Prediction",
        "meta": {
          "query": "Ethical considerations of AlphaFold 3 predictions",
          "question": "How can we ensure that the predictions generated by AlphaFold 3 are used responsibly and ethically in scientific research, especially in terms of potential biases and unintended consequences?",
          "placement": "root"
        },
        "citation_uuid": 39
      },
      "40": {
        "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
        "description": "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor ...",
        "snippets": [
          "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor AlphaFold 2, this innovation has astonished the world with its capacity and speed."
        ],
        "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
        "meta": {
          "query": "Ethical considerations of AlphaFold 3 predictions",
          "question": "How can we ensure that the predictions generated by AlphaFold 3 are used responsibly and ethically in scientific research, especially in terms of potential biases and unintended consequences?",
          "placement": "root"
        },
        "citation_uuid": 40
      },
      "41": {
        "url": "https://www.nature.com/articles/s41586-024-07487-w",
        "description": "AlphaFold 3 has a substantially updated architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and modified residues with greatly improved accuracy over many previous specialized tools.",
        "snippets": [
          "The introduction of AlphaFold 21 has spurred a revolution in modelling the structure of proteins and their interactions, enabling a huge range of applications in protein modelling and design2\u20136. Here we describe our AlphaFold 3 model with a substantially updated diffusion-based architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and modified residues."
        ],
        "title": "Accurate structure prediction of biomolecular interactions with ...",
        "meta": {
          "query": "Ethical considerations of AlphaFold 3 predictions",
          "question": "How can we ensure that the predictions generated by AlphaFold 3 are used responsibly and ethically in scientific research, especially in terms of potential biases and unintended consequences?",
          "placement": "root"
        },
        "citation_uuid": 41
      },
      "42": {
        "url": "https://www.isomorphiclabs.com/articles/alphafold-3-predicts-the-structure-and-interactions-of-all-of-lifes-molecules",
        "description": "We are reimagining the entire drug discovery process from first principles with an AI-first approach.",
        "snippets": [
          "AlphaFold 3 predicts the structure and interactions of all of life\u2019s molecules"
        ],
        "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
        "meta": {
          "query": "Ethical considerations of AlphaFold 3 predictions",
          "question": "How can we ensure that the predictions generated by AlphaFold 3 are used responsibly and ethically in scientific research, especially in terms of potential biases and unintended consequences?",
          "placement": "root"
        },
        "citation_uuid": 42
      },
      "43": {
        "url": "https://www.nature.com/articles/s41592-023-02087-4",
        "description": "An analysis of AlphaFold protein structure predictions shows that while in many cases the predictions are highly accurate, there are also many instances where the predicted structures or parts of predicted structures do not agree with experimentally resolved data.",
        "snippets": [
          "Artificial intelligence-based protein structure prediction methods such as AlphaFold have revolutionized structural biology. The accuracies of these predictions vary, however, and they do not take into account ligands, covalent modifications or other environmental factors."
        ],
        "title": "AlphaFold predictions are valuable hypotheses and accelerate but ...",
        "meta": {
          "query": "Ethical considerations of AlphaFold 3 predictions",
          "question": "How can we ensure that the predictions generated by AlphaFold 3 are used responsibly and ethically in scientific research, especially in terms of potential biases and unintended consequences?",
          "placement": "root"
        },
        "citation_uuid": 43
      },
      "44": {
        "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
        "description": "The complexity of drug interactions and physiological responses often requires more than accurate structural predictions to achieve effective therapeutic results [24,37]. ... The limited and proprietary nature of AlphaFold's accessibility raises concerns regarding equitable access to cutting-edge technology. Such restrictions can impact scientific transparency and public accountability, which are crucial for the advancement and democratization of scientific research ...",
        "snippets": [
          "The complexity of drug interactions and physiological responses often requires more than accurate structural predictions to achieve effective therapeutic results . ... The limited and proprietary nature of AlphaFold's accessibility raises concerns regarding equitable access to cutting-edge technology. Such restrictions can impact scientific transparency and public accountability, which are crucial for the advancement and democratization of scientific research ."
        ],
        "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
        "meta": {
          "query": "Responsible use of AlphaFold 3 predictions in scientific research",
          "question": "How can we ensure that the predictions generated by AlphaFold 3 are used responsibly and ethically in scientific research, especially in terms of potential biases and unintended consequences?",
          "placement": "root"
        },
        "citation_uuid": 44
      },
      "45": {
        "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10011655/",
        "description": "Three-dimensional protein structure is directly correlated with its function and its determination is critical to understanding biological processes and addressing human health and life science problems in general. Although new protein structures ...",
        "snippets": [
          "Due to the difficulty of determining protein structures by experimental methods, their predictions have been one of the central problems of the scientific community. The advent of AlphaFold2 and the release of millions of protein structures predicted with high accuracy and available in AlphaFold DB allowed an unprecedented expansion of different research fields in life science, impacting the most biological sciences, followed by biochemistry and cell biology, genetics, medical and health sciences and chemical sciences (Varadi and Velankar, 2022)."
        ],
        "title": "Before and after AlphaFold2: An overview of protein structure ...",
        "meta": {
          "query": "Responsible use of AlphaFold 3 predictions in scientific research",
          "question": "How can we ensure that the predictions generated by AlphaFold 3 are used responsibly and ethically in scientific research, especially in terms of potential biases and unintended consequences?",
          "placement": "root"
        },
        "citation_uuid": 45
      },
      "46": {
        "url": "https://blog.google/technology/ai/how-we-built-alphafold-3/",
        "description": "Since its launch in 2020, more than 2 million researchers have used Google DeepMind\u2019s AlphaFold 2 model for protein predictions in their work on vaccine development, cancer treatments and more \u2014 helping solve a problem that researchers had been working on for over 50 years.",
        "snippets": [
          "Instead, they got started on AlphaFold 3. This newer model, which the teams at Google DeepMind and Isomorphic Labs launched in May, builds on our previous models by predicting not just protein folding structures, but predicting the structure and interactions of all of life's molecules, including DNA, RNA and ligands (small molecules that bind to proteins). \u201cWith AlphaFold 2, we made enormous progress on this decades-old open problem of protein folding, but if you look at recent high-impact research, researchers are moving beyond that,\u201d says Jonas Adler, research scientist at Google DeepMind."
        ],
        "title": "How we built AlphaFold 3 to predict the structure and interaction ...",
        "meta": {
          "query": "Responsible use of AlphaFold 3 predictions in scientific research",
          "question": "How can we ensure that the predictions generated by AlphaFold 3 are used responsibly and ethically in scientific research, especially in terms of potential biases and unintended consequences?",
          "placement": "root"
        },
        "citation_uuid": 46
      },
      "47": {
        "url": "https://blog.google/technology/ai/google-deepmind-isomorphic-alphafold-3-ai-model/",
        "description": "We\u2019ll also be expanding our free ... and research, including on underfunded areas such as neglected diseases and food security. We\u2019ll continue to work with the scientific community and policy makers to develop and deploy AI technologies responsibly. 7BBV - Enzyme: AlphaFold 3\u2019s prediction for a molecular ...",
        "snippets": [
          "We\u2019ll also be expanding our free AlphaFold education online course with EMBL-EBI and partnerships with organizations in the Global South to equip scientists with the tools they need to accelerate adoption and research, including on underfunded areas such as neglected diseases and food security. We\u2019ll continue to work with the scientific community and policy makers to develop and deploy AI technologies responsibly. 7BBV - Enzyme: AlphaFold 3\u2019s prediction for a molecular complex featuring an enzyme protein (blue), an ion (yellow sphere) and simple sugars (yellow), along with the true structure (gray)."
        ],
        "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
        "meta": {
          "query": "Responsible use of AlphaFold 3 predictions in scientific research",
          "question": "How can we ensure that the predictions generated by AlphaFold 3 are used responsibly and ethically in scientific research, especially in terms of potential biases and unintended consequences?",
          "placement": "root"
        },
        "citation_uuid": 47
      },
      "48": {
        "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
        "description": "It takes humans years to determine ... with the receptors but AlphaFold 3 predicts the same structure in seconds. The version's utility is unimaginable in the field of drug discoveries, vaccines, enzymatic processes, and determining the rate and effect of different biological ...",
        "snippets": [
          "It takes humans years to determine the structure of various proteins and how the shape works with the receptors but AlphaFold 3 predicts the same structure in seconds. The version's utility is unimaginable in the field of drug discoveries, vaccines, enzymatic processes, and determining the rate and effect of different biological processes."
        ],
        "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
        "meta": {
          "query": "Effects of using AlphaFold 3 in drug discovery process",
          "question": "How do you think the adoption of AlphaFold 3 in the drug discovery process will affect the overall timeline and cost of bringing new drugs to market?",
          "placement": "root -> Adoption Impact -> Effects of using AlphaFold 3 in drug discovery process"
        },
        "citation_uuid": 48
      },
      "49": {
        "url": "https://www.isomorphiclabs.com/articles/rational-drug-design-with-alphafold-3",
        "description": "We are reimagining the entire drug discovery process from first principles with an AI-first approach.",
        "snippets": [
          "We believe that this broader understanding of the context within which drug targets operate will translate into more effective drugs in the clinic. ... To demonstrate the potential for rational structure-based drug design with AlphaFold 3, we examined TIM-3, an immune checkpoint protein identified as a potential target for cancer immunotherapy following a 2021 publication. ... The study focused on the discovery and design of small molecules capable of binding TIM-3 with high affinity."
        ],
        "title": "Rational drug design with AlphaFold 3 - Isomorphic Labs",
        "meta": {
          "query": "Effects of using AlphaFold 3 in drug discovery process",
          "question": "How do you think the adoption of AlphaFold 3 in the drug discovery process will affect the overall timeline and cost of bringing new drugs to market?",
          "placement": "root -> Adoption Impact -> Effects of using AlphaFold 3 in drug discovery process"
        },
        "citation_uuid": 49
      },
      "50": {
        "url": "https://www.theatlantic.com/sponsored/google/ai-powered-future-drug-discovery/3962/",
        "description": "But now, AI systems are poised ... process. One area in which AlphaFold 3 shows particular promise is the rational design of drugs. AlphaFold 3 can efficiently predict how ligands, a structural component of many drugs, will bind to a target protein, thereby guiding researchers in designing drug candidate structures for improved efficacy and reduced side effects. This not only hastens the drug discovery process but ...",
        "snippets": [
          "But now, AI systems are poised to dramatically accelerate this painstaking process. One area in which AlphaFold 3 shows particular promise is the rational design of drugs. AlphaFold 3 can efficiently predict how ligands, a structural component of many drugs, will bind to a target protein, thereby guiding researchers in designing drug candidate structures for improved efficacy and reduced side effects. This not only hastens the drug discovery process but also has the potential to ultimately impact the overall cost of development."
        ],
        "title": "The AI-Powered Future of Drug Discovery - Sponsor Content - Google",
        "meta": {
          "query": "Effects of using AlphaFold 3 in drug discovery process",
          "question": "How do you think the adoption of AlphaFold 3 in the drug discovery process will affect the overall timeline and cost of bringing new drugs to market?",
          "placement": "root -> Adoption Impact -> Effects of using AlphaFold 3 in drug discovery process"
        },
        "citation_uuid": 50
      },
      "51": {
        "url": "https://www.isomorphiclabs.com/articles/alphafold-3-predicts-the-structure-and-interactions-of-all-of-lifes-molecules",
        "description": "We are reimagining the entire drug discovery process from first principles with an AI-first approach.",
        "snippets": [
          "AlphaFold 3 predicts the structure and interactions of all of life\u2019s molecules"
        ],
        "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
        "meta": {
          "query": "Effects of using AlphaFold 3 in drug discovery process",
          "question": "How do you think the adoption of AlphaFold 3 in the drug discovery process will affect the overall timeline and cost of bringing new drugs to market?",
          "placement": "root -> Adoption Impact -> Effects of using AlphaFold 3 in drug discovery process"
        },
        "citation_uuid": 51
      },
      "52": {
        "url": "https://www.pharmavoice.com/news/google-alphafold-3-drug-discovery-pharma-buzz/716496/",
        "description": "The \u201cNobel Prize-worthy invention\u201d could be worth hundreds of billions commercially \u2014 and have a deep impact on drug R&D.",
        "snippets": [
          "And while AlphaFold 3 could identify promising compounds faster, the usual hurdles to market will remain. \u201cThis isn't necessarily a Holy Grail to instantly make the drug development process more successful,\u201d Bangert said. \u201cYou're still going to have the traditional challenges, but this is a piece of that puzzle that's fitting better now.\u201d \u00b7 AI has secured a footing in drug discovery."
        ],
        "title": "Why AlphaFold 3 is stirring up so much buzz in pharma | PharmaVoice",
        "meta": {
          "query": "Effects of using AlphaFold 3 in drug discovery process",
          "question": "How do you think the adoption of AlphaFold 3 in the drug discovery process will affect the overall timeline and cost of bringing new drugs to market?",
          "placement": "root -> Adoption Impact -> Effects of using AlphaFold 3 in drug discovery process"
        },
        "citation_uuid": 52
      },
      "53": {
        "url": "https://www.pharmavoice.com/news/google-alphafold-3-drug-discovery-pharma-buzz/716496/",
        "description": "The \u201cNobel Prize-worthy invention\u201d could be worth hundreds of billions commercially \u2014 and have a deep impact on drug R&D.",
        "snippets": [
          "The \u201cNobel Prize-worthy invention\u201d could be worth hundreds of billions commercially \u2014 and have a deep impact on drug R&D. ... This audio is auto-generated. Please let us know if you have feedback. The artificial intelligence program AlphaFold 3, rolled out by Google DeepMind and Isomorphic Labs earlier this month, has been called \u201cgroundbreaking,\u201d holding transformative potential in drug discovery."
        ],
        "title": "Why AlphaFold 3 is stirring up so much buzz in pharma | PharmaVoice",
        "meta": {
          "query": "AlphaFold 3 adoption impact on drug discovery timeline and cost",
          "question": "How do you think the adoption of AlphaFold 3 in the drug discovery process will affect the overall timeline and cost of bringing new drugs to market?",
          "placement": "root -> Adoption Impact -> AlphaFold 3 adoption impact on drug discovery timeline and cost"
        },
        "citation_uuid": 53
      },
      "54": {
        "url": "https://www.nature.com/articles/d41586-024-01383-z",
        "description": "Latest version of the AI models how proteins interact with other molecules \u2014 but DeepMind restricts access to the tool.",
        "snippets": [
          "Latest version of the AI models how proteins interact with other molecules \u2014 but DeepMind restricts access to the tool. Latest version of the AI models how proteins interact with other molecules \u2014 but DeepMind restricts access to the tool."
        ],
        "title": "Major AlphaFold upgrade offers boost for drug discovery",
        "meta": {
          "query": "AlphaFold 3 adoption impact on drug discovery timeline and cost",
          "question": "How do you think the adoption of AlphaFold 3 in the drug discovery process will affect the overall timeline and cost of bringing new drugs to market?",
          "placement": "root -> Adoption Impact -> AlphaFold 3 adoption impact on drug discovery timeline and cost"
        },
        "citation_uuid": 54
      },
      "55": {
        "url": "https://www.labiotech.eu/in-depth/alpha-fold-3-drug-discovery/",
        "description": "Find out how Google DeepMind's AlphaFold3 platform could help scientists revolutionize the field of drug discovery.",
        "snippets": [
          "The sheer potential of DeepMind\u2019s AlphaFold technology, reinforced by the awarding of the 2024 Nobel Prize in Chemistry to its developers Demis Hassabis and John Jumper, shows just how much of an impact AI can really have on molecular biology and overall drug development."
        ],
        "title": "AlphaFold3: Revolutionizing drug discovery and development",
        "meta": {
          "query": "AlphaFold 3 adoption impact on drug discovery timeline and cost",
          "question": "How do you think the adoption of AlphaFold 3 in the drug discovery process will affect the overall timeline and cost of bringing new drugs to market?",
          "placement": "root -> Adoption Impact -> AlphaFold 3 adoption impact on drug discovery timeline and cost"
        },
        "citation_uuid": 55
      },
      "56": {
        "url": "https://www.isomorphiclabs.com/articles/rational-drug-design-with-alphafold-3",
        "description": "We are reimagining the entire drug discovery process from first principles with an AI-first approach.",
        "snippets": [
          "This builds upon Google DeepMind\u2019s foundational work of predicting the structure of proteins with AlphaFold 2, to now include how multiple proteins, DNA, RNA, and small molecule ligands come together and interact, as well as predicting the structural impact of post-translational modifications and ions on these molecular systems. This model is a powerful unified framework for structure prediction, encompassing unprecedented breadth and accuracy. ... This breakthrough opens up exciting possibilities for drug discovery, allowing us to rationally develop therapeutics against targets that were previously difficult or deemed intractable to modulate."
        ],
        "title": "Rational drug design with AlphaFold 3 - Isomorphic Labs",
        "meta": {
          "query": "AlphaFold 3 adoption impact on drug discovery timeline and cost",
          "question": "How do you think the adoption of AlphaFold 3 in the drug discovery process will affect the overall timeline and cost of bringing new drugs to market?",
          "placement": "root -> Adoption Impact -> AlphaFold 3 adoption impact on drug discovery timeline and cost"
        },
        "citation_uuid": 56
      },
      "57": {
        "url": "https://www.analyticsvidhya.com/blog/2024/05/deepmind-ai-alphafold/",
        "description": "AlphaFold 3, the AI revolutionizing molecular understanding beyond proteins. Explore its power to predict DNA, RNA, and drug structures!",
        "snippets": [
          "AlphaFold 3\u2019s impact goes far beyond predicting molecule shapes. It can potentially revolutionize various fields, accelerate research, and raise ethical considerations."
        ],
        "title": "AlphaFold 3 Will Change the Biological World and Drug Discovery",
        "meta": {
          "query": "AlphaFold 3 adoption impact on drug discovery timeline and cost",
          "question": "How do you think the adoption of AlphaFold 3 in the drug discovery process will affect the overall timeline and cost of bringing new drugs to market?",
          "placement": "root -> Adoption Impact -> AlphaFold 3 adoption impact on drug discovery timeline and cost"
        },
        "citation_uuid": 57
      },
      "58": {
        "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11292590/",
        "description": "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor AlphaFold ...",
        "snippets": [
          "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor AlphaFold 2, this innovation has astonished the world with its capacity and speed."
        ],
        "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
        "meta": {
          "query": "AlphaFold 3 expanded capabilities",
          "question": "The enhanced predictive accuracy and expanded capabilities of AlphaFold 3 can greatly impact the field of protein engineering and design by providing more accurate and reliable structural information for designing novel proteins with specific functions. With AlphaFold 3's ability to predict the 3D coordinates of non-hydrogen atoms for various biomolecules, including proteins, DNA, RNA, and small molecules, researchers can now have a better understanding of protein interactions and structural features . This can lead to the design of proteins with improved stability, functionality, and specificity, which is crucial for developing new therapeutic agents, enzymes, and biomaterials. By leveraging AlphaFold 3's advancements in biomolecular structure prediction, protein engineers can accelerate the process of designing custom proteins tailored for specific applications in biotechnology, medicine, and other fields .",
          "placement": "root -> Impact -> Scientific community -> Benefits of AlphaFold 3 in drug discovery -> Impact on protein engineering and design"
        },
        "citation_uuid": 58
      },
      "59": {
        "url": "https://www.nature.com/articles/s41586-024-07487-w",
        "description": "AlphaFold 3 has a substantially updated architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and modified residues with greatly improved accuracy over many previous specialized tools.",
        "snippets": [
          "The introduction of AlphaFold 21 has spurred a revolution in modelling the structure of proteins and their interactions, enabling a huge range of applications in protein modelling and design2\u20136. Here we describe our AlphaFold 3 model with a substantially updated diffusion-based architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and modified residues."
        ],
        "title": "Accurate structure prediction of biomolecular interactions with ...",
        "meta": {
          "query": "How does AlphaFold 3 improved stability and functionality of proteins",
          "question": "Highlight the specific implications of AlphaFold 3's enhanced predictive accuracy on designing novel proteins with improved stability and functionality.",
          "placement": "root -> Impact -> Scientific community -> How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry? -> Implications of AlphaFold 3 on Protein Design"
        },
        "citation_uuid": 59
      },
      "60": {
        "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011655/",
        "description": "Three-dimensional protein structure is directly correlated with its function and its determination is critical to understanding biological processes and addressing human health and life science problems in general. Although new protein structures are ...",
        "snippets": [
          "For this, ESM Metagenomic Atlas is an important 3D protein structures resource to be deeply investigated by the scientific community (Lin et al., 2022). Finally, the efforts to better predict how mutations affect protein structure using these new approaches are essential to gain insights in human genetic disease and further improve disease management and prediction. Today, these methods do not outperform AlphaFold2, but with the improvement of deep language models and the enrichment of these models with biological information through multi-task learning, they promise to revolutionize the protein structural biology."
        ],
        "title": "Before and after AlphaFold2: An overview of protein structure ...",
        "meta": {
          "query": "How does AlphaFold 3 improved stability and functionality of proteins",
          "question": "Highlight the specific implications of AlphaFold 3's enhanced predictive accuracy on designing novel proteins with improved stability and functionality.",
          "placement": "root -> Impact -> Scientific community -> How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry? -> Implications of AlphaFold 3 on Protein Design"
        },
        "citation_uuid": 60
      },
      "61": {
        "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
        "description": "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor ...",
        "snippets": [
          "By providing detailed insights into how molecules interact and influence biological functions, it paves the way for groundbreaking advancements in medical science and research . ... AlphaFold 3 represents a significant evolution from its predecessor, AlphaFold 2, primarily through its advanced architectural framework . The core of this new model, the Evoformer module, has been significantly enhanced to improve performance across a broader spectrum of biomolecules, extending beyond proteins to include DNA, RNA, and ligands . This architectural refinement has enabled AlphaFold 3 to achieve unprecedented accuracy in predicting drug-like interactions, setting a new benchmark in the field ."
        ],
        "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
        "meta": {
          "query": "How does AlphaFold 3 improved stability and functionality of proteins",
          "question": "Highlight the specific implications of AlphaFold 3's enhanced predictive accuracy on designing novel proteins with improved stability and functionality.",
          "placement": "root -> Impact -> Scientific community -> How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry? -> Implications of AlphaFold 3 on Protein Design"
        },
        "citation_uuid": 61
      },
      "62": {
        "url": "https://blog.google/technology/ai/google-deepmind-isomorphic-alphafold-3-ai-model/",
        "description": "Our new AI model AlphaFold 3 can predict the structure and interactions of all life\u2019s molecules with unprecedented accuracy.",
        "snippets": [
          "Advancing our knowledge of such immune-system processes helps better understand coronaviruses, including COVID-19, raising possibilities for improved treatments. Given an input list of molecules, AlphaFold 3 generates their joint 3D structure, revealing how they all fit together. It models large biomolecules such as proteins, DNA and RNA, as well as small molecules, also known as ligands \u2014 a category encompassing many drugs. Furthermore, AlphaFold 3 can model chemical modifications to these molecules which control the healthy functioning of cells, that when disrupted can lead to disease."
        ],
        "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
        "meta": {
          "query": "How does AlphaFold 3 improved stability and functionality of proteins",
          "question": "Highlight the specific implications of AlphaFold 3's enhanced predictive accuracy on designing novel proteins with improved stability and functionality.",
          "placement": "root -> Impact -> Scientific community -> How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry? -> Implications of AlphaFold 3 on Protein Design"
        },
        "citation_uuid": 62
      },
      "63": {
        "url": "https://en.wikipedia.org/wiki/AlphaFold",
        "description": "AlphaFold 3 was announced on 8 May 2024. It can predict the structure of complexes created by proteins with DNA, RNA, various ligands, and ions. The new prediction method shows a minimum 50% improvement in accuracy for protein interactions with other molecules compared to existing methods.",
        "snippets": [
          "The inclusion of metagenomic data has improved the quality of the prediction of MSAs. One of the biggest sources of the training data was the custom-built Big Fantastic Database (BFD) of 65,983,866 protein families, represented as MSAs and hidden Markov models (HMMs), covering 2,204,359,010 protein sequences from reference databases, metagenomes, and metatranscriptomes. AlphaFold 2's results at CASP14 were described as \"astounding\" and \"transformational\"."
        ],
        "title": "AlphaFold - Wikipedia",
        "meta": {
          "query": "How does AlphaFold 3 improved stability and functionality of proteins",
          "question": "Highlight the specific implications of AlphaFold 3's enhanced predictive accuracy on designing novel proteins with improved stability and functionality.",
          "placement": "root -> Impact -> Scientific community -> How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry? -> Implications of AlphaFold 3 on Protein Design"
        },
        "citation_uuid": 63
      },
      "64": {
        "url": "https://blog.google/technology/ai/google-deepmind-isomorphic-alphafold-3-ai-model/",
        "description": "Our new AI model AlphaFold 3 can predict the structure and interactions of all life\u2019s molecules with unprecedented accuracy.",
        "snippets": [
          "Isomorphic Labs is using AlphaFold 3 to accelerate and improve the success of drug design \u2014 by helping understand how to approach new disease targets, and developing novel ways to pursue existing ones that were previously out of reach. 8AW3 - RNA modifying protein: AlphaFold 3\u2019s prediction for a molecular complex featuring a protein (blue), a strand of RNA (purple), and two ions (yellow) closely matches the true structure (gray)."
        ],
        "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
        "meta": {
          "query": "AlphaFold 3 enhanced predictive accuracy implications on designing novel proteins",
          "question": "Highlight the specific implications of AlphaFold 3's enhanced predictive accuracy on designing novel proteins with improved stability and functionality.",
          "placement": "root -> Comparisons -> AlphaFold 3 vs previous versions predictive accuracy comparison"
        },
        "citation_uuid": 64
      },
      "65": {
        "url": "https://www.pharmavoice.com/news/google-alphafold-3-drug-discovery-pharma-buzz/716496/",
        "description": "The \u201cNobel Prize-worthy invention\u201d could be worth hundreds of billions commercially \u2014 and have a deep impact on drug R&D.",
        "snippets": [
          "AlphaFold 3\u2019s capabilities, outlined in the journal Nature, build on two of its earlier AI models, enabling drug developers to quickly identify promising targets, potentially slashing the time to market by years. Earlier versions of AlphaFold spurred a leap forward in drug development by rapidly and accurately predicting 3-D protein structures, a decades-long problem that had vexed computational biologists seeking to understand how shape affects protein function as a disease indicator."
        ],
        "title": "Why AlphaFold 3 is stirring up so much buzz in pharma | PharmaVoice",
        "meta": {
          "query": "AlphaFold 3 disease targets pharmaceutical industry",
          "question": "Request additional information on the potential impact of AlphaFold 3 on accelerating drug discovery processes and identifying new disease targets in the pharmaceutical industry.",
          "placement": "root -> Impact -> Drug discovery"
        },
        "citation_uuid": 65
      },
      "66": {
        "url": "https://blog.google/technology/ai/google-deepmind-isomorphic-alphafold-3-ai-model/",
        "description": "Using AlphaFold 3 in combination ... projects as well as with pharmaceutical partners. Isomorphic Labs is using AlphaFold 3 to accelerate and improve the success of drug design \u2014 by helping understand how to approach new disease targets, and developing novel ways to pursue ...",
        "snippets": [
          "Using AlphaFold 3 in combination with a complementary suite of in-house AI models, Isomorphic Labs is working on drug design for internal projects as well as with pharmaceutical partners. Isomorphic Labs is using AlphaFold 3 to accelerate and improve the success of drug design \u2014 by helping understand how to approach new disease targets, and developing novel ways to pursue existing ones that were previously out of reach."
        ],
        "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
        "meta": {
          "query": "AlphaFold 3 disease targets pharmaceutical industry",
          "question": "Request additional information on the potential impact of AlphaFold 3 on accelerating drug discovery processes and identifying new disease targets in the pharmaceutical industry.",
          "placement": "root -> Impact -> Drug discovery"
        },
        "citation_uuid": 66
      },
      "67": {
        "url": "https://www.isomorphiclabs.com/articles/rational-drug-design-with-alphafold-3",
        "description": "This builds upon Google DeepMind\u2019s ... with AlphaFold 2, to now include how multiple proteins, DNA, RNA, and small molecule ligands come together and interact, as well as predicting the structural impact of post-translational modifications and ions on these molecular systems. This model is a powerful unified framework for structure prediction, encompassing unprecedented breadth and accuracy. ... This breakthrough opens up exciting possibilities for drug discovery, allowing ...",
        "snippets": [
          "This builds upon Google DeepMind\u2019s foundational work of predicting the structure of proteins with AlphaFold 2, to now include how multiple proteins, DNA, RNA, and small molecule ligands come together and interact, as well as predicting the structural impact of post-translational modifications and ions on these molecular systems. This model is a powerful unified framework for structure prediction, encompassing unprecedented breadth and accuracy. ... This breakthrough opens up exciting possibilities for drug discovery, allowing us to rationally develop therapeutics against targets that were previously difficult or deemed intractable to modulate."
        ],
        "title": "Rational drug design with AlphaFold 3 - Isomorphic Labs",
        "meta": {
          "query": "AlphaFold 3 impact on drug discovery",
          "question": "Request additional information on the potential impact of AlphaFold 3 on accelerating drug discovery processes and identifying new disease targets in the pharmaceutical industry.",
          "placement": "root -> Impact -> Scientific community -> Benefits of AlphaFold 3 in drug discovery -> Accelerating drug discovery processes"
        },
        "citation_uuid": 67
      },
      "68": {
        "url": "https://blog.google/technology/ai/google-deepmind-isomorphic-alphafold-3-ai-model/",
        "description": "This new window on the molecules ... actions of drugs, the production of hormones and the health-preserving process of DNA repair. The impacts of AlphaFold 3 and our free AlphaFold Server will be realized through how they empower scientists to accelerate discovery across open ...",
        "snippets": [
          "This new window on the molecules of life reveals how they\u2019re all connected and helps understand how those connections affect biological functions \u2014 such as the actions of drugs, the production of hormones and the health-preserving process of DNA repair. The impacts of AlphaFold 3 and our free AlphaFold Server will be realized through how they empower scientists to accelerate discovery across open questions in biology and new lines of research."
        ],
        "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
        "meta": {
          "query": "AlphaFold 3 impact on drug discovery",
          "question": "Request additional information on the potential impact of AlphaFold 3 on accelerating drug discovery processes and identifying new disease targets in the pharmaceutical industry.",
          "placement": "root -> Impact -> Scientific community -> Benefits of AlphaFold 3 in drug discovery -> Accelerating drug discovery processes"
        },
        "citation_uuid": 68
      },
      "69": {
        "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11292590/",
        "description": "This expansion is crucial for drug discovery as it includes many drugs under the ligand category. Additionally, AlphaFold 3 can model chemical modifications to these molecules, which play a significant role in the healthy functioning of cells. Disruptions in these processes can lead to disease, thus highlighting the model's potential in understanding and addressing medical conditions [9-11]. Impact ...",
        "snippets": [
          "This expansion is crucial for drug discovery as it includes many drugs under the ligand category. Additionally, AlphaFold 3 can model chemical modifications to these molecules, which play a significant role in the healthy functioning of cells. Disruptions in these processes can lead to disease, thus highlighting the model's potential in understanding and addressing medical conditions [9-11]. Impact on Drug Discovery and Biological Understanding"
        ],
        "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
        "meta": {
          "query": "AlphaFold 3 impact on drug discovery",
          "question": "Request additional information on the potential impact of AlphaFold 3 on accelerating drug discovery processes and identifying new disease targets in the pharmaceutical industry.",
          "placement": "root -> Impact -> Scientific community -> Benefits of AlphaFold 3 in drug discovery -> Accelerating drug discovery processes"
        },
        "citation_uuid": 69
      },
      "70": {
        "url": "https://time.com/6975934/google-deepmind-alphafold-3-ai/",
        "description": "The innovative AI model, announced on May 8, is likely to dramatically accelerate biological research.",
        "snippets": [
          "In 2021, Google parent company Alphabet announced the creation of Isomorphic Labs, which aims to take an AI-first approach to drug discovery. Researchers from Isomorphic Labs contributed to the development of AlphaFold 3 and, while AlphaFold Server can be used by anyone from non-commercial research, researchers at Isomorphic Labs will have exclusive access to AlphaFold 3 for commercial use."
        ],
        "title": "Google DeepMind\u2019s AlphaFold 3 Could Transform Drug Discovery",
        "meta": {
          "query": "AlphaFold 3 impact on drug discovery",
          "question": "Request additional information on the potential impact of AlphaFold 3 on accelerating drug discovery processes and identifying new disease targets in the pharmaceutical industry.",
          "placement": "root -> Impact -> Scientific community -> Benefits of AlphaFold 3 in drug discovery -> Accelerating drug discovery processes"
        },
        "citation_uuid": 70
      },
      "71": {
        "url": "https://www.drugdiscoverytrends.com/laying-groundwork-alphafold-3-drug-discovery/",
        "description": "With the right approach, AlphaFold 3 promises to streamline drug discovery with advanced biomolecular predictions.",
        "snippets": [
          "Despite this challenge and the significant costs of building the necessary foundation, AlphaFold is an order of magnitude \u2014 or two \u2014 less expensive than traditional methods in medicinal chemistry. \u201cWe\u2019re talking about a completely game-changing technology as far as drug discovery is concerned,\u201d Bangert said."
        ],
        "title": "Laying the groundwork to tap AlphaFold 3's potential in drug ...",
        "meta": {
          "query": "AlphaFold 3 impact on drug discovery",
          "question": "Request additional information on the potential impact of AlphaFold 3 on accelerating drug discovery processes and identifying new disease targets in the pharmaceutical industry.",
          "placement": "root -> Impact -> Scientific community -> Benefits of AlphaFold 3 in drug discovery -> Accelerating drug discovery processes"
        },
        "citation_uuid": 71
      },
      "72": {
        "url": "https://pubs.rsc.org/en/content/articlelanding/2023/sc/d2sc05709c",
        "description": "The application of artificial intelligence (AI) has been considered a revolutionary change in drug discovery and development. In 2020, the AlphaFold computer program predicted protein structures for the whole human genome, which has been considered a remarkable breakthrough in both AI applications ...",
        "snippets": [
          "b Insilico Medicine Kong Kong Ltd, Unit 310, 3/F, Building 8W, Phase 2, Hong Kong Science Park, Pak Shek Kok, Hong Kong, China"
        ],
        "title": "AlphaFold accelerates artificial intelligence powered drug discovery: ...",
        "meta": {
          "query": "AlphaFold 3 impact on drug discovery",
          "question": "Request additional information on the potential impact of AlphaFold 3 on accelerating drug discovery processes and identifying new disease targets in the pharmaceutical industry.",
          "placement": "root -> Impact -> Scientific community -> Benefits of AlphaFold 3 in drug discovery -> Accelerating drug discovery processes"
        },
        "citation_uuid": 72
      },
      "73": {
        "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
        "description": "Isomorphic Labs leverages AlphaFold 3 in collaboration with pharmaceutical partners to enhance drug design processes [6]. This partnership approach not only accelerates drug development cycles but also ensures that new treatments are both innovative and effective, addressing previously intractable ...",
        "snippets": [
          "Isomorphic Labs leverages AlphaFold 3 in collaboration with pharmaceutical partners to enhance drug design processes . This partnership approach not only accelerates drug development cycles but also ensures that new treatments are both innovative and effective, addressing previously intractable disease targets."
        ],
        "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
        "meta": {
          "query": "AlphaFold 3 partnerships",
          "question": "please provider some strategies or partnerships",
          "placement": "root -> Impact -> Scientific community -> How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry? -> Partnerships for AlphaFold 3 Integration"
        },
        "citation_uuid": 73
      },
      "74": {
        "url": "https://www.drugdiscoverytrends.com/laying-groundwork-alphafold-3-drug-discovery/",
        "description": "Thanks to AlphaFold, startups with roughly $5\u201310 million in VC funding have \u201ca realistic chance at developing a new drug,\u201d which can be sufficient to cover the costs of infrastructure, talent acquisition and initial research. But Big Pharma companies tend to accumulate vast datasets over the years while forging partnerships ...",
        "snippets": [
          "Thanks to AlphaFold, startups with roughly $5\u201310 million in VC funding have \u201ca realistic chance at developing a new drug,\u201d which can be sufficient to cover the costs of infrastructure, talent acquisition and initial research. But Big Pharma companies tend to accumulate vast datasets over the years while forging partnerships with organizations."
        ],
        "title": "Laying the groundwork to tap AlphaFold 3's potential in drug ...",
        "meta": {
          "query": "AlphaFold 3 partnerships",
          "question": "please provider some strategies or partnerships",
          "placement": "root -> Impact -> Scientific community -> How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry? -> Partnerships for AlphaFold 3 Integration"
        },
        "citation_uuid": 74
      },
      "75": {
        "url": "https://blog.google/technology/ai/google-deepmind-isomorphic-alphafold-3-ai-model/",
        "description": "We also participated in community-wide ... 3\u2019s launch. AlphaFold Server reflects our ongoing commitment to share the benefits of AlphaFold, including our free database of 200 million protein structures. We\u2019ll also be expanding our free AlphaFold education online course with EMBL-EBI and partnerships with organizations ...",
        "snippets": [
          "We also participated in community-wide forums and discussions ahead of AlphaFold 3\u2019s launch. AlphaFold Server reflects our ongoing commitment to share the benefits of AlphaFold, including our free database of 200 million protein structures. We\u2019ll also be expanding our free AlphaFold education online course with EMBL-EBI and partnerships with organizations in the Global South to equip scientists with the tools they need to accelerate adoption and research, including on underfunded areas such as neglected diseases and food security."
        ],
        "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
        "meta": {
          "query": "AlphaFold 3 partnerships",
          "question": "please provider some strategies or partnerships",
          "placement": "root -> Impact -> Scientific community -> How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry? -> Partnerships for AlphaFold 3 Integration"
        },
        "citation_uuid": 75
      },
      "76": {
        "url": "https://www.labiotech.eu/in-depth/alpha-fold-3-drug-discovery/",
        "description": "The withholding of the code was largely down to commercial reasons, as co-developer Isomorphic Labs, a DeepMind spinoff company, is using AlphaFold3 internally to speed up its drug discovery efforts. The company currently has partnerships potentially worth $3 billion with Eli Lilly and Novartis ...",
        "snippets": [
          "The withholding of the code was largely down to commercial reasons, as co-developer Isomorphic Labs, a DeepMind spinoff company, is using AlphaFold3 internally to speed up its drug discovery efforts. The company currently has partnerships potentially worth $3 billion with Eli Lilly and Novartis aimed at developing multiple drugs."
        ],
        "title": "Can AlphaFold3's open-source platform revolutionize the way we ...",
        "meta": {
          "query": "AlphaFold 3 partnerships",
          "question": "please provider some strategies or partnerships",
          "placement": "root -> Impact -> Scientific community -> How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry? -> Partnerships for AlphaFold 3 Integration"
        },
        "citation_uuid": 76
      },
      "77": {
        "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
        "description": "This capability is instrumental ... treatments and vaccines [23,24]. By modeling these interactions with high accuracy, AlphaFold 3 aids in the development of therapeutic strategies that are finely tuned to the nuances of immune system behavior [8]....",
        "snippets": [
          "This capability is instrumental in advancing our understanding of how diseases like COVID-19 can be combated through the immune system, potentially leading to more effective treatments and vaccines . By modeling these interactions with high accuracy, AlphaFold 3 aids in the development of therapeutic strategies that are finely tuned to the nuances of immune system behavior ."
        ],
        "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
        "meta": {
          "query": "AlphaFold 3 strategies",
          "question": "please provider some strategies or partnerships",
          "placement": "root -> Impact -> Scientific community -> How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry? -> Strategies for AlphaFold 3 Integration"
        },
        "citation_uuid": 77
      },
      "78": {
        "url": "https://blog.google/technology/ai/google-deepmind-isomorphic-alphafold-3-ai-model/",
        "description": "Our new AI model AlphaFold 3 can predict the structure and interactions of all life\u2019s molecules with unprecedented accuracy.",
        "snippets": [
          "We hope AlphaFold 3 will help transform our understanding of the biological world and drug discovery. Scientists can access the majority of its capabilities, for free, through our newly launched AlphaFold Server, an easy-to-use research tool."
        ],
        "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
        "meta": {
          "query": "AlphaFold 3 strategies",
          "question": "please provider some strategies or partnerships",
          "placement": "root -> Impact -> Scientific community -> How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry? -> Strategies for AlphaFold 3 Integration"
        },
        "citation_uuid": 78
      },
      "79": {
        "url": "https://deepmind.google/technologies/alphafold/",
        "description": "AlphaFold has revealed millions of intricate 3D protein structures, and is helping scientists understand how all of life\u2019s molecules interact.",
        "snippets": [
          "Made from long chains of amino acids, each has a unique complex 3D structure. But figuring out just one of these can take several years, and hundreds of thousands of dollars. In 2020, AlphaFold solved this problem, with the ability to predict protein structures in minutes, to a remarkable degree of accuracy."
        ],
        "title": "AlphaFold - Google DeepMind",
        "meta": {
          "query": "AlphaFold 3 strategies",
          "question": "please provider some strategies or partnerships",
          "placement": "root -> Impact -> Scientific community -> How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry? -> Strategies for AlphaFold 3 Integration"
        },
        "citation_uuid": 79
      },
      "80": {
        "url": "https://blog.google/technology/ai/how-we-built-alphafold-3/",
        "description": "In order to get AlphaFold 3 to work with this much wider range of biomolecules, the team vastly expanded the data that the newer model was trained on to include DNA, RNA, small molecules and more. \u201cWe were able to say, \u2018Let's just train on everything that exists in this dataset that helped ...",
        "snippets": [
          "In order to get AlphaFold 3 to work with this much wider range of biomolecules, the team vastly expanded the data that the newer model was trained on to include DNA, RNA, small molecules and more. \u201cWe were able to say, \u2018Let's just train on everything that exists in this dataset that helped us so much with proteins and let\u2019s see how far we can get,\u2019\u201d Lindsay says."
        ],
        "title": "How we built AlphaFold 3 to predict the structure and interaction ...",
        "meta": {
          "query": "AlphaFold 3 strategies",
          "question": "please provider some strategies or partnerships",
          "placement": "root -> Impact -> Scientific community -> How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry? -> Strategies for AlphaFold 3 Integration"
        },
        "citation_uuid": 80
      },
      "81": {
        "url": "https://www.nature.com/articles/s41586-024-07487-w",
        "description": "AlphaFold 3 has a substantially updated architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and modified residues with greatly improved accuracy over many previous specialized tools.",
        "snippets": [
          "The introduction of AlphaFold 21 has spurred a revolution in modelling the structure of proteins and their interactions, enabling a huge range of applications in protein modelling and design2\u20136. Here we describe our AlphaFold 3 model with a substantially updated diffusion-based architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and modified residues."
        ],
        "title": "Accurate structure prediction of biomolecular interactions with ...",
        "meta": {
          "query": "AlphaFold 3 strategies",
          "question": "please provider some strategies or partnerships",
          "placement": "root -> Impact -> Scientific community -> How do you envision the integration of AlphaFold 3 technology in the drug discovery process in the pharmaceutical industry? -> Strategies for AlphaFold 3 Integration"
        },
        "citation_uuid": 81
      }
    },
    "info_hash_to_uuid_dict": {
      "1367227104119470298": 1,
      "2019811102681643787": 2,
      "168674979033325200": 3,
      "935378041759127237": 4,
      "829485796144487607": 5,
      "327432842267338818": 6,
      "1310336336320428652": 7,
      "1776106162096348908": 8,
      "2243450519564160689": 9,
      "1380686372565698305": 10,
      "887148751624439707": 11,
      "1940915866457205986": 12,
      "1026449628329044350": 13,
      "1201118247825878125": 14,
      "1500729620398230959": 15,
      "86008172028054637": 16,
      "1102519162795974981": 17,
      "799257493743556638": 18,
      "216126017133533855": 19,
      "1610957081566556042": 20,
      "1391499452525220665": 21,
      "1605202816183069917": 22,
      "1179875011237593239": 23,
      "283141893795405414": 24,
      "2230591548759818768": 25,
      "1650353332679088516": 26,
      "1445646760671060954": 27,
      "489414094925877955": 28,
      "20545682550823922": 29,
      "444304702799418269": 30,
      "630326475381905976": 31,
      "2133264746941817912": 32,
      "1639489915396612144": 33,
      "1150055936742537516": 34,
      "1709359795182279030": 35,
      "325972126265780044": 36,
      "1675367026913149205": 37,
      "1721066040299556580": 38,
      "1668862139010624367": 39,
      "213096443444565965": 40,
      "1808354193318283550": 41,
      "1268902640962244402": 42,
      "1979718018374499270": 43,
      "1728303152733888595": 44,
      "1679217525834190967": 45,
      "1753068891512826752": 46,
      "247883035752055178": 47,
      "1519077579597808066": 48,
      "1423283567008615577": 49,
      "1493950817587776674": 50,
      "88043093251930204": 51,
      "1806211273719339437": 52,
      "132277161274454640": 53,
      "904125520088964619": 54,
      "2131624898936833413": 55,
      "2137454036061108933": 56,
      "1592916202052541682": 57,
      "1945709786140808513": 58,
      "1055688159476984729": 59,
      "2212026348233357780": 60,
      "49562536444255835": 61,
      "564167769933514612": 62,
      "711363100185630506": 63,
      "1893513152849468993": 64,
      "1564709500804941333": 65,
      "188664816787588623": 66,
      "1210317418213862778": 67,
      "1369135788163957958": 68,
      "777024002489064733": 69,
      "1472697778355028968": 70,
      "1455562775735756007": 71,
      "1458780935384235511": 72,
      "1412290003278113304": 73,
      "1218857709705791018": 74,
      "745655825769459374": 75,
      "439846198800351474": 76,
      "258544137115001767": 77,
      "1625086861768193833": 78,
      "417137837860403586": 79,
      "1884599491456043637": 80,
      "1684273619373156244": 81
    }
  }
}